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Recent	   studies	   into	   the	   stringent	   response	   and	   the	   discovery	   of	   a	   number	   of	   RNA	  
polymerase	  binding	  proteins	  suggests	  that	  the	  model	  for	  bacterial	  transcription	  initiation	  
in	  Actinobacteria	  may	  differ	  from	  that	  in	  Escherichia	  coli.	  	  In	  E.	  coli,	  the	  alarmone	  ppGpp,	  
together	  with	  DksA,	  binds	  to	  RNA	  polymerase	  to	  elicit	  the	  stringent	  response.	  	  However,	  
the	  ppGpp	  binding	  site	  on	  RNA	  polymerase	  is	  not	  conserved	  in	  S.	  coelicolor,	  although	  the	  
organism	  possesses	  a	  DksA	  homologue.	  	  Deletion	  of	  DksA	  did	  not	  affect	  the	  growth	  and	  
development	   of	   S.	   coelicolor,	   although	   its	   overexpression	   stimulated	   antibiotic	  
production.	  	  Evidence	  is	  presented	  that	  suggests	  that	  this	  occurs	  through	  binding	  to	  the	  
RNA	  polymerase	  secondary	  channel.	  	  The	  biological	  role	  of	  this	  protein	  remains	  unknown.	  	  
CarD	  and	  RbpA	  are	  two	  RNA	  polymerase-­‐binding	  proteins	  present	  in	  all	  Actinobacteria,	  
including	  S.	  coelicolor	  and	  M.	  tuberculosis.	  	  Both	  proteins	  are	  critical	  for	  growth	  and	  have	  
been	   identified	   as	   transcriptional	   activators	   from	   σHrdB-­‐dependent	   promoters	   in	   vitro.	  	  
Here	   it	   was	   demonstrated	   that	   CarD	   and	   RbpA	   activate	   transcription	   from	   rRNA	  
promoters	  with	  a	  poorly	  conserved	  -­‐35	  element.	  	  Surprisingly	  it	  was	  also	  found	  that	  both	  
proteins	   can	   inhibit	   transcription	   from	  synthetic	  promoters	  with	  highly	   conserved	   -­‐35	  
elements.	   	   Chromatin	   immunoprecipitation	   followed	   by	   high	   throughput	   sequencing	  
(ChIP-­‐seq)	  experiments	  revealed	  that	  CarD	  and	  RbpA	  are	  found	  exclusively	  at	  promoter	  
regions.	  	  RbpA	  is	  localised	  only	  at	  promoters	  recognised	  by	  σHrdB,	  whereas	  CarD	  also	  co-­‐
localises	  with	  the	  alternative	  sigma	  factor	  σR	  during	  oxidative	  stress	  indicating	  that	  it	  lacks	  
RNA	  polymerase	  holoenzyme	  specificity.	  	  The	  sigma	  specificity	  of	  RbpA	  was	  tested	  by	  the	  
generation	  of	  sigma	  mutants	  that	  were	  defective	  in	  binding.	  	  In	  vivo,	  in	  vitro	  and	  ChIP-­‐seq	  
data	  presented	   in	   this	   study	   suggest	   that	  CarD	  and	  RbpA	  have	  an	  overlapping	   role	   in	  
transcription	  initiation	  at	  σHrdB-­‐dependent	  promoters	  in	  S.	  coelicolor.	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1   Introduction	  
1.1   Actinobacteria	  
The	   Actinobacteria,	   one	   of	   the	   largest	   phyla	   of	   bacteria,	   are	   characterised	   as	   Gram	  
positives	  with	  a	  high	  guanine-­‐cytosine	   (GC)	  content	   ranging	   from	  51%	  to	  over	  70%	   in	  
some	  species	  of	  Streptomyces	  and	  Frankia	  (Ventura	  et	  al.,	  2007).	  	  The	  Actinobacteria	  are	  
highly	  pleomorphic,	  with	  morphologies	  ranging	  from	  coccoid	  forms	  (e.g.	  Micrococci)	  to	  
fragmenting,	   rod-­‐shaped	   forms	   (e.g.	  Nocardia)	   to	   branching,	   filamentous	   forms	   (e.g.	  
Streptomyces)	  (Tortora	  et	  al.,	  2012).	  	  They	  are	  found	  in	  a	  diverse	  range	  of	  environments	  
from	  soil	  and	  aquatic	  environments	  (e.g.	  Streptomyces,	  Rhodococci)	  as	  well	  as	  pathogens	  
(e.g.	  Mycobacteria,	   Corynebacteria,	   Nocardia)	   and	   gastrointestinal	   commensals	   (e.g.	  
Bifidobacteria).	  
1.1.1   Streptomyces	  
Within	   the	   Actinobacteria	   exists	   a	   group	   of	  mycelial	   bacteria	   including	   Streptomyces,	  
Frankia,	  Nocardia	  and	  Actinomyces	  species	  informally	  known	  as	  the	  actinomycetes,	  due	  
to	  their	  branching,	  filamentous	  morphology.	  	  The	  most	  studied	  and	  best-­‐characterised	  
members	  of	  this	  group	  are	  the	  soil-­‐dwelling	  streptomycetes.	  
Unlike	  the	  vast	  majority	  of	  bacteria,	  Streptomyces	  exhibit	  a	  complex	  multicellular	  lifestyle.	  	  
For	  a	  number	  of	  years,	  the	  true	  phylogeny	  of	  Streptomyces	  genus	  was	  unknown.	  	  Their	  
lifestyle	   is	   similar	   to	   filamentous	   fungi	   and	   they	   were	   originally	   considered	   an	  
intermediate	   between	   fungi	   and	   bacteria	   (Hopwood,	   1999).	   	   Evidence	   of	   this	  
misunderstanding	  is	  still	  present	  in	  the	  name	  “Streptomyces”	  which	  translates	  to	  “twisted	  
or	  chain-­‐like	  fungus”.	  	  Closer	  observations	  of	  the	  organism,	  for	  instance	  the	  discovery	  of	  
a	  bacterial	  cell	  wall	  and	  the	  susceptibility	  to	  a	  number	  of	  antibacterial	  compounds,	  began	  
to	  reveal	  its	  true	  phylogeny	  as	  a	  bacterium.	  	  The	  issue	  was	  concluded	  following	  electron	  
microscopy	   studies	   on	   germinated	   Streptomyces	   spores	   revealing	   the	   absence	   of	   a	  
nuclear	  membrane	  making	  them	  by	  definition	  prokaryotes	  (Hopwood	  and	  Glauert,	  1960).	  
One	   reason	   for	   such	   interest	   in	   this	   group	   of	   bacteria	   is	   their	   ability	   to	   thrive	   in	   a	  
challenging	  environment	  as	  complex	  and	  variable	  as	  soil.	  	  They	  are	  an	  essential	  member	  
of	  the	  ecosystem	  due	  to	  their	  ability	  to	  degrade	  insoluble	  compounds	  such	  as	  chitin	  and	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lignocellulose	  from	  the	  remains	  of	  other	  organisms.	  	  This	  can	  be	  attributed	  to	  their	  ability	  
to	  secrete	  proteins	  such	  as	  extracellular	  enzymes	  and	  import	  the	  degraded	  products	  as	  a	  
major	  source	  of	  nutrients	  (reviewed	  by	  Chater	  et	  al.	  2010).	  	  In	  addition	  to	  these	  systems,	  
they	   are	  metabolically	   highly	   adapted	   to	  exist	   in	   an	  oligotrophic	   environment.	   	   Soil	   is	  
typically	   rich	   in	   carbon	   but	   nitrogen	   and	   phosphate-­‐poor,	   and	   streptomycetes	   are	  
adapted	  to	  exploit	  this	  (Hodgson,	  2000).	  	  	  For	  example,	  streptomycetes	  typically	  invest	  in	  
a	  number	  of	  carbohydrate	  catabolic	  pathways	  which	  reflects	   the	  presence	  of	  multiple	  
carbon	  sources	  within	  the	  soil	  (Hodgson,	  2000).	  
Another	   feature	   of	   streptomycetes	   that	   allow	   them	   to	   survive	   in	   this	   challenging	  
environment	  is	  their	  ability	  to	  produce	  and	  secrete	  an	  array	  of	  bioactive	  compounds	  or	  
“antibiotics”	  that	  may	  inhibit	  the	  growth	  of	  competing	  organisms	  and	  provide	  a	  selective	  
advantage	   in	   the	   local	   environment.	   	   This	   phenomenon,	   first	   identified	   by	   Alexander	  
Fleming	  in	  his	  study	  of	  Penicillium	  bacteria	  and	  the	  effects	  of	  beta-­‐lactam	  antibiotics,	  was	  
further	   studied	   in	   actinomycete	   species	   by	   Selman	   Waksman.	   	   Unlike	   Fleming,	   who	  
discovered	   the	   inhibitory	   properties	   of	   penicillin	   by	   chance	   after	   accidental	  
contamination	  of	  a	  Staphylococcus	  plate	  by	  an	  airborne	  mould,	  Waksman	  took	  a	  more	  
systematic	   approach,	   screening	   the	   inhibitory	   effect	   of	   thousands	   of	   soil	   isolates	   on	  
pathogenic	   bacteria	   (Waksman	   and	   Lechevalier,	   1951).	   	   Through	   this	   approach,	  
Waksman	  and	  his	  colleagues	  at	  Rutgers	  University	  isolated	  as	  many	  as	  15	  novel	  antibiotics	  
throughout	   the	   1940s.	   	   The	   first	   antibiotic	   to	   be	   isolated	   through	   this	   method	   was	  
actinomycin	  from	  the	  strain	  Actinomyces	  antibioticus	   (Waksman	  and	  Woodruff,	  1941).	  	  
Further	  work	  yielded	  the	  discovery	  of	  streptomycin	  from	  Streptomyces	  griseus,	  the	  first	  
antibiotic	  active	  against	  tuberculosis	  for	  which	  Waksman	  won	  a	  Nobel	  prize	  (Schatz	  et	  al.,	  
1944).	  	  Since	  this	  work	  started	  by	  Waksman,	  Streptomyces	  species	  have	  been	  responsible	  
for	  the	  discovery	  of	  up	  to	  two	  thirds	  of	  the	  clinically	  useful	  natural	  product	  antibiotics	  in	  
use	  today	  and	  consequently	  this	  remains	  one	  of	  the	  major	  reasons	  for	  research	  into	  the	  
genus	  (Bentley	  et	  al.,	  2002).	  
In	  addition	  to	  these	  compounds	  secreted	  by	  streptomycetes	  and	  other	  actinomycetes,	  
they	  have	  also	  been	  identified	  as	  the	  producers	  of	  the	  potent	  chemical	  geosmin	  that	  gives	  
soil	  its	  “earthy”	  odour	  (Gerber	  and	  Lechevalier,	  1965).	  	  Whilst	  a	  number	  of	  theories	  exist	  
for	  the	  importance	  of	  this	  chemical,	  its	  true	  function	  remains	  unknown.	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Streptomyces	  coelicolor	  A3(2)	  
Streptomyces	  coelicolor	  (A3)2	  is	  the	  most	  widely	  studied	  and	  the	  model	  organism	  for	  the	  
Streptomyces	  genus.	   	  First	  genetic	  studies	  on	  the	   isolate	  were	  published	   in	  the	  1950s,	  
originally	  characterised	  and	  named	  “coelicolor”	  after	  its	  ability	  to	  produce	  a	  bright	  blue	  
pigment,	  later	  identified	  as	  the	  polyketide	  antibiotic	  actinorhodin	  (Sermonti	  and	  Spada-­‐
Sermonti,	  1955)	  (Figure	  1.1A).	  In	  2002	  its	  8.7	  Mb	  genome	  was	  sequenced	  (Bentley	  et	  al.,	  
2002).	  	  The	  genome	  has	  a	  high	  GC	  content	  (72.1	  %)	  predicted	  to	  encode	  7,825	  coding	  
sequences	   on	   a	   single	   linear	   chromosome.	   	   This	   linear	   chromosome	   has	   a	   centrally	  
located	  origin	  of	  replication	  (oriC)	  and	  terminal	   inverted	  repeats	  (TIRs)	  with	  covalently	  
bound	  terminal	  proteins	  (TPs)	  at	  the	  5’	  ends	  of	  the	  chromosome	  (Bentley	  et	  al.,	  2002).	  	  
In	   addition	   to	   this	   large	   linear	   chromosome	   the	   organism	   possesses	   two	   additional	  
plasmids:	   the	   356	   kb	   linear	   SCP1	   and	   the	   31	   kb	   circular	   SCP2	   (Kinashi	   and	   Shimaji-­‐
Murayama,	   1991;	   Haug	   et	   al.,	   2003).	   	   The	   most	   commonly	   used	   strain,	   M145,	   is	   a	  
prototrophic	  derivative	  of	  S.	  coelicolor	  A3(2)	  lacking	  both	  SCP1	  and	  SCP2	  plasmids	  (Chater	  
et	  al.,	  1982).	  
	  
Figure	  1.1	  -­‐	  Colonies	  of	  S.	  coelicolor	  producing	  actinorhodin	  and	  coelimycin.	   	   (A)	  Colonies	  of	  S.	  coelicolor	  producing	  
actinorhodin	   (ACT).	   	   Photo	   by	   Mervyn	   Bibb	   and	   Andrew	   Davis	   (John	   Innes	   Centre).	   	   (B)	   Close	   up	   of	   S.	  coelicolor	  
producing	  coelimycin	  (CPK).	  	  Photo	  by	  Marco	  Gottelt	  (University	  of	  Groningen).	  




S.	  coelicolor	  life	  cycle	  and	  regulation	  
The	  life	  cycle	  of	  S.	  coelicolor	  (and	  indeed	  most	  streptomycetes)	  begins	  with	  formation	  of	  
a	   vegetative,	   multinucleate	   mycelium	   that	   colonises	   the	   local	   environment.	   	   Once	   a	  
feeding	  substrate	  has	  been	  established,	  the	  mycelium	  differentiates	  into	  aerial	  hyphae	  
that	   grow	   upwards	   from	   the	   surface	   into	   the	   air.	   	   These	   hyphae	   develop	   into	   coils,	  
followed	  by	  septation,	  which	   leads	   to	  production	  of	  unigenomic,	   reproductive	  spores.	  	  
Following	   environmental	   distribution,	   these	   spores	   can	   give	   rise	   to	   new	   mycelial	  
networks	  and	  the	  streptomycete	  life	  cycle	  continues.	  
	  
Figure	  1.2	  -­‐	  Developmental	  life	  cycle	  of	  S.	  coelicolor.	  	  Illustration	  of	  the	  developmental	  life	  cycle	  of	  S.	  coelicolor,	  showing	  
the	  germination	  of	  a	  spore,	  production	  of	  a	  vegetative	  and	  aerial	  hyphae	  through	  tip	  extension	  and	  branching,	  and	  the	  
process	  of	  sporulation.	  	  Figure	  adapted	  from	  Flärdh	  and	  Buttner	  (2009),	  copyright	  license	  number:	  3700341005397.	  
When	  a	  spore	  encounters	  conditions	  suitable	  for	  growth,	  germination	  occurs	  leading	  to	  
formation	  of	  one	  or	  two	  germ	  tubes	  per	  spore.	  	  Each	  germ	  tube	  grows	  by	  tip	  extension	  
and	   branching	   leading	   to	   formation	   of	   a	   vegetative,	   mycelial	   network.	   	   This	   type	   of	  
growth,	  starkly	  different	  from	  typical	  cell	  division	  observed	  in	  model	  bacteria	  such	  as	  E.	  
coli	  and	  B.	  subtilis,	  is	  a	  defining	  feature	  of	  streptomycetes.	  	  Notably,	  streptomycete	  cell	  
division	  does	  not	  require	  the	  bacterial	  actin	  homologue	  MreB	  for	  formation	  of	  a	  new	  cell	  
wall	  and	  elongation	  (Flärdh	  and	  Buttner,	  2009).	  	  In	  contrast,	  streptomycete	  cell	  growth	  











(Hempel	  et	  al.,	  2008).	  	  In	  order	  to	  grow	  apically,	  meaning	  unevenly	  from	  one	  pole,	  the	  
cell	  must	  localize	  the	  necessary	  components	  for	  cell	  wall	  biosynthesis	  to	  that	  particular	  
locus.	  	  DivIVA	  acts	  as	  the	  key	  factor	  that	  localises	  to	  the	  cell	  poles,	  interacts	  with	  the	  cell	  
membrane	  and	  acts	  as	  a	  recruitment	  factor	  for	  the	  peptidoglycan	  biosynthetic	  machinery	  
among	  other	  proteins	  which	  direct	  cell	  growth	  (Flärdh	  et	  al.,	  2012).	  	  The	  importance	  of	  
this	  protein	  was	  particular	  evident	  during	  protein	  overexpression	  experiments	  which	  led	  
to	   irregular	  growth	   including	  multiple	  sites	  of	  tip	  growth	  and	  hyper-­‐branching	  (Flärdh,	  
2003;	  Hempel	  et	  al.,	  2008).	  	  
Formation	  of	  aerial	  hyphae	  is	  complex	  and	  highly	  regulated	  by	  a	  series	  of	  genes	  known	  
as	  the	  bld	  cascade.	  	  The	  12	  bld	  genes	  were	  named	  as	  “bald”	  following	  mutagenesis	  studies	  
identifying	   their	   essentiality	   in	   formation	   of	   the	   aerial	   hyphae	   that	   give	   S.	  coelicolor	  
colonies	   their	   “fuzzy”	   colony	   morphology.	   	   SapB	   (spore	   associated	   protein	   B)	   is	   a	  
surfactant	  peptide	  absolutely	  required	  by	  S.	  coelicolor	  to	  break	  the	  surface	  tension	  of	  the	  
medium	  and	  form	  aerial	  hyphae	  (Flärdh	  and	  Buttner,	  2009).	  	  It	  is	  a	  21-­‐amino	  acid	  peptide	  
produced	  from	  the	  ramCSAB	  operon	  and	  is	  often	  described	  as	  “lantibiotic-­‐like”	  due	  to	  its	  
similarities	  to	  the	  class	  of	  ribosomally-­‐synthesised	  oligopeptide	  antibiotics	  (Kodani	  et	  al.,	  
2004).	  	  Despite	  this,	  it	  seems	  to	  have	  no	  antimicrobial	  functionality	  but	  acts	  solely	  as	  a	  
bio-­‐surfactant	  secreted	  by	  S.	  coelicolor	  that	  coats	  the	  hyphae	  in	  a	  hydrophobic	  sheath.	  	  
As	  evidence	  of	   its	   importance	   in	   formation	  of	  aerial	  hyphae	  and	  sporulation,	  mutants	  
unable	  to	  produce	  SapB	  have	  a	  pronounced	  bald	  phenotype	  under	  all	  growth	  conditions	  
(Capstick	   et	   al.,	   2007).	   	   Whilst	   all	   bld	   genes	   are	   required	   for	   production	   of	   SapB,	  
overexpression	  of	  ramR,	  the	  activator	  of	  SapB	  production,	  complements	  all	  bld	  mutants	  
(Willey	  et	  al.,	  1991;	  Nguyen	  et	  al.,	  2002).	   	  Surprisingly,	  different	  bld	  mutants	  grown	  in	  
proximity	  to	  one	  another	  are	  able	  to	  complement	  each	  other	  in	  a	  phenomenon	  known	  
as	  “bld-­‐bld	  extracellular	  complementation”	   (Willey	  et	  al.,	  1991).	   	  Together,	   these	  data	  
have	  been	  used	  to	  develop	  a	  model	  for	  an	  extracellular	  signalling	  cascade	  that	  ultimately	  
controls	  the	  production	  of	  SapB,	  inducing	  formation	  of	  aerial	  hyphae.	  
Following	  the	  formation	  of	  aerial	  hyphae,	  further	  differentiation	  occurs	  in	  the	  process	  of	  
sporulation.	  	  Similar	  to	  the	  bld	  cascade,	  a	  number	  of	  the	  genes	  identified	  as	  essential	  for	  
sporulation	   are	   named	   whi	   following	   mutagenesis	   studies	   where	   colonies	   appeared	  
white,	  arrested	  in	  the	  later	  stages	  of	  aerial	  hyphae	  formation	  and	  absent	  of	  grey	  spore	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pigment.	   	   These	  whi	   genes	   can	   be	   further	   divided	   into	   “early-­‐whi	   genes”,	   of	   which	  
mutants	  cannot	  form	  pre-­‐spore	  compartments,	  and	  “late-­‐whi	  genes”	  of	  which	  mutant	  
spores	   do	   not	   fully	   divide	   or	   produce	   grey	   spore	   pigment.	   	  whiG	   is	   the	   earliest	   gene	  
involved	  in	  the	  process	  of	  sporulation	  which	  encodes	  an	  alternative	  sigma	  factor,	  σWhiG.	  	  
Activation	  of	  this	  sigma	  factor	  is	  considered	  the	  key	  step	  for	  commitment	  to	  sporulation	  
from	  aerial	  hyphae.	  
Antibiotic	  production	  and	  regulation	  
Streptomyces	  species	  are	  responsible	  for	  producing	  over	  two-­‐thirds	  of	  natural	  product	  
antibiotics	  used	  in	  modern	  medicine	  today,	  as	  well	  many	  other	  compounds	  used	  as	  anti-­‐
fungals,	  chemotherapeutics	  and	  immunosuppressants	  (Bentley	  et	  al.,	  2002).	  	  In	  a	  period	  
of	  discovery	  in	  the	  1940s-­‐1960s	  known	  as	  the	  golden	  age	  of	  antibiotics,	  massive	  screening	  
programmes	   isolated	  as	  many	  12,000	  bioactive	  compounds,	  with	  160	  reaching	  clinical	  
markets	   (Marinelli,	  2009).	   	  Notable	  antibiotics	   isolated	  from	  Streptomyces	  and	  related	  
species	  include	  streptomycin,	  neomycin,	  vancomycin	  and	  chloramphenicol,	  with	  diverse	  
targets	  and	  mechanisms	  of	  action	  including	  inhibition	  of	  protein,	  cell	  wall	  and	  DNA/RNA	  
synthesis.	   	   Screening	   bioactive	   compounds	   for	   cytotoxity	   identified	   a	   number	   of	  
compounds	  that	  are	  effective	  as	  anti-­‐cancer	  chemotherapy	  agents	  including	  doxorubicin,	  
bleomycin	  and	  mitomycin	  C,	  due	  to	  their	  ability	  to	  bind	  or	  damage	  DNA.	  
In	   producing	   strains,	   antibiotic	   biosynthetic	   genes	   are	   found	   throughout	   genomes	  
organised	  in	  large	  clusters,	  tens	  of	  kilobases	  in	  size.	  	  Conserved	  features	  and	  organisation	  
of	   such	   clusters	  has	  enabled	  mining	  and	  discovery	  of	  otherwise	  unexpressed,	   “silent”	  
biosynthetic	  operons	  (Challis,	  2008).	  	  To	  activate	  these	  otherwise	  unexpressed	  clusters	  
and	   for	   increasing	   production	   yields	   for	   industrial	   purposes,	  much	   research	   has	   been	  
invested	  into	  understanding	  the	  regulation	  of	  antibiotic	  production.	  
As	   the	  model	  organism	  for	   the	  streptomycetes,	  S.	  coelicolor	  produces	   five	  structurally	  
diverse	   antibiotics	   (Figure	   1.3).	   	   The	   blue-­‐pigmented	   polyketide	   actinorhodin	   (ACT)	  
(Wright	  and	  Hopwood,	  1976b),	  the	  red-­‐pigmented,	  tripyrrole	  undecylprodigiosin	  (RED)	  
(Rudd	  and	  Hopwood,	  1980),	  the	  nonribosomal	  lipopeptide	  calcium-­‐dependent	  antibiotic	  
(CDA)	   (Hopwood	   and	   Wright,	   1983),	   the	   cyclopentanone	   methylenomycin	   (MM)	  	  
encoded	  on	  the	  plasmid	  SCP1	  (Wright	  and	  Hopwood,	  1976a)	  and	  the	  recently	  discovered	  




Figure	   1.3	   -­‐	   Structure	   of	   five	   antibiotics	   produced	   by	   S.	   coelicolor	   A3(2).	   	   Structures	   of	   actinorhodin	   (ACT),	  
methylenomycin	  (MM),	  undecylprodigiosin	  (RED),	  calcium-­‐dependent	  antibiotic	  (CDA)	  and	  coelimycin	  (CPK).	   	  Figure	  
modified	  (with	  addition	  of	  coelimycin	  structure)	  with	  permission	  from	  Liu	  et	  al.	  (2013)	  Microbiol.	  Mol.	  Biol.	  Rev.	  vol.	  77	  
no.	  1	  112-­‐143.	  
One	   feature	  conserved	   in	  antibiotic	  biosynthetic	  operons	   is	   the	  presence	  of	  a	  cluster-­‐
situated	  regulator	  (CSR)	  which	  acts	  as	  a	  specific	  activator	  for	  transcription	  of	  the	  operon	  
and	  subsequent	  antibiotic	  production.	  	  In	  S.	  coelicolor,	  actII-­‐ORF4,	  redD	  and	  cdaR	  serve	  
as	   the	   CSR	   for	   ACT,	   RED	   and	   CDA	   synthesis,	   respectively.	   	   The	   regulation	   of	   CSR	  
transcription,	   translation	   or	   protein	   activity	   serves	   as	   a	   single	   point	   of	   regulation	   for	  
biosynthesis,	   over	  which	   a	  number	  of	   conditions,	   pathways	   and	  global	   regulators	   can	  
influence.	  	  	  
Control	   	   of	   ACT	  production	  has	   been	  widely	   studied	   and	   currently	   serves	   as	   the	  best	  
model,	   revealing	   the	   true	   complexity	   of	   regulation	   of	   antibiotic	   biosynthesis.	  	  
Transcription	  of	  actII-­‐ORF4	  is	  a	  target	  of	  at	  least	  eight	  known	  regulatory	  proteins	  (Liu	  et	  
al.,	  2013).	   	  DasR,	  a	   transcriptional	   repressor	   regulated	  by	  carbon	  and	  nitrogen	  source	  








actII-­‐ORF4	  (Rigali	  et	  al.,	  2008).	  	  When	  GlcNAc	  enters	  the	  cytoplasm,	  it	  is	  phosphorylated	  
and	  deacetylated	  to	  form	  GlcN-­‐6P,	  an	  allosteric	  inhibitor	  of	  DasR.	  	  As	  DasR	  represses	  actII-­‐
ORF4,	   the	   presence	   of	  N-­‐acetylglucosamine	   results	   in	   derepression	   of	   actII-­‐ORF4	   and	  
stimulates	   actinorhodin	   synthesis.	   	   Curiously	   and	   inconsistent	   with	   the	   known	   DasR	  
system,	  this	  effect	  is	  only	  observed	  on	  minimal	  media,	  whilst	  presence	  of	  GlcNAc	  on	  rich	  
media	  has	  the	  opposite	  effect	  (Rigali	  et	  al.,	  2008).	  	  	  
Other	  known	  positive	  and	  negatives	  regulators	  that	  directly	  feed	  into	  regulation	  of	  ACT	  
production	  through	  actII-­‐ORF4	  include	  AbsA2,	  AdpA,	  LexA,	  DraR,	  AfsQ1,	  AtrA,	  GlnR	  and	  
ROK7B7	  (reviewed	  by	  Liu	  et	  al.,	  2013).	  	  	  
1.1.2   Mycobacteria	  
The	  mycobacteria	  are	  another	  well-­‐studied	  genus	  of	  bacteria	  within	  the	  actinobacteria.	  	  
They	   are	   strictly	   aerobic	   and	   typically	   rod-­‐shaped	   although,	   as	   the	   prefix	   “myco-­‐“	  
suggests,	   can	   sometimes	  exhibit	   filamentous	   fungus-­‐like	  morphologies	   (Tortora	   et	   al.,	  
2012).	   	   Whilst	   mycobacteria	   are	   Gram-­‐positive	   bacteria,	   they	   are	   characteristically	  
resistant	  to	  Gram	  staining	  due	  to	  a	  distinctive	   lipid-­‐rich	  cell	  wall	  and	  are	  consequently	  
known	  as	   “acid-­‐fast”	  bacteria	   (Bloch,	  1953).	   	   	   	   This	   cell	  wall	   structure	  also	  makes	   this	  
group	  of	   bacteria	   resistant	   to	   acids,	   bases,	   a	   number	  of	   other	   cellular	   stresses	   and	   is	  
largely	  the	  reason	  why	  mycobacteria	  are	  resistant	  to	  many	  antibiotics	  (Hett	  and	  Rubin,	  
2008).	   	  Whilst	  mycobacterial	   species	   can	  exist	   in	  a	  number	  of	  different	  environments	  
including	  soil	  and	  water	  sources,	  the	  better	  known	  and	  researched	  members	  of	  the	  genus	  
are	   human	   and	   animal	   pathogens	   including	  M.	   tuberculosis	   and	  M.	   leprae	   that	   cause	  
tuberculosis	  and	  leprosy,	  respectively.	  	  As	  these	  strains	  are	  pathogenic,	  slow	  growing	  and	  
difficult	  to	  work	  with	  in	  a	  laboratory	  setting,	  the	  non-­‐pathogenic,	  faster	  growing	  species	  
M.	  smegmatis	  is	  often	  used	  a	  model	  organism	  for	  the	  genus	  (Reyrat	  and	  Kahn,	  2001).	  
Mycobacterium	  tuberculosis	  
Mycobacterium	   tuberculosis	  was	   first	   identified	  as	   the	  causative	  agent	  of	   tuberculosis	  
(TB)	  by	  Robert	  Koch	   in	  1882	   (Koch,	  1882).	   	  Prior	   to	   this	   research,	  he	  established	   four	  
criteria	   for	   identifying	   the	  microorganism	   responsible	   for	  a	  disease,	   known	  as	   “Koch’s	  
Postulates”.	   	  He	   subsequently	   tested	  his	   four	  postulates	  on	  guinea	  pigs	   to	  prove	   that	  
tuberculosis	  was	  caused	  by	  M.	  tuberculosis.	  	  For	  this	  ground-­‐breaking	  research,	  he	  was	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awarded	  the	  Nobel	  Prize	  in	  Physiology	  or	  Medicine	  in	  1905	  and	  it	  is	  one	  of	  the	  reasons	  
he	  is	  considered	  the	  “founder	  of	  modern	  bacteriology”.	  
In	  1998,	  the	  4.4	  Mb	  M.	  tuberculosis	  H37Rv	  genome	  was	  sequenced	  (Cole	  et	  al.,	  1998).	  	  At	  
the	  time	  of	  its	  publication,	  it	  was	  the	  second	  largest	  bacterial	  genome	  sequenced	  after	  
E.	  coli	  K-­‐12.	  	  It	  has	  a	  high	  GC	  content	  (65.6%)	  and	  is	  predicted	  to	  encode	  3,924	  coding	  
sequences	  on	  a	  single	  circular	  chromosome.	  	  Most	  notably,	  the	  genome	  contains	  up	  to	  
250	  genes	  responsible	  for	  lipid	  metabolism.	  	  	  
Tuberculosis	   is	   one	  of	   the	  world’s	   greatest	   infectious	   killers,	   second	  only	   to	  HIV/AIDS	  
(World	  Health	  Organisation,	  2015).	  	  It	  is	  responsible	  for	  almost	  9	  million	  new	  cases	  and	  
1.7	  million	  deaths	  per	  year.	  	  Pulmonary	  infection	  typically	  occurs	  following	  inhalation	  of	  
droplets	  containing	  M.	  tuberculosis,	  spread	  from	  other	  infected	  humans,	  which	  colonise	  
the	   lungs.	   	   Following	   an	   immune	   response,	   M.	   tuberculosis	   is	   able	   to	   survive	   in	  
macrophages	  due	  to	  a	  number	  of	  survival	  mechanisms	  including	  inhibition	  of	  phagosome	  
acidification	  and	  fusion	  with	  the	  lysosome	  (reviewed	  by	  Russell,	  2007).	  	  Production	  of	  an	  
inflammatory	  response	  by	  the	  infected	  macrophage	  recruits	  additional	  immune	  cells	  and	  
results	  in	  formation	  of	  a	  granuloma,	  a	  hallmark	  of	  M.	  tuberculosis	  infection.	  	  
When	  diagnosed	  and	  where	  available,	  tuberculosis	  can	  be	  treated	  with	  antibiotics.	  	  The	  
discovery	  of	  streptomycin	  was	  a	  landmark	  event,	  making	  tuberculosis,	  often	  recalcitrant	  
to	  many	  antibiotics,	  a	   treatable	  condition.	   	  Nowadays,	   tuberculosis	   is	  managed	  with	  a	  
combination	  of	  first	  line	  drugs	  including	  ethambutol,	  isoniazid,	  pyrazinamide,	  rifampicin	  
and	  streptomycin	  (Zumla	  et	  al.,	  2013).	  	  As	  M.	  tuberculosis	  has	  a	  very	  slow	  growth	  rate,	  
doubling	  every	  24	  h,	  effective	  treatment	  with	  these	  drugs	  may	  take	  months.	  	  In	  recent	  
years,	  there	  has	  been	  an	  emergence	  of	  multi-­‐drug	  resistant	  TB	  (MDR-­‐TB),	  characterised	  
as	  resistant	  to	  at	  least	  isoniazid	  and	  rifampicin,	  and	  extensively-­‐drug	  resistant	  TB	  (XDR-­‐
TB),	  with	  additional	  resistance	  to	  fluoroquinolones	  and	  at	  least	  one	  second	  line	  injectable	  
drug	  such	  as	  amikacin,	  kanamycin,	  or	  capreomycin	  (World	  Health	  Organization,	  2010).	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1.2   Bacterial	  transcription	  
Transcription,	   a	   key	   component	   of	   the	   “central	   dogma	   of	   molecular	   biology”,	   is	   the	  
transfer	  of	  information	  from	  DNA	  to	  RNA.	  It	  is	  the	  fundamental	  first	  step	  in	  the	  process	  
of	   gene	   expression	   and	   is	   evolutionarily	   conserved	   across	   all	   known	   life	   forms.	   	   This	  
process	   of	   RNA	   synthesis	   is	   catalysed	   by	   the	   multi-­‐subunit	   enzyme	   RNA	   polymerase	  
(RNAP).	   	   Unlike	   in	   eukaryotes,	   prokaryotic	   transcription	   occurs	   in	   the	   cytoplasm	   and	  
therefore	   can	   occur	   simultaneously	   with	   translation.	   	   It	   is	   a	   process	   that	   is	   highly	  
regulated	  by	  both	   intra-­‐	  and	  extracellular	   signals	  and	   is	   consequently	   regarded	  as	   the	  
major	  focus	  of	  lifestyle	  regulation	  in	  bacteria.	  	  	  
1.2.1   Promoters	  
Upstream	   of	   every	   RNA-­‐coding	   region	   lies	   a	   section	   of	   DNA	   known	   as	   a	   promoter,	  
responsible	  for	  binding	  RNA	  polymerase	  and	  initiating	  transcription.	  	  Among	  a	  number	  of	  
features	  intrinsic	  to	  the	  DNA	  sequence,	  bacterial	  promoters	  contain	  two	  6-­‐bp	  elements	  
known	   as	   the	   -­‐10	   and	   -­‐35	   elements.	   	   The	   -­‐10	   element	   is	   located	   approximately	   7	   bp	  
upstream	  from	  the	  +1	  (the	  first	  transcribed	  base)	  and	  is	  recognised	  by	  σ	  regions	  2.3-­‐2.4	  
(see	  1.2.3	  Sigma	  Factors)	  (Dombroski	  et	  al.,	  1992;	  Feklistov	  and	  Darst,	  2011).	   	  The	  -­‐35	  
element	  is	  located	  17	  bp	  upstream	  of	  the	  -­‐10	  element	  and	  is	  recognised	  by	  σ	  region	  4.2	  
(Dombroski	  et	  al.,	  1992).	  	  The	  -­‐10	  and	  -­‐35	  consensus	  sequences	  recognised	  by	  the	  E.	  coli	  
primary	   sigma	   factor	   σ70	   have	   been	   identified	   as	   TATAAT	   and	   TTGACA,	   respectively	  
(Hawley	  and	  McClure,	  1983;	  Harley	  and	  Reynolds,	  1987).	  	  Whilst	  consensus	  sequences	  
vary	   between	  primary	   and	   alternative	   sigma	  promoters,	   studies	   in	   a	   diverse	   range	  of	  
organisms	  have	   revealed	   that	   the	   -­‐10	  and	   -­‐35	   consensus	   sequence	   for	  primary	   sigma	  
factors	   is	   largely	   conserved	   throughout	   eubacteria	   (Helmann,	   1995;	   Rodrigue	   et	   al.,	  
2006).	  	  In	  addition	  to	  recruiting	  RNA	  polymerase,	  features	  of	  the	  promoter	  including	  the	  
“spacer”	  between	  the	  -­‐10	  and	  -­‐35	  and	  elements	  upstream	  of	  the	  -­‐35	  such	  as	  the	  “UP	  
element”	  may	  have	  an	  impact	  on	  transcription	  initiation	  efficiency	  and	  consequently	  may	  
have	  a	  regulatory	  function	  (Haugen	  et	  al.,	  2008a).	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1.2.2   RNA	  polymerase	  
RNA	  polymerase	  is	  the	  central	  component	  of	  transcription	  which	  catalyses	  the	  synthesis	  
of	  RNA.	  	  In	  bacteria,	  core	  RNAP,	  capable	  in	  principle	  of	  initiating	  transcription	  at	  any	  point	  
on	  a	  DNA	  molecule,	  is	  composed	  of	  five	  subunits	  –	  two	  alpha	  subunits	  (αI	  and	  αII,	  encoded	  
by	  rpoA),	  beta	  (β,	  encoded	  by	  rpoB),	  beta	  prime	  (β’,	  encoded	  by	  rpoC)	  and	  omega	  (ω,	  
encoded	  by	  rpoZ)	  (Figure	  1.4).	  
	  
Figure	  1.4	  -­‐	  Structure	  of	  T.	  aquaticus	  RNAP	  holoenzyme	  in	  complex	  with	  promoter	  DNA.	   	  Structure	  of	  T.	  aquaticus	  
RNAP	  holoenzyme	  in	  complex	  with	  fork	  junction	  promoter	  DNA.	  	  The	  β	  subunit	  is	  green,	  the	  β’	  is	  pink,	  the	  αI,	  αII	  and	  
ω	  subunits	  are	  grey	  and	  σ70	  subunit	  is	  shown	  as	  a	  phosphate-­‐backbone	  worm.	  	  The	  fork	  junction	  DNA	  is	  green	  with	  
the	  -­‐10	  and	  -­‐35	  elements	  in	  yellow	  and	  extended	  -­‐10	  in	  red.	  	  Figure	  adapted	  from	  Murakami	  and	  Darst	  (2003),	  copyright	  
license	  number:	  3702491184886	  
Following	  many	  years	  of	  attempts	  to	  solve	  the	  structure	  of	  E.	  coli	  RNAP	  by	  a	  number	  of	  
research	  groups,	  the	  breakthrough	  came	  in	  1999	  with	  the	  publication	  of	  the	  structure	  of	  
Thermus	  aquaticus	  RNAP	  core,	  solved	  by	  X-­‐ray	  crystallography	  at	  3.3	  Å	  resolution	  (Zhang	  
et	  al.,	  1999).	  	  This	  was	  closely	  followed	  by	  the	  publication	  of	  the	  remarkably	  similar	  crystal	  
structure	  of	  RNAP	  II	  from	  the	  eukaryote	  Saccharomyces	  cerevisiae	  (Cramer	  et	  al.,	  2000).	  	  
Both	  structures	  revealed	  a	  molecule	  shaped	  like	  a	  crab	  claw,	  with	  the	  β	  and	  β’	  subunits	  
forming	  two	  “pincers”	  and	  a	  central	  catalytic	  cleft.	  	  The	  enzyme	  active	  site	  is	  located	  on	  
the	  back	  wall	  of	  the	  central	  cleft	  where	  a	  catalytically	  essential	  Mg2+	  ion	  is	  bound	  by	  3	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aspartic	  acid	  residues.	   	   	   	   In	  addition	  to	  these,	  other	  notable	  features	  highly	  conserved	  
throughout	   prokaryotes	   and	   eukaryotes	   include	   a	   large	   channel	   on	   the	   surface	   to	  
accommodate	   double	   stranded	   DNA	   either	   side	   of	   the	   transcription	   bubble,	   an	   exit	  
channel	  through	  which	  RNA	  leaves	  the	  enzyme	  and	  the	  secondary	  channel	  that	  allows	  
access	  to	  the	  active	  site	  by	  substrate	  nucleotides,	  small	  molecules	  and	  effector	  proteins.	  
Following	  the	  publication	  of	  the	  structure	  of	  bacterial	  RNAP,	   it	  was	  possible	  to	  further	  
understand	  the	  role	  of	  each	  subunit	  in	  detail.	  	  The	  α	  subunits	  are	  largely	  responsible	  for	  
initial	  assembly	  of	  the	  core	  enzyme.	   	  Two	  α	  subunits	  dimerise	  and	  subsequently	  bring	  
together	   the	   β	   and	   β’	   subunits	   through	   interactions	   with	   the	   N-­‐terminal	   domains	  
(αNTDs).	   	   The	   C-­‐terminal	   domains	   of	   the	   α	   subunits	   (αCTDs)	   are	   typically	   involved	  
interaction	   with	   upstream	   DNA	   elements	   as	   well	   as	   being	   a	   target	   on	   RNAP	   for	  
transcription	  factors	  that	  bind	  upstream	  of	  the	  -­‐10	  and	  -­‐35	  promoter	  regions	  (Hochschild	  
and	  Dove,	  1998;	  Gourse	  et	  al.,	  2000).	  	  	  
The	   β	   and	   β’	   subunits,	   are	   the	   largest	   subunits	   of	   bacterial	   RNAP	   and	   comprise	   the	  
catalytic	  core	  of	  the	  enzyme	  (Zhang	  et	  al.,	  1999).	  	  Crosslinking	  studies	  have	  identified	  that	  
both	  β	  and	  β’	  contact	  the	  template	  and	  non-­‐template	  strands	  as	  well	  as	  DNA/RNA	  hybrid	  
formed	  in	  the	  transcription	  bubble.	  	  	  
Finally,	   ω	   is	   the	   smallest	   RNAP	   subunit	   and	   although	   its	   function	   is	   not	   completely	  
understood,	  structural	  models	  have	  shown	  that	  it	  binds	  the	  N	  and	  C-­‐terminal	  ends	  of	  the	  
β’	   subunit.	   	   It	   is	   thought	   to	  have	  a	   role	   in	  RNAP	  core	  assembly	  although	  studies	  have	  
identified	  the	  ω-­‐coding	  rpoZ	  gene	  as	  non-­‐essential	  in	  a	  number	  of	  strains	  including	  E.	  coli	  
and	   S.	   coelicolor	   (Ghosh	   et	   al.,	   2001;	  Gentry	   and	   Burgess,	   1989;	   Santos-­‐Beneit	   et	   al.,	  
2011).	  	  Recent	  studies	  have	  identified	  the	  interface	  between	  ω	  and	  β’	  as	  the	  proposed	  
binding	   site	   for	   ppGpp	   in	   E.	   coli	   (Ross	   et	   al.,	   2013)	   (see	   section	   1.2.6	   The	   stringent	  
response).	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1.2.3   Sigma	  factors	  
Promoter-­‐directed	  gene	   transcription	   requires	   the	   formation	  of	   an	  RNAP	  holoenzyme	  
with	   the	   sixth	   subunit,	   sigma	   (σ)	   (Burgess	   et	   al.,	   1969).	   A	   sigma	   factor	   is	   a	   small,	  
dissociable	   RNA	   polymerase	   subunit	   that	   performs	   a	   number	   of	   distinct	   functions	  
essential	   to	   the	   process	   of	   promoter	   recognition	   and	   transcription	   initiation.	   	   Most	  
bacteria	  possess	  multiple	  sigma	  factors,	  each	  specific	  to	  a	  different	  promoter	  sequence,	  
which	  allows	   targeting	  of	  particular	   sets	  of	  genes	  or	   regulons.	   	   Following	  holoenzyme	  
formation,	  DNA	  binding	  and	  transcription	  initiation,	  the	  sigma	  factor	  dissociates	  from	  the	  
core	   in	  a	   stochastic	  manner	  as	   transcription	  elongation	  occurs	   (Raffaelle	  et	  al.,	  2005).	  	  
This	   allows	   the	   free	   sigma	  molecule	   to	   bind	   a	   different	   core	   polymerase	   and	   initiate	  
transcription	  at	  another	  locus.	  	  	  
Every	  prokaryotic	  organism	  possesses	  one	  primary	  or	  “housekeeping”	  sigma	  factor	  that	  
is	   highly	   abundant,	   constitutively	   expressed	   and	   responsible	   for	   transcription	  of	  most	  
genes	  involved	  in	  normal	  growth.	  	  In	  E.	  coli	  the	  primary	  sigma	  factor	  is	  σ70	  (although	  in	  
most	  organisms	  the	  homologue	   is	  called	  σA)	   (Figure	  1.5)	  and	  alternative	  sigma	  factors	  
consequently	  compete	  with	  this	  primary	  sigma	  factor	  for	  the	  core	  polymerase	  in	  a	  model	  
known	   as	   “sigma	   factor	   competition”	   (Farewell	   et	   al.,	   1998;	   Nyström,	   2004).	   E.	   coli	  
possesses	  seven	  sigma	  factors	  but	  more	  are	  not	  uncommon	  with	  as	  many	  as	  65	  found	  in	  
S.	   coelicolor	   (Sharma	   and	   Chatterji,	   2010;	   Bentley	   et	   al.,	   2002).	   	   As	   alternative	   sigma	  
factors	  are	  typically	  responsible	  for	  responding	  to	  environmental	  stresses	  it	  is	  generally	  
thought	  that	  possession	  of	  more	  sigma	  factors	  correlates	  with	  the	  ability	  of	  an	  organism	  
to	  exist	  in	  a	  more	  diverse	  or	  challenging	  environment	  (Mittenhuber,	  2002).	  
Sigma	   factors	   can	   be	   categorised	   into	   two	   broad	   families	   based	   on	   their	   structural	  
homology	  to	  two	  sigma	  factors	  found	  in	  E.	  coli:	  the	  aforementioned	  primary	  sigma	  factor,	  
σ70;	   and	   σ54,	   which	   performs	   the	   same	   role	   in	   directing	   transcription	   but	   shares	   no	  
domain	   organisation	   or	   sequence	   similarity	   to	   σ70,	   in	   addition	   to	   requiring	   enhancer	  
proteins	  and	  ATP	  hydrolysis	  to	  initiate	  transcription	  (Buck	  et	  al.,	  2000).	  	  Whilst	  common	  
in	  other	  bacteria,	  no	  σ54	  family	  sigma	  factors	  are	  present	  in	  S.	  coelicolor	  or	  indeed	  any	  





Figure	  1.5	  -­‐	  Structure	  of	  E.	  coli	  RNAP	  σ70	  holoenzyme.	  	  Structure	  of	  E.	  coli	  RNAP	  σ70	  holoenzyme.	  	  The	  β	  subunit	  is	  cyan,	  
the	  β’	  is	  pink,	  the	  αI,	  αII	  and	  ω	  subunits	  are	  grey	  and	  σ70	  subunit	  is	  green.	  	  Structure	  downloaded	  from	  RCSB	  PDB	  under	  
accession	  number	  4YG2	  and	  visualised	  with	  PyMOL	  (version	  1.3).	  
Sigma	   factors	   belonging	   to	   the	   σ70	   family	   can	   be	   classified	   into	   4	   groups	   based	   on	  
structure	   and	   function.	   	   Group	   I	   contains	   the	   primary	   sigma	   factors	   which	   are	   all	  
structurally	   similar	   to	  σ70	   and	  essential	   for	   function.	   	  Group	   II	   sigma	   factors	   are	  most	  
similar	  to	  primary	  sigma	  factors	  but	  are	  non-­‐essential	  for	  normal	  bacterial	  growth.	  	  Group	  
III	  sigma	  factors	  are	  less	  closely	  related	  and	  usually	  activate	  responses	  to	  general	  stress	  
and	  heat	  shock	  or	  processes	  such	  as	  sporulation	  or	  flagella	  biosynthesis.	  	  Group	  IV	  sigma	  
factors,	  often	  referred	  to	  as	  ECF	  (Extra-­‐Cytoplasmic	  Function)	  sigma	  factors,	  are	  the	  most	  
functionally	   and	   structurally	   diverse,	   and	   regulate	   responses	   to	   extracellular,	  
environmental	  signals.	  	  	  
The	  structure	  and	  function	  of	  primary	  sigma	  factors	  
The	  group	  I	  primary	  sigma	  factors	  all	  possess	  four	  helical	  structured	  domains	  connected	  
by	  flexible	  linkers;	  σ1.1,	  σ2,	  σ3,	  σ4	  comprising	  of	  regions	  1.1,	  1.2	  -­‐	  2.4,	  3.0	  -­‐	  3.2,	  4.1	  -­‐	  4.2,	  









σ1.1,	   composed	  of	   a	   three-­‐helix	  bundle	   connected	   to	   region	  1.2	  by	  a	   flexible	   linker,	   is	  
responsible	   for	   preventing	   sigma	   from	   binding	   to	   DNA	   in	   the	   absence	   of	   core	   RNAP.	  	  
Biochemical	  studies	  identified	  that	  σ70	  mutants	  lacking	  region	  1.1	  were	  more	  able	  to	  bind	  
promoter	  DNA	  (Dombroski	  et	  al.,	  1993).	  	  Following	  structural	  and	  crosslinking	  studies	  it	  
has	   been	   suggested	   that	   the	   mechanism	   behind	   this	   auto-­‐inhibition	   is	   due	   to	  
intra-­‐domain	   interactions	   between	   the	   negatively-­‐charged	   region	   1.1	   and	   the	   DNA	  
binding	  elements	  σ2	  and	  σ4	  (Schwartz	  et	  al.,	  2008).	   	  Once	  sigma	  is	  bound	  to	  the	  RNAP	  
core,	   region	   1.1	   still	   has	   an	   important	   role	   in	   transcription.	   	   FRET	   experiments	   and	  
structural	  studies	  have	  identified	  that	  in	  the	  absence	  of	  DNA,	  region	  1.1	  sits	  in	  the	  active-­‐
site	  cleft	  downstream	  of	  the	  transcription	  start	  site,	  possibly	  due	  to	  possessing	  a	  similar	  
negative	  charge	  (Mekler	  et	  al.,	  2002;	  Murakami,	  2013).	  	  Consequently,	  for	  open-­‐complex	  
formation	   to	   occur	   DNA	   must	   displace	   region	   1.1.	   	   This	   also	   provides	   a	   suitable	  
explanation	  for	  previous	  results	  showing	  that	  region	  1.1	  affects	  the	  formation	  but	  not	  
stability	  of	  open	  complexes	  (Vuthoori	  et	  al.,	  2001).	  	  Interestingly,	  region	  1.1	  was	  able	  to	  
promote	   open	   complex	   formation	   at	   certain	   promoters	   whilst	   inhibit	   it	   at	   other	  
promoters.	  	  Further	  in	  vitro	  experiments	  identified	  that	  the	  differential	  effect	  of	  region	  
1.1	  was	  in	  fact	  due	  to	  the	  spacer	  sequence	  between	  the	  -­‐10	  and	  -­‐35	  elements,	  as	  opposed	  
to	  the	  DNA	  binding	  elements	  themselves	  (Hook-­‐Barnard	  and	  Hinton,	  2009).	  
σ2,	  composed	  of	  regions	  1.2-­‐2.4	  is	  the	  most	  highly	  conserved	  of	  the	  4	  sigma	  regions	  and	  
forms	   the	   largest	   interaction	  with	   the	   core	  RNAP	   through	   interaction	  between	   the	  β’	  
subunit	  and	  the	  region	  2.2	  helix	  (Young	  et	  al.,	  2001).	  	  σ2	  is	  also	  responsible	  for	  recognition	  
of	  the	  -­‐10	  promoter	  element	  through	  interaction	  between	  regions	  2.3-­‐2.4	  of	  the	  sigma	  
factor	  and	  the	  non-­‐template	  strand.	  	  Interactions	  occur	  between	  σ2	  and	  every	  nucleotide	  
in	  the	  -­‐10	  hexamer	  although	  most	  importantly	  base-­‐specific	  interactions	  occur	  at	  A-­‐11	  and	  
T-­‐7.	  	  These	  two	  nucleotides,	  A-­‐11	  and	  T-­‐7,	  are	  flipped	  out	  of	  the	  single-­‐stranded	  base	  stack	  
and	  into	  complementary	  hydrophobic	  and	  hydrophilic	  pockets	  of	  σ2,	  respectively,	  acting	  
as	  the	  critical	  step	  for	  melting	  to	  occur	  (see	  section	  1.2.4	  Transcription	  cycle)	  (Feklistov	  
and	  Darst,	  2011).	  	  	  
In	   addition	   to	   regions	   2.3-­‐2.4	   responsible	   for	   -­‐10	   element	   recognition,	   region	   1.2,	  
comprised	   of	   two	   alpha	   helices	   oriented	   at	   90°	   to	   one	   another,	   was	   most	   recently	  
identified	  as	  an	  additional	  point	  of	  σ-­‐DNA	  contact	  and	  transcriptional	  regulation	  (Haugen	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et	  al.,	  2006;	  Feklistov	  et	  al.,	  2006;	  Haugen	  et	  al.,	  2008b).	  	  Region	  1.2	  interacts	  with	  a	  GC-­‐
rich	  region	  immediately	  downstream	  of	  the	  -­‐10	  hexamer	  known	  as	  a	  discriminator	  region,	  
originally	   identified	   over	   30	   years	   ago	   when	   investigating	   stringently	   controlled	  
promoters	  (Travers,	  1980).	  	  Between	  regions	  1.2-­‐2.1	  lies	  a	  non-­‐conserved	  region	  (NCR)	  
that	   varies	   in	   size	   and	   structure	   between	   organisms	   (Lonetto	   et	   al.,	   1992).	   	   Whilst	  
uncharacterised	  in	  most	  organisms,	  in	  E.	  coli	  the	  NCR	  has	  been	  identified	  to	  contact	  β’	  
and	  appears	  to	  play	  a	  role	  in	  promoter	  escape	  (Leibman	  and	  Hochschild,	  2007).	  
Domain	  σ3	  (region	  3.0-­‐3.2),	  composed	  of	  three	  helices,	   interacts	  with	  double	  stranded	  
DNA	   upstream	   of	   the	   -­‐10	   promoter	   element,	   in	   a	   region	   known	   as	   an	   extended	   -­‐10	  
element.	  	  One	  study	  performed	  multiple	  sequence	  alignments	  of	  554	  promoter	  regions	  
from	  E.	  coli	  (Mitchell	  et	  al.,	  2003).	  	  20%	  of	  the	  analysed	  promoters	  possessed	  at	  T-­‐15	  G-­‐14	  
motif,	   and	   44%	   promoters	   possessed	   a	   G-­‐14	   base.	   	   Further	   analysis	   showed	   that	  
promoters	   with	   extended	   -­‐10	   elements	   often	   had	   longer	   spacer	   lengths	   and	   poorly	  
conserved	  -­‐35	  regions	  (Mitchell	  et	  al.,	  2003;	  Campbell	  et	  al.,	  2002).	  	  In	  vitro	  and	  structural	  
studies	  also	  proved	  that	  the	  extended	  -­‐10	  element	  compensated	  for	  these	  features	  by	  
stabilising	  initiation	  complexes	  (Barne	  et	  al.,	  1997;	  Zuo	  and	  Steitz,	  2015).	  
Domain	   σ4	   (region	   4.1-­‐4.2)	   composed	   of	   four	   helices,	   interacts	  with	   the	   -­‐35	   element	  
through	  a	  helix-­‐turn-­‐helix	  motif.	  	  In	  addition	  to	  this	  contact	  with	  DNA,	  σ4	  forms	  a	  large	  
contact	  point	  with	  RNAP	  through	  the	  β	  flap.	  	  σ4	  can	  also	  serve	  as	  a	  contact	  point	  for	  DNA-­‐
bound	  activators	  of	  transcription	  (Dove	  et	  al.,	  2003).	  
	  
Figure	  1.6	  -­‐	  Domain	  organization	  and	  promoter	  recognition	  by	  the	  σ70	  family.	  	  Figure	  adapted	  from	  Paget	  (2015).	  	  This	  
figure	  is	  licensed	  under	  a	  Creative	  Commons	  Attribution	  (CC	  BY)	  4.0	  Generic	  License	  attributed	  to	  Mark	  Paget	  and	  
can	  be	  accessed	  in	  Biomolecules	  2015,	  5(3),	  1245-­‐1265.	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The	  structure	  and	  function	  of	  alternative	  sigma	  factors	  	  
Group	  II	  sigma	  factors	  are	  the	  most	  closely	  related	  to	  primary	  σ70	  sigma	  factors	  however	  
structurally	  differ	  by	  the	  absence	  of	  region	  1.1,	  the	  region	  which	  inhibits	  DNA	  binding	  in	  
the	  absence	  of	  the	  RNAP	  core	  and	  is	  only	  found	  in	  group	  I	  sigma	  factors	  (Lonetto	  et	  al.,	  
1992).	   	   Additionally,	   unlike	   primary	   sigma	   factors,	   they	   are	   non-­‐essential	   for	   growth	  
(Paget	  and	  Helmann,	  2003).	  	  The	  best	  characterised	  member	  of	  the	  group	  II	  sigma	  factors	  
is	  E.	  coli	  σS,	  the	  master	  regulator	  of	  the	  general	  stress	  response	  (Weber	  et	  al.,	  2005).	  	  In	  
rapidly	  growing	  cells	  σS	  is	  expressed,	  although	  translation	  is	  inhibited	  and	  any	  σS	  that	  is	  
produced	   is	   rapidly	   degraded	   (Lange	   and	   Hengge-­‐Aronis,	   1994).	   	   However,	   upon	  
exposure	  to	  a	  range	  of	  stresses	  including	  nutrient	  limitation,	  pH	  change	  and	  DNA	  damage,	  
these	  inhibitory	  mechanisms	  are	  overcome,	  σS	  levels	  increase	  rapidly	  and	  the	  σS	  regulon	  
(approximately	  500	  genes	  or	  10%	  of	  the	  genome)	  can	  be	  expressed.	  	  Some	  of	  these	  genes	  
are	  uniquely	  expressed	  by	  σS	  although	  a	  large	  number	  are	  also	  controlled	  by	  the	  primary	  
sigma	  factor,	  σ70.	  	  The	  consensus	  sequence	  for	  promoters	  regulated	  by	  these	  two	  sigma	  
factors	  are	  highly	  conserved	  and	  in	  vitro	  transcription	  experiments	  have	  shown	  that	  σ70	  
and	   σS	   holoenzymes	   recognise	   the	   same	   consensus	   hexamer	   sequences	   (Gaal	   et	   al.,	  
2001).	  	  Further	  experiments	  identified	  that	  a	  G/T-­‐14C-­‐13	  motif	  was	  highly	  conserved	  in	  σS-­‐
dependent	  promoters	  and	  led	  to	  highest	  expression	  by	  σS	  holoenzymes	  in	  vitro	  (Becker	  
and	  Hengge-­‐Aronis,	  2001).	  	  This	  interaction	  between	  an	  extended	  -­‐10	  and	  region	  3	  could	  
therefore	  act	  as	  a	  feature	  for	  σS	  promoter	  selection.	  
Group	  III	  sigma	  factors	  are	  structurally	  and	  functionally	  diverse	  from	  groups	  I	  and	  II	  sigma	  
factors,	   and	   only	   possess	   domains	   σ2,	   σ3	   and	   σ4.	   	   They	   usually	   activate	   responses	   to	  
general	  stress	  and	  heat	  shock	  or	  processes	  such	  as	  sporulation	  or	  flagella	  biosynthesis.	  	  
Examples	   of	  well	   characterised	   group	   3	   sigma	   factors	   are	  B.	   subtilis	   σF,	   σE,	   σG	   and	  σK	  
implicated	  in	  regulation	  of	  endospore	  formation	  (reviewed	  by	  Errington,	  2003).	  
Group	   IV	  sigma	  factors	  are	  often	  referred	  to	  as	  ECF	  (extracytoplasmic	   function)	  sigma	  
factors.	  	  They	  are	  the	  most	  functionally	  and	  structurally	  diverse	  group	  of	  sigma	  factors	  
and	  regulate	  responses	  to	  extracellular,	  environmental	  signals.	  	  Group	  IV	  sigma	  factors	  
differ	  from	  other	  σ	  factors	  by	  the	  absence	  of	  σ1.1,	  σ1.2	  and	  σ3,	  possessing	  only	  domain	  σ2	  
and	   σ4.	   	   Recent	   structural	   studies	   performed	   on	   σ2	   of	  E.	   coli	   σE,	   an	   ECF	   σ	   factor	   that	  
controls	   the	   response	   to	   cell	   envelope	   stress,	   revealed	   the	  mechanism	   for	   promoter	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melting	  and	  open	  complex	  formation	  differs	  from	  the	  studied	  mechanism	  in	  group	  I	  sigma	  
factors	  (Campagne	  et	  al.,	  2014).	  	  Whilst	  promoter	  melting	  in	  group	  I	  sigma	  factors	  occurs	  
through	  flipping	  of	  nucleotides	  A-­‐11	  and	  T-­‐7	  into	  complementary	  pockets	  on	  σ2	  (see	  section	  
1.2.4	  Transcription	  cycle),	  a	  single	  nucleotide	  C-­‐10	  is	  flipped	  into	  σ2	  to	  initiate	  promoter	  
melting	  at	  alternative	  σ	  promoters.	  
Anti-­‐sigma	  factors	  
Sigma	  factors	  represent	  an	  efficient	  and	  precise	  method	  for	  simultaneously	  controlling	  
expression	  of	  a	  large	  number	  of	  genes.	  	  To	  exploit	  this	  ability,	  the	  activity	  of	  the	  sigma	  
factor	  must	  also	  be	  regulated	  and	  a	  number	  of	  mechanisms	  exist	  for	  this	  purpose.	  	  The	  
amount	  of	  sigma	  factor	  present	  in	  the	  cell	  can	  be	  controlled	  by	  regulating	  transcription	  
and	  translation	  or	  by	  actively	  degrading	  the	  protein;	  for	  example,	  all	  of	  these	  mechanisms	  
are	  used	  to	  regulate	  the	  activity	  of	  σS	  in	  E.	  coli	  (Battesti	  et	  al.,	  2011).	  	  	  
A	   more	   common	   approach	   for	   controlling	   sigma	   activity,	   particularly	   for	   ECF	   sigma	  
factors,	  is	  binding	  by	  an	  anti-­‐sigma	  factor	  and	  inhibition	  of	  holoenzyme	  formation.	  	  This	  
σ-­‐anti-­‐σ	  interaction	  is	  reversible	  and	  typically	  disrupted	  by	  a	  direct	  signal	  that	  releases	  
the	  sigma	  factor	  and	  induces	  expression	  of	  the	  regulon.	  	  Typically,	  ECF	  sigma	  factors	  are	  
positively	  auto-­‐regulated	  and	  co-­‐expressed	  with	  their	  anti-­‐sigma	  factor;	  this	  ensures	  that	  
stoichiometric	  levels	  of	  the	  sigma	  and	  anti-­‐sigma	  are	  present	  in	  the	  cell.	  	  One	  advantage	  
of	   this	   mechanism	   is	   that	   cells	   can	   respond	   rapidly	   to	   a	   stimulus	   by	   releasing	   an	  
alternative	  sigma,	  which	  does	  not	  require	  a	  lag	  time	  for	  transcription	  and	  translation	  to	  
occur.	  
Two	  mechanisms	  for	  anti-­‐σ	  binding	  that	  effectively	  sequester	  σ	  and	  prevent	  holoenzyme	  
formation	  have	  been	  identified.	  	  The	  first	  are	  anti-­‐σ	  factors	  that	  bind	  σ	  between	  domains	  
σ2	  and	  σ4	  through	  a	  conserved	  structural	  motif	  found	  in	  40%	  of	  anti-­‐σ	  factors	  including	  
RseA,	  the	  anti-­‐σ	  that	  binds	  σE	  in	  E.	  coli	  (Campbell	  et	  al.,	  2003,	  2007).	  	  In	  this	  conserved	  
mechanism,	  three	  alpha	  helices	  bind	  between	  σ2	  and	  σ4	  whilst	  a	  fourth	  helix	  binds	  σ2.2	  
preventing	  interaction	  with	  the	  β’	  subunit	  of	  core	  RNAP.	  	  In	  addition	  to	  σE,	  this	  mechanism	  
for	  anti-­‐σ	  interaction	  is	  also	  used	  for	  sequestration	  of	  S.	  coelicolor	  σR,	  R.	  sphaeroides	  σE,	  
and	  B.	  subtilis	  σW	  by	  RsrA,	  ChrR,	  and	  RsiW,	  respectively	  (Li	  et	  al.,	  2002;	  Campbell	  et	  al.,	  
2007;	  Schöbel	  et	  al.,	  2004)	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The	  second	  group	  of	  anti-­‐σ	  factors	  are	  those	  that	  wrap	  around	  σ2	  and	  σ4,	  maintaining	  
free	  sigma	  in	  a	  compact	  form	  unable	  to	  bind	  neither	  RNAP	  nor	  DNA.	  	  This	  mechanism	  for	  
anti-­‐σ	   binding,	   identified	   in	   Aquifex	   aeolicus	   σ28/FlgM,	   appears	   to	   be	   conserved	   in	  
Cupriavidus	  metallidurans	  σCnrH	  and	   its	  anti-­‐σ	  CnrY,	  and	  Alphaproteobacteria	  PhyR	  and	  
anti-­‐σ-­‐like	   NepR	   despite	   no	   similarity	   (Sorenson	   et	   al.,	   2004;	   Campagne	   et	   al.,	   2012;	  
Maillard	  et	  al.,	  2014).	  
σ70	  and	  Rsd	  
In	   E.	   coli,	   the	   switch	   from	   exponential	   to	   stationary	   phase	   requires	   drastic	   lifestyle	  
changes	  that	  are	  largely	  governed	  by	  the	  alternative	  sigma	  factor	  σS	  taking	  over	  from	  the	  
primary	  sigma	  factor	  σ70.	  	  For	  a	  number	  of	  years	  this	  change	  was	  poorly	  understood,	  as	  
σ70	  levels	  stay	  constant	  through	  growth	  into	  stationary	  phase,	  at	  a	  higher	  concentration	  
and	   binding	   affinity	   for	   RNAP	   core	   than	   σS	   (Jishage	   and	   Ishihama,	   1998).	   	   The	  
breakthrough	  came	  upon	  discovery	  of	   the	  σ70-­‐binding	  anti-­‐sigma	   factor,	  Rsd,	  which	   is	  
upregulated	  upon	  entry	  into	  stationary	  phase	  (Jishage	  and	  Ishihama,	  1998,	  1999).	  Similar	  
to	  the	  mechanism	  of	  other	  anti-­‐sigma	  factors,	  Rsd	   inhibits	  RNAP	  core	  binding	  through	  
interactions	  with	  regions	  2	  and	  4	  of	  σ70	  (Patikoglou	  et	  al.,	  2007;	  Yuan	  et	  al.,	  2008;	  Paget,	  
2015).	   	  More	  recently,	   ligand	  fishing	  experiments	  identified	  Hpr,	  a	  member	  of	  the	  PTS	  
phosphotransferase	  system	  which	  responds	  to	  sugar	  availability,	  as	  a	  binding	  target	  Rsd	  
(Park	   et	   al.,	   2013).	   	   Hpr	   was	   shown	   to	   only	   bind	   Rsd	   in	   its	   dephosphorylated	   state,	  
suggesting	  that	  model	  that	  in	  the	  absence	  of	  the	  preferred	  sugar	  source	  Rsd	  can	  bind	  σ70	  
and	  promote	  σS	  activity.	  
Sigma	  factors	  in	  the	  actinomycetes	  
Following	  the	  sequencing	  of	  the	  S.	  coelicolor	  genome	  it	  was	  revealed	  that	  it	  produced	  as	  
many	   as	   65	   sigma	   factors,	   at	   the	   time	   an	   unprecedented	   number	   of	   sigma	   factors	  
(Bentley	  et	  al.,	  2002).	  	  	  
Initially,	  four	  S.	  coelicolor	  genes	  that	  encode	  a	  sigma	  factors	  similar	  to	  σ70	  were	  cloned	  
using	  primers	  based	  on	  the	  sequence	  of	  E.	  coli	  σ70	  and	  B.	  subtilis	  σA	  (Tanaka	  et	  al.,	  1988).	  	  
The	  amplified	  genes	  were	  named	  hrdA,	  hrdB,	  hrdC	  and	  hrdD	  (homologue	  of	  rpoD	  A-­‐D).	  	  
Mutagenesis	  studies	  revealed	  that	  hrdA,	  hrdC	  and	  hrdD	  were	  all	  non-­‐essential	  genes	  and	  
stable	   deletion	   mutants	   were	   “unaffected	   in	   differentiation,	   gross	   morphology,	   and	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antibiotic	  production”	  (Buttner	  et	  al.,	  1990;	  Buttner	  and	  Lewis,	  1992).	  	  In	  contrast,	  hrdB	  
was	  identified	  as	  an	  essential	  gene.	  	  Following	  isolation	  of	  RNAP	  that	  can	  transcribe	  the	  
dagA	   agarase	   gene	   in	   vitro,	   σHrdB	   was	   identified	   as	   a	   co-­‐eluting	   66	   kDa	   polypeptide	  
essential	  for	  transcription	  (Brown	  et	  al.,	  1992).	  	  Alignment	  of	  the	  -­‐10	  and	  -­‐35	  elements	  
for	  this	  promoter	  revealed	  the	  similarity	  to	  the	  sequence	  for	  other	  major	  bacterial	  sigma	  
factors,	  concluding	  that	  σHrdB	   is	  the	  principle	  sigma	  factor	  in	  S.	  coelicolor.	   	  The	  roles	  of	  
σHrdA,	  σHrdC	  and	  σHrdD	  still	  remain	  largely	  unknown	  although	  it	  has	  been	  shown	  that	  whilst	  
deletion	  mutants	  had	  no	  effect	  on	  antibiotic	  production,	  σHrdD	  activates	  transcription	  of	  
antibiotic	  CSRs	  actII-­‐ORF4	  and	  redD	  in	  vitro.	  	  Of	  the	  61	  remaining	  sigma	  factors,	  only	  a	  
handful	   have	   been	   studied	   in	   further	   detail.	   	   Ten	   of	   these	   are	   type	   III	   sigma	   factors	  
including	  σWhiG	  and	  σF,	  required	  for	  the	  process	  of	  sporulation	  (Flärdh	  and	  Buttner,	  2009).	  	  	  
Of	  the	  45	  ECF	  sigma	  factors	  identified	  following	  sequencing	  of	  the	  genome,	  only	  4	  have	  
been	   characterised.	   	   σE	   is	   an	   ECF	   sigma	   factor	   involved	   in	   maintenance	   of	   cell	   wall	  
structure	  in	  response	  to	  envelope	  stress	  (Paget	  et	  al.,	  1999b,	  1999a).	  	  The	  σE-­‐regulon	  is	  
induced	   by	   transcription	   of	   its	   gene	   sigE,	   regulated	   by	   a	   two-­‐component	   signal	  
transduction	  system.	  	  In	  response	  to	  cell	  wall	  stress,	  the	  sensor	  kinase	  CseC	  and	  response	  
regulator	  CseB	  activate	  transcription	  of	  sigE	   (Paget	  et	  al.,	  1999a).	   	  Based	  on	  promoter	  
sequence	  prediction,	   the	  σE-­‐regulon	   includes	  genes	   implicated	   in	  maintaining	  cell	  wall	  
integrity	   through	   glycan	  biosynthesis.	   	   σBldN	   is	   a	   developmentally-­‐regulated	   ECF	   sigma	  
required	  for	  formation	  of	  aerial	  mycelium	  (Bibb	  et	  al.,	  2000).	  	  Deletion	  mutants	  identified	  
through	   a	   genetic	   screen	   present	   a	   classic	   bald	   phenotype.	   	   ChIP-­‐chip	   experiments	  
performed	   on	   Streptomyces	   venezuelae	   σBldN	   identified	   that	   in	   addition	   to	   the	   bld	  
cascade,	   σBldN	   also	   regulates	   the	   rodlin	   and	   chaplin	   genes	  which	   form	   a	   hydrophobic	  
sheath	  around	  streptomycete	  aerial	  mycelium	  and	  spores	  (Bibb	  et	  al.,	  2012).	  	  σT	  is	  the	  
most	  poorly	  understood	  of	  the	  studied	  S.	  coelicolor	  ECF	  sigma	  factors.	  	  With	  its	  cognate	  
anti-­‐σ	  factor	  RstA,	  it	  is	  believed	  to	  be	  involved	  in	  differentiation	  and	  antibiotic	  production	  
with	   deletion	   mutants	   showing	   accelerated	   growth	   and	   enhanced	   production	   of	  
antibiotics	  ACT	  and	  RED	  (Mao	  et	  al.,	  2009;	  Feng	  et	  al.,	  2011).	  
σR	  and	  RsrA	  
σR	   is	   an	  S.	   coelicolor	  ECF	   sigma	   factor	   that	   regulates	   the	   response	   to	   oxidative	   stress	  
(Paget	  et	  al.,	  1998).	  	  It	  was	  first	  identified	  as	  a	  31	  kDa	  protein	  present	  in	  purified	  RNAP	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preparations	  (Kang	  et	  al.,	  1997).	   	   It	  was	  purified	  from	  an	  SDS-­‐PAGE	  gel,	  renatured	  and	  
titrated	  into	  core	  RNAP	  before	  use	  in	  in	  vitro	  transcription	  assays.	  	  When	  performed	  on	  a	  
range	   of	   templates	   it	   directed	   transcription	   from	   actIIIpx2,	   hrdDp2	   and	   glnRp2	  
promoters.	   	  Whilst	   a	  possible	  promoter	   consensus	   sequence	  could	  be	  extracted	   from	  
alignments	   of	   these	   promoter	   sequences,	   the	   function	   of	   the	   sigma	   factor	   remained	  
unknown.	   	   The	   breakthrough	   came	  when	   it	   was	   observed	   that	   an	   S.	   coelicolor	   ∆sigR	  
mutant	   was	   sensitive	   to	   a	   number	   of	   redox	   cycling	   compounds,	   especially	   the	   thiol-­‐
specific	  oxidising	  agent	  diamide	  (Paget	  et	  al.,	  1998).	  	  The	  decreased	  ability	  of	  the	  mutant	  
to	   reduce	   disulphide	   bonds	   caused	   by	   these	   agents	   suggested	   that	   the	   ∆sigR	   was	  
deficient	  in	  the	  thioredoxin	  system.	  	  The	  trxBA	  operon	  was	  shown	  to	  be	  under	  the	  control	  
of	   σR	   and	   induced	   by	   diamide,	   suggesting	   a	   homeostatic	   model	   for	   responding	   to	  
oxidative	  stress.	   	  As	  common	   in	  many	  ECF	  sigma	  factor	  systems	  (Helmann,	  2002),	   the	  
cognate	   σR-­‐specific	   anti-­‐sigma	   factor	   RsrA	   is	   located	   directly	   downstream	   and	   co-­‐
transcribed	  with	   sigR	   (Kang	   et	   al.,	   1999).	   	   RsrA	  was	   shown	   to	   bind	   σR	   and	   inhibit	   σR-­‐
directed	  transcription	  when	  in	  a	  reduced	  state.	  	  Inactivation	  of	  RsrA	  and	  the	  release	  of	  σR	  
is	  dependent	  redox-­‐active	  cysteine	  residues	  present	  in	  RsrA	  which	  form	  intramolecular	  
disulphide	  bonds	  upon	  exposure	   to	  an	  oxidising	  agent	   (Paget	  et	  al.,	  2001b).	   	  As	   these	  
intramolecular	  disulphide	  bonds	  are	  a	  target	  for	  the	  thioredoxin	  system,	  this	  represents	  
a	  homeostatic	  model	  for	  the	  σR-­‐RsrA	  response	  to	  oxidative	  stress.	  
Using	   a	   consensus	   sequence	   derived	   from	   three	   previously	   identified	   σR-­‐dependent	  
promoters,	  Paget	  et	  al.	   (2001a)	  were	  able	  to	   identify	  and	  confirm	  27	  new	  genes	  as	  σR	  
targets.	  	  This	  defined	  regulon	  was	  later	  expanded	  to	  108	  genes	  following	  microarray	  and	  
ChIP-­‐on-­‐chip	  experiments	   (Kallifidas	  et	  al.,	   2010;	  Kim	  et	  al.,	   2012).	   	   In	  addition	   to	   the	  
thioredoxin	   system,	   other	   members	   of	   the	   σR-­‐regulon	   include	   genes	   responsible	   for	  
protein	   quality	   degradation/control	   (e.g.	   ssrA,	   clpX,	   lon),	   ribosome-­‐associated	   genes	  
(translation	   initiation	   factors	   IF-­‐2	   and	   IF-­‐3,	   50S	   ribosomal	   proteins)	   and	   a	   number	   of	  
transcription	  factors	  (hrdB,	  rbpA).	  	  The	  size	  and	  diversity	  of	  this	  regulon	  emphasises	  the	  
importance	  of	  σR	  in	  controlling	  redox	  balance	  and	  maintaining	  protein	  quality	  in	  response	  
to	  oxidative	  stress.	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1.2.4   Transcription	  cycle	  
The	  process	  of	  transcription	  can	  be	  separated	  into	  3	  distinct	  phases:	  initiation,	  where	  the	  
RNAP	  holoenzyme	  recognises	   the	  promoter,	  opens	  a	  13bp	  transcription	  “bubble”	  and	  
begins	   the	   process	   of	   making	   RNA;	   elongation,	   the	   major	   processive	   state	   of	  
transcription;	   and	   termination,	  where	  elongating	  RNAP	  dissociates	   from	   the	   template	  
DNA	  and	  releases	  the	  nascent	  RNA.	  
Initiation	  
Following	   holoenzyme	   assembly,	   initiation	   is	   the	   first	   step	   of	   the	   transcription	   cycle	  
defined	   by	   stages	   from	   promoter	   recognition	   through	   to	   promoter	   escape	   into	  
elongation	  and	  synthesis	  of	  RNA.	  	  Regulation	  of	  transcription	  is	  a	  major	  focus	  of	  lifestyle	  
regulation	   in	   bacteria	   and	   initiation	   is	   considered	   the	  primary	   point	   of	   transcriptional	  
regulation,	   effected	   by	   binding	   proteins	   and	   small	   molecules,	   as	   well	   as	   a	   target	   of	  
antibiotics	  such	  as	  rifampicin.	  
The	   first	  step	  of	   transcription	   initiation	   is	  promoter	  binding	  and	  formation	  of	  a	  closed	  
complex	   (RPc).	   	  When	   σ	   binds	   RNAP	   core,	   a	   conformational	   change	   exposes	   regions	  
2.3-­‐2.4	   and	   4.1-­‐4.2	   allowing	   recognition	   of	   the	   promoter	   -­‐10	   and	   -­‐35	   elements,	  
respectively	  	  (Murakami	  et	  al.,	  2002).	  	  	  
Following	   RPc	   formation,	   the	   transition	   to	   open	   complex	   (RPo)	   can	   be	   divided	   into	   a	  
number	  of	  unstable	  isomerisation	  intermediates	  (I)	  (Figure	  1.7).	  	  For	  elucidation	  of	  these	  
short-­‐lived	  conformations,	  much	  of	  the	  work	  was	  performed	  at	  low	  temperatures	  on	  the	  
λPR	  promoter.	  	  The	  first	  intermediate,	  I1,E	  (Early),	  is	  formed	  when	  DNA	  bending	  occurs	  
upstream	  of	  the	  -­‐35	  region	  identified	  by	  OH	  footprinting	  experiments	  (Davis	  et	  al.,	  2007).	  
Bending	  and	  nonspecific	  interaction	  of	  this	  upstream	  DNA	  with	  the	  αCTD	  is	  important	  for	  
open	  complex	  formation,	  with	  truncated	  DNA	  fragments	  having	  1.5-­‐2	  times	  less	  efficient	  
isomerisation	  (Davis	  et	  al.,	  2005).	  
Formation	  of	  I1,L	  (Late)	  requires	  bending	  of	  the	  duplex	  DNA	  upstream	  of	  the	  -­‐10	  element	  
by	  at	   least	  90°	   into	  the	  RNAP	  cleft.	   	  Additionally,	  this	  step	   includes	  flipping	  of	  a	  highly	  
conserved	   A-­‐11	   residue	   from	   the	   base	   stack	   on	   the	   non-­‐template	   strand	   into	   a	  
complementary	   hydrophobic	   pocket	   on	   σ2	   (Feklistov	   and	   Darst,	   2011)	   (Figure	   1.6).	  	  
Specific	  interactions	  in	  this	  pocket	  account	  for	  the	  almost	  universal	  conservation	  of	  an	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adenine	  base	  at	  position	  -­‐11	  (A-­‐11)	  on	  σ70	  promoters.	  	  Similarly,	  a	  T-­‐7	  residue	  flips	  into	  a	  
hydrophilic	  pocket	  on	  σ2	  (Feklistov	  and	  Darst,	  2011).	  	  Whilst	  this	  pocket	  is	  more	  spacious	  
and	  would	  accommodate	   the	  pyrimidine	  cytosine,	   specific	   interactions	  are	   lost	  with	  a	  
serious	  effect	  on	  open	  complex	  formation.	  	  This	  protein-­‐base	  interaction	  is	  an	  important	  
requirement	  for	  transcription	  initiation	  and	  seemingly	  explains	  high	  conservation	  of	  T-­‐7	  
to	  similar	   levels	  as	  A-­‐11.	   	  The	  order	  of	  DNA	  bending	  and	  base-­‐flipping	  in	  open	  complex	  
formation	   is	  currently	  unknown;	   it	  has	  been	  hypothesised	  that	  either	  bending	  of	  DNA	  
nucleates	   base	   flipping	   into	   complementary	   pockets,	   or	   alternatively,	   base-­‐flipping	  
occurs	  allowing	  DNA	  to	  bend	  into	  the	  RNAP	  cleft	  (Feklistov	  and	  Darst,	  2011).	  
Formation	  of	  the	  intermediate	  I2	   involves	  melting	  and	  opening	  of	  DNA	  to	  form	  a	  13bp	  
transcription	  bubble	  extending	  from	  -­‐11	  to	  +2.	  	  Whilst	  existing	  data	  is	  not	  conclusive,	  it	  is	  
believed	  that	  formation	  of	  this	  transcription	  bubble	  begins	  with	  the	  flipping	  of	  A-­‐11	  and	  
“unzips”	   downstream	   towards	   the	   site	   of	   transcription	   initiation.	   	   Through	   this	  
mechanism,	   the	   exposed	   +1	   is	   positioned	   at	   the	   RNAP	   active	   site	   for	   transcription	  
initiation	   to	   occur.	   	   Formation	   of	   the	   final	   isomerisation	   intermediate,	   I3,	   before	   RPo	  
involves	  large	  conformational	  changes	  in	  RNAP	  for	  assembly	  of	  the	  β	  and	  β’	  clamp/jaw	  
apparatus.	  	  
	  
Figure	  1.7	  -­‐	  Schematic	  representation	  of	  proposed	  intermediates	  in	  open	  complex	  formation	  	  Figure	  from	  Ruff	  et	  al.	  
(2015).	  	  This	  figure	  is	  licensed	  under	  a	  Creative	  Commons	  Attribution	  (CC	  BY)	  4.0	  Generic	  License	  attributed	  to	  Emily	  F.	  
Ruff,	  Thomas	  Record	  Jr,	  and	  Irina	  Artsimovitch	  and	  can	  be	  accessed	  in	  Biomolecules	  2015,	  5(2),	  1035-­‐1062.	  
Abortive	  transcription	  is	  the	  final	  process	  of	  initiation	  that	  occurs	  following	  open	  complex	  
formation	  where	  short	  RNA	  transcripts,	  up	  to	  9-­‐10	  nt	  in	  size	  are	  produced	  before	  RNAP	  
escapes	  the	  promoter	   into	  elongation.	   	  RNA	  synthesis	  begins	  and	  downstream	  DNA	   is	  
pulled	   into	   the	   active	   site.	   	   However	   as	   contacts	   between	   RNAP	   and	   promoter	   DNA	  
remain,	   template	  DNA	   is	  unable	   to	   leave	   the	  active	  site	  and	  DNA	  “scrunching”	  occurs	  
(Kapanidis	   et	   al.,	   2006).	   	  When	   9-­‐10	   nt	   is	   formed,	   the	   stress	   caused	   by	   scrunching	   is	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relieved	  either	  by	  release	  of	  a	  small	  abortive	  transcript,	  or	  by	  disruption	  of	  the	  RNAP-­‐
promoter	  contacts	  allowing	  promoter	  escape	  into	  elongation	  (Zuo	  and	  Steitz,	  2015).	  	  
Elongation	  	  
Elongation	   is	   the	   major	   processive	   state	   of	   RNA	   transcription	   that	   occurs	   following	  
successful	  promoter	  escape.	   	  The	  process	  of	  elongation	   is	  composed	  of	   three	  defined	  
steps.	   	  An	  NTP	  molecule	  binds	   to	   the	  exposed	  complementary	   template	  strand	   in	   the	  
active	  site	  of	  elongating	  RNAP.	  	  Upon	  binding,	  the	  RNA	  chain	  is	  extended	  by	  a	  reaction	  
between	   the	   3’-­‐OH	   of	   the	   last	   NTP	   with	   the	   α-­‐phosphate	   of	   the	   newly	   added	   NTP	  
(releasing	  the	  β	  and	  γ	  phosphate	  groups)	  forming	  a	  phosphodiester	  bond.	  	  The	  final	  stage	  
is	  translocation	  of	  RNAP	  to	  position	  the	  next	  exposed	  template	  base	  at	  the	  centre	  of	  the	  
active	  site.	  	  Without	  interruption,	  this	  process	  of	  elongation	  occurs	  at	  an	  rate	  of	  50-­‐100	  
nucleotides	  per	  second	  (Roberts	  et	  al.,	  2008).	  	  	  
Termination	  
The	  final	  stage	  of	   transcription	   is	   termination,	   the	  dissociation	  of	  RNAP	  from	  the	  DNA	  
template	  and	  release	  of	  the	  nascent	  RNA.	  	  There	  are	  two	  distinct	  forms	  of	  prokaryotic	  
transcription	  termination:	  intrinsic	  termination	  and	  Rho-­‐dependent	  termination.	  
Intrinsic	  termination	  occurs	  at	  specific	  template	  sequences	  with	  the	  requirement	  for	  no	  
additional	   factors.	   	   At	   intrinsic	   terminators,	   the	  mRNA	   has	   two	   defined	   features	   that	  
cause	  RNAP	  dissociation;	  a	  GC	  rich	  sequence	  that	  forms	  a	  hairpin	  structure	  7-­‐20	  bases	  in	  
length	  (d'Aubenton	  Carafa	  et	  al.,	  1990),	  closely	  followed	  by	  a	  short	  run	  of	  uracil	  residues	  
(Gusarov	  and	  Nudler,	  1999).	  	  The	  RNA	  hairpin	  has	  the	  function	  of	  causing	  RNAP	  to	  stall	  
and	  the	  rU-­‐dA	  interaction	  formed	  in	  the	  transcription	  bubble	  is	  unusually	  weak.	  	  When	  
these	  two	  features	  are	  located	  in	  close	  proximity	  in	  a	  terminator	  sequence,	  RNAP	  stalls	  
at	  the	  hairpin,	  the	  weak	  RNA-­‐DNA	  interaction	  at	  the	  U-­‐rich	  region	  separates	  and	  RNAP	  is	  
released	   from	   the	   template	   DNA.	   	   Computational	   analyses	   initially	   suggested	   that	  
intrinsic	  terminators	  were	  found	  at	  the	  termini	  of	  50%	  of	  E.	  coli	  genes	  (Lesnik	  et	  al.,	  2001).	  	  
However,	   following	  genome	  scale	  ChIP	  analysis	  of	  Rho,	   it	  was	  estimated	   that	   intrinsic	  
termination	  (where	  Rho	  is	  absent)	  is	  responsible	  for	  transcriptional	  termination	  at	  80%	  
all	  E.	  coli	  genes	  (Peters	  et	  al.,	  2009).	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The	   second	  mechanism	   of	   prokaryotic	   transcription	   termination	   is	   dependent	   on	   the	  
essential	  protein	  Rho.	  	  Rho-­‐dependent	  terminators	  do	  not	  share	  the	  features	  of	  intrinsic	  
terminators	  but	  instead	  rely	  on	  the	  absence	  of	  RNA	  secondary	  structures	  allowing	  Rho	  
translocation.	   	   Rho-­‐dependent	   termination	   is	   initiated	   by	   binding	   of	   a	   Rho	   complex,	  
composed	   of	   six	   Rho	  molecules	   arranged	   in	   an	   open	   circle	   (Skordalakes	   and	   Berger,	  
2003),	   to	   a	   cytosine	   rich	   rut	   (Rho	   utilisation)	   site	   on	   the	   nascent	   RNA	   (Chen	   and	  
Richardson,	   1987).	   	   Once	   bound,	   Rho	   translocates	   along	   RNA	   in	   a	   5’	   to	   3’	   direction	  
through	   its	   ATP-­‐dependent	   helicase	   activity	   until	   it	   encounters	   an	   RNAP	   transcription	  
elongation	  complex.	  	  Upon	  meeting	  the	  RNAP	  complex,	  although	  the	  mechanism	  is	  not	  
fully	   understood,	   it	   is	   assumed	   that	   Rho	   causes	   transcription	   termination	   through	   its	  
helicase	  activity	  on	  the	  RNA-­‐DNA	  hybrid	  (Epshtein	  et	  al.,	  2010).	  
1.2.5   RNA	  polymerase	  binding	  factors	  
Secondary	  channel	  binding	  factors	  
The	  secondary	  channel	   is	  a	  narrow	  pathway	  from	  the	  surface	  to	  the	  RNAP	  active	  site,	  
roughly	  10-­‐12	  Å	  in	  size,	  formed	  by	  two	  regions	  of	  the	  β’	  subunit	  (Zhang	  et	  al.,	  1999).	  	  Due	  
to	  the	  size	  of	  the	  channel,	  it	  was	  predicted	  that	  neither	  double	  nor	  single	  stranded	  DNA	  
would	  fit	  and	  was	  consequently	  proposed	  as	  an	  access	  point	  for	  NTP	  substrates.	  	  Since	  
this	  suggestion,	   the	  secondary	  channel	  has	  also	  been	   identified	  as	  a	  binding	  site	   for	  a	  
number	  of	  proteins	  collectively	  known	  as	  second	  channel-­‐binding	  factors	  (SCBFs).	  
SCBFs	   are	   structurally	   similar,	   typically	   possessing	   a	   globular	   domain	   responsible	   for	  
binding	  to	  RNAP	  and	  a	  coiled-­‐coil	  structure	  which	  protrudes	  into	  the	  secondary	  channel	  
and	  regulates	  transcription	  through	  interactions	  between	  the	  tip	  and	  the	  RNAP	  active	  site	  
(Zenkin	  and	  Yuzenkova,	  2015).	  	  	  
GreA	   and	   GreB	   are	   two	   SCBFs	   that	   modify	   transcription	   by	   rescuing	   backtracked	  
elongation	   complexes.	   	   Backtracking	   occurs	   when	   RNAP	   slides	   backwards	   along	   the	  
transcribed	  DNA	  template,	  leaving	  the	  3’	  end	  of	  the	  nascent	  RNA	  away	  from	  the	  active	  
site	  (Komissarova	  and	  Kashlev,	  1997).	  	  This	  renders	  RNAP	  unable	  to	  extend	  the	  3’	  end	  of	  
nascent	  RNA	  causing	  an	  arrest	  of	  transcription.	  	  In	  the	  absence	  of	  a	  Gre	  factor,	  the	  RNAP	  
trigger	   loop	   is	  able	  to	  cleave	  the	  nascent	  RNA	  and	  position	  a	  new	  3’	  end	   in	  the	  RNAP	  
active	  site	  (Yuzenkova	  and	  Zenkin,	  2010).	  	  GreA	  and	  GreB	  are	  able	  to	  displace	  the	  trigger	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loop	   when	   positioned	   in	   the	   secondary	   channel	   and	   hydrolyse	   RNA	   in	   a	  much	  more	  
efficient	  manner	  (Roghanian	  et	  al.,	  2011).	  	  	  
DksA	   is	   an	   SCBF	   that	   acts	   in	   concert	  with	   ppGpp	   to	   regulate	   transcription	   during	   the	  
stringent	  response.	  	  Together	  ppGpp	  and	  DksA	  are	  able	  to	  both	  positively	  and	  negatively	  
regulate	  the	  expression	  of	  many	  genes,	  dependent	  on	  intrinsic	  promoter	  properties	  (see	  
section	  1.2.6).	  	  	  
In	  addition	  to	  its	  role	  in	  regulation	  of	  transcription	  initiation,	  DksA	  has	  also	  been	  identified	  
to	  have	  effects	  on	  transcription	  elongation.	  	  Indeed,	  recent	  ChIP	  studies	  performed	  on	  
DksA	  have	  identified	  it	  as	  located	  on	  elongation	  complexes	  as	  well	  as	  at	  promoter	  regions	  
(Zhang	   et	   al.,	   2014).	   	   It	   was	   initially	   identified	   that	   upon	   exposure	   to	   UV	   light,	   DNA	  
damaging	  agents	  or	  nutrient	  stress,	  DNA	  replication	  was	   inhibited	   in	  a	  ∆dksA	  deletion	  
mutant	  (Trautinger	  et	  al.,	  2005;	  Tehranchi	  et	  al.,	  2010).	  	  Further	  experiments	  suggested	  
that	   this	   inhibition	   was	   caused	   by	   arrested	   RNAP	   elongation	   complexes	   blocking	  
replication	  fork	  progression.	  	  Interestingly,	  gre	  factors	  appeared	  to	  functionally	  overlap	  
this	  role	  of	  DksA,	  as	  overexpression	  of	  greA	  rescued	  a	  ∆dksA	  deletion	  mutant	  (Tehranchi	  
et	   al.,	   2010),	   presumably	   through	   its	   understood	   mechanism	   of	   rescuing	  
backtracked/stalled	   elongation	   complexes.	   	   However,	   the	   mechanism	   through	   which	  
DksA	  prevents	  collision	  between	   replication	  and	  elongation	  complexes	   is	   still	  not	   fully	  
understood.	  	  It	  was	  initially	  suggested	  that	  DksA	  displaced	  stalled	  elongation	  complexes	  
or	  prevented	  backtracking	  (Tehranchi	  et	  al.,	  2010)	  however	  in	  vitro	  data	  suggested	  DksA	  
does	  not	  bind	  or	  effect	  backtracked	  or	  active	  elongation	  complexes	  	  (Furman	  et	  al.,	  2013;	  
Roghanian	  et	  al.,	  2015).	  	  More	  recently,	  it	  has	  been	  suggested	  that	  DksA,	  potentiated	  by	  
ppGpp,	  functions	  on	  elongation	  through	   increasing	  transcription	  fidelity	   (Roghanian	  et	  
al.,	  2015).	   	  By	  reducing	  nucleotide	  misincorporation,	  which	  consequently	  causes	  RNAP	  
stalling/backtracking,	  DksA	  is	  able	  to	  prevent	  formation	  of	  stalled	  RNAP	  complexes	  and	  
therefore	  reduces	  collision	  of	  transcription	  and	  replication	  machinery.	  	  	  
CarD	  
CarD	  is	  an	  18	  kDa	  RNA	  polymerase	  binding	  protein	  first	   identified	  in	  screens	  for	  genes	  
involved	  in	  the	  DNA	  damage	  response	  in	  M.	  smegmatis	  (Stallings	  et	  al.,	  2009).	  	  In	  these	  
screens	  carD	  was	  one	  of	  the	  most	  upregulated	  genes	  in	  response	  to	  a	  number	  of	  DNA	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damaging	  agents	  including	  bleomycin,	  ciprofloxacin,	  MMS	  and	  the	  double	  strand	  break-­‐
forming	  endonuclease	  I-­‐SceI.	  
Genetic	  studies	   identified	  CarD	  as	  an	  essential	  protein.	   	  Authors	  Stallings	  et	  al.	   (2009)	  
found	   it	   not	   possible	   to	   create	   a	   carD	   deletion	   strain	   without	   the	   presence	   of	   an	  
additional	   copy	   of	   the	   gene	   under	   the	   control	   of	   an	   ATc-­‐inducible	   promoter	   in	   both	  
M. smegmatis	  and	  M. tuberculosis.	  	  Whole-­‐genome	  microarray	  transcriptional	  profiling	  
of	  these	  strains	  depleted	  of	  the	  inducer	  revealed	  a	  large	  number	  of	  genes	  upregulated	  in	  
the	  absence	  of	  CarD	   including	  translational	  machinery	  such	  as	  ribosomal	  proteins	  and	  
rRNA	  operons.	  	  This	  is	  largely	  reminiscent	  of	  the	  transcriptional	  profile	  of	  relaxed	  mutants	  
characteristically	  unable	  to	  mount	  a	  stringent	  response	  by	  downregulation	  of	  rRNA	  and	  
ribosomal	   proteins	   (see	   section	  1.2.6).	   	   Additionally,	   heterologous	   expression	  of	   CarD	  
rescued	   an	   E.	   coli	   dksA	   deletion	   mutant	   unable	   to	   downregulate	   rRNA	   transcription	  
following	  nutrient	  limitation.	  	  As	  CarD	  accumulates	  in	  response	  to	  a	  range	  of	  stresses	  and	  
regulates	   rRNA	   it	   was	   at	   this	   point	   thought	   that	   the	   protein	   could	   play	   a	   role	   in	   the	  
mycobacterial	  stringent	  response.	  	  	  
However,	   despite	   these	   experiments	   suggesting	   CarD	   as	   a	   negative	   regulator	   of	  
transcription,	   in	  vitro	  run	  off	  transcription	  experiments	  performed	  on	  rRNA	  promoters	  
have	   since	   identified	   CarD	   as	   an	   activator	   of	   transcription	   (Srivastava	   et	   al.,	   2013).	  	  
Further	   experiments	   performed	   in	   vitro	   have	   demonstrated	   that	   CarD	   acts	   on	  
transcription	   initiation,	   specifically	   through	   stabilising	   open	   promoter	   complexes	  
(Rammohan	  et	  al.,	  2015;	  Davis	  et	  al.,	  2015).	  DNAse	  I	  and	  KMnO4	  footprinting	  experiments	  
demonstrated	  that	  CarD	  does	  not	  affect	  RNAP-­‐promoter	  interaction	  or	  structure	  of	  the	  
transcription	   bubble	   but	   rather	   stabilises	   and	   prevents	   transcription	   bubble	   collapse.	  	  
Comparisons	  between	  E.	  coli	  and	  M.	  bovis	   systems	  revealed	   that	  mycobacterial	  RNAP	  
holoenzymes	   form	   very	   unstable	   open	   complexes.	   	   Addition	   of	   CarD	   rescues	   these	  
intrinsically	   unstable	   holoenzymes,	   potentially	   revealing	   the	   importance	   and	   essential	  
nature	  of	  CarD	  (Davis	  et	  al.,	  2015).	  	  	  
CarD	  is	  composed	  of	  two	  functional	  domains.	  	  The	  N-­‐terminal	  RNAP-­‐interacting	  domain	  
(RID)	   is	   highly	   similar	   in	   amino	   acid	   sequence	   and	   structure	   to	   the	   RNAP-­‐interacting	  
domain	   of	   transcription-­‐repair	   coupling	   factor	   (TRCF),	   the	   product	   of	   the	  mfd	   gene	  
(Stallings	  et	  al.,	  2009;	  Srivastava	  et	  al.,	  2013).	  	  The	  N-­‐terminal	  RID	  is	  composed	  of	  a	  Tudor-­‐
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like	  fold	  consisting	  of	  four	  anti-­‐parallel	  β	  strands.	  	  TRCF	  and	  CarD	  interact	  with	  the	  β1	  lobe	  
of	   the	   β	   subunit	   of	   RNAP	   through	   similar	   mechanisms	   however	   there	   is	   no	   known	  
functional	  overlap,	  with	  TRCF	  unable	  to	  complement	  a	  CarD	  mutant	  (Westblade	  et	  al.,	  
2010;	  Stallings	  et	  al.,	  2009).	  	  Weakening	  the	  CarD-­‐RNAP	  interaction	  through	  site-­‐directed	  
mutagenesis	  significantly	  affected	  M.	  tuberculosis	  viability,	  highlighting	  the	  importance	  
of	  CarD	  action	  on	  RNAP	  in	  vivo	  (Weiss	  et	  al.,	  2012).	  	  Despite	  these	  interaction	  mutants	  
having	  similar	  effects	  on	  viability	  as	  depletion	  of	  CarD,	  the	  picture	  was	  less	  clear	  when	  
comparing	   antibiotic-­‐susceptibility	   profiles.	   	  Whilst	   depletion	  mutants	   are	   sensitive	   to	  
ciprofloxacin	   but	   not	   rifampicin,	  mutants	   with	   attenuated	   RNAP-­‐CarD	   interaction	   are	  
particularly	  sensitive	  to	  rifampicin	  and	  streptomycin.	  	  This	  finding	  is	  of	  particular	  interest	  
as	   it	   suggests	   the	  CarD-­‐RNAP	   interaction	  as	  a	  novel	  drug	   target	   in	   rifampicin-­‐resistant	  
strains	  of	  M.	  tuberculosis	  (Weiss	  et	  al.,	  2012).	  
The	  CarD-­‐CTD	  has	  no	  sequence	  or	  structural	  similarity	  to	  any	  previously	  characterised	  
protein	  or	  fold	  (Srivastava	  et	  al.,	  2013).	  	  It	  is	  a	  compact	  domain,	  composed	  of	  five	  alpha	  
helices.	   	   Among	   these	   alpha	   helices	   is	   a	   surface	   exposed	   tryptophan	   residue,	   almost	  
universally	  conserved	  in	  all	  CarD	  homologues,	  surrounded	  by	  a	  patch	  of	  basic	  residues.	  	  
Based	  on	  the	  structure	  of	  TRCF-­‐RID	  in	  complex	  with	  the	  RNAP	  β1	  lobe	  it	  was	  possible	  to	  
model	  CarD	  onto	  a	  structure	  of	   the	  T.	   thermophilus	  RNAP	  open	  complex.	   	  Due	   to	   the	  
structural	  rigidity	  of	  CarD,	  this	  model	  revealed	  that	  when	  bound	  to	  RNAP	  the	  CarD-­‐CTD	  
is	   positioned	   to	   directly	   interact	   with	   the	   upstream	   edge	   of	   the	   -­‐10	   element	   of	   the	  
promoter	  DNA	  (Srivastava	  et	  al.,	  2013).	  	  Closer	  inspection	  revealed	  that	  this	  interaction	  
potentially	  occurs	  through	  the	  highly	  conserved	  tryptophan	  residue.	  	  When	  the	  structure	  
of	  CarD	  was	  modelled	  onto	  an	  RNAP	  closed-­‐complex	  structure,	  the	  tryptophan	  residue	  
and	  surrounding	  basic	  patch	  clashed	  with	  the	  promoter	  DNA.	  	  Site-­‐directed	  mutagenesis	  





Figure	  1.8	  -­‐	  Structure	  of	  CarD	  modelled	  onto	  T.	  thermophilus	  RNAP	  open	  complex.	  	  (A,	  B)	  	  Structure	  of	  T.	  thermophilus	  
CarD	  modelled	  onto	  β1-­‐lobe	  T.	   thermophilus	   RNAP	  open	  complex.	   	   (C)	  Close	  up	   view	  of	  CarD/RPo	  model	   showing	  
potential	  steric	  clash	  and	  close	  approach	  of	  CarD-­‐W86	  with	  DNA	  in	  RPc	  and	  RPo	  models,	  respectively.	  	  Figure	  adapted	  
with	  permission	  from	  Srivastava	  et	  al	  (2013)	  can	  be	  accessed	  in	  Proc	  Natl	  Acad	  Sci	  USA.	  	  2013,	  110(31),	  12619-­‐24.	  








RbpA	  is	  a	  14	  kDa	  RNA	  polymerase	  binding	  protein	  (RNA	  polymerase	  binding	  protein	  A)	  
first	  identified	  through	  its	  consistent	  presence	  in	  purified	  S.	  coelicolor	  RNAP	  preparations	  
(Paget	  et	  al.,	  2001a).	   	   It	   is	  widespread	  throughout	  but	  exclusive	  to	  the	  Actinobacteria.	  	  
Studies	   into	   the	  oxidative	  stress	   response	   identified	   it	  as	  a	  member	  of	   the	  σR	   regulon	  
although	  at	  this	  point	  its	  function	  was	  still	  unknown	  (Paget	  et	  al.,	  2001a).	  	  
Deletion	  mutants	  demonstrated	  the	  importance	  of	  RbpA	  in	  growth,	  with	  rbpA	  mutants	  
exhibiting	  a	  slow	  growth	  phenotype	  (Newell	  et	  al.,	  2006).	  	  Colonies	  appear	  significantly	  
smaller	  on	  all	  studied	  solid	  media	  and	  have	  extended	  lag	  and	  slow	  exponential	  phases	  in	  
liquid	   culture.	   	   Despite	   such	   significant	   growth	   defects,	   rbpA	   mutants	   appear	  
morphologically	   unaffected,	   with	   colonies	   eventually	   forming	   aerial	   hyphae	   and	  
sporulating	  comparable	  to	  wild-­‐type	  strains.	  	  	  
Multi-­‐round	  in	  vitro	  transcription	  studies	  identified	  RbpA	  as	  an	  activator	  of	  transcription	  
from	   σHrdB-­‐dependent	   promoters	   (Newell	   et	   al.,	   2006;	   Tabib-­‐Salazar	   et	   al.,	   2013)	   and	  
single-­‐round	  reactions	  suggest	  that	  this	  occurs	  through	  the	  initiation	  step	  of	  transcription	  
(Hu	  et	  al.,	  2012).	  	  	  
RbpA	  binds	  RNAP	  through	  interactions	  with	  the	  σ	  subunit.	  	  Bacterial	  two-­‐hybrid	  (BACTH)	  
experiments	  have	  shown	  that	  this	   interaction	  is	  specific	  to	  the	  primary	  σ	  factors,	  σHrdB	  
and	  σA,	  in	  S.	  coelicolor	  and	  M.	  tuberculosis	  respectively,	  in	  addition	  to	  some	  group	  II	  sigma	  
factors	  (Hu	  et	  al.,	  2012;	  Tabib-­‐Salazar	  et	  al.,	  2013).	  	  Further	  binding	  and	  structural	  studies	  
have	  shown	  that	  the	  flexible	  C-­‐terminal	  region	  of	  RbpA	  binds	  to	  σ2.	  	  The	  structure	  of	  this	  
sigma-­‐interaction	  domain	  (SID)	  in	  complex	  with	  domain	  2	  of	  σA	  was	  solved	  by	  Hubin	  et	  al.	  
(2015).	  	  When	  modelled	  upon	  the	  Thermus	  aquaticus	  RNAP	  open	  complex	  structure,	  it	  
unexpectedly	  revealed	  that	  the	  RbpA	  basic	  linker	  contacts	  DNA	  on	  the	  upstream	  edge	  of	  
the	  -­‐10	  promoter	  element.	  	  Indeed,	  crosslinking	  studies	  confirmed	  interaction	  between	  
the	  basic	  linker	  and	  promoter	  DNA	  and	  mutagenesis	  of	  interacting	  residues	  identified	  this	  
DNA	  interaction	  as	  essential	  for	  RbpA	  function.	   	   It	  had	  previously	  been	  suggested	  that	  
RbpA	  could	  regulate	  transcription	  through	  binding	  to	  the	  β/β’	  active-­‐site	  channel	  near	  
the	  rifampicin	  binding	  site	  (Dey	  et	  al.,	  2011)	  or	  through	  binding	  to	  the	  β	  subunit	  (Hu	  et	  
al.,	  2012).	  	  Structural	  data	  predicting	  distances	  of	  53	  Å	  and	  80	  Å	  from	  the	  RbpA	  binding	  




Figure	  1.9	  -­‐	  Structural	  model	  of	  M.	  tuberculosis	  RbpA	  on	  T.	  thermophilus	  RPo.	  	  Figure	  adapted	  with	  permission	  from	  
Hubin	  et	  al.	  (2015)	  can	  be	  accessed	  in	  Proc	  Natl	  Acad	  Sci	  USA.	  2015,	  112(23),	  7171-­‐7176.	  
Crl	  
Crl	  is	  a	  γ-­‐proteobacterial	  regulatory	  protein	  that	  binds	  to	  the	  group	  II	  sigma	  factor	  σS,	  the	  
so-­‐called	   “master	   regulator”	   of	   the	   stress	   response.	   	   Crl	   functions	   as	   an	   activator	   of	  
transcription	  from	  σS-­‐dependent	  promoters,	  purportedly	  through	  facilitating	  assembly	  of	  
σS	  with	  core	  RNAP	  (Pratt	  and	  Silhavy,	  1998;	  Gaal	  et	  al.,	  2006).	  	  In	  addition	  to	  this	  role	  it	  
has	   been	   suggested	   that	   Crl	   can	   potentiate	   promoter	   binding	   and	   open	   complex	  
formation	  (Bougdour	  et	  al.,	  2004;	  England	  et	  al.,	  2008).	   	  Bacterial	   two-­‐hybrid	  (BACTH)	  
experiments	  have	  identified	  that	  Crl	  interacts	  with	  domain	  2	  of	  σS	  (Monteil	  et	  al.,	  2010).	  	  	  
The	   full	  mechanism	  of	  how	  Crl	  promotes	  holoenzyme	  assembly	   is	  not	  yet	  understood	  
however	  it	  has	  been	  suggested	  to	  act	  as	  a	  tether	  or	  by	  promoting	  holoenzyme	  stability	  
(Banta	  et	  al.,	  2014).	  
1.2.6   The	  stringent	  response	  
The	  stringent	  response	  is	  an	  adaptive	  response	  to	  amino	  acid	  starvation	  observed	  in	  a	  
wide	  range	  of	  bacteria	  and	  plant	  chloroplasts.	  	  It	  is	  characterised	  by	  a	  number	  of	  changes	  
in	   cellular	   activity,	  most	   notably	   a	   decrease	   in	   stable	   RNA	   (rRNA	   and	   tRNA)	   synthesis	  
(Lazzarini	  and	  Dahlberg,	  1971),	  which	  can	  otherwise	  account	  for	  up	  to	  80%	  of	  bacterial	  
total	   RNA,	   and	   an	   increase	   in	   transcription	   of	   genes	   responsible	   for	   amino	   acid	  




RelA	  and	  (p)ppGpp	  synthesis	  
Early	  research	  into	  the	  stringent	  response	  identified	  a	  “magic	  spot”	  appearing	  on	  thin-­‐
layer	  chromatograms	  that	  coincided	  with	  nutrient	  limitation	  (Cashel	  and	  Gallant,	  1969).	  	  
Additionally,	   “magic	   spot”	  production	  was	  not	  observed	   in	   “relaxed”	   strains	  of	  E.	   coli,	  
unable	   to	  mount	  a	   stringent	   response.	   	   This	   “magic	   spot”	  was	   soon	   identified	  as	   two	  
phosphorylated	  nucleotides,	  guanosine	  tetraphosphate	  (ppGpp	  or	  MS	  I)	  and	  guanosine	  
pentaphosphate	  (pppGpp	  or	  MS	  II),	  collectively	  known	  as	  (p)ppGpp	  but	  often	  referred	  to	  
as	  ppGpp	  (Cashel	  and	  Kalbacher,	  1970).	  	  	  
(p)ppGpp	   synthesis	   occurs	   when	   a	   deacetylated	   tRNA,	   symptomatic	   of	   amino	   acid	  
starvation,	  enters	  the	  acceptor	  site	  (A-­‐site)	  of	  a	  ribosome	  (Haseltine	  and	  Block,	  1973).	  	  
RelA,	  bound	  to	  the	  50S	  ribosome	  subunit,	  detects	  the	  presence	  of	  the	  uncharged	  tRNA	  
and,	  through	  a	  change	  in	  conformation,	  begins	  synthesis	  of	  ppGpp	  and	  pppGpp	  from	  GDP	  
and	  GTP,	   respectively.	   	   In	  addition	   to	   these	  phosphorylated	  guanosine	  substrates,	   the	  
reaction	  also	  requires	  ATP	  as	  the	  source	  of	  two	  phosphate	  molecules.	  	  Upon	  synthesis	  of	  
ppGpp,	   RelA	   is	   dislodged	   from	   the	   ribosome	   although	   single-­‐molecule	   studies	   have	  
shown	   that	   it	   remains	   in	   an	   active	   conformation	   for	   a	   short	   amount	   of	   time	   and	  
synthesises	   ppGpp	   in	   the	   cytosol	   (Wendrich	   et	   al.,	   2002;	   English	   et	   al.,	   2011).	   	   This	  
supports	  the	  “hopping”	  model,	  which	  suggests	  that	  RelA	  moves	  between	  ribosomes	  and	  
explains	  how	  low	  concentrations	  of	  RelA	  (1	  per	  200	  ribosomes)	  (Pedersen	  and	  Kjeldgaard,	  
1977)	  can	  suitably	  monitor	  presence	  of	  uncharged	  tRNA	  molecules	  throughout	  the	  entire	  
cell.	  	  	  
In	   addition	   to	  RelA,	  E.	   coli	   possesses	  an	  additional	   gene	  with	  ppGpp	   synthase	  activity	  
called	  SpoT.	  	  Unlike	  RelA,	  SpoT	  produces	  ppGpp	  in	  response	  to	  diverse	  signals	  other	  than	  
amino	   acid	   starvation	   including	   fatty	   acid	   and	   iron	   limitation	   (Seyfzadeh	   et	   al.,	   1993;	  
Vinella	  et	  al.,	  2005).	  	  Compared	  to	  RelA,	  SpoT	  possesses	  weaker	  ppGpp	  synthase	  ability	  
and	  also	  has	  ppGpp	  hydrolase	  activity,	  allowing	  it	  to	  degrade	  ppGpp	  to	  GTP	  or	  GDP	  (Xiao	  
et	   al.,	   1991)	   	   Since	   the	   discovery	   of	   SpoT,	   proteins	  with	   ppGpp	   synthase	   activity	   are	  
referred	  to	  as	  RelA-­‐SpoT	  homologue	  (RSH)	  enzymes.	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Direct	  regulation	  of	  transcription	  by	  ppGpp	  and	  DksA	  
Following	  the	  discovery	  of	  ppGpp,	  characterisation	  of	  its	  synthesis	  via	  RelA	  in	  a	  range	  of	  
bacterial	  species	  and	  understanding	  of	  its	  effects	  on	  stable	  RNA	  synthesis,	  the	  mechanism	  
of	  action	  through	  which	  a	  small	  molecule	  exhibited	  such	  drastic	  physiological	  changes	  
remained	  unknown	  for	  a	  number	  of	  decades.	  	  To	  exhibit	  such	  a	  broad	  range	  of	  changes,	  
regulation	  of	  transcription	  through	  RNA	  polymerase	  was	  considered	  the	  most	  obvious	  
target	  (Wagner,	  2002).	  	  This	  idea	  was	  supported	  by	  multiple	  studies	  on	  Relaxed	  mutants	  
resistant	  to	  ppGpp	  possessing	  mutations	  in	  the	  rpoB	  gene	  (Nene	  and	  Glass,	  1983;	  Little	  
et	  al.,	  1983;	  Tedin	  and	  Bremer,	  1992).	  	  	  
In	   2001,	   authors	   Barker	   et	   al.	   identified	   ppGpp	   as	   a	   direct	   transcriptional	   regulator	  
through	  a	  series	  of	  in	  vitro	  and	  in	  vivo	  experiments	  (Barker	  et	  al.,	  2001b,	  2001a).	  	  In	  vivo	  
studies	  identified	  ppGpp-­‐null	  strains	  having	  lower	  activity	  from	  amino	  acid	  biosynthetic	  
promoters	  and	  higher	  activity	  from	  rRNA	  promoters.	  	  In	  vitro	  transcription	  experiments	  
identified	   ppGpp	   inhibits	   transcription	   from	   rRNA	   promoters	   at	   the	   initiation	   step	   by	  
decreasing	  the	  half-­‐life	  of	  RNAP	  open	  complexes	  (Barker	  et	  al.,	  2001b).	  	  Since	  promoters	  
have	   a	   wide	   variety	   of	   basal	   stability,	   ppGpp	   will	   destabilise	   and	   downregulate	  
transcription	  from	  some	  promoters	  more	  than	  others.	  	  rRNA	  promoters	  form	  unusually	  
unstable	   open	   complexes	   and	   are	   therefore	   particularly	   sensitive	   to	   ppGpp-­‐mediated	  
destabilisation	  (Barker	  et	  al.,	  2001b).	  	  ppGpp	  also	  has	  the	  ability	  to	  activate	  transcription	  
of	  many	  genes,	  including	  those	  responsible	  for	  amino	  acid	  biosynthesis.	  	  This	  was	  initially	  
thought	  to	  occur	  as	  an	  indirect	  effect	  of	  negative	  regulation;	  not	  only	  are	  these	  RNAP-­‐
promoter	   open	   complexes	   for	   these	   genes	   more	   stable	   but	   the	   reduction	   in	   rRNA	  
synthesis	  was	  thought	  to	  increase	  the	  availability	  of	  free	  RNAP	  to	  initiate	  new	  complexes	  
(Magnusson	   et	   al.,	   2007).	   	   In	   addition	   to	   this	   model	   for	   indirect	   activation,	   another	  
mechanism	  of	  direct	  activation	  was	  identified	  following	  the	  characterisation	  of	  DksA.	  	  
DksA	   is	   a	   secondary	   channel-­‐binding	   factor	   that	   acts	   synergistically	   with	   ppGpp	   to	  
potentiate	   the	   stringent	   response.	   	   It	   was	   initially	   identified	   as	   a	   suppressor	   of	  
temperature	  sensitive	  growth	  of	  DnaK	  deletion	  mutants	  when	  expressed	  on	  a	  multicopy	  
plasmid	  (DnaK	  suppressor	  A)	  (Kang	  and	  Craig,	  1990).	  	  dksA	  deletion	  mutants	  are	  unable	  
to	   regulate	   rRNA	   in	   response	   to	   changes	   in	  amino	  acid	   concentration,	   growth	   rate	  or	  
growth	  phase	  (Paul	  et	  al.,	  2004).	  	  In	  vitro	  transcription	  experiments	  identified	  that	  DksA	  
35	  
	  
greatly	  enhances	  the	  effects	  of	  ppGpp	  on	  inhibition	  rRNA	  transcription	  (Paul	  et	  al.,	  2004).	  	  
Before	   discovery	   of	   DksA,	   activation	   of	   transcription	   by	   ppGpp	   in	   vitro	   had	   not	   been	  
demonstrated.	   	   Subsequently,	   it	  was	   shown	   that	  DksA	  potentiates	  direct	  activation	  of	  
amino	  acid	  promoters	  by	  ppGpp	  in	  vitro	  (Paul	  et	  al.,	  2005).	  	  	  
Following	   x-­‐ray	   crystallography	   studies	   performed	   on	   T.	   thermophilus	   RNAP,	   it	   was	  
initially	  proposed	  that	  ppGpp	  binds	  RNAP	  at	  the	  active	  site	  (Artsimovitch	  et	  al.,	  2004).	  
Contrary	   to	   this,	   further	  mutagenesis	   of	   proposed	   binding	   residues	   in	   E.	   coli	   did	   not	  
weaken	  the	  effect	  of	  ppGpp	  in	  vitro	  and	  it	  was	  suggested	  that	  initial	  results	  could	  have	  
been	  influenced	  by	  an	  insufficient	  concentration	  of	  ω	  in	  RNAP	  preparations	  	  (Vrentas	  et	  
al.,	  2005,	  2008).	  	  Interestingly,	  it	  has	  since	  been	  shown	  that	  (p)ppGpp	  does	  not	  bind	  or	  
affect	  T.	   thermophilus	  RNAP	   in	  vitro	  but	  acts	   through	  other	  protein	   targets	   (Liu	  et	  al.,	  
2015).	  	  	  
The	  requirement	  of	  ω	  for	  RNAP	  to	  respond	  to	  ppGpp	  in	  vitro	  (Vrentas	  et	  al.,	  2005)	  was	  
soon	  better	  understood.	  	  Two	  independent	  crosslinking	  and	  structural	  studies	  on	  E.	  coli	  
RNAP	   identified	  a	  binding	  site	   for	  ppGpp,	  at	   the	   interface	  between	  ω	  and	  β’	   subunits	  
(Ross	   et	   al.,	   2013;	   Zuo	   et	   al.,	   2013).	   Site-­‐directed	  mutagenesis	   revealed	   that	   several	  
predicted	  binding	  residues	  are	  essential	  for	  a	  response	  to	  ppGpp.	  	  Considering	  the	  ppGpp	  
binding	   region	  of	  RNAP	   is	  not	  directly	   involved	   in	   the	  enzymatic	  activity	  of	  RNAP,	   the	  
mechanism	   of	   action	   of	   ppGpp	   is	   considered	   allosteric.	   	   The	   mechanism	   is	   not	   yet	  
understood	   although	   it	   has	   been	   suggested	   that	   ppGpp	   affects	   the	   stability	   of	   open	  
complexes	  through	  binding	  to	  the	  RNAP	  shelf	  and	  core	  domains	  involved	  in	  open	  complex	  
formation	  (Ross	  et	  al.,	  2013;	  Zuo	  et	  al.,	  2013).	  	  Additionally,	  it	  also	  also	  unknown	  how	  this	  
binding	  site	  and	  mechanism	  relates	  to	  the	  activity	  of	  DksA	  in	  the	  secondary	  channel.	  
Regulation	  of	  GTP	  biosynthesis	  by	  ppGpp	  
Direct	   regulation	   of	   RNAP	   by	   ppGpp	   has	   been	   well	   studied	   in	   E.	   coli	   however	   is	   not	  
conserved	   in	  all	  bacteria	  and	  alternative	   targets	   for	  controlling	   the	  stringent	  response	  
have	  been	  identified.	  	  In	  both	  E.	  coli	  and	  B.	  subtilis,	  rRNA	  promoters	  have	  been	  shown	  to	  
have	  characteristically	  short	  half-­‐lives	  dependent	  on	  high	  concentrations	  of	  the	  initiating	  
NTP	  (iNTP)	  (Gaal	  et	  al.,	  1997;	  Krásný	  and	  Gourse,	  2004).	   	  Whilst	  E.	  coli	  regulates	  rRNA	  
transcription	  through	  ppGpp	  binding	  RNAP,	   the	  stringent	  response	   in	  B.	  subtilis	  works	  
through	  regulation	  of	  concentrations	  of	  GTP,	  the	  iNTP	  at	  all	  rRNA	  promoters.	  	  ppGpp	  does	  
36	  
	  
not	  affect	  B.	  subtilis	  RNAP	  and	  the	  binding	  site	  is	  not	  conserved	  (Krásný	  and	  Gourse,	  2004;	  
Ross	  et	  al.,	  2013)	  but	   instead	   inhibits	   the	  activity	  of	  a	  number	  of	  enzymes	   in	   the	  GTP	  
biosynthesis	   pathway.	   	   Through	  metabolic	   profiling	   of	  WT	   and	  ppGpp0	  mutants	   upon	  
exposure	  to	  amino	  acid	  limitation,	  authors	  Kriel	  et	  al.	  (2012)	  were	  able	  to	  identify	  ppGpp	  
targets.	   	   Two	  enzymes,	  Gmk,	  which	   converts	  GMP	   to	  GDP,	   and	  HprT,	  which	   converts	  
hypoxanthine	  to	   IMP	  and	  guanine	  to	  GMP,	  were	   identified	  as	  putative	  ppGpp	  targets.	  	  
Microarray	  data	  showed	  that	  transcript	  levels	  weren’t	  affected	  but	  in	  vitro	  enzyme	  assays	  
showed	  ppGpp	  potently	  inhibited	  activity	  of	  both	  purified	  Gmk	  and	  HprT	  (Liu	  et	  al.,	  2015).	  
ppGpp	  and	  the	  stringent	  response	  in	  Streptomyces	  spp.	  
Following	   its	   discovery	   in	   E.	   coli,	   ppGpp	   was	   identified	   as	   present	   in	   a	   number	   of	  
Streptomyces	   species	   (Oki	   et	   al.,	   1975;	   Hamagishi	   et	   al.,	   1981;	   Ochi,	   1987a,	   1987b).	  	  
Following	   isolation	   of	   a	   number	   of	   relaxed	   mutants,	   a	   connection	   between	   the	  
production	  of	  ppGpp,	  antibiotic	  production	  and	  morphological	  differentiation	  was	  soon	  
made	   (Ochi,	   1986,	   1987b,	   1990).	   Relaxed	   mutants	   of	   Streptomyces	   sp.	   MA406-­‐A-­‐1,	  
S.	  griseus	  and	  S.	  coelicolor	  that	  lacked	  the	  ability	  to	  accumulate	  ppGpp	  were	  unable	  to	  
produce	   the	   antibiotics	   formycin,	   streptomycin,	   and	   actinorhodin	   and	   prodigiosin,	  
respectively.	   	   Strauch	   et	   al.	   (1991)	   were	   able	   to	   elicit	   the	   stringent	   response	   in	  
S.	  coelicolor	  by	  addition	  of	  serine	  hydroxamate	  or	  performing	  a	  nutrient	  downshift	  on	  
exponentially	  growing	  cultures.	  	  In	  response	  to	  these	  conditions,	  an	  increase	  in	  ppGpp	  
was	   observed	   and	   total	   RNA	   synthesis	   decreased.	   	   S1	   nuclease	  mapping	   experiments	  
performed	   on	   the	   rrnD	   gene	   set	   showed	   a	   decrease	   in	   transcription	   from	   all	   four	  
promoters.	  	  Interestingly,	  in	  these	  experiments,	  especially	  following	  nutrient	  downshift,	  
it	  was	  observed	  that	  an	  increase	  in	  ppGpp	  coincided	  with	  a	  drastic	  decrease	  in	  cellular	  
GTP	  concentrations.	  	  Deletion	  of	  the	  relA	  gene	  in	  S.	  coelicolor	  created	  a	  strain	  completely	  
unable	  to	  produce	  ppGpp	  upon	  entry	  into	  stationary	  phase	  (Chakraburtty	  and	  Bibb,	  1997;	  
Kang	  et	  al.,	  1998).	  	  Following	  amino	  acid	  depletion,	  the	  relA	  deletion	  mutant	  showed	  no	  
decrease	  in	  rRNA	  synthesis	  and	  failed	  to	  produce	  both	  ACT	  and	  RED.	  	  	  
In	  a	  novel	  method	  for	  studying	  the	  stringent	  response,	  Hesketh	  et	  al.	  (2001)	  placed	  an	  N-­‐
terminal	   truncation	   of	   relA	   under	   the	   control	   of	   a	   thiostrepton-­‐inducible	   promoter.	  	  
Expression	  of	  this	  fragment	  allowed	  production	  of	  ppGpp	  in	  a	  thiostrepton-­‐dependent	  
manner,	   independent	  of	  nutrient	  sufficiency.	   	  Microarray	  experiments	  performed	  with	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this	  strain	  revealed	  a	  more	  global	  picture	  of	  the	  stringent	  response	  in	  S.	  coelicolor	  but	  did	  
not	  provide	  an	  explanation	  for	  how	  ppGpp	  induces	  antibiotic	  production	  (Hesketh	  et	  al.,	  
2007).	   	   More	   recently,	   it	   has	   also	   been	   shown	   that	   ppGpp	   inhibits	   the	   enzyme	  
polynucleotide	   phosphorylase	   (PNPase)	   in	   Streptomyces	   spp.	   (Gatewood	   and	   Jones,	  
2010).	   	   PNPase	   is	   an	   enzyme	   with	   both	   exonuclease	   and	   RNA	   3’-­‐polyribonucleotide	  
polymerase	   activity,	   responsible	   for	   degradation	   of	   RNA	   and	   synthesis	   of	  
heteropolymeric	   RNA	   tails.	   	   Experiments	   showed	   that	   ppGpp	   effectively	   inhibits	   both	  
activities	  in	  vitro,	  as	  well	  increasing	  the	  half-­‐life	  of	  bulk	  mRNA	  in	  S.	  coelicolor.	  From	  this	  it	  
was	  suggested	   that	  an	   increase	   in	   stability	  of	  bulk	  mRNA	  may	  contribute	   to	  antibiotic	  
biosynthesis	   as	   part	   of	   the	   stringent	   response	   however	   this	   remains	   experimentally	  




Chapter	  2:	  	  
Materials	  and	  methods	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2   Materials	  and	  methods	  
2.1   Materials	  
2.1.1   Chemicals	  and	  reagents	  
•   Agarose	  (Melford)	  
•   Amaranth	  (Sigma-­‐Aldrich)	  
•   Ammonium	  Persulfate	  (APS)	  (Sigma-­‐Aldrich)	  
•   Ampicillin	  (Melford	  Laboratories)	  
•   Antifoam	  (Sigma-­‐Aldrich)	  
•   Apramycin	  (Duchefa	  Biochemie)	  
•   Bromophenol	  Blue	  (Amersham	  Biosciences)	  
•   Casamino	  Acids	  (Difco)	  
•   Chloramphenicol	  (Melford	  Laboratories)	  
•   Chloroform	  (Sigma-­‐Aldrich)	  
•   Deoxyribonucleotide	  phosphates	  (dNTPs)	  (New	  England	  Biolabs)	  
•   Dimethylsulphoxide	  (DMSO)	  (Sigma-­‐Aldrich)	  
•   Dithiothreitol	  (DTT)	  (Melford	  Laboratories)	  
•   Glycerol	  (Fisher	  Scientific)	  
•   Isopropyl-­‐β-­‐D-­‐thiogalactopyranoside	  (IPTG)	  (Melford	  Laboratories)	  
•   Kanamycin	  (Melford	  Laboratories)	  
•   Malt	  extract	  (Oxoid)	  
•   Mannitol	  (Sigma-­‐Aldrich)	  
•   Nalidixic	  acid	  (Duchefa	  Biochemie)	  
•   N,	  N-­‐dimethyl-­‐formamide	  (Fisher	  Scientific)	  
•   Nutrient	  agar	  (Difco)	  
•   Orange	  G	  dye	  (Fisher	  Scientific)	  
•   Phenol	  (Fisher	  Scientific)	  
•   Phenylmethylsulfonyl	  Fluoride	  (PMSF)	  (Sigma-­‐Aldrich)	  
•   1,4-­‐Piperazinediethanesulfonic	  acid	  (PIPES)	  (Sigma-­‐Aldrich)	  
•   Protease	  Inhibitor	  Cocktail	  tablets	  (Sigma-­‐Aldrich)	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•   Protein	  A	  magnetic	  beads	  (New	  England	  Biolabs)	  
•   Protein	  G	  magnetic	  beads	  (New	  England	  Biolabs)	  
•   SequaGel	  -­‐	  UreaGel	  System	  (National	  Diagnostics)	  
•   Sigmacote®	  (Sigma-­‐Aldrich)	  
•   Sodium	  dodecyl	  sulphate	  (SDS)	  (Fisher	  Scientific)	  
•   Sodium	  trichloroacetate	  (NaTCA)	  (Sigma-­‐Aldrich)	  
•   Soya	  flour	  (Infinity	  Foods)	  
•   Sucrose	  (Sigma-­‐Aldrich)	  
•   TES	   (N-­‐Tris(hydroxymethyl)methyl-­‐2-­‐aminoethane	   sulfonic	   acid)	   (Fisher	  
Scientific)	  
•   Tetramethyl-­‐ethylenediamine	  (TEMED)	  (Fisher	  Scientific)	  
•   Thrombin	  from	  bovine	  plasma	  (Sigma-­‐Aldrich)	  
•   Sodium	  tri-­‐isopropylnapthalene	  sulfate	  (TPNS)	  (Acros	  Organics)	  
•   Trichloroacetic	  acid	  (TCA)	  (Sigma)	  
•   Tris	  (2-­‐Amino-­‐2-­‐hydroxymethyl-­‐propane-­‐1,3-­‐diol)	  (Fisher	  Scientific)	  
•   Tryptone	  (Difco)	  
•   X-­‐gal	  (Melford	  Laboratories)	  
•   Xylene	  cyanol	  (Sigma-­‐Aldrich)	  
•   Yeast	  extract	  (Difco/Oxoid)	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2.1.2   Enzymes	  
DNA	  polymerases	  
•   DNA	  Polymerase	  I,	  Large	  (Klenow)	  Fragment	  (New	  England	  Biolabs)	  
•   Phusion	  High-­‐Fidelity	  DNA	  Polymerase	  (New	  England	  Biolabs)	  
•   GoTaq	  DNA	  Polymerase	  (qPCR	  Master	  Mix)	  (Promega)	  
DNA	  modifying	  enzymes	  
•   Antarctic	  Phosphatase	  (New	  England	  Biolabs)	  
•   T4	  DNA	  Kinase	  (New	  England	  Biolabs)	  
•   T4	  DNA	  Ligase	  (New	  England	  Biolabs)	  
DNA/RNA	  restriction	  enzymes	  
•   DNA	  endonucleases	  (New	  England	  Biolabs)	  
•   S1	  Nuclease	  (Life	  Technologies)	  
•   RNase	  A	  from	  bovine	  pancreas	  (Sigma-­‐Aldrich)	  
•   RQ1	  RNase-­‐free	  DNase	  (Promega)	  
•   RiboShredder™	  RNase	  Blend	  (Cambio)	  
2.1.3   Antibodies	  
•   anti-­‐FLAG	  M2	  monoclonal	  antibody,	  from	  mouse,	  Sigma	  F18041MG.	  
•   anti-­‐σHrdB	  polyclonal	  antibody,	  from	  rabbit,	  a	  gift	  from	  P.	  Doughty.	  
•   anti-­‐σR	  polyclonal	  antibody,	  from	  rabbit,	  a	  gift	  from	  M.	  Feeney	  and	  M.	  Buttner.	  
•   anti-­‐RNAP	  β	  subunit	  monoclonal	  antibody,	  from	  mouse,	  Abcam	  ab12087.	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2.1.4   Buffers	  and	  solutions	  
DNA	  Manipulation	  
TE	  buffer	  (pH	  8.0):	  	  10	  mM	  Tris-­‐HCl	  (pH	  8.0),	  1	  mM	  EDTA	  
10X	  TBE	  electrophoresis	  buffer	   (1	  L):	   	  108	  g	  Tris	  base,	  55	  g	  boric	  acid,	  9.3	  g	  Na2EDTA,	  
dissolved	  in	  1	  L	  dH2O	  
5X	  DNA	  loading	  buffer:	  40%	  sucrose,	  0.25%	  orange	  G	  dye,	  dissolved	  in	  dH2O	  
Alkaline	  lysis	  solution	  I:	  50	  mM	  Tris-­‐HCl	  (pH	  8.0),	  10	  mM	  EDTA	  
Alkaline	  lysis	  solution	  II:	  	  0.2	  N	  NaOH,	  1%	  (v/v)	  SDS,	  	  
Alkaline	  lysis	  solution	  III:	  	  3	  M	  potassium	  acetate	  (pH	  5.5)	  
2X	   Kirby	   mix	   (100	   mL):	   	   2	   g	   TPNS,	   12	   g	   sodium	   4-­‐aminosalicilate,	   5	   mL	   2M	   Tris-­‐HCl	  
(pH	  	  8.0),	  6	  mL	  equilibrated	  phenol	  (pH	  8.0),	  up	  to	  100	  mL	  with	  dH2O	  
Phenol:Chloroform:Isoamyl	   Alcohol	   (P:C:IAA)	   (50	   mL):	   25	   mL	   equilibrated	   phenol	  
(pH	  8.0),	  24	  mL	  chloroform,	  1	  mL	  isoamyl	  alcohol	  
STE	  buffer:	  10.3%	  sucrose,	  25	  mM	  Tris-­‐HCl	  pH	  8.0,	  25	  mM	  EDTA,	  2	  mg/ml	  lysozyme	  from	  
hen	  egg	  white	  
TFBI	  buffer:	  100	  mM	  RbCl2,	  50	  mM	  MnCl	  2	  .4H	  2	  O,	  30	  mM	  potassium	  acetate,	  10	  mM	  
CaCl2.2H2O,	  15%	  (v/v)	  glycerol	  
TFBII	  buffer:	  10	  mM	  MOPS,	  10	  mM	  RbCl2,	  10	  mM	  CaCl2.2H2O,	  15%	  (v/v)	  glycerol	  
S1	  Nuclease	  mapping	  
S1	  hybridisation	  buffer:	   	   2.53	  g	  PIPES	  dissolved	   in	  90	  mL	  dH2O,	  1.67	  mL	  0.5	  M	  EDTA,	  
adjusted	  to	  pH	  7.0,	  autoclaved.	  	  93.1	  g	  NaTCA	  added	  and	  volume	  up	  to	  167.4	  mL	  with	  
dH2O.	  	  Stored	  as	  100	  µL	  aliquots	  at	  -­‐70	  °C.	  
5X	  S1	  digestion	  buffer	  (100	  mL):	  	  1.4	  M	  NaCl,	  150	  mM	  sodium	  acetate	  (pH	  4.4),	  22.5	  mM	  
zinc	   acetate,	   100	   µg/mL	   partially-­‐cleaved,	   non-­‐homologous	   DNA,	   heated	   at	   97	   °C	   for	  
5	  min,	  stored	  at	  -­‐70	  °C.	  
S1	  termination	  solution:	  	  2.5	  M	  ammonium	  acetate,	  50	  mM	  EDTA.	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Formamide	  loading	  buffer:	  	  80%	  (w/v)	  deionised	  formamide,	  1	  mM	  EDTA,	  0.01%	  (w/v)	  
xylene	  cyanol,	  0.01%	  (w/v)	  bromophenol	  blue.	   	  For	   loading	  S1	  nuclease	  reactions	  add	  
10	  mM	  NaOH.	  
Protein	  purification	  
Ni-­‐NTA	  charge	  buffer:	  50	  mM	  NiCl2.6H2O	  
Ni-­‐NTA	  binding	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  0.5	  M	  NaCl,	  5	  mM	  imidazole	  
Ni-­‐NTA	  wash	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  0.5	  M	  NaCl,	  20	  mM	  imidazole	  
Ni-­‐NTA	  elution	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  0.5	  M	  NaCl,	  1	  M	  imidazole	  
Ni-­‐NTA	  strip	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  0.5	  M	  NaCl,	  100	  mM	  EDTA	  
Gel	  Filtration	  (GF)	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  50	  mM	  NaCl,	  5%	  (w/v)	  glycerol,	  5	  mM	  
β-­‐mercaptoethanol	  
Anion-­‐exchange	  binding	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  50	  mM	  NaCl,	  5%	  (v/v)	  glycerol,	  
5	  mM	  β-­‐mercaptoethanol	  
Anion-­‐exchange	  elution	  buffer:	  50	  mM	  Tris-­‐HCl	  pH	  7.9,	  1	  M	  NaCl,	  5%	  (v/v)	  glycerol,	  5	  mM	  
β-­‐mercaptoethanol	  
SDS-­‐PAGE	  Coomassie	  Brilliant	  Blue	  stain:	  0.25%	  (w/v)	  Coomassie	  Brilliant	  Blue	  (Sigma),	  
50%	  (v/v)	  methanol,	  10%	  (v/v)	  glacial	  acetic	  acid	  
SDS-­‐PAGE	  de-­‐stain	  solution:	  50%	  (v/v)	  methanol,	  10%	  (v/v)	  glacial	  acetic	  acid	  
In	  vitro	  transcription	  
RNAP	  dilution	  buffer:	  10	  mM	  Tris-­‐HCl,	  pH	  8.0,	  10	  mM	  KCl,	  5%	  (v/v)	  glycerol,	  0.4	  mg/ml	  
BSA,	  0.1%	  Triton	  X-­‐100	  and	  10	  mM	  β-­‐mercaptoethanol	  
2X	  in	  vitro	  transcription	  buffer:	  80	  mM	  Tris-­‐HCl	  pH	  7.9,	  20	  mM	  MgCl2,	  1.2	  mM	  EDTA,	  40%	  
glycerol.	  	  Autoclave	  and	  add	  0.1	  vol	  8	  mM	  KH2PO4	  pH	  7.5.	  	  Prior	  to	  use	  add	  1.5	  mM	  DTT	  
and	  0.25	  mg/mL	  BSA.	  
15X	  NTP	  mix:	  1.5	  mM	  ATP,	  1.5	  mM	  CTP,	  1.5	  mM	  GTP,	  0.75	  mM	  UTP,	  5	  mCi	  [α-­‐32P]	  UTP	  
Formamide	  loading	  buffer:	  	  80%	  (w/v)	  deionized	  formamide,	  1	  x	  TBE	  buffer,	  10	  mM	  EDTA,	  
0.08%	  (w/v)	  xylene	  cyanol,	  0.08%	  (w/v)	  amaranth.	  
44	  
	  
2.1.5   Strains	  
Streptomyces	  strains	  used	  and	  created	  in	  this	  study	  
Name	   Genotype	   Reference	  
M145	   SCP1-­‐	  SCP2-­‐	   (Bentley	  et	  al.,	  2002)	  
J1915	   M145	  ∆glkA	  	   (Kelemen	  et	  al.,	  1995)	  
S101	   J1915	  ∆rbpA::aac(3)IV	   (Newell	  et	  al.,	  2006)	  
S129	   M145	  ∆rpoC::rpoCHIS	  ΔrbpA::aac(3)IV)	   (Newell	  et	  al.,	  2006)	  
M570	   M600	  ∆relA::hyg	   (Chakraburtty	  and	  Bibb,	  1997)	  
	   M145	  ∆dksA	   This	  study,	  chapter	  3	  
	   M145	  ∆SCO6164	  ∆SCO6165	   This	  study,	  chapter	  3	  
	   M145	  ∆dksA	  ∆SCO6164	  ∆SCO6165	   This	  study,	  chapter	  3	  
S200	   J1915	  ∆carD::hyg	  tipAp-­‐carD	   This	  study,	  chapter	  4	  
S201	   J1915	  ∆carD::hyg	  pRT802::carD-­‐DAS+4	   This	  study,	  chapter	  4	  
S202	   J1915	  ∆carD::hyg	  pRT802::carD-­‐3XFLAG	   This	  study,	  chapter	  5	  
Table	  2.1	  –	  A	  table	  listing	  the	  Streptomyces	  strains	  used	  in	  this	  study	  
E.	  coli	  strains	  used	  in	  this	  study	  
Table	  2.2	  –	  A	  table	  listing	  the	  E.	  coli	  strains	  used	  in	  this	  study.	  
	   	  
Name	   Genotype	   Reference	  
DH5α	  
	  
F–	  Φ80lacZΔM15	  Δ(lacZYA-­‐argF)	  
U169	  recA1	  endA1	  hsdR17	  (rK–,	  mK+)	  phoA	  supE44	  
λ–	  thi-­‐1	  gyrA96	  relA1	  
(Angelis,	  1986)	  




dam-­‐13::Tn9,	  dcm-­‐6,	  hsdM,	  Cmr,	  pUZ8002	  is	  a	  derivative	  
of	  RK2	  with	  a	  mutation	  in	  the	  oriT	  (aph)	  
(MacNeil	   et	   al.,	  
1992;	   Paget	   et	   al.,	  
1999b)	  
ET12567	  (pR9406)	   dam-­‐13::Tn9,	  dcm-­‐6,	  hsdM,	  Cmr,	  pR	  is	  a	  derivative	  of	  RK2	  
with	  a	  mutation	  in	  the	  oriT	  (amp)	  
(Jones	  et	  al.,	  2013)	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2.1.6   Plasmids	  
Name	   Features	   Source/Reference	  
pBluescript	  II	  SK+	   E.	  coli	  sub-­‐cloning	  vector:	  
bla,	  lacZα,	  AmpR	  
Stratagene,(Alting-­‐Mees	  
and	  Short,	  1989)	  
pIJ6902	   S.	  coelicolor	  integrative	  expression	  plasmid:	  
aac(3)IV,	  tipAp,	  oriT,	  tsr,	  ΦC31	  attP,	  AprR,	  ThioR	  
(Huang	  et	  al.,	  2005)	  
pIJ6650	   S.	  coelicolor	  counter-­‐selectable	  suicide	  plasmid:	  
aac(3)IV,	  oriT,	  glkA,	  lacZα,	  ori	  (pUC18),	  AprR	  
(Paget	  et	  al.,	  2001b)	  
pKC1132	   S.	  coelicolor	  suicide	  plasmid:	  
aac(3)IV,	  oriT,	  lacZα,AprR	  
(Bierman	  et	  al.,	  1992)	  
pIJ963	   S.	  coelicolor	  plasmid,	  possesses	  hyg	  gene.	   (Zalacain	  et	  al.,	  1986)	  
pSX162	   S.	  coelicolor	  integrative	  expression	  plasmid:	  
aac(3)IV,	  oriT,	  ermEp*,	  lacZα,	  ΦC31	  attP,	  AprR.	  
(Newell	  et	  al.,	  2006)	  
pRT802	   S.	  coelicolor	  integrative	  plasmid:	  
aphII,	  oriT,	  lacZα,	  ΦBT1	  attP,	  KanR.	  
(Gregory	  et	  al.,	  2003)	  
pET15b	   E.	  coli	  T7	  based	  His-­‐tag	  expression	  vector,	  AmpR	   Novagen	  
Table	  2.3	  –A	  table	  listing	  the	  plasmids	  used	  in	  this	  study.	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2.1.7   Oligonucleotides	  
All	  oligonucleotides	  are	  5’	  to	  3’	  with	  restriction	  sites	  in	  bold.	  
Chapter	  3	  
Name	   Sequence	  (5'	  to	  3')	   	  
DksA_HindIII_F	   CCAAGCTTGTGACGTAGTCGGCGTTCAC	   dksA	  upstream	  flank	  
DksA_BamHI_R	   CCGGATCCCGTCTTCTTCTTCGCCACCATG	  
DksA_BamHI_F	   CCGGATCCAAGCAGGAGCGCCGGTACTGAG	   dksA	  downstream	  flank	  
DksA_EcoRI_R	   CCGAATTCAGCAGGGAGGCGGCGCGGAAG	  
61645_up_for	   CCCAAGCTTCGGCTCCCGGTCGAGGATGA	   SCO6164/5	  upstream	  flank	  
61645_up_rev	   CCCTCTAGAGCGGGAGGCGTCGAGCGACAC	  
61645_down_for	   CCCTCTAGAGTGCGGGAGGCCGGACGATGA	   SCO6164/5	  downstream	  flank	  
61645_down_rev	   CCCGAATTCGAGAAGCAGGTGCGGTGCTT	  
61645_col_for	   CGCGGCATACCCATATGGCC	   ∆SCO6164-­‐5	  colony	  PCR	  
61645_col_rev	   AAGGTCACCGTCGGCACGTC	  
DksA_O_F	   GGGATCCCTCCTGCTTCTGCTTGCACTC	   dksA	  overexpression	  
DksA_O_R	   GAAGCTTGACTGAGCACGAGGGTAC	  
F_D164N	   GAGGCGGACACAGGCAGCAAGAACATCA	   dksA	  D164N	  mutagenesis	  
R_D164N	   GTTGTCGCCCGCGCCGTCGCCGGA	  
F_D167N	   ACAGGCAGCAAGAACATCACGCGCGA	   dksA	  D167N	  mutagenesis	  
R_D167N	   GTTCGCCTCGTCGTCGCCCGCGCCGT	  
F_D1647N	   GCGAACACAGGCAGCAAGAACATCACGCGCG
A	  
dksA	  D164/7N	  mutagenesis	  
R_D1647N	   CTCGTTGTCGCCCGCGCCGTCGCCGGA	  
Table	  2.4	  -­‐	  A	  table	  listing	  the	  DNA	  oligonucleotides	  used	  in	  chapter	  3	  of	  this	  study.	  




Name	   Sequence	  (5'	  to	  3')	   	  
carD_eco_F	   CGAATTCGTCCACCGGACACGGCGAAG	   carD	  upstream	  flank	  
carD_bam_R	   CGGATCCTCCTTTGATCTGGCGAGTTTC	  
carD_bam_F	   CGGATCCCTCGCCTCCTGATCCGACTG	  	   carD	  downstream	  flank	  
carD_xba_R	  	   GTCTAGACCACCTGCACCGCGACGTTC	  	  
carD_D_F	   GCATATGACGTTCAAGGTTGGCGAC	  	   carD	  expression	  from	  tipAp	  
carD_O_R	  	   GAAGCTTAGTCGGATCAGGAGGCGAGCAC	  
ext_carD_F	  	   CCAGATCTATACAGGTCGGGATCGGTAC	  	   carD	  full	  complementation	  
ext_carD_R	  	   CCAGATCTAATCACGGCGGCGGTCCTGG	  	  
carD_3XFLAG_F	  	   CCCCAAGCTTTCGCACACGCGGAACCGGAC	   carD-­‐DAS+4/3XFLAG	  
carD_3XFLAG_R	  	   CCCCAAGCTTGGAGGCGAGCACCTCGTCGA	  
atpIp_F	   GCCGCAATACCAGACAAGTTGC	   atpIp	  in	  vitro	  transcription	  
atpIp_R	   GCCGCGGGCACGGCAGCCTG	  
rrnDp1-­‐4_F	   GTGACGTCGAGGCAGCCGAAC	   rrnDp1-­‐4	  in	  vitro	  transcription	  	  























rrnD_S1_F	   GTGACGTCGAGGCAGCCGAAC	   rrnDp1-­‐4	  S1	  mapping	  probe	  
rrnD_S1_R	   GTATCAACATATCTGGCGTTG	  




Name	   Sequence	  (5'	  to	  3')	   	  
RbpA_3XFLAG_F	   CCACTAGTCCAAGCTTCGGCTGCGGCTGCGAC	   rbpA-­‐3XFLAG	  
RbpA_3XFLAG_R	   CCGGATCCCTACTTATCGTCATCGTCCT	  
Table	  2.6	  -­‐	  A	  table	  listing	  the	  DNA	  oligonucleotides	  used	  in	  chapter	  5	  of	  this	  study	  
Chapter	  6	  
Name	   Sequence	  (5'	  to	  3')	   	  
PSCO6551_F	   	  GCGCTTTACACAGCGTGAG	  	  	  	  	  	   SCO6551p	  promoter	  qPCR	  
PSCO6551_R	   	  GATCCTTCGGTTGTGGTCAG	  	  	  	  	  	  
PSCO2763_F	  	   CGTACGCGCCTGATCACC	   SCO2763p	  promoter	  qPCR	  
PSCO2763_R	  	  	   CCTGCTCACCTGATCTACCG	  	  	  
PTRXC_EXT	   CAGTGCGAGGTGAACTCGTCC	   trxCp	  in	  vitro	  transcription	  
PTRXC_INT	   CACCACTCCGCCCAGAAGTCG	  
SigA_F	   GGCATATGGCAGCGACCAAAGCAAG	   σ
A	  expression	  
SigA_R	   CCAGATCTGCGCTCTCAGTCCAGGTAGTCGCG	  
SigA-­‐VRA_F	   CGCGCCACGCAGCTGATGACCGAGCTTAGCGAG	   σ
A	  (VR)	  mutagenesis	  
SigA-­‐VRA_R	   GACGCCAGCCTCGATCCGCTTGGCTAGCTCGAC	  
SigA-­‐double_F	   GCTGGCGTCCGCGCCACGCAGCTGATGACCGAG
CTTAGC	  
σA	  (RTVR)	  mutagenesis	  
SigA-­‐double_R	   CTCGATCCGGGTGGCTAGGCGGACCTCTTCCTCG
GCGTTG	  
Table	  2.7	  –	  A	  table	  listing	  the	  DNA	  oligonucleotides	  used	  in	  chapter	  6	  of	  this	  study	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2.2   Growth,	  selection	  and	  storage	  of	  bacterial	  strains	  
2.2.1   Media	  
E.	  coli	  
Lennox	  broth	   (LB):	  A	   liquid	  media	  used	   for	  growth	  of	  E.	  coli	  strains.	   	  10	  g	  Difco	  Bacto	  
tryptone,	  5	  g	  Difco	  yeast	  extract,	  5	  g	  NaCl,	  1	  g	  glucose	  dissolved	  in	  1	  L	  dH2O.	  	  Typically	  
divided	  into	  100	  mL	  aliquots	  in	  screw	  cap	  bottles	  and	  autoclaved.	  	  	  
Lennox	   agar	   (LA):	   A	   solid	   media	   used	   for	   growth	   of	   E.	   coli	   strains.	   10	   g	   Difco	   Bacto	  
tryptone,	  5	  g	  Difco	  yeast	  extract,	  5	  g	  NaCl,	  1	  g	  glucose	  dissolved	  in	  1	  L	  dH2O.	  	  Typically	  
divided	  into	  100	  mL	  aliquots	  in	  250	  mL	  Erlenmeyer	  flasks	  with	  1.5	  g	  agar,	  stoppered	  with	  
a	  foam	  bung	  and	  foil,	  and	  autoclaved.	  
2	  x	  YT	  broth:	  A	  richer	  liquid	  media	  used	  for	  growth	  of	  E.	  coli	  strains.	  	  Also	  used	  when	  heat	  
shocking	  Streptomyces	  spores	  in	  conjugation	  protocol.	  	  	  
Streptomyces	  
Mannitol	  soya	  flour	  (MS)	  agar:	  	  A	  solid	  media	  used	  for	  general	  growth	  of	  Streptomyces	  
strains,	  especially	  when	  good	  sporulation	  is	  required.	  	  20	  g	  mannitol	  dissolved	  in	  1	  L	  tap	  
water.	  	  Typically	  divided	  into	  100	  mL	  aliquots	  in	  250	  mL	  Erlenmeyer	  flasks	  with	  2	  g	  agar	  
and	   2	   g	   soya	   flour,	   stoppered	  with	   a	   foam	   bung	   and	   foil,	   and	   autoclaved	   twice	  with	  
shaking	  in	  between.	  
2	   x	   Pre-­‐germination	   (PG)	   medium:	   	   A	   liquid	   media	   used	   for	   pre-­‐germination	   of	  
Streptomyces	  spores	  before	  liquid	  cultures.	  	  1	  g	  Difco	  yeast	  extract,	  1	  g	  Difco	  casamino	  
acids,	   dissolved	   in	   100	  mL	   dH2O.	   	   Typically	   divided	   into	   10	  mL	   aliquots	   in	   screw	   cap	  
universal	  bottles	  and	  autoclaved.	  
Difco	   Nutrient	   (DN)	   agar:	   A	   rich,	   solid	  media	   used	   for	   rapid	   growth	   of	   Streptomyces	  
strains	  for	  testing	  antibiotic	  resistance/sensitivity.	  	  2.3	  g	  Difco	  nutrient	  agar	  dissolved	  in	  
100	  mL	  dH2O	  and	  autoclaved.	  
YEME	  (10%	  sucrose):	  A	  rich,	  liquid	  media	  used	  for	  growth	  of	  Streptomyces	  strains.	  	  3	  g	  
Difco	  yeast	  extract,	  5	  g	  Difco	  bacto-­‐peptone,	  3	  g	  Oxoid	  malt	  extract,	  10	  g	  glucose	  (or	  10	  
g	  glycerol	  for	  J1915	  based	  strains),	  100	  g	  sucrose,	  dissolved	  in	  1	  L	  dH2O	  and	  autoclaved.	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Prior	   to	   use	   add	   2	  mL/litre	   2.5	  M	  MgCl2.6H2O	   (5	  mM	   final)	   and	   1	  mL/litre	   10%	   (v/v)	  
antifoam.	  
Supplemented	   minimal	   medium,	   solid	   (SMMS):	   	   A	   minimal,	   solid	   medium	   used	   for	  
production	   of	   S.	   coelicolor	   antibiotics.	   	   2	   g	   Difco	   casamino	   acids,	   5.73	   g	   TES	   buffer,	  
dissolved	  in	  1	  L	  dH2O	  and	  adjusted	  to	  pH	  7.2	  with	  5N	  NaOH.	  	  Typically	  divided	  into	  200	  mL	  
aliquots	  in	  250	  mL	  Erlenmeyer	  flasks	  with	  3	  g	  agar,	  stoppered	  with	  a	  foam	  bung	  and	  foil,	  
and	  autoclaved.	  	  Prior	  to	  use	  add	  2	  mL	  50	  mM	  NaH2PO4	  +	  K2HPO4	  (1	  mM	  final),	  1	  mL	  1M	  
MgSO4	   (5mM	   final),	   3.6	  mL	   50%	   (w/v)	   glucose	   (50	  mM	   final)	   and	   0.2	  mL	   SMM	   trace	  
element	  solution	  (see	  below).	  
SMM	   trace	   element	   solution:	   0.1	   g/L	   each	   of	   ZnSO4.7H2O,	   FeSO4.7H2O,	  MnCl2.4H2O,	  
CaCl2.6H2O,	  and	  NaCl,	  made	  fresh	  over	  2-­‐4	  weeks,	  stored	  at	  4	  °C.	  
Minimal	  media	  (MM):	  A	  minimal,	  solid	  medium	  used	  for	  growth	  of	  Streptomyces	  strains	  
and	  screening	   for	  2-­‐deoxyglucose	  sensitivity.	   	  0.5	  g	  L-­‐asparagine,	  0.5	  g	  K2HPO4,	  0.2	  g	  
MgSO4.7H2O,	  0.01	  g	  FeSO4.7H2O,	  5	  g	  mannitol,	  dissolved	   in	  1	  L	  dH2O	  and	  adjusted	   to	  
pH	  7.0	  -­‐	  7.2.	  	  Typically	  divided	  into	  200	  mL	  aliquots	  in	  250	  mL	  Erlenmeyer	  flasks	  with	  2	  g	  
agar,	  stoppered	  with	  a	  foam	  bung	  and	  foil,	  and	  autoclaved.	  	  	  
2.2.2   Antibiotic	  selection	  






Ampicillin	  (amp)	   100	  mg/mL,	  dissolved	  in	  dH2O,	  	  filter	  sterilised	   100	  µg/mL	   100	  µg/mL	  
Apramycin	  (apr)	   50	  mg/mL,	  dissolved	  in	  dH2O,	  	  filter	  sterilised	   25	  µg/mL	   25	  µg/mL	  
Chloramphenicol	  (cml)	   34	  mg/ml,	  dissolved	  in	  100%	  EtOH	   34	  µg/mL	   25	  µg/mL	  
Hygromycin	  (hyg)	   50	  mg/mL,	  dissolved	  in	  dH2O,	  	  filter	  sterilised	   10	  µg/mL	   10	  µg/mL	  
Kanamycin	  (kan)	   50	  mg/mL,	  dissolved	  in	  dH2O,	  	  filter	  sterilised	   20	  µg/mL	   20	  µg/mL	  
Nalidixic	  acid	  (nali)	   25	  mg/mL,	  dissolved	  in	  0.15	  M	  NaOH	   25	  µg/mL	   25	  µg/mL	  
Thiostrepton	  (thio)	   50	  mg/mL,	  dissolved	  in	  DMSO	   15	  µg/mL	   15	  µg/mL	  
Table	  2.8	  -­‐	  A	  table	  listing	  the	  antibiotics	  used	  in	  this	  study	  and	  stock/working	  concentrations	  in	  liquid	  and	  solid	  media.	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2.2.3   Growth	  and	  storage	  
E.	  coli	  
General	  growth	  conditions:	  	  E.	  coli	  were	  grown	  on	  solid	  or	  liquid	  media	  at	  37	  °C	  for	  up	  to	  
24	  h.	  	  For	  liquid	  culture,	  E.	  coli	  were	  grown	  in	  LB	  (with	  selection)	  in	  an	  orbital	  shaker	  at	  
250	  rpm.	  	  For	  solid	  culture,	  E.	  coli	  were	  grown	  on	  LA	  (with	  selection)	  and	  once	  colonies	  
formed	  plates	  were	  stored	  at	  4	  °C	  for	  up	  for	  2	  weeks.	  
Making	  glycerol	  stocks:	  	  For	  long	  term	  storage	  of	  E.	  coli	  strains,	  0.5	  mL	  40%	  glycerol	  was	  
added	  to	  0.5	  mL	  overnight	  culture	  and	  stored	  at	  -­‐80	  °C.	  
Streptomyces	  
General	  growth	  conditions:	  Streptomyces	  were	  grown	  on	  solid	  media	  at	  30	  °C	   for	  5-­‐7	  
days	  until	  colony	  formation	  and	  sporulation.	  
Growing	  S.	  coelicolor	  liquid	  cultures:	  Spore	  stock	  concentrations	  were	  measured	  and	  the	  
required	  volume	  to	  give	  a	  starting	  OD450	  of	  0.05	  was	  added	  1	  mL	  TES	  buffer.	  	  The	  mixture	  
was	   briefly	   centrifuged,	   the	   supernatant	   was	   removed	   and	   the	   spore	   pellet	   was	  
resuspended	  in	  1	  mL	  of	  TES	  buffer.	  	  The	  spore	  suspension	  was	  heat	  shocked	  at	  50	  °C	  for	  
10	  min,	  mixed	  with	  1	  mL	  2	  X	  PG	  media	  and	  2	  µL	  5	  M	  CaCl2,	  and	  incubated	  in	  a	  universal	  
tube	  at	  37	  °C	  with	  vigorous	  shaking	  for	  3-­‐5	  h.	  Following	  pre-­‐germination	  of	  spores,	  the	  
culture	  was	  briefly	  centrifuged	  and	  resuspended	  in	  1	  mL	  YEME	  media.	  	  The	  suspension	  
was	  used	   to	   inoculate	   the	  S.	   coelicolor	   liquid	   culture	  which	  was	   grown	  at	   30	  °C	   in	   an	  
orbital	  shaker	  at	  200	  rpm.	  	  S.	  coelicolor	  were	  grown	  in	  Erlenmeyer	  flasks	  with	  a	  stainless	  
steel	  spring	  loop	  in	  the	  base	  of	  the	  flask	  to	  prevent	  formation	  of	  mycelium	  clumps	  and	  
improve	  aeration.	  
Making	   spore	   stocks:	   	   A	   single	   colony	   was	   streaked	   to	   confluency	   on	   MS	   agar	   and	  
incubated	  at	  30	  °C	  for	  5	  days	  until	  the	  mycelium	  turned	  dark	  grey,	  indicating	  production	  
of	  mature	   spores.	   	   To	  harvest	   spores,	  9	  mL	   sterile	  water	  was	  added	   to	   the	  plate	  and	  
scraped	  with	  a	  metal	   loop	  suspending	  spores	  in	  the	  water.	   	  The	  crude	  suspension	  was	  
filtered	  through	  a	  "spore	  tube"	  (2	  cm	  of	  non-­‐absorbent	  cotton	  wool	  in	  a	  10	  mL	  syringe,	  
autoclaved	  to	  sterilise)	  into	  a	  15	  mL	  tube	  and	  centrifuged	  at	  1,000	  x	  g	  for	  10	  min.	  	  The	  
supernatant	  was	  discarded	  and	  the	  pellet	  was	  resuspended	  in	  1-­‐2	  mL	  sterile	  20%	  glycerol.	  	  
52	  
	  
Spore	  stocks	  were	  stored	  at	  -­‐20	  °C	  and	  remain	  viable	  for	  years,	  even	  if	  repeatedly	  thawed	  
and	  re-­‐frozen.	  
Making	  mycelial	  preps:	  	  For	  strains	  defective	  in	  sporulation,	  a	  single	  colony	  was	  streaked	  
to	  confluency	  on	  MS	  agar	  and	  incubated	  at	  30	  °C	  for	  5	  days.	   	  10	  mL	  sterile	  water	  was	  
added	  to	  the	  plate	  and	  vigorously	  scraped	  with	  a	  metal	  loop	  suspending	  the	  mycelium	  in	  
the	  water.	  	  5	  mL	  of	  the	  suspension	  was	  used	  to	  inoculate	  50	  mL	  YEME	  (with	  appropriate	  
selection)	  and	  grown	  in	  a	  sprung	  flask	  for	  1-­‐2	  days	  at	  30	  °C	  in	  a	  250	  rpm	  shaking	  incubator.	  	  
Once	   sufficiently	   grown,	   the	   culture	  was	   transferred	   to	   a	   50	  mL	   centrifuge	   tube	   and	  
centrifuged	  at	  2,000	  x	  g	  for	  10	  min.	  	  The	  pellet	  was	  washed	  with	  25	  mL	  10.3%	  sucrose	  
solution,	  centrifuged	  at	  2,000	  x	  g	  for	  10	  min	  and	  resuspended	  in	  5	  mL	  20%	  glycerol	  before	  
dividing	  into	  200	  µL	  aliquots	  and	  frozen	  at	  -­‐70	  °C.	  
Replica	  plating:	  An	  MS	  agar	  plate	  containing	  ~300	  sporulating	  colonies	  was	  pressed	  onto	  
a	  sterile	  velvet	  firmly	  enough	  to	  transfer	  spores	  only.	  The	  velvet	  was	  then	  “replica	  plated”	  
onto	  a	  maximum	  of	  four	  DN	  agar	  plates	  with	  selection	  for	  different	  antibiotic	  resistance	  
markers.	  Typically,	  the	  last	  plate	  was	  non-­‐selective	  to	  confirm	  absence	  of	  growth	  on	  any	  
previous	  plates	  was	  due	  to	  antibiotic	  selection	  and	  not	  a	  problem	  transferring	  cells.	  Plates	  
were	  incubated	  overnight	  at	  30	  °C	  to	  show	  antibiotic	  sensitive	  and	  resistant	  colonies	  on	  
the	  original	  plate.	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2.3   DNA	  Manipulation	   	  
2.3.1   DNA	  digest	  
DNA	   digests	   were	   typically	   performed	   with	   ~1	   µg	   plasmid	   DNA,	   dissolved	   in	   1X	  
appropriate	   restriction	   buffer	   and	   ~10U	   restriction	   enzyme.	   Digests	   were	   typically	  
performed	  at	  37	  °C	  at	  least	  3	  h.	  
2.3.2   Polymerase	  Chain	  Reaction	  (PCR)	  
Polymerase	  chain	  reactions	  were	  performed	  in	  0.2	  mL	  thin-­‐walled	  reaction	  tubes	  using	  
the	  following	  components:	  
Component	   Volume	   Final	  Concentration	  
5X	  Phusion	  HF	  or	  GC	  Buffer	   10	  µL	   1X	  
10	  mM	  dNTPs	   1	  µL	   200	  µM	  
10	  µM	  Forward	  Primer	   2.5	  µL	   0.5	  µM	  
10	  µM	  Reverse	  Primer	   2.5	  µL	   0.5	  µM	  
Template	  DNA	   variable	   <	  250	  ng	  
DMSO	  (optional)	   (1.5	  µL)	   3%	  
Phusion	  DNA	  Polymerase	   0.5	  µL	   1.0	  units/50	  µL	  PCR	  
Nuclease-­‐free	  water	   to	  50	  µL	   	  	  
	  
Reaction	  conditions	  were	  varied	  according	  to	  primer	  melting	  temperature	  and	  required	  
PCR	  product	  size	  as	  follows:	  	  
Step	  	   Temperature	   Time	  
Initial	  Denaturation	   98	  °C	   30	  s	  
25-­‐35	  Cycles	   98	  °C	  
45–72	  °C	  
72	  °C	  
5	  -­‐	  10	  s	  
10	  -­‐	  30	  s	  
15	  -­‐	  30	  s	  per	  kb	  
Final	  Extension	   72	  °C	   5	  -­‐	  10	  min	  
Hold	   4–10	  °C	   	  	  
	  
2.3.3   S.	  coelicolor	  colony	  PCR	  
A	  colony	  was	  picked	   from	  an	  MS	  agar	  plate,	  homogenised	   in	  50	  µL	  dH2O	   in	  a	  1.5	  mL	  
microcentrifuge	  tube,	  and	  heated	  in	  a	  boiling	  water	  bath	  for	  5	  min.	  	  The	  cell	  debris	  was	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removed	  by	  centrifugation	  at	  16,000	  x	  g	  for	  2	  min	  and	  2	  µL	  of	  the	  supernatant	  was	  used	  
as	  template	  DNA	  in	  standard	  PCR	  reaction	  conditions.	  
2.3.4   Inverse	  PCR	  for	  site-­‐directed	  mutagenesis	  
Prior	  to	  PCR,	  200	  pmol	  of	  each	  primer	  was	  phosphorylated	  in	  1X	  T4	  kinase	  buffer	  with	  2	  
mM	   ATP	   and	   0.005U	   T4	   DNA	   kinase	   (New	   England	   Biolabs).	   	   The	   reaction	   mix	   was	  
incubated	  at	  37	  °C	  for	  30	  min	  before	  heat	  inactivation	  at	  90	  °C	  for	  5	  min.	  	  Phosphorylated	  
primers	  were	  used	  for	  PCR	  following	  standard	  conditions.	   	  Following	  PCR,	  the	  product	  
was	  self-­‐ligated	  following	  standard	  conditions,	  treated	  with	  ~10U	  DpnI	  enzyme	  to	  remove	  
plasmid	  template	  and	  transformed	  into	  competent	  E.	  coli.	  
2.3.5   Gel	  electrophoresis	  
Agarose	  gel	  electrophoresis	  was	  used	  for	  analysis	  of	  DNA	  size	  and	  quality.	  0.8%	  and	  1%	  
agarose	  gels	  were	  used	  for	  undigested	  plasmids	  and	  DNA	  fragments	  respectively,	  run	  at	  
2	  V/cm.	  For	  visualisation,	  gels	  were	  post-­‐stained	  with	  GelRed™	  Nucleic	  Acid	  Gel	   Stain	  
(Biotium)	  according	  to	  manufacturer’s	  instructions.	  The	  stained	  gel	  was	  visualised	  using	  
a	  UV	  transilluminator.	  
2.3.6   Gel	  purification	  
To	   purify	   DNA	   fragments	   following	   gel	   electrophoresis,	   agarose	   gel	   fragments	   were	  
excised	  with	  a	  scalpel	  and	  purified	  with	  the	  Wizard®	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System	  
(Promega)	  according	  to	  manufacturer's	  instructions.	  
2.3.7   DNA	  dephosphorylation	  
DNA	  was	  dephosphorylated	   in	   1X	  Antarctic	   Phosphatase	  buffer	  with	  5	  units	  Antarctic	  
Phosphatase	   (New	  England	  Biolabs)	  and	   incubated	  at	  37	   °C	   for	  15	  min	   (60	  min	   for	  3’	  




2.3.8   DNA	  ligation	  
DNA	   ligations	  were	   typically	   performed	   in	  10	  µL	  1X	  T4	   ligase	  buffer	  with	   an	   insert	   to	  
vector	  ratio	  of	  3:1	  and	  0.2U	  T4	  DNA	  ligase	  (New	  England	  Biolabs).	  	  Ligations	  were	  typically	  
performed	  at	  16	  °C	  for	  at	  least	  3	  h.	  
2.3.9   Oligonucleotide	  annealing	  for	  construction	  of	  dsDNA	  fragments	  
To	   anneal	   single	   stranded	   oligonucleotides	   for	   construction	   of	   double	   stranded	   DNA	  
fragments,	  10	  µL	  of	  each	  oligo	  (100	  µM)	  were	  added	  to	  25	  µL	  nuclease-­‐free	  water	  and	  
5	  µL	  NEBuffer	  3	   restriction	  digest	  buffer.	   	   The	  mixture	  was	  heated	  at	  95	   °C	   for	  5	  min	  
before	  allowing	   to	  cool	   to	   room	  temperature.	   	  The	  mixture	  was	  diluted	  100-­‐fold	  with	  
nuclease-­‐free	  water	  and	  1	  µL	  was	  added	  to	  a	  standard	  ligation	  mix	  before	  transformation	  
of	  E.	  coli.	  
2.3.10  Determining	  DNA/RNA	  concentration	  
For	  rough	  estimations,	  DNA	  and	  RNA	  concentrations	  were	  determined	  using	  a	  NanoDrop	  
1000	  (Thermo	  Fisher	  Scientific).	  	  1	  µL	  DNA	  was	  loaded	  onto	  the	  pedestal	  and	  measured	  
using	  the	  appropriate	  sample	  settings.	  	  For	  more	  accurate	  calculations	  typically	  prior	  to	  
in	  vitro	  assays,	  DNA	  concentrations	  were	  determined	  using	  a	  Qubit	  High	  Sensitivity	  DNA	  
Assay	  Kit	  and	  Qubit	  2.0	  Fluorometer	  according	  to	  manufacturer’s	  instructions.	  
2.4   Nucleic	  acid	  extraction	  and	  purification	  	  
2.4.1   Small	  scale	  plasmid	  isolation	  from	  E.	  coli	  (Wizard	  Miniprep)	  
To	  purify	  plasmid	  DNA	  from	  E.	  coli,	  the	  Wizard®	  Plus	  SV	  Miniprep	  DNA	  Purification	  System	  
was	  used	  according	  to	  manufacturer's	  instructions.	  
2.4.2   Small	  scale	  plasmid	  isolation	  from	  E.	  coli	  (Alkaline	  Lysis	  method)	  
To	  purify	  plasmid	  DNA	  from	  E.	  coli,	  cells	  were	  harvested	  from	  3	  mL	  overnight	  culture	  at	  
16,000	  x	  g	  for	  5	  min	  and	  the	  cell	  pellet	  was	  resuspended	  in	  200	  µL	  alkaline	  lysis	  solution	  
I.	  400	  µL	  alkaline	  lysis	  solution	  II	  was	  added,	  mixed	  by	  inverting	  5	  times	  before	  addition	  
of	  300	  µL	  alkaline	  lysis	  solution	  III	  +	  1	  µL	  10	  mg/mL	  RNase	  A	  and	  incubation	  for	  10	  min	  at	  
room	   temperature.	   	   The	   mixture	   was	   centrifuged	   at	   16,000	   x	   g	   for	   10	  min	   and	   the	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supernatant	  was	  transferred	  to	  a	  new	  tube.	  	  150	  µL	  P:C:IAA	  was	  added,	  vortexed	  for	  2	  
min,	  centrifuged	  at	  16,000	  x	  g	  for	  10	  min	  and	  the	  upper	  phase	  was	  transferred	  to	  a	  new	  
tube.	  	  600	  µL	  isopropanol	  was	  added,	  chilled	  on	  ice	  for	  10	  min	  and	  centrifuged	  at	  16,000	  
x	  g	  for	  10	  min.	  	  The	  supernatant	  was	  removed	  and	  the	  pellet	  was	  washed	  with	  200	  µL	  
70%	   ethanol	   before	   centrifugation	   at	   16,000	   x	   g	   for	   1	   minute.	   	   All	   supernatant	   was	  
removed	  and	  the	  pellet	  was	  resuspended	  in	  50	  µL	  dH2O.	  
2.4.3   Large	  scale	  plasmid	  isolation	  from	  E.	  coli	  (Qiagen	  Midiprep)	  
To	  purify	  plasmid	  DNA	  from	  E.	  coli	  on	  a	  large	  scale,	  the	  QIAGEN	  Plasmid	  Midi	  Kit	  (Qiagen)	  
was	  used	  according	  to	  manufacturer's	  instructions.	  
2.4.4   Chromosomal	  DNA	  isolation	  from	  S.	  coelicolor	  
To	   isolate	   chromosomal	  DNA	   from	   S.	   coelicolor,	   cells	  were	   harvested	   from	  1.5	  mL	   of	  
overnight	  culture	  at	  16,000	  x	  g	  for	  5	  min	  and	  the	  cell	  pellet	  was	  washed	  with	  1	  mL	  10.3	  
%	  sucrose.	  	  The	  pellet	  was	  resuspended	  in	  250	  µL	  STE	  buffer	  and	  incubated	  at	  37	  °C	  for	  
30	  min.	  	  330	  µL	  2X	  Kirby	  mix	  was	  added	  and	  vortexed	  for	  30	  s.	  	  670	  µL	  of	  P:C:IAA	  was	  
added	  and	  vortexed	  for	  30	  s.	  	  The	  mixture	  was	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min	  and	  
the	   upper	   phase	   was	   transferred	   to	   a	   new	   tube.	   	   250	   µL	   of	   P:C:IAA	   was	   added	   and	  
vortexed	  for	  30	  s.	  	  The	  mixture	  was	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min	  and	  the	  upper	  
phase	  was	  transferred	  to	  a	  new	  tube.	  	  0.1	  volume	  3M	  sodium	  acetate	  (pH	  6)	  and	  1	  volume	  
isopropanol	  was	  added,	  mixed	  and	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min.	  	  The	  pellet	  was	  
resuspended	  in	  200	  µL	  TE	  buffer	  containing	  10	  µg/mL	  RNase	  A	  and	  incubated	  at	  37	  °C	  for	  
30	  min.	  	  As	  before,	  0.1	  volume	  3M	  sodium	  acetate	  (pH	  6)	  and	  1	  volume	  isopropanol	  was	  
added,	  mixed	  and	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min.	  	  The	  pellet	  was	  washed	  with	  70%	  
ethanol	  and	  air-­‐dried	  for	  15	  min.	  	  Finally,	  the	  DNA	  pellet	  was	  resuspended	  in	  100	  µL	  TE	  
buffer.	  
2.4.5   RNA	  isolation	  from	  S.	  coelicolor	  
To	  isolate	  RNA	  from	  S.	  coelicolor,	  cells	  were	  harvested	  from	  10	  mL	  of	  culture	  at	  6,000	  x	  g	  
for	  1	  minute,	  the	  supernatant	  removed	  and	  the	  cell	  pellet	  resuspended	  in	  1	  mL	  2X	  Kirby	  
mix.	  	  The	  cells	  were	  disrupted	  by	  sonication	  (3	  x	  3s	  @	  35%	  ampl.),	  500	  µL	  P:C:IAA	  was	  
added,	  mixed	  and	  stored	  at	  -­‐20	  °C	  until	  ready	  to	  process.	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The	  mixture	  was	  thawed	  and	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min.	  	  The	  upper	  phase	  was	  
transferred	   to	   a	   new	   tube,	   600	   µL	   of	   P:C:IAA	   was	   added,	   vortexed	   for	   2	   min	   and	  
centrifuged	  at	  16,000	  x	  g	  for	  5	  min.	  	  The	  upper	  phase	  was	  transferred	  to	  a	  new	  tube,	  0.1	  
volume	   3M	   sodium	   acetate	   (pH	   6)	   and	   1	   volume	   isopropanol	  was	   added,	  mixed	   and	  
incubated	  at	  -­‐20	  °C	  overnight.	  	  The	  mixture	  was	  centrifuged	  at	  16,000	  x	  g	  for	  10	  min,	  the	  
supernatant	   discarded	   and	   the	   pellet	  was	  washed	  with	   70%	  ethanol.	   	   The	   pellet	  was	  
resuspended	  in	  200	  µL	  1X	  DNase	  buffer	  +	  0.5	  µL	  DNase	  and	  incubated	  at	  37	  °C	  for	  30	  min.	  	  
200	  µL	  of	  RNase-­‐free	  water	  and	  200	  µL	  P:C:IAA	  was	  added	  and	  mixed.	  	  The	  mixture	  was	  
centrifuged	  at	  16,000	  x	  g	  for	  10	  min	  and	  the	  upper	  phase	  was	  transferred	  to	  a	  new	  tube.	  	  
0.1	  volume	  3M	  sodium	  acetate	  (pH	  6)	  and	  1	  volume	  isopropanol	  was	  added,	  mixed	  and	  
incubated	  at	  -­‐20	  °C	  for	  1	  h.	   	  The	  mixture	  was	  centrifuged	  at	  16,000	  x	  g	  for	  5	  min,	  the	  
pellet	  washed	  with	  100	  µL	  70%	  ethanol	  and	  the	  RNA	  pellet	  was	  resuspended	  in	  50	  µL	  
RNase-­‐free	  H2O.	  
2.5   Introduction	  of	  DNA	  into	  E.	  coli	  
2.5.1   Preparation	  of	  chemically	  competent	  E.	  coli	  (CaCl2	  method)	  
An	  overnight	  culture	  was	  used	  to	  inoculate	  50	  mL	  LB	  with	  selection	  (1:100	  dilution)	  and	  
grown	   at	   37	   °C	   to	   an	  OD600	   of	   0.4	   -­‐	   0.6.	   	   Cells	   were	   harvested	   by	   centrifugation	   at	  
2,000	  x	  g	  for	  10	  min,	  resuspended	  in	  20	  mL	  ice-­‐cold	  0.1	  M	  CaCl2,	  and	  incubated	  on	  wet	  
ice	  for	  30	  min.	  	  Following	  incubation,	  cells	  were	  pelleted	  by	  centrifugation	  at	  2,000	  x	  g	  
for	  10	  min,	  gently	  resuspended	  in	  2	  mL	  0.1	  M	  CaCl2	  +	  15%	  glycerol,	  and	  snap	  frozen	  in	  
100	  µL	  aliquots	  in	  a	  dry	  ice-­‐ethanol	  bath.	  	  Competent	  cell	  aliquots	  were	  stored	  at	  -­‐80	  °C	  
for	  up	  to	  6	  months.	  
2.5.2   Preparation	  of	  chemically	  competent	  E.	  coli	  (RbCl2	  method)	  
An	  overnight	  culture	  was	  used	  to	  inoculate	  50	  mL	  LB	  with	  selection	  (1:100	  dilution)	  and	  
grown	   at	   37	   °C	   to	   an	  OD600	   of	   0.4	   -­‐	   0.6.	   	   Cells	   were	   harvested	   by	   centrifugation	   at	  
2,000	  x	  g	  for	  10	  min,	  resuspended	  in	  6	  mL	  TFBI	  buffer,	  and	  incubated	  on	  wet	  ice	  for	  30	  
min.	  	  Following	  incubation,	  cells	  were	  pelleted	  by	  centrifugation	  at	  2,000	  x	  g	  for	  10	  min,	  
gently	   resuspended	  1	  mL	  TFBII	  buffer	  and	  snap	   frozen	   in	  100	  µL	  aliquots	   in	  a	  dry	   ice-­‐
ethanol	  bath.	  	  Competent	  cell	  aliquots	  were	  stored	  at	  -­‐80	  °C	  for	  up	  to	  6	  months.	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2.5.3   Transformation	  of	  chemically	  competent	  E.	  coli	  
E.	  coli	  transformations	  were	  typically	  performed	  with	  1	  -­‐	  10	  ng	  of	  DNA	  (plasmid	  mini-­‐prep	  
or	  ligation	  mix)	  with	  100	  µL	  of	  competent	  cells.	  	  Cells	  were	  thawed	  on	  wet	  ice,	  DNA	  was	  
mixed	  gently	  and	  incubated	  on	  ice	  for	  30	  min.	  	  The	  mixture	  was	  heat	  shocked	  in	  a	  water	  
bath	  at	  42	  °C	  for	  45	  s,	  returned	  to	  ice	  for	  2	  min,	  900	  µL	  LB	  added	  and	  incubated	  at	  37	  °C.	  
The	  transformation	  mix	  was	  plated	  onto	  LA	  with	  the	  appropriate	  selection	  and	  incubated	  
overnight	  at	  37	  °C.	  
2.6   Introduction	  of	  DNA	  into	  S.	  coelicolor	  
2.6.1   Conjugation	  from	  E.	  coli	  
To	  introduce	  DNA	  into	  S.	  coelicolor	  via	  conjugation,	  the	  plasmid	  was	  first	  introduced	  into	  
the	   donor	   strain	   E.	   coli	   ET12567	   (pUZ8002)	   (cmlR	   kanR)	   via	   transformation.	   	   For	  
conjugation	  of	  kanR	  plasmids,	  the	  donor	  strain	  E.	  coli	  ET12567	  (pR9406)	  (cmlR	  ampR)	  was	  
used.	   	   A	   single	   colony	   was	   used	   to	   inoculate	   a	   5	   mL	   LB	   (with	   cml,	   kan	   and	   plasmid	  
selection)	  overnight	  culture.	  	  The	  following	  day	  the	  overnight	  culture	  was	  diluted	  1:100	  
to	  inoculate	  50	  mL	  LB	  (with	  kan	  and	  plasmid	  selection)	  and	  grown	  at	  37	  °C	  to	  an	  OD600	  
of	  0.4	  -­‐	  0.6.	  	  The	  cells	  were	  washed	  twice	  with	  50	  mL	  LB	  and	  resuspended	  in	  0.1	  volume	  
of	  LB.	  	  While	  washing	  the	  E.	  coli,	  approximately	  108	  Streptomyces	  spores	  were	  added	  to	  
0.5	  mL	  2	  x	  YT	  broth,	  heat	  shocked	  in	  a	  water	  bath	  at	  50	  °C	  for	  10	  min	  before	  allowing	  to	  
cool	  to	  room	  temperature.	  	  To	  conjugate,	  mix	  0.5	  mL	  E.	  coli	  with	  0.5	  mL	  heat	  shocked	  
Streptomyces	   spores.	   	   Mix,	   centrifuge	   briefly	   for	   15	   s	   and	   pour	   off	   most	   of	   the	  
supernatant	  (leaving	  ~100	  µL).	  	  The	  pellet	  was	  resuspended	  in	  the	  residual	  liquid,	  plated	  
out	  onto	  MS	  agar	  +	  10	  mM	  MgCl2	  and	  incubated	  at	  30	  °C	  for	  16	  -­‐	  20	  h.	   	  To	  select	  for	  
transconjugants,	  overlay	  the	  plate	  with	  1	  mL	  dH2O	  containing	  0.5	  mg	  nalidixic	  acid	  and	  
the	  appropriate	  antibiotic	  for	  selection	  of	  the	  transferred	  plasmid.	  	  Plates	  were	  incubated	  
at	  30	  °C	  for	  5	  -­‐	  7	  days	  and	  transconjugants	  were	  picked	  and	  streaked	  to	  single	  colonies	  
on	  MS	  agar	  plates	  containing	  25	  ug/mL	  nalidixic	  acid	  and	  the	  appropriate	  antibiotic	  for	  
selection	  of	  the	  transferred	  plasmid.	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2.7   Analysis	  of	  nucleic	  acids	  
2.7.1   S1	  nuclease	  protection	  assay	  
To	  create	  the	  probe,	  the	  reverse	  primer	  (downstream	  from	  the	  5’	  end)	  was	  first	  labelled	  
with	  32P	  as	  follows:	  
Component	   Volume	  
Reverse	  primer	  (10	  pmol/µL)	   3	  µL	  
10X	  T4	  Polynucleotide	  kinase	  buffer	   4	  µL	  
ATP	  [γ-­‐32P]	   5	  µL	  
Polynucleotide	  kinase	  (10	  U/µL)	   1	  µL	  
dH2O	   Up	  to	  40	  µL	  
	  
Incubate	  for	  30	  min	  at	  37	  °C	  then	  add	  4	  µL	  3M	  sodium	  acetate	  (pH	  6)	  and	  80	  µL	  100%	  
ethanol.	  	  Vortex	  to	  mix	  and	  leave	  at	  -­‐80	  °C	  overnight.	  	  The	  following	  day	  the	  mixture	  was	  
centrifuged	  at	  16,000	  x	  g	  for	  30	  min	  at	  4	  °C	  and	  the	  radioactive	  supernatant	  was	  removed.	  	  
The	  pellet	  was	  washed	  with	  100	  µL	  75%	  ethanol,	  the	  supernatant	  removed	  and	  the	  pellet	  
air-­‐dried	   for	   20	  min.	   	   The	   remaining	   PCR	   reaction	   was	  mixed,	   added	   to	   the	   labelled	  
reverse	  primer	  and	  amplified	  using	  standard	  conditions.	  
Following	  PCR,	  the	  probe	  was	  purified	  using	  a	  Qiagen	  PCR	  purification	  kit,	  eluting	  with	  
50	  µL	  RNase-­‐free	  water.	  	  To	  confirm	  successful	  amplification,	  2	  µL	  of	  the	  PCR	  product	  was	  
run	  on	  an	  agarose	  gel.	  	  A	  reading	  of	  >200	  cpm/µL	  generally	  indicated	  a	  good	  probe.	  
To	  perform	  S1	  mapping,	  30-­‐40	  µg	  RNA	  was	  mixed	  with	  5-­‐10	  ng	  of	  probe	  and	  lyophilised	  
with	  a	  Speedivac.	  	  The	  dried	  pellet	  was	  resuspended	  in	  20	  µL	  1X	  S1	  hybridisation	  buffer,	  
incubated	  in	  a	  waterbath	  at	  70	  °C	  for	  10	  min	  before	  allowing	  the	  temperature	  to	  fall	  to	  
42	  °C	  overnight.	  	  300	  µL	  S1	  digestion	  mix	  was	  forcibly	  added	  to	  the	  mixture,	  thoroughly	  
mixed	  and	  placed	  in	  ice	  water	  until	  all	  samples	  were	  ready.	  	  The	  digest	  mix	  was	  incubated	  
in	  a	  waterbath	  at	  37	  °C	  for	  45	  min	  until	  the	  reaction	  was	  stopped	  by	  addition	  of	  75	  µL	  S1	  
stop	  buffer.	   	   1	  µL	   glycogen	  and	  400	  µL	   isopropanol	  was	   added,	  mixed	  and	   incubated	  
at	   -­‐20°C	  for	  1	  h.	   	  The	  mixture	  was	  centrifuged	  at	  16,000	  x	  g	  at	  4°C	  for	  15	  min	  and	  all	  
supernatant	  was	  removed.	  	  The	  pellet	  was	  washed	  with	  70%	  ethanol	  and	  air-­‐dried	  for	  10	  
min.	  	  The	  pellet	  was	  resuspended	  in	  6	  µL	  S1	  formamide	  loading	  buffer,	  heated	  at	  95	  °C	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for	  2	  min	  and	  3	  µL	  was	  run	  on	  an	  8%	  UREA-­‐PAGE	  sequencing	  gel	  at	  600V	  for	  1	  h	  20	  min.	  	  
The	  gel	  was	  dried	  onto	  Whatman	  paper	  and	  exposed	  overnight	   in	  a	  phosphorimaging	  
cassette	  before	  visualisation	  the	  next	  day	  with	  a	  Typhoon	  phosphoimager.	  	  
2.7.2   qPCR	  
qPCR	  was	  performed	  in	  a	  96-­‐well	  PCR	  plate	  using	  a	  StepOnePlus	  Real-­‐Time	  PCR	  system	  
(Applied	  Biosystems).	  	  Each	  reaction	  contained	  12.5	  µL	  GoTaq®	  qPCR	  Master	  Mix,	  2	  µL	  
sample	  DNA,	  up	  and	  downstream	  primers	  (0.1–1	  µM	  each)	  and	  dH2O	  up	  to	  a	  final	  volume	  
of	  25	  µL.	   	  Data	  was	   collected	  and	  analysed	  using	  Applied	  Biosystems®	  Real-­‐Time	  PCR	  
Software.	  
2.8   In	  vitro	  transcription	  
To	  perform	  in	  vitro	  transcription,	  50	  nM	  RNAP,	  100	  nM	  σ	  and	  appropriate	  concentrations	  
of	  additional	  proteins	  were	  combined	  in	  1X	  in	  vitro	  transcription	  buffer	  and	  incubated	  on	  
ice	  for	  10	  min.	  	  5	  nM	  DNA	  template	  was	  added	  and	  incubated	  at	  30	  °C	  for	  10	  min.	  	  The	  
reaction	  was	  started	  by	  addition	  of	  radioactive	  NTP	  mix.	  	  After	  incubation	  at	  30	  °C	  for	  10	  
min,	  1	  µL	  5	  mg/mL	  heparin	  was	  added	  and	  incubated	  at	  30	  °C	  for	  5	  min.	  	  1	  µL	  10	  mM	  UTP	  
was	  added	  and	  incubated	  at	  30	  °C	  for	  10	  min.	  	  The	  reaction	  was	  stopped	  by	  addition	  of	  
formamide	  loading	  buffer.	   	  Samples	  were	  run	  on	  an	  8%	  UREA-­‐PAGE	  sequencing	  gel	  at	  
600V	  for	  1	  h	  20	  minutes.	  	  The	  gel	  was	  dried	  onto	  Whatman	  paper	  and	  exposed	  overnight	  
in	   a	   phosphorimaging	   cassette	   before	   visualisation	   the	   next	   day	   with	   a	   Typhoon	  
phosphoimager.	  	  
2.9   Protein	  purification	  
2.9.1   Ni-­‐NTA	  sepharose	  affinity	  chromatography	  	  
For	  preparation	  of	  a	  Ni-­‐NTA	  sepharose	  column,	  iminodiacetic	  acid	  (IDA)	  sepharose	  fast-­‐
flow	  resin	  was	  added	  to	  a	  syringe	  stopped	  with	  glass	  wool	  to	  give	  a	  column	  volume	  of	  1-­‐
4	  mL.	   	  Resin	  was	  washed	  with	  3	  column	  volumes	   (CV)	  dH2O	   followed	  by	  5	  CV	  Ni-­‐NTA	  
charge	  buffer	  and	  5	  CV	  Ni-­‐NTA	  binding	  buffer.	  	  Cleared	  cell	  lysate	  was	  loaded	  onto	  the	  
column	  before	  washing	  with	  10	  CV	  Ni-­‐NTA	  binding	  buffer,	  5	  CV	  Ni-­‐NTA	  wash	  buffer	  and	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1	  CV	  Ni-­‐NTA	  elution	  buffer.	  	  The	  column	  was	  washed	  with	  5	  CV	  Ni-­‐NTA	  strip	  buffer,	  5	  CV	  
dH2O	  and	  stored	  in	  20%	  ethanol.	  
2.9.2   Anion-­‐exchange	  chromatography	  
Anion-­‐exchange	  chromatography	  was	  performed	  using	  a	  Mono	  Q	  5/50	  GL	  column	  (GE	  
Healthcare)	  and	  ÄKTA	  FPLC	  (Amersham	  PLC).	  	  The	  complete	  system	  was	  washed	  with	  5	  
CV	  dH2O	  followed	  by	  equilibration	  with	  5	  CV	  anion-­‐exchange	  binding	  buffer.	  	  Protein	  was	  
loaded	  onto	   the	  column	  and	  eluted	  using	  a	   linear	  gradient	  of	  anion-­‐exchange	  binding	  
buffer.	  	  1	  mL	  fractions	  were	  collected,	  analysed	  by	  SDS-­‐PAGE	  and	  pooled	  as	  appropriate.	  	  
Following	  elution,	  the	  column	  was	  washed	  with	  5	  CV	  dH2O	  and	  5	  CV	  20%	  ethanol	  before	  
storage.	  
2.9.3   Size	  exclusion	  chromatography	  
Size-­‐exclusion	  chromatography	  was	  performed	  using	  a	  HiLoad	  TM	  16/60	  Superdex	  200	  
pg	  column	  (GE	  Healthcare)	  and	  ÄKTA	  FPLC	  (Amersham	  PLC).	  	  The	  complete	  system	  was	  
washed	  with	  1	  CV	  dH2O	  followed	  by	  equilibration	  with	  1	  CV	  gel	  filtration	  buffer.	  	  Protein	  
was	  loaded	  onto	  the	  column	  and	  1	  mL	  fractions	  were	  collected,	  analysed	  by	  SDS-­‐PAGE	  
and	  pooled	  as	  appropriate.	  	  Following	  elution,	  the	  column	  was	  washed	  with	  1	  CV	  dH2O	  
and	  1	  CV	  20%	  ethanol	  before	  storage.	  
2.9.4   Protein	  sample	  analysis	  by	  SDS-­‐PAGE	  
For	  analysis	  of	  purified	  protein	  samples	  by	  SDS-­‐PAGE,	  precast	  NuPAGE®	  4-­‐12%	  Bis-­‐Tris	  
polyacrylamide	  gels	  (Invitrogen)	  were	  used.	  	  Samples	  were	  dissolved	  in	  1X	  NuPAGE®	  LDS	  
sample	  buffer	  and	  run	  according	  to	  manufacturer’s	  instructions.	  
2.9.5   Determining	  protein	  concentration	  
Samples	  were	  analysed	   for	  protein	   concentration	  using	   a	  Qubit	   Protein	  Assay	  Kit	   and	  
Qubit	  2.0	  Fluorometer	  according	  to	  manufacturer’s	  instructions.	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3   Investigating	  the	  role	  of	  DksA	  in	  S.	  coelicolor	  
3.1   Overview	  
ppGpp	   and	   the	   stringent	   response	   has	   long	   been	   implicated	   in	   the	   production	   of	  
antibiotics.	  	  This	  chapter	  sets	  out	  to	  identify	  how	  ppGpp	  and	  DksA	  regulate	  transcription	  
in	   S.	   coelicolor.	   	   This	   chapter	   shows	   that	   the	   ppGpp	   binding	   site	   on	   RNAP	   recently	  
identified	  in	  E.	  coli	  is	  not	  conserved	  in	  S.	  coelicolor.	  	  This	  suggests	  that	  ppGpp	  regulates	  
transcription	   through	   a	   different	   binding	   site	   or	   by	   binding	   to	   alternative	   targets.	  	  
Although	   the	   mechanism	   by	   which	   ppGpp	   regulates	   transcription	   in	   S.	   coelicolor	   is	  
different	  to	  that	  in	  E.	  coli,	  S.	  coelicolor	  possesses	  three	  DksA-­‐like	  proteins.	  	  Whilst	  deletion	  
of	   these	  proteins	   appears	   to	  have	  no	  effect	   on	   the	   growth	  of	  S.	   coelicolor	   under	   any	  
tested	  conditions,	  overexpression	  of	  DksA	  stimulates	  antibiotic	  production	  dependent	  on	  
conserved	  aspartic	  acid	  residues	  at	  the	  predicted	  coiled-­‐coil	  tip.	  
3.2   The	  proposed	  E.	  coli	  ppGpp	  binding	  site	  is	  not	  conserved	  in	  S.	  coelicolor	  
Structural	   studies	   on	   E.	   coli	   RNAP	   identified	   the	   ppGpp-­‐binding	   site	   at	   the	   interface	  
between	  ω	  and	  β’	  subunits	  (Ross	  et	  al.,	  2013;	  Zuo	  et	  al.,	  2013).	  	  Following	  elucidation	  of	  
the	  ppGpp	  binding	  site,	  Ross	  et	  al.	  (2013)	  performed	  multiple	  sequence	  alignments	  of	  the	  
ppGpp-­‐binding	   regions	   on	   β’	   and	   ω	   subunits	   with	   the	   corresponding	   subunits	   from	  
B.	  subtilis	  and	  T.	  thermophilus.	  	  In	  these	  two	  distantly	  related	  bacterial	  species,	  RNAP	  did	  
not	  crosslink	  ppGpp	  and	  was	  unaffected	  by	  ppGpp	   in	  vitro	   (Krásný	  and	  Gourse,	  2004;	  
Vrentas	  et	  al.,	  2008).	  	  Sequence	  alignments	  revealed	  that	  residues	  in	  β’	  and	  ω,	  identified	  
as	  essential	  for	  ppGpp-­‐binding,	  are	  not	  conserved	  in	  these	  species.	  	  Either	  this	  suggested	  
the	   existence	   of	   an	   alternative	   ppGpp-­‐binding	   site	   on	   RNAP,	   or	   that	   ppGpp	  does	   not	  
affect	  RNAP	  but	  has	  alternative	  targets	  in	  these	  species.	  	  Indeed,	  later	  studies	  have	  shown	  
that	  ppGpp	  has	  the	  ability	  to	  regulate	  enzymes	  in	  the	  GTP	  biosynthesis	  pathway	  including	  
guanylate	   kinase	   (GMK)	   that	   converts	   GMP	   to	   GDP,	   which	   mediates	   the	   stringent	  
response	  (Liu	  et	  al.,	  2015).	  
To	   investigate	   whether	   ppGpp	   binds	   to	   RNAP	   in	   S.	   coelicolor,	   multiple	   sequence	  
alignments	   were	   performed	   to	   investigate	   the	   conservation	   of	   the	   proposed	   ppGpp	  
binding	  site	  (Figure	  3.1).	  	  Amino	  acid	  sequences	  for	  β’	  and	  ω	  from	  E.	  coli,	  R.	  sphaeroides,	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B.	   pertussis,	  M.	   xanthus,	   B.	   subtilis	   and	   S.	   coelicolor	   were	   obtained	   from	   NCBI	   and	  
clustalW	  alignments	  of	  the	  three	  ppGpp-­‐binding	  regions	  (β’	  600-­‐657,	  β’	  340-­‐399	  and	  ω	  
1-­‐59)	  were	  performed	  (Figure	  3.1).	  	  	  
Organisms	  closely	  related	  to	  the	  γ-­‐proteobacterium	  E.	  coli,	  such	  as	  α-­‐proteobacterium	  
R.	  sphaeroides,	   β-­‐proteobacterium	   B.	  pertussis,	   and	   δ-­‐proteobacterium	   M.	  xanthus,	  
show	  high	  conservation	  of	  the	  ppGpp	  binding	  site.	  	  In	  ppGpp-­‐binding	  region	  1	  on	  the	  β’	  
subunit	  three	  of	  the	  four	  binding	  residues	  were	  identical	  or	  physicochemically	  similar	  in	  
all	  proteobacteria.	  	  The	  fourth	  residue,	  Y626,	  was	  not	  conserved	  in	  any	  of	  these	  species	  
suggesting	  it	  is	  less	  important	  for	  ppGpp	  binding.	  	  In	  B.	  subtilis	  and	  T.	  thermophilus,	  where	  
ppGpp	  does	  not	  affect	  RNAP	   in	  vitro,	  residues	  K615	  and	  I619	  were	  not	  conserved	  and	  
physicochemically	   dissimilar.	   	   D622	   was	   conserved	   in	   all	   species	   and	   Y626	   was	   only	  
conserved	  in	  T.	  thermophilus.	  	  In	  S.	  coelicolor,	  D622	  was	  conserved	  whilst	  K615,	  I619	  and	  
Y626	  were	  all	  exchanged	  for	  physicochemically	  dissimilar	  residues.	  
In	  ppGpp-­‐binding	  region	  2	  on	  the	  β’	   subunit,	  R362	  was	  conserved	  or	  exchanged	   for	  a	  
similarly	  charged	  lysine	  in	  all	  aligned	  sequences	  including	  B.	  subtilis	  and	  T.	  thermophilus	  
where	  ppGpp	  does	  not	  affect	  RNAP	  in	  vitro.	  	  In	  S.	  coelicolor,	  a	  lysine	  residue	  was	  present	  
at	  the	  aligned	  position.	  
In	  ppGpp-­‐binding	  region	  3	  on	  the	  ω	  subunit,	  the	  ARVT	  motif	  was	  conserved	  in	  all	  aligned	  
proteobacterial	  sequences.	  	  In	  B.	  subtilis	  and	  T.	  thermophilus	  sequences,	  the	  motif	  was	  
poorly	  conserved	  with	  only	  one	  of	  four	  residues	  conserved	  in	  each.	  	  In	  S.	  coelicolor,	  none	  
of	  four	  ppGpp-­‐binding	  residues	  on	  the	  ω	  subunit	  were	  conserved.	  





Figure	  3.1	  -­‐	  The	  proposed	  ppGpp	  binding	  site	  is	  not	  conserved	  in	  S.	  coelicolor.	  	  A	  multiple	  sequence	  alignment	  of	  the	  
amino	  acid	  sequence	  of	  three	  regions	  β’	  600-­‐657,	  β’	  340-­‐399	  and	  ω	  1-­‐59,	  that	  form	  the	  proposed	  ppGpp	  binding	  site.	  	  
Performed	  using	  CLUSTALW	  multiple	  sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  was	  performed	  using	  
BOXSHADE	  3.21,	   using	   “consensus	   to	   a	   single	   sequence”	   function	   against	  E.	   coli	   sequences.	   Identical	   residues	   are	  
shaded	  black,	  similar	  residues	  are	  shaded	  grey	  and	  residues	  predicted	  to	  contact	  ppGpp	  are	  indicated	  with	  arrows.	  	  	  
For	  β’	  (rpoC)	  Escherichia	  coli	  K12-­‐W3110,	  gene	  ECK3979;	  Rhodobacter	  sphaeroides	  2.4.1,	  gene	  RSP_1712;	  Bordetella	  
pertussis	  Tohama	  I,	  gene	  BP0016;	  Myxococcus	  xanthus	  DK	  1622,	  gene	  MXAN_307;	  Bacillus	  subtilis	  subtilis	  168,	  gene	  
BSU01080;	  Thermus	  thermophilus	  HB8,	  gene	  TTHA1812;	  Streptomyces	  coelicolor	  A3(2),	  gene	  SCO4655.	  For	  ω’	  (rpoZ),	  
Escherichia	   coli	   K12-­‐W3110,	   gene	   ECK3639;	   Rhodobacter	   sphaeroides	   2.4.1,	   gene	   RSP_1669;	   Bordetella	   pertussis	  
Tohama	  I,	  gene	  BP1577;	  Myxococcus	  xanthus	  DK	  1622,	  gene	  MXAN_4890;	  Bacillus	  subtilis	  subtilis	  168,	  gene	  BSU15690;	  
Thermus	  thermophilus	  HB8,	  gene	  TTHA1561;	  Streptomyces	  coelicolor	  A3(2),	  gene	  SCO1478.	  	  
	   	  
Region 1: β’ 600-657 
E. coli (γ)        600 AISKMLNTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPEKKHEIISEAEA  659 
R. sphaeroides (α)  601 DVQNVIDTVYRYCGQKESVIFCDQIMGMGFREAFKAGISFGKDDMLIPDTKWPIVNEVRD  660 
B. pertussis (β)    600 EISRLINQSFRRCGLRDTVIFADKLMQSGFRLATRGGISIAMEDMLIPKAKEGILAEASR  659 
M. xanthus (δ)      588 SLGGLIDLCYRLTGEKETVLLADRVRSLGYYNATRAGISIALKDMIIPAKKQEFLDFARK  647 
B. subtilis         619 ILGKIIAEIFKRFHITETSKMLDRMKNLGFKYSTKAGITVGVSDIVVLDDKQEILEEAQS  678 
T. thermophilus     910 SLKDLVYQAFLRLGMEKTARLLDALKYYGFTFSTTSGITIGIDDAVIPEEKKQYLEEADR  969 
S. coelicolor       687 QLSEIVNDLAERYPKVIVAATLDNLKAAGFFWATRSGVTVAISDIVVPDAKKEIVKGYEG  746 
	  
	  
Region 2: β’ 340-399 
E. coli (γ)        340 QNLLGKRVDYSGRSVITVGPYLRLHQCGLPKKMALELFKPFIYGKLELRGLATTIKAAKK  399 
R. sphaeroides (α) 343 QNLLGKRVDFSGRSVIVTGPELKLHQCGLPKKMALELFKPFIYSRLEAKGLSSTVKQAKK  402 
B. pertussis (β)   340 QNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKLMALELFKPFIFNRLEMMGLATTIKAAKK  399 
M. xanthus (δ)     341 QNLLGKRVDYSGRSVIVVGPELRLHQCGLPKIMALELFKPFIYNKLEEKGYVTTIKSAKK  400 
B. subtilis        329 QNLLGKRVDYSGRSVIVVGPHLKMYQCGLPKEMALELFKPFVMKELVEKGLAHNIKSAKR  388 
T. thermophilus    616 QNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKRMALELFKPFLLKKMEEKGIAPNVKAARR  675 
S. coelicolor      415 QNLLGKRVDYSARSVIVVGPQLKLHQCGLPKAMALELFKPFVMKRLVDLNHAQNIKSAKR  474 
	  
	  
Region 3: ω 1-59 
E. coli (γ)          1 MARVTVQDAVEKIGNRFDLVLVAARRARQMQVGGKDPLVPEE-NDKTTVIALREIEEGLI  59 
R. sphaeroides (α)   1 MARVTVEDCVDKVPNRFELVMLAAHRAREIASGS-SLTIDRD-NDKNPVVALREIAEETQ  58 
B. pertussis (β)     1 MARITVEDCLNQIPNRFKLTLAATYRARELVQGHAPRLDSK---DKPTVTALREIASGLT  57 
M. xanthus (δ)       1 MARVTVEDCLPLVDNRFALVLLGAKRARQLMAGARPILEQS--KNKPPVLSLREVATGRV  58 
B. subtilis          1 MLDPSIDSLMNKLDSKYTLVTVSARRAREMQIKK------------DQMIEHTISHKYVG  48 
T. thermophilus      1 MAEPGIDKLFGMVDSKYRLTVVVAKRAQQLLRHGFKNTVLEP-EERPKMQTLEGLFDDPN  59 
S. coelicolor       10 IINPPIDELLEATDSKYSLVIYAAKRARQINAYYSQLGEGLL-EYVGPLVDTHVHEKPLS  69	  
66	  
	  
3.3   Identification	  and	  bioinformatic	  analysis	  of	  DksA	  in	  S.	  coelicolor	  
Although	  ppGpp	  might	  not	  bind	  RNAP,	  it	  is	  still	  conceivable	  that	  DksA	  might	  bind	  RNAP	  
and	   elicit	   a	   stringent	   response	   in	   S.	   coelicolor.	   	   To	   identify	   homologues	   of	   DksA	   in	  
S.	  coelicolor,	  a	  BLASTP	  search	  was	  performed	  using	  the	  Department	  of	  Energy	  (DOE)	  Joint	  
Genome	   Institute’s	   (JGI)	   Integrated	   Microbial	   Genomes	   (IMG)	   service	  
(http://img.jgi.doe.gov/).	   	  BLASTP	  searches	  with	   the	  E.	   coli	  DksA	  sequence	  against	   the	  
S.	  coelicolor	   genome	   returned	   the	   hypothetical	   protein	   SCO2075	   with	   an	   E	   value	   of	  
2	  x	  10-­‐6.	  	  A	  clustalW	  alignment	  of	  the	  two	  proteins	  showed	  that	  SCO2075	  possesses	  an	  
additional	  81	  amino	  acid,	  lysine-­‐rich	  N-­‐terminal	  extension	  (Figure	  3.2A).	  	  A	  BLASTP	  search	  
performed	  with	  this	  region	  revealed	  a	  histone	  H1-­‐like	  region,	  similar	  to	  Hc2	  in	  Chlamydia	  
trachomatis	   (Pedersen	  et	  al.,	   1996).	   	   The	  alignment	  also	   revealed	   that	   the	   two	  highly	  
conserved	  essential	  aspartic	  acid	  residues	  (D71	  and	  D74)	  present	  at	  the	  coiled-­‐coil	  tip	  of	  
E.	  coli	  DksA	  are	  present	  in	  SCO2075,	  as	  is	  the	  conserved	  four	  cysteine	  zinc-­‐finger	  motif	  
(Tehranchi	  et	  al.,	  2010;	  Henard	  et	  al.,	  2014).	  
A	   structural	  prediction	  performed	  with	  Phyre2	  modelled	  130	   residues	   (G109-­‐R238)	  of	  
SCO2075	   using	   the	   DksA	   structure	   as	   the	   highest	   scoring	   template	  
(Perederina	  et	  al.,	  2004;	  Kelley	  et	  al.,	  2015).	  	  The	  structure	  was	  highly	  similar	  to	  DksA	  and	  
the	  two	  conserved	  aspartic	  acid	  residues	  (D164	  and	  D167)	  were	  present	  at	  the	  tip	  of	  a	  
coiled-­‐coil	  structure	  (Figure	  3.2B).	  	  	  





Figure	  3.2	   -­‐	  SCO2075	   is	  a	  DksA	  homologue.	   	   (A)	  A	  multiple	  sequence	  alignment	  of	  E.	  coli	  DksA	   (gene	  JW0141)	  and	  
S.	  coelicolor	  SCO2075	  performed	  using	  CLUSTALW	  multiple	  sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  
was	  performed	  using	  BOXSHADE	  3.21.	   	   Identical	  amino	  acid	  residues	  are	  shaded	  black,	  similar	  residues	  are	  shaded	  
grey,	  conserved	  aspartic	  acid	  residues	  are	  indicated	  with	  a	  black	  circle	  and	  conserved	  cysteine	  residues	  that	  form	  a	  
zinc-­‐finger	  motif	  are	  indicated	  with	  a	  black	  triangle.	  	  (B)	  Structural	  prediction	  of	  SCO2075	  residues	  108-­‐239,	  prediction	  
performed	  with	  Phyre2	  and	  visualised	  with	  PyMOL	  (version	  1.3).	  	  Conserved	  aspartic	  acid	  residues	  D164	  and	  D167	  side	  
chains	  are	  labelled	  and	  shown	  as	  stick	  models.	  
Whilst	   searches	  with	   the	  E.	   coli	  DksA	   sequence	  only	   returned	  SCO2075,	  performing	  a	  
BLASTP	  search	  with	  the	  SCO2075	  amino	  acid	  sequence	  against	  the	  S.	  coelicolor	  genome	  
returned	  two	  additional	  proteins,	  SCO6164	  and	  SCO6165	  with	  E	  values	  of	  9	  x	  10-­‐7	  and	  
5	  x	  10-­‐9,	  respectively.	  	  They	  are	  encoded	  by	  neighbouring	  genes,	  separated	  by	  70	  bp	  so	  
are	   potentially	   expressed	   in	   an	   operon.	   	  Multiple	   sequence	   alignments	   revealed	   that	  
SCO6164	  and	  SCO6165	  lack	  the	  N-­‐terminal	  histone-­‐like	  region	  that	  SCO2075	  possesses	  
and	  are	  more	  similar	   in	  size	  to	  E.	  coli	  DksA	  (Figure	  3.3).	   	  Phyre2	  structural	  predictions	  
modelled	  104	  and	  115	  residues	  of	  SCO6164	  and	  SCO6165,	  respectively,	  with	  E.	  coli	  DksA	  
as	  the	  top-­‐scoring	  template.	  	  Similar	  to	  SCO2075,	  the	  predicted	  structures	  possessed	  a	  
coiled-­‐coil	  motif	  (data	  not	  shown).	  	  Unlike	  SCO2075,	  SCO6165	  only	  had	  one	  conserved	  








DksA       1 --------------------------------------------------
SCO2075    1 MVAKKKTTAAKQSAAEESAAEQDPARKKAAEKTAAKKSPARKTAAKKSPA
DksA       1 -------------------------------MQEGQNRKTSSLSILAIAG
SCO2075   51 EKTAAKKSTAKKSTAKKVGAAEAAEQTGATTVVAKKTPGTATAAKTAVPK
DksA      20 VEPYQEKPGEEYMNEAQLAHFRRILEAWRNQLRDEVDRTVTHMQDEAANF
SCO2075  101 ARGTAAVPGDLAVRPGEEPWTPQEVEEARGELQSEADRLRTEIDTSERSL
DksA      70 P------------DPVDRAAQEEEFSLELRNRDRERKLIKKIEKTLKKVE
SCO2075  151 QGMMRDSGDGAGDDEADTGSKNITREHELALAATAREVLSQTERALDRLD
DksA     108 DEDFGYCESCGVEIGIRRLEARPTADLCIDCKTLAEIREKQMAG




Figure	  3.3	  -­‐	  S.	  coelicolor	  possesses	  two	  additional	  DksA	  paralogues.	  	  A	  multiple	  sequence	  alignment	  of	  the	  amino	  acid	  
sequence	   of	   E.	   coli	   DksA	   (gene	   JW0141)	   and	   S.	   coelicolor	   SCO2075,	   SCO6164	   and	   SCO6165.	   	   Performed	   using	  
CLUSTALW	  multiple	  sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  was	  performed	  using	  BOXSHADE	  3.21,	  
using	  “consensus	  to	  a	  single	  sequence”	  function	  against	  E.	  coli	  DksA	  sequence.	  	  Identical	  residues	  are	  shaded	  black,	  
similar	   residues	   are	   shaded	  grey,	   conserved	   aspartic	   acid	   residues	   are	   indicated	  with	   a	  black	   circle	   and	   conserved	  
cysteine	  residues	  that	  form	  a	  zinc-­‐finger	  motif	  are	  indicated	  with	  a	  black	  triangle.	  	  	  	  
3.4   Deletion	  of	  DksA	  has	  no	  effect	  on	  growth	  
3.4.1   A	  ∆dksA	  (∆SCO2075)	  mutant	  has	  no	  observable	  phenotype	  
One	  of	  the	  most	  commonly	  used	  methods	  for	  gene	  deletion	  in	  prokaryotes	  is	  deletion	  via	  
homologous	  recombination	  of	  a	  mutant	  allele.	   	   In	  this	  method,	   large	  sections	  of	  DNA,	  
homologous	  to	  the	  regions	  upstream	  and	  downstream	  of	  the	  target	  gene,	  are	  adjoined,	  
creating	   a	   “mutant	   allele”.	   	   Two	   crossovers	   can	   then	   occur,	   either	   simultaneously	   or	  
sequentially,	   replacing	  the	  wild-­‐type	  copy	  of	   the	  gene	  with	  a	  stable	  mutant	  allele.	   	  To	  
allow	   positive	   selection	   of	   a	  mutant	   allele,	   a	   selectable	  marker	   such	   as	   an	   antibiotic	  




















Figure	  3.4	  -­‐	  Construction	  of	  a	  ∆dksA	  deletion	  mutant.	  	  The	  diagram	  shows	  the	  plasmid	  pKC1132∆dksA,	  the	  homologous	  
regions	  and	  the	  two	  possible	  stable	  double	  crossover	  strains,	  M145∆dksA	  and	  M145	  wild	  type	  revertant	  (M145	  WT	  
rev).	  
The	  strategy	   for	  creation	  of	  a	  ∆dksA	   (∆SCO2075)	  mutant	   is	  outlined	   in	  Figure	  3.4.	   	  To	  
create	  a	  ∆dksA	  mutant	  allele,	  1.5	  kb	  upstream	  and	  downstream	  flanking	  regions	  were	  
first	   PCR	   amplified	   from	   gDNA	   with	   the	   primers	   DksA_HindIII_F/DksA_BamHI_R	   and	  
DksA_BamHI_F/DksA_EcoRI_R,	   respectively.	   	   The	   PCR	   products	   were	   cloned	   into	  
EcoRV-­‐cut	  pBlueScript	  SKII+	  and	  sequenced	  to	  confirm	  successful	  amplification	  with	  no	  
mutations.	   	   The	   flanks	   were	   combined	   by	   sub-­‐cloning	   the	   upstream	   flank	   as	   a	  
HindIII/BamHI	   fragment	   into	   pKC1132,	   followed	   by	   the	   downstream	   flank	   as	   a	  
BamHI/EcoRI	   fragment,	   creating	   an	   in-­‐frame	  markerless	   mutant	   allele	   in	   pKC1132,	   a	  
conjugative,	  non-­‐replicating	  plasmid.	   	  The	  mutant	  allele	  construct,	  pKC1132∆dksA	  was	  
confirmed	  by	  restriction	  analysis	  before	  transformation	  of	  E.	  coli	  ET12567/pUZ8002	  and	  





















plating	  onto	  MS	  agar	  +	  apramycin.	  	  To	  allow	  a	  second	  crossover	  recombination	  event	  to	  
occur,	   single	   crossover	   recombinants	   were	   passed	   through	   a	   round	   of	   non-­‐selective	  
growth	  on	  MS	  agar,	  spores	  were	  harvested	  and	  approximately	  400	  cfu	  were	  plated	  out	  
onto	  MS	  agar.	  	  To	  screen	  for	  ∆dksA	  mutants,	  colonies	  were	  replica	  plated	  onto	  DN	  agar	  
and	   DN	   agar	   containing	   apramycin.	   	   Apramycin-­‐sensitive	   colonies	   were	   assumed	   to	  
represent	  either	  ∆dksA	  mutants	  or	  wild	  type	  revertants.	  	  ∆dksA	  mutants	  were	  identified	  
through	  colony	  PCR	  by	  amplification	  with	  the	  primer	  set	  dksA_O_F/dksA_O_R	  that	  bind	  
either	  side	  of	  the	  dksA	  ORF.	  
	   	  
71	  
	  
A	  ∆dksA	  mutant	  strain	  was	  selected	  and	  grown	  on	  a	  variety	  of	  media	  including	  MS	  agar	  
(a	  medium	   suitable	   for	   normal	   growth	   and	   sporulation)	   (Figure	   3.5A),	   SMMS	   agar	   (a	  
minimal	  media	  optimal	  for	  observing	  antibiotic	  production	  (Kieser	  et	  al.,	  2000))	  (Figure	  
3.5B)	  and	  L	  agar	  (Figure	  3.5C).	  	  Under	  all	  tested	  conditions,	  no	  phenotypic	  difference	  to	  
wild	  type	  M145	  was	  observed.	  	  It	  had	  previously	  been	  reported	  that	  when	  grown	  in	  the	  
presence	   of	   0.25	  M	   KCl,	   a	   ∆dksA	   mutant	   overproduced	   actinorhodin.	   	   In	   this	   study,	  
M145∆dksA	   had	   no	   observed	   difference	   from	   M145	   when	   grown	   on	   SMMS	   agar	  
containing	  0.25	  M	  KCl	  (Figure	  3.5D).	  
	  
Figure	   3.5	   -­‐	   A	   ∆dksA	   mutant	   has	   no	   observable	   phenotype.	   	   M145,	   M145∆dksA,	  M145∆SCO6164-­‐5,	   M145∆dksA	  
∆SCO6164-­‐5	  and	  M570	  streaked	  onto	  (A)	  MS	  agar	  (B)	  SMMS	  agar	  (C)	  L	  agar	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  (D)	  
M145,	   M145∆dksA,	   M145∆SCO6164-­‐5,	   and	   M145∆dksA	   ∆SCO6164-­‐5	   streaked	   onto	   MS	   agar	   +	   0.25M	   KCl	   and	  

































3.4.2   A	  ∆dksA	  ∆SCO6164	  ∆SCO6165	  triple	  mutant	  has	  no	  observable	  phenotype	  
As	  no	  obvious	  phenotype	  could	  be	  seen	  in	  a	  ∆dksA	  deletion	  mutant	   it	  was	  considered	  
that	  there	  might	  be	  a	  functional	  redundancy	  between	  dksA,	  SCO6164	  and	  SCO6165.	  	  To	  
investigate	   this,	   ∆SCO6164	   ∆SCO6165	   (∆SCO6164-­‐5)	   double	   and	   ∆dksA	   ∆SCO6164-­‐5	  
triple	  deletion	  mutant	  strains	  were	  made.	  	  As	  SCO6164	  and	  SCO6165	  are	  neighbouring	  
genes,	   it	  was	  possible	   to	  delete	  both	  genes	   simultaneously.	   	   To	  create	  a	  ∆SCO6164-­‐5	  
mutant	   allele,	   1.5	   kb	   upstream	  and	   downstream	   flanking	   regions	  were	   PCR	   amplified	  
from	   gDNA	   with	   the	   primer	   sets	   61645_up_for/61645_up_rev	   and	  
61645_down_for/61645_down_rev	   respectively.	   	   The	   PCR	   products	  were	   cloned	   into	  
EcoRV-­‐cut	  pBlueScript	  SKII+	  and	  sequenced	  to	  confirm	  successful	  amplification	  with	  no	  
mutations.	  	  The	  flanks	  were	  combined	  by	  sub-­‐cloning	  both	  fragments	  sequentially	  into	  
pKC1132,	   a	   conjugative,	   non-­‐replicating	   plasmid,	   creating	   the	   plasmid	  
pKC1132∆SCO6164-­‐5.	  	  The	  mutant	  allele	  construct	  was	  confirmed	  by	  restriction	  analysis	  
before	   transformation	   of	   E.	   coli	   ET12567/pUZ8002	   and	   conjugation	   into	   S.	   coelicolor	  
M145	  and	  M145∆dksA.	  	  Single	  crossover	  transconjugants	  were	  selected	  by	  plating	  onto	  
MS	  agar	  containing	  apramycin.	   	  As	  with	  creating	  the	  ∆dksA	  mutant,	  to	  allow	  a	  second	  
crossover	  recombination	  event	  to	  occur	  single	  crossover	  recombinants	  were	  passaged	  
through	   a	   round	   of	   non-­‐selective	   growth	   on	   MS	   agar,	   spores	   were	   harvested	   and	  
approximately	   400	   cfu	   were	   plated	   out	   onto	   MS	   agar.	   	   To	   screen	   for	   ∆SCO6164-­‐5	  
mutants,	   colonies	   were	   replica	   plated	   onto	   DN	   agar	   and	   DN	   agar	   +	   apramycin.	  	  
Apramycin-­‐sensitive	  colonies	  were	  assumed	  to	  represent	  either	  ∆SCO6164-­‐5	  mutants	  or	  
wild	   type	   revertants.	   	   ∆SCO6164-­‐5	  mutants	   were	   identified	   through	   colony	   PCR	   by	  
amplification	  with	  the	  primer	  set	  61645_col_for/61645_col_rev	  that	  bind	  either	  side	  of	  
the	  SCO6164-­‐5	  region.	  
On	  MS	   agar,	   wildtype	  M145,	  M145∆dksA,	   the	   double	  mutant	  M145∆SCO6164-­‐5	   and	  
triple	  mutant,	  M145∆dksA	  ∆SCO6164-­‐5	  were	  identical	  in	  colony	  size,	  morphology	  and	  all	  
other	  notable	   features	   (Figure	  3.5A).	   	  For	  comparison,	  M570,	  a	  ∆relA	   strain	  unable	   to	  
produce	  ppGpp	  and	  consequently	  elicit	   the	  stringent	   response,	  was	  also	   streaked	  out	  
onto	  MS	   agar.	   	   Consistent	  with	   a	   published	   phenotype,	  M570	   produced	   large,	  white	  
colonies	  due	  to	  production	  of	  fewer	  mature	  spores	  and	  an	  inability	  to	  cease	  outgrowth	  
in	   response	   to	  amino	  acid	   limitation.	   	  On	  SMMS	  agar,	  M145,	  M145∆dksA,	   the	  double	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mutant	  M145∆SCO6164-­‐5	  and	  triple	  mutant,	  M145∆dksA	  ∆SCO6164-­‐5	  were	  identical	  in	  
production	   of	   actinorhodin	   (Figure	   3.5B).	   	   In	   contrast	   and	   consistent	   with	   published	  
observations,	   M570	   was	   unable	   to	   produce	   actinorhodin	   under	   these	   conditions	  
(Chakraburtty	   and	   Bibb,	   1997).	   	   Similar	   to	   previous	   observations	   with	   M145∆dksA,	  
deletion	  of	  SCO6164-­‐5	  had	  no	  effect	  on	  growth	  on	  SMMS	  agar	  containing	  250	  mM	  KCl	  
(Figure	  3.5D).	  
3.5   Overexpression	  of	  DksA	  stimulates	  antibiotic	  production	  
3.5.1   Cloning	  dksA	  downstream	  of	  ermEp*	  promoter	  stimulates	  ACT	  production	  
To	   further	   investigate	   the	   role	   of	   DksA,	   we	   aimed	   to	   overexpress	   the	   protein	   in	  
S.	  coelicolor	  by	  placing	  it	  under	  the	  control	  of	  the	  strong,	  constitutive	  ermEp*	  promoter	  
on	  the	  integrative	  expression	  plasmid	  pSX162	  (Bibb	  et	  al.,	  1986;	  Newell	  et	  al.,	  2006).	  	  	  
The	  dksA	  ORF	  was	  PCR	  amplified	  from	  gDNA	  using	  the	  primers	  dksA_O_F/dksA_O_R.	  	  The	  
forward	  and	  reverse	  primers	  were	  designed	  to	  introduce	  a	  BamHI	  site	  30	  bp	  upstream	  of	  
the	  start	  codon	  to	  ensure	  inclusion	  of	  the	  dksA	  ribosome	  binding	  site	  and	  a	  HindIII	  site	  
downstream	  of	  the	  stop	  codon,	  respectively.	  	  The	  PCR	  product	  was	  cloned	  into	  EcoRV-­‐cut	  
pBlueScript	  SKII+,	  sequenced	  to	  confirm	  amplification	  with	  no	  mutations	  and	  sub-­‐cloned	  
into	  pSX162	  as	  a	  BamHI/BamHI	  fragment	  (using	  a	  BamHI	  site	  downstream	  of	  the	  primer	  
HindIII	  site	  from	  pBlueScript	  SKII+),	  creating	  the	  plasmid	  pSX162::dksA.	  	  The	  recombinant	  
plasmid	  was	  confirmed	  by	  restriction	  digest	  analysis	  to	  ensure	  correct	  orientation	  of	  the	  
BamHI/BamHI	   dksA	   fragment,	   used	   to	   transform	   E.	   coli	   ET12567/pUZ8002	   and	  
transferred	  via	   conjugation	   into	  S.	   coelicolor	  M145.	   	  As	  a	  negative	  control,	   the	  empty	  
plasmid	   pSX162	   was	   also	   transferred	   via	   conjugation	   into	   S.	   coelicolor	   M145.	  	  
Transconjugants	  were	  selected	  by	  overlaying	  with	  apramycin.	  
When	  grown	  on	  SMMS	  agar,	  the	  strain	  overexpressing	  dksA	  from	  the	  constitutive	  ermEp*	  
promoter	   on	   pSX162	   appeared	   to	   produce	   significantly	   more	   pigmented	   blue	  




Figure	  3.6	  -­‐	  Overexpression	  of	  DksA	  stimulates	  actinorhodin	  production.	  	  (A)	  M145/pSX162	  and	  M145/pSX162::dksA	  
streaked	   onto	   SMMS	   agar	   and	   incubated	   for	   5	   days	   at	   30	   °C.	   	   (B)	   M145/pSX162,	   M145/pSX162::dksA,	  
M145/pSX162::dksAD164N,	  M145/pSX162::dksAD167N	  and	  M145/pSX162::dksAD164N/D167N	  streaked	  onto	  SMMS	  agar	  and	  
incubated	  for	  5	  days	  at	  30	  °C.	  
3.5.2   Effect	  of	  dksA	  overexpression	  requires	  aspartic	  acid	  residues	  at	  coiled-­‐coil	  
tip	  
In	  E.	  coli,	  it	  has	  been	  shown	  that	  the	  two	  aspartic	  acid	  residues	  at	  the	  tip	  of	  the	  DksA	  are	  
essential	  for	  function	  in	  transcription	  initiation	  (Perederina	  et	  al.,	  2004;	  Tehranchi	  et	  al.,	  
2010).	   	  To	  study	   if	   the	  dksA	  overexpression	  phenotype	  was	  specific	   to	   the	  role	  of	   the	  
protein	   in	   initiation,	   investigations	   were	  made	   into	   the	   importance	   of	   the	   conserved	  
aspartic	   acid	   residues	   at	   the	   coiled-­‐coil	   tip	   in	   overexpressed	   DksA.	   	   Site-­‐directed	  
mutagenesis	  by	  inverse	  PCR	  was	  performed	  on	  the	  template	  pBlueScript::dksA	  using	  the	  
primers	  F_D164N/R_D164N,	  F_D167N/R_D167N	  and	  F_D1647N/R_D1647N,	  creating	  the	  
alleles	  dksAD164N,	  dksAD167N	  and	  dksAD164N/D167N,	  respectively.	  	  Sequencing	  was	  performed	  
on	   transformants	   to	   confirm	   successful	   creation	   of	   these	   alleles	   with	   no	   additional	  
mutations.	  	  As	  with	  creation	  of	  pSX162::dksA,	  each	  allele	  was	  sub-­‐cloned	  into	  pSX162	  as	  
a	  BamHI/BamHI	  fragment	  and	  the	  correct	  orientation	  of	  the	  fragment	  was	  confirmed	  by	  
restriction	   analysis.	   	   Recombinant	   plasmids	   pSX162::dksAD164N,	   pSX162::dksAD167N	   and	  
pSX162::dksAD164N/D167N	  were	  used	  to	  transform	  E.	  coli	  ET12567/pUZ8002	  and	  transferred	  
via	   conjugation	   into	  S.	   coelicolor	  M145.	   	  Transconjugants	  were	   selected	  by	  overlaying	  
with	  apramycin.	  











When	  grown	  on	  SMMS	  agar,	  as	  seen	  previously,	  the	  strain	  overexpressing	  dksA	  from	  the	  
constitutive	   ermEp*	   promoter	   on	   pSX162	   appeared	   to	   produce	   significantly	   more	  
pigmented	   blue	   actinorhodin	   than	   the	   negative	   control	   strain	   harbouring	   the	   empty	  
plasmid	  pSX162	   (Figure	  3.6B).	   	   In	   strains	  overexpressing	  dksAD164N	  or	  dksAD167N	   alleles	  
where	  just	  one	  of	  the	  aspartic	  acid	  residues	  had	  been	  mutated	  to	  an	  alanine	  residue,	  the	  
amount	   of	   actinorhodin	   produced	   appeared	   to	   be	   more	   than	   the	   negative	   control	  
however	   less	   than	   the	   strain	   overexpressing	   the	   wild	   type	   dksA.	   	   The	   strain	  
overexpressing	   the	  dksAD164N/D167N	  allele,	  where	  both	  aspartic	  acid	  residues	  have	  been	  
mutated	  to	  alanine	  residues	  produced	  no	  more	  actinorhodin	  than	  the	  negative	  control	  
strain	  harbouring	  the	  empty	  plasmid	  pSX162.	  
	   	  
76	  
	  
3.6   Discussion	  
3.6.1   The	  proposed	  E.	  coli	  ppGpp	  binding	  site	  is	  not	  conserved	  in	  S.	  coelicolor	  
Following	  crystallography	  studies	  on	  T.	  thermophilus	  RNAP,	  it	  was	  initially	  proposed	  that	  
ppGpp	   orchestrates	   the	   stringent	   response	   through	   binding	   RNAP	   at	   the	   active	   site	  
(Artsimovitch	  et	  al.,	  2004).	  	  This	  binding	  site	  was	  later	  disproved	  following	  mutagenesis	  
studies	  on	  the	  proposed	  ppGpp-­‐binding	  residues	  (Vrentas	  et	  al.,	  2008).	  	  During	  the	  course	  
of	  the	  current	  study,	  a	  new	  binding	  site	   for	  ppGpp	  at	  the	   interface	  between	  ω	  and	  β’	  
subunits	   (Ross	   et	   al.,	   2013;	   Zuo	  et	   al.,	   2013).	   	  However,	   amino	   acid	   alignment	  of	   the	  
proposed	   ppGpp-­‐binding	   regions	   from	   diverse	   bacterial	   species	   indicated	   that	   key	  
interacting	   residues	   are	   not	   conserved	   in	   all	   organisms.	   	   Furthermore,	   in	   vitro	  
transcription	  reactions	  performed	  with	  RNAP	  from	  organisms	  that	  lack	  the	  key	  ppGpp-­‐
binding	   residues	   (such	  as	  B.	   subtilis	   and	  T.	   thermophilus)	   revealed	   that	  ppGpp	  has	  no	  
effect	   on	   transcription	   (Krásný	   and	   Gourse,	   2004;	   Vrentas	   et	   al.,	   2008).	   	   Similar	  
alignments	  performed	  in	  this	  study	  have	  identified	  that	  the	  proposed	  ppGpp-­‐binding	  site	  
is	  not	  conserved	  in	  S.	  coelicolor.	   	  Of	  the	  nine	  residues	  identified	  in	  E.	  coli,	  only	  two	  are	  
conserved	  or	  similar	  in	  S.	  coelicolor.	  	  This	  suggests	  that	  if	  ppGpp	  is	  able	  to	  bind	  to	  RNAP	  
in	  S.	  coelicolor	  it	  must	  be	  through	  an	  alternative	  mechanism	  or	  binding	  site	  altogether.	  
3.6.2   How	  does	  ppGpp	  exert	  the	  stringent	  response	  in	  S.	  coelicolor?	  
In	  B.	   subtilis,	   it	  was	   proposed	   that	   that	   ppGpp	  exerts	   the	   stringent	   response	   through	  
modulation	  of	  intracellular	  GTP	  levels,	  although	  the	  underlying	  mechanism	  was	  initially	  
unclear	  (Krásný	  and	  Gourse,	  2004).	  	  The	  recent	  discovery	  that	  ppGpp	  directly	  inhibits	  the	  
activity	  of	  enzymes	  involved	  in	  biosynthesis	  of	  GTP,	  the	  initiating	  NTP	  for	  rRNA	  promoters,	  
appears	  to	  have	  answered	  this	  question	  (Liu	  et	  al.,	  2015).	  	  Experiments	  performed	  by	  Liu	  
et	  al.	  (2015)	  identified	  the	  mechanism	  through	  which	  ppGpp	  competitively	  inhibits	  GMK	  
activity.	   	   This	  activity	  was	  demonstrated	  on	  purified	  GMK	  enzymes	   from	  a	  number	  of	  
bacterial	  species	  including	  B.	  subtilis,	  T.	  thermophilus	  and	  notably	  S.	  coelicolor,	  but	  not	  
on	  the	  enzymes	  from	  most	  tested	  proteobacterial	  species	  including	  E.	  coli.	  
With	  the	  exception	  of	  two	  alphaproteobacterial	  species,	  A.	  tumefaciens	  and	  S.	  meliloti,	  
the	  two	  mechanisms	  for	  regulation	  of	  transcription	  by	  ppGpp	  on	  RNAP	  and	  GMK	  appear	  
to	  be	  distinctly	  conserved,	  with	  organisms	  exclusively	  using	  one	  mechanism	  or	  the	  other	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(Liu	   et	   al.,	   2015).	   	   This	   suggests	   that	   ppGpp	   regulates	   the	   stringent	   response	   in	  
S.	  coelicolor	  through	  regulation	  of	  intracellular	  GTP	  concentrations.	  
For	   effective	   regulation	   of	   transcription	   by	   intracellular	   GTP	   concentrations,	   the	  
promoters	  would	  be	  expected	  to	  initiate	  transcription	  with	  a	  GTP	  at	  the	  +1	  position.	  	  In	  
B.	   subtilis,	   all	   of	   the	   rrnB	   and	   rrnO	   promoters	   initiate	   with	   GTP	   and	   are	   stringently	  
controlled	  (Krásný	  and	  Gourse,	  2004).	  	  	  
S1	   nuclease	   mapping	   experiments	   on	   the	   S.	   coelicolor,	   rrnD	   region	   identified	   four	  
promoters	  	  (Baylis	  and	  Bibb,	  1988)	  each	  of	  are	  stringently	  controlled	  (Strauch	  et	  al.,	  1991)	  
(Figure	  3.7).	  	  Whilst	  transcription	  was	  predicted	  to	  initiate	  from	  each	  promoter	  with	  CTP	  
or	  ATP,	  the	  authors	  note	  that	  due	  to	  experimental	   limitations	  this	  could	  vary	  by	  1	  bp.	  	  
Notably,	  transcription	  1	  bp	  downstream	  from	  each	  of	  the	  predicted	  transcription	  start	  
sites	  would	   initiate	  with	  GTP.	   	   Given	   that	   purine	   nucleotides	   are	   highly	   preferred	   for	  
transcription	  initiation	  in	  bacteria	  (Basu	  et	  al.,	  2014),	  it	  seems	  likely	  that	  initiation	  at	  these	  
promoters	  initiates	  with	  GTP.	  	  
	  
Figure	  3.7	  -­‐	  rrnDp1-­‐4	  with	  predicted	  promoter	  regions	  and	  transcription	  start	  sites.	  	  DNA	  sequence	  of	  the	  S.	  coelicolor	  
rrnD	  promoter	  region.	  	  Open	  circles	  indicate	  the	  transcription	  start	  sites	  predicted	  by	  Baylis	  and	  Bibb	  (1988),	  predicted	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3.6.3   S.	  coelicolor	  possesses	  a	  DksA	  homologue	  although	  it	  is	  not	  important	  for	  
growth	  
In	   E.	   coli,	   ppGpp	   and	   DksA	   directly	   regulate	   transcription	   and	   the	   stringent	   response	  
through	  binding	  RNAP.	  	  Liu	  et	  al.	  (2015)	  reported	  that	  presence	  of	  DksA	  homologue	  was	  
restricted	  to	  organisms	  where	  ppGpp	  binds	  RNAP	  and	  directly	  regulates	  transcription.	  	  It	  
was	  also	  suggested	  that	  DksA	  was	  absent	  from	  organisms	  where	  GMK	  activity	  is	  directly	  
inhibited	  by	  ppGpp,	  including	  S.	  coelicolor.	  	  In	  contrast	  to	  this	  finding,	  BLASTP	  searches	  
performed	   in	   this	   study	  with	   the	  E.	   coli	  DksA	   sequence	   identified	  a	  DksA	  homologue,	  
SCO2075,	  and	  two	  putative	  paralogues,	  SCO6164	  and	  SC06165,	  in	  S.	  coelicolor.	  	  Previous	  
searches	   performed	   by	   Liu	   et	   al.	   (2015)	   used	   sequence	   homology	   and	   presence	   of	   a	  
DxxDxA	  motif	   at	   the	   coiled-­‐coil	   tip	   to	   identify	   DksA.	   	   As	   S.	  coelicolor	   SCO2075	   has	   a	  
DxxDxG	  motif	  at	  the	  coiled-­‐coil	  tip	  this	  could	  have	  prevented	  previous	  identification.	  	  	  
This	   chapter	   details	   the	   creation	   of	   S.	   coelicolor	   ∆dksA	   single	   deletion	   mutant,	  
∆SCO6164-­‐6165	   double	  mutant	   and	   ∆dksA	   ∆SCO6164-­‐6165	   triple	  mutant.	   	   Under	   all	  
studied	  conditions,	  deletion	  of	  any	  combination	  of	  these	  genes	  had	  no	  observed	  effect	  
on	  growth.	  	  Diverse	  roles	  for	  DksA	  have	  been	  suggested	  outside	  of	  transcription	  initiation	  
in	  concert	  with	  ppGpp,	  including	  resolving	  conflict	  between	  transcription	  and	  replication	  
machinery	  (Tehranchi	  et	  al.,	  2010).	  	  If	  indeed	  ppGpp	  does	  not	  act	  directly	  on	  transcription	  
initiation	  in	  S.	  coelicolor,	  it	  is	  possible	  that	  the	  function	  of	  S.	  coelicolor	  DksA	  is	  exclusively	  
in	  regulation	  of	  transcription	  elongation.	  	  Due	  to	  the	  reported	  functional	  overlap	  of	  the	  
Gre	   factors	   and	   DksA	   (Zenkin	   and	   Yuzenkova,	   2015),	   it	   is	   possible	   that	   presence	   of	  
S.	  coelicolor	  Gre	  factors	  are	  complementing	  the	  role	  of	  DksA	  in	  the	  strains	  created	  in	  this	  
study.	  	  To	  further	  clarify	  the	  role	  of	  S.	  coelicolor	  DksA	  it	  may	  be	  necessary	  to	  investigate	  
the	  function	  of	  Gre	  factors.	  
3.6.4   Overexpression	  of	  DksA	  induces	  antibiotic	  production	  in	  S.	  coelicolor	  
This	  chapter	  also	  details	  the	  overexpression	  of	  DksA	  in	  S.	  coelicolor.	  	  When	  placed	  under	  
the	  control	  of	  the	  strong,	  constitutive	  ermEp*	  promoter,	  overexpression	  of	  DksA	  led	  to	  
overproduction	  of	  the	  blue	  pigmented	  antibiotic	  actinorhodin.	  	  Experiments	  performed	  
by	  Aldridge	  et	  al.	  (2013)	  showed	  that	  overexpression	  of	  S.	  coelicolor	  DksA	  from	  a	  tipAp	  
promoter	  had	  no	  effect	  on	  antibiotic	  production	   in	  an	  M145	  background.	   	  Whilst	   this	  
79	  
	  
result	  appears	  to	  contradict	  the	  findings	  of	  this	  study,	  it	  is	  possible	  that	  expression	  from	  
tipAp	  is	  significantly	  lower	  than	  from	  ermEp*	  promoter	  and	  was	  insufficient	  to	  cause	  the	  
observed	  phenotype	  in	  this	  study.	  	  Aldridge	  et	  al.	  (2013)	  showed	  that	  overexpression	  of	  
DksA	  from	  a	  tipAp	  promoter	  restored	  production	  of	  both	  actinorhodin	  and	  prodigines	  in	  
a	   relA	  mutant	  background.	   	   This	  demonstrates	   that	  DksA	   is	   able	   to	  work	   in	   a	  ppGpp-­‐
independent	  manner.	  	  	  
Site-­‐directed	  mutagenesis	  was	  performed	  on	  the	  aspartic	  acid	  residues	  at	  the	  coiled-­‐coil	  
tip,	   creating	   alleles	   with	   one	   or	   both	   residues	   changed	   to	   an	   asparagine	   residue.	  	  
Overexpression	   of	   alleles	  without	   both	   aspartic	   acid	   residues	   intact	   had	   no	   effect	   on	  
actinorhodin	   production.	   	   This	   suggests	   that	   the	  DksA	   overexpression	   phenotype	   is	   a	  
consequence	  of	  DksA	  binding	   to	  RNAP	  and	   inserting	   its	   coiled-­‐coli	   into	   the	   secondary	  
channel.	   	   Separation-­‐of-­‐function	   studies	  have	   shown	   that	   the	   conserved	  aspartic	   acid	  
residues	  are	  required	  for	  the	  role	  of	  DksA	  in	  transcription	  initiation	  but	  are	  not	  required	  
for	  the	  role	  of	  DksA	  on	  elongation	  preventing	  replication	  arrest	  (Perederina	  et	  al.,	  2004;	  
Tehranchi	  et	  al.,	  2010).	   	  This	  suggests	  that	  despite	  the	  fact	  ppGpp	  does	  not	  appear	  to	  
directly	  affect	  RNAP	   in	  S.	  coelicolor,	   the	  overexpression	  phenotype	  observed	   is	  due	  to	  
effects	  of	  DksA	  on	  transcription	  initiation.	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4   Investigating	  the	  role	  of	  CarD	  in	  S.	  coelicolor	  
4.1   Overview	  
CarD	   was	   identified	   as	   an	   essential	   transcriptional	   activator	   in	   M.	   smegmatis	   and	  
M.	  tuberculosis	  (Stallings	  et	  al.,	  2009).	  	  It	  was	  initially	  thought	  to	  be	  a	  negative	  regulator	  
of	  rRNA,	  was	  able	  to	  rescue	  an	  E.	  coli	  ∆dksA	  null	  mutant	  and	  was	  therefore	  thought	  to	  
have	  a	   role	   in	   the	   stringent	   response.	   	   The	   stringent	   response	   is	   closely	   linked	   to	   the	  
production	   of	   antibiotics	   and	   other	   useful	   secondary	   metabolites	   in	   S.	  coelicolor	   and	  
therefore,	  with	  the	  rising	  need	  for	  new	  compounds	  effective	  against	  multidrug	  resistance	  
infections,	  it	  is	  important	  to	  understand	  the	  regulation	  and	  synthesis	  of	  such	  products.	  	  
This	  chapter	  sets	  out	  to	  identify	  the	  role	  of	  CarD	  in	  S.	  coelicolor,	  initially	  by	  confirming	  its	  
importance	  for	  growth	  in	  vivo	  and	  its	  role	  as	  a	  transcriptional	  regulator	  through	  in	  vitro	  
transcription	   assays.	   	   This	   chapter	   also	   details	   the	   purification	   and	   analysis	   of	  
recombinant	  CarD	  and	  RNAP	  from	  E.	  coli	  and	  S.	  coelicolor,	  respectively.	  
4.2   Identification	  and	  bioinformatic	  analysis	  of	  CarD	  in	  S.	  coelicolor	  
4.2.1   Conservation	  of	  CarD	  in	  Streptomyces	  species	  
CarD	  was	  initially	  identified	  as	  being	  highly	  conserved	  in	  all	  sequenced	  mycobacteria	  with	  
M.	   smegmatis	   CarD	   sharing	   98.1%	   and	   95.7%	   homology	  with	   CarD	   proteins	   found	   in	  
M.	  tuberculosis	   and	  M.	   leprae,	   respectively	   (Stallings	   et	   al.,	   2009).	   A	   BLASTP	   search	  
identified	  SCO4232	  as	  a	  putative	  CarD	  orthologue	  in	  S.	  coelicolor,	  with	  the	  NCBI	  accession	  
number	  GI:7242753.	  	  The	  S.	  coelicolor	  carD	  gene	  is	  483	  bp	  in	  length	  and	  encodes	  a	  160	  
amino	   acid	   protein.	   	   A	   number	   of	   other	   bacterial	   species	   including	   the	   fellow	  
Actinobacteria	   Corynebacterium	   glutamicum	   and	   diverse	   non-­‐actinobacterial	   species	  
such	  as	  Bacillus	  subtilis	  and	  gram-­‐negative	  species	  such	  as	  Caulobacter	  crescentus	  and	  
Thermus	  thermophilus	  were	  also	  found	  to	  possess	  a	  CarD	  homologue.	  	  	  
To	  identify	  homologues	  of	  CarD	  found	  in	  other	  Streptomyces	  species,	  a	  BLASTP	  search	  
was	   performed	   using	   the	   Integrated	   Microbial	   Genomes	   (IMG)	   service	  
(http://img.jgi.doe.gov/).	   	   The	   SCO4232	   amino	   acid	   sequence,	   obtained	   from	   the	  
Streptomyces	  Annotation	  Server	  StrepDB	  (http://strepdb.streptomyces.org.uk),	  was	  used	  
to	  search	  the	  database	  of	  all	  25	  finished	  Streptomyces	  genomes.	  	  A	  CarD	  homologue	  was	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found	  in	  every	  annotated	  finished	  genome	  with	  the	  conservation	  ranging	  from	  100%	  to	  
98.1%	  (GI:477544984,	  S.	  albus	  J1074).	  
A	   TBLASTN	   search	   performed	   on	   CarD	   against	   a	   number	   of	   Streptomyces	   genomes	  
identified	   that	   the	  nucleotide	   sequence	  of	   the	  ORF	  was	  very	  highly	   conserved.	   	  More	  
interestingly,	  a	  CLUSTALW	  alignment	  showed	  that	   the	  region	  directly	  upstream	  of	   the	  
carD	   ORF	   was	   very	   highly	   conserved	   in	   Streptomyces	   spp.	   for	   approximately	   300	   bp	  
(Figure	   4.1).	   	   This	   raises	   the	   possibility	   of	   an	   upstream	   regulatory	   element	   such	   as	   a	  
transcription	   factor	   binding	   site,	   riboswitch	   or	   even	   an	   unannotated	   gene	   or	   RNA,	  
potentially	  relevant	  to	  the	  role	  of	  CarD.	  
	  
Figure	  4.1	  -­‐	  Multple	  sequence	  alignment	  of	  the	  carD	  upstream	  region.	  	  A	  multiple	  sequence	  alignment	  of	  the	  first	  107	  
bp	  of	   the	  carD	  ORF	  and	  400	  bp	  of	  upstream	  DNA	   from	  a	   range	  of	  Streptomyces	   spp.,	  performed	  using	  CLUSTALW	  
multiple	  sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  was	  performed	  using	  BOXSHADE	  3.21.	  Identical	  
residues	  are	  shaded	  black,	  similar	  residues	  are	  shaded	  grey.	  
S.coelicolor         1 ---ATACA-----GGTCGGGATCG-GTAC GCGAAATTTC-CGTGA---------AGGAATGCGCGG-ACGGCCAGGAAATTGATCACCGGGGGACGG---CCGGGGGGCG 
S.lividans           1 ---ATACA-----GGTCGGGATCG-GTAC GCGAAATTTC-CGTGA---------AGGAATGCGCGG-ACGGCCAGGAAATTGATCACCGGGGGACGG---CCGGGGGGCG 
S.avermitilis        1 -TCACATAAGTGCGGTCGCCATCG-GCTT GCGGATTTTCTCGTAAGGCCCCGTAAGGAATGCATGG--CGGCCCGAAAATTGATCATCGG----------CCGA------ 
S.hygroscopicus      1 CCCGCCCC------CTCACAACGACGCTC GCAAAATGTC-CGTGA---------AGGAATGCGCGA-GCCTCCCGGATATTGATCA-CGGAGCACCCCT-CCGGCAGCCG 
S.scabiei            1 --AACACGC-----GCGGGAACCG--CCC TCGAAACGTCACCGGA---------ACGGCTTCAGAACACGATCCGGTAACGGCGGAACGGAGGGGGTTGATCGA-----A 
S.violaceusniger     1 CGAATATCGGCTCGGCCGTTCGCG---CC GGAGATTATC-GGTAA----------GGAATCCATGC-ATG-TCCGAGAATTGATCA-CAGACTTGATGCGCTCTG----- 
S.rapamycinicus      1 ------------CGACCGGTCGCG---CG GGAGATTATC-GGTAA----------GGAATCCATGC-ATG-TCCGAGAATTGATCA-CAGACTTGATCCGCTCTG----- 
S.bingchenggensis    1 -------------GG-------------- AGCGATTATC-GGTAA----------GGAATGTGTGG-ACG-TCCGAGAATTGATCAGCACTCTTGATCCACTCTTGATCC 
S.griseus            1 TCTGCCCGC-----TCCGGGGCGG--CGT GGTGGTTTCTTCGCCATTCC------CGGCTTCGCGG--------GGGAAAGGG--ACCGGGCGCCATG---TGG------ 
S.venezuelae         1 --CATAACC-----GCCTTGATCA-ATTC GAGGCTCGCCCCGGTATTCC-----GCGGAGCCGTAC----CCCCGGAAAATCCCGGACGCGCG-------TCGA------ 
S.albus              1 ----------------TGTGATCA--CCC CGTGATCGCGCCGTGATCCCGCCCGGCGTTTCCCCGG--CGCCCCCGAGCCGGCCCCTCCGGGGGCC----CCGGACGCGC 
 
 
S.coelicolor        88 TGTCGTGATCAATTCCG--------GATT CGTC-----------CGGAACC--CTGCAGCGGCCTCCGAACGGAGTAGCGGAA--GTCGCACACGCGGAACCGGACATAT 
S.lividans          88 TGTCGTGATCAATTCCG--------GATT CGTC-----------CGGAACC--CTGCAGCGGCCTCCGAACGGAGTAGCGGAA--GTCGCACACGCGGAACCGGACATAT 
S.avermitilis       91 ---CTTGATCAATTCTG--------GATT CGTC-----------TCGTACC--CGACTCCAGTCATCGAACGGAGTAGCTGAA--GTCGAGCACTTGGGGGTGGACAAAT 
S.hygroscopicus     92 ----TTGATCAATTTCT--------GAAT CGTC-----------CCGCATC--CGGCCATGGTCACCGAACGGAGTAGCGGAA--GTCGCACGCTTGAGACCGGACAAAT 
S.scabiei           88 CTCCTTGATCAATTCCG--------GATT CGTC-----------TCGTACC--CGACTCCGCTCATCGAACGGAGTAGCGTAA--GTCGCACACATGGGGCCGGACAAAG 
S.violaceusniger    89 ---TGTGATCAA---------------TT CGCGA---ATCGGGGCCGGATCGCTCGCTCCTGAT-CCGAACGGAGTAGCGGAA--GTCCATCGACTGGACTCCGGCAAAA 
S.rapamycinicus     77 ---CGTGATCAACTC---CGTGATCAATT CGCGA---ATCGGGGCCGGATCCCTCGCTCCTGAT-CCGAACGGAGTAGCGGAA--GTCCATCGACTGGACTCCGGCAAAA 
S.bingchenggensis   71 ACCCCTGATCCACTCTGGCGTGATCAATT CGGGA---AAGACGATGGGATCACTCGCTCCAGGC-CCGAACGGAGTAGCGGAA--GTCCTTCGACTGGACTCCGGCAAAA 
S.griseus           79 ---CTTGATCAATTTCATTG----CGGTC GGACA---GTTACGCCCGTACGGGCGA--GCGATCATCGAACGGAGTA-CGGAAT-GATGGTCATCTCGAAACCGACAAAA 
S.venezuelae        81 ----CTGATCAATTGCG--------GAAT CACCCCACGATGCATCCGTACGGGTGG--ACGATCCTCGAACGGAGTA-CGTGAA-GAAGGCCACTCCGAACCCGACAAAA 
S.albus             87 CCGCGTGATCAATTCCG--------GCAA TGCCG------------GGAAGTGTGACGCGGTCCCTCGAACGCGGGAGCCGTACAGGGGGTCACC--GTACCGGACAAAA 
 
 
S.coelicolor       175 CGGGATCTTCGGGCGGGTGGTGAGGGCTC CGGATGTGTGTGACGTGCGTGTTTCGACCGGCCTGGACAGCGGCTCCGACCTGCGAATACTTTCTTCCGCTCGCTCGGCGC 
S.lividans         175 CGGGATCTTCGGGCGGGTGGCGAGGGCTC CGGATGTGTGTGACGTGCGTGTTTCGACCGGCCTGGACAGCGGCTCCGACCTGCGAATACTTTCTTCCGCTCGCTCGGCGC 
S.avermitilis      175 GGGGATGTTCGGGCGCCGGCCGGGGGCTT CCGAGGTGTGTAACGTGCACGTTTCACCCTGCCCGCAGAGCCGCTCCGACCTGCGAATACCCTCTTCCGCTACCCCCCTGG 
S.hygroscopicus    175 CAGGATGTTCCGCCACTTGGAACGGCCTC CCGAGGCGTGTGACGTACGTGTTTCACCCCGCCCGGAGAGCCCCTCCGACCTGCGAATACCCGGTTCCGGAGGCTCCCCGC 
S.scabiei          175 CGGGACGTTCGGGCGCTCGTGCGGCCCTC CGGATGCGTGTAACGTACGCGTTTCCTTCCGCCCGGAGAGCGGCTCCGACCTGCGGATACCCTCTTCCGTTCGGCCCTCGC 
S.violaceusniger   175 CGGGACGTACGGCCACTCGTCCGGGCTTC TTCGGGTGCGTAACGGGCGGGTTTCCGCGTACCCGGACAGCGGCTCCCACCTGCGAATACCCGGTTCCGCACGCCTCGTGC 
S.rapamycinicus    175 CGGGACGTAGGACCACTCGTCCGGGCTTC TTCCGACGCGTAACGGGTGGGTTTCGGGGTGCCCGGACAGCCGCTCCCACCTGCGAATACCCGGTTCCGCAGGCCTCGTGC 
S.bingchenggensis  175 CGGGACGTAAGGTCACTCGTGAGGGGTTG TTGGGGGGTGTAACGTGCGGGTTTCACTACGCCCGTGCAGCCACTCTCACCTGCGAATACCCGGTTCCGCAGGCCCCGCCC 
S.griseus          175 CGGGACTTTCGTCCCCTTCTGTAAGGCAT CGGGGCCATGTGACGCGGGTGTTTCGCTCCGGGCGCACAGTGGCTCCGACCTGCGAATACCGTCTTCCGGAAGCCTTCCGC 
S.venezuelae       175 CGGGGCATCGAGCCTACCCTGGGGGGCTC CGGGTAGGTGTAACGTGCGCGTTTCTCTCCGTCCGCGCAGCCGCTCCGACCTGCGAATACCGCCTTCCGGAAGCCCTCCGC 
S.albus            175 CAGGACATAAAGCCCTTCCTTTACGGCTT CAACTACCTGTAACGTACGCGTTTCCCTTTCCCCGGAGAGCTGCCCCGACCTGCGAATACCTCGTTCCGCAGGCCCTTCGC 
 
                       AGCACGTTCCTGTTGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCAT-35GAAGACGCCGTTTCCGTGTT-10CTGGATAGCC+1CGGAAGGGGTACC 
S.coelicolor       285 AGCACGTTCCTGTTGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGACGCCGTTTCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.lividans         285 AGCACGTTCCTGTTGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGACGCCGTTTCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.avermitilis      285 AGCACGTCCCTGTTGCGGTTGTCAAGCCC TGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGACGCCGTTTCCGTGTTACTCTTGATAGCCACGGAAGGGGTACC 
S.hygroscopicus    285 AGCACGTTCCGGTTGCTGTTGTCAAGCCC TGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGACGCCGTATCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.scabiei          285 AGCACGTTCCTGTTGCAGTTGTCAAGCCC CGAGATGCGCCCTGACCTGCGAAAACGCCATTCAGAACACGCCGTTTCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.violaceusniger   285 AGCACGTTGCGGTCGCACTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGAAGGCGTTCCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.rapamycinicus    285 AGCACGTCCCTGCCGCACTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGAAGGCGTTCCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.bingchenggensis  285 AGCACGTTCCGCCCGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGAAGGCGTTCCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.griseus          285 AGCACGTTCGTGTCGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGGAGATGCGATTCTCGTGTTACTCTGGATAGCCACGGAAGGGGTACC 
S.venezuelae       285 AGCACGTTCGTGTCGCTGTTGTCAAGCCC CGAGATATGCCCTGACCTGCGAAAACGCCATTCAGAAGAAGCCGTATCCGTGTTACCCTGGATAGCCACGGAAGGGGTACC 
S.albus            285 AGCACGTTCGCGTTGTTGTTGTCAAGCCC CGAGATATGGCCTGACCTGCGAAAACGCCATTCAAGGGCCCCGATTCTCGTGTTACCCTTGATAGCCACGGAAGGGGTACC 
 
                       TGTCACATG start codonACGTTCAA GGTTGGCGACACCGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCTATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.coelicolor       395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCTATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.lividans         395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCTATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.avermitilis      395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCTATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.hygroscopicus    395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.scabiei          395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATTGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.violaceusniger   395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.rapamycinicus    395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.bingchenggensis  395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.griseus          395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCTATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.venezuelae       395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCCATCGAAACTCGCCAGATCAAAGGCGTGGACAAGACCTACTT 
S.albus            395 TGTCACATGACGTTCAAGGTTGGCGACAC CGTGGTCTATCCCCATCACGGGGCCGCGCTGATCGAGGCAATCGAAACTCGTCAGATCAAGGGTGTGGACAAGAACTACCT 
 
 
S.coelicolor       505 GGTGCTGAAGGTCGCCCAGGGCGACCTGA CGGTACGTGTGCCAGCGGACAATGCGGAGTTCGTCGGCGTGCGTGATGTGGTCGGTCAGGACGGGCTGGACCGGGTCTTCG 
S.lividans         505 GGTGCTGAAGGTCGCCCAGGGCGACCTGA CGGTACGTGTGCCAGCGGACAATGCGGAGTTCGTCGGCGTGCGTGATGTGGTCGGTCAGGACGGGCTGGACCGGGTCTTCG 
S.avermitilis      505 GGTGCTGAAGGTCGCCCAGGGCGACCTGA CGGTGCGTGTGCCAGCGGACAATGCGGAGTTCGTCGGCGTGCGTGATGTGGTCGGTCAGGACGGGCTGGACCGGGTCTTCG 
S.hygroscopicus    505 GGTGCTGAAGGTCGCCCAGGGTGACCTGA CGGTGCGTGTGCCAGCGGACAATGCGGAGTTCGTCGGCGTGCGTGATGTGGTCGGTCAGGACGGGCTGGACCGGGTCTTCG 
S.scabiei          505 GGTGCTCAAGGTCGCTCAGGGCGACCTGA CGGTGCGTGTGCCGGCGGACAATGCGGAGTTCGTCGGTGTACGTGATGTGGTCGGTCAAGACGGCCTGGACCGGGTCTTCG 
S.violac u niger   505 GGTGCTGAAGGTCGCTCAGGGTGACCTGA CGGTTCGTGTGCCGGCGGACAATGCGGAGTTCGTCGGTGTGCGTGATGTGGTCGGCCAGG CGGGCTGGATCGGGTCTTCG 
S.rapamycinicus    505 GGTGCTGAAGGTCGCCCAGGGTGACCTGA CGGTTCGTGTGCCGGCGGACAATGCGGAGTTCGTCGGTGTGCGTGATGTGGTCGGCCAGGACGGGCTGGACCGGGTCTTCG 
S.bingchenggensis  505 GGTGCTGAAGGTCGCTCAGGGTGACCTGA CGGTTCGTGTGCCGGCGGACAATGCGGAGTTCGTCGGTGTGCGTGATGTGGTTGGCCAGGACGGGCTGGACCGGGTCTTCG 
S.griseus          505 GGTGCTCAAGGTCGCCCAGGGCGACTTGA CGGTTCGTGTGCCGGCGGACAATGCGGAGTTCGTGGGCGTGCGCGACGTGGTCGGGCAGGACGGACTGGACCGGGTCTTCG 
S.venezuelae       505 GGTGCTCAAGGTCGCGCAGGGCGACCTGA CGGTTCGTGTGCCGGCGGACAATGCGGAGTTCGTCGGTGTTCGCGACGTGGTCGGTCAGGACGGGCTGGACCGGGTCTTCG 
S.albus            505 GGTTCTCAAGGTCGCGCAAGGCGACCTGA CGGTGCGTGTGCCCGCGGACAACGCGGAGCTGGTCGGCGTGCGCGACGTAGTGGGCCAGGACGGTCTGGACCGGGTCTTCG 
 
 
S.coelicolor       615 AAGTACTGCGCGCGCCGTACGCCGAAGAG CCCACGAACTGGTCGCGTCGTTACAAGGCAAATCTGGAGAAGCTCGCCTCCGGCGACGTCATCAAGGTCGCGGAAGTCGTG 
S.lividans         615 AAGTACTGCGCGCGCCGTACGCCGAAGAG CCCACGAACTGGTCGCGTCGTTACAAGGCAAATCTGGAGAAGCTCGCCTCCGGCGACGTCATCAAGGTCGCGGAAGTCGTG 
S.avermitilis      615 AGGTGCTGCGCGCGCCGTATGCCGAGGAG CCCACGAACTGGTCGCGTCGTTACAAGGCAAATCTGGAGAAGCTCGCCTCCGGCGACGTCATCAAGGTCGCGGAAGTCGTG 
S.hygroscopicus    615 AGGTGCTGCGCGCGCCGTACGCCGAGGAG CCCACGAACTGGTCCCGTCGCTACAAGGCAAACCTGGAGAAGCTCGCCTCCGGCGATGTCATCAAGGTCGCGGAAGTCGTG 
S.scabiei          615 AGGTGCTGCGCGCACCGTATGCCGAGGAG CCCACGAACTGGTCGCGTCGCTACAAGGCAAATCTGGAGAAGCTCGCCTCCGGCGATGTCATCAAGGTCGCGGAAGTCGTG 
S.violaceusniger   615 AGGTGCTGCGTGCACCGTATGCGGAAGAA CCGACGAACTGGTCCCGTCGTTACAAGGCAAATCTCGAGAAGCTCGCCTCCGGCGATGTGATCAAGGTGGCCGAGGTCGTG 
S.rapamycinicus    615 AGGTGCTGCGCGCACCGTATGCGGAAGAA CCGACTAACTGGTCCCGTCGCTACAAGGCAAATCTCGAGAAGCTCGCCTCCGGCGATGTGATCAAGGTTGCCGAGGTCGTG 
S.bingchenggensis  615 AGGTGCTGCGCGCACCGTACGCCGAAGAG CCGACGAACTGGTCCCGTCGCTACAAGGCAAATCTCGAGAAGCTCGCCTCCGGCGACGTTATCAAGGTCGCCGAAGTGGTG 
S.griseus          615 AGGTGCTGCGCGCACCGTATGCCGAGGAG CCGACGAACTGGTCCCGGCGCTACAAGGCAAATCTCGAAAAGCTCGCCTCCGGCGATGTCATCAAGGTCGCCGAGGTAGTG 
S.venezuelae       615 AGGTGCTGCGCGCGCCGTACGCCGAAGAG CCGACGAACTGGTCCCGTCGCTACAAGGCAAATCTCGAGAAGCTCGCCTCCGGCGATGTCATCAAGGTCGCCGAAGTAGTC 
S.albus            615 AGGTGCTGCGAGCGCCGTATGCCGAGGAG CCGACCAACTGGTCCCGACGCTACAAGGCGAATCTGGAGAAGCTGGCGTCGGGCGATGTGATCCGCGTCGCCGAGGTCGTC 
 
 
S.coelicolor       725 CGCGACCTGTGGCGCCGCGAGCGCGAGCG CGGACTCTCCGCAGGTGAGAAGCGCATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTGGCTCTCGCGGAGAACAC 
S.lividans         725 CGCGACCTGTGGCGCCGCGAGCGCGAGCG CGGACTCTCCGCAGGTGAGAAGCGCATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTGGCTCTCGCGGAGAACAC 
S.avermitilis      725 CGTGACCTGTGGCGCCGGGAGCGCGAGCG CGGACTCTCCGCAGGTGAGAAGCGCATGCTCGCCAAGGCGCGGCAGATCCTGGTGAGCGAGCTCGCCCTCGCGGAGAACAC 
S.hygroscopicus    725 CGTGACCTGTGGCGTCGCGAGCGCGAGCG TGGACTGTCCGCCGGCGAGAAGCGCATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTGGCTCTCGCGGAGAACAC 
S.scabiei          725 CGTGACCTGTGGCGTCGCGAGCGGGAGCG CGGACTCTCCGCCGGCGAGAAGCGGATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTCGCCCTCGCGGAGAACAC 
S.violaceusniger   725 CGTGATCTGTGGCGCCGAGAGCGTGAGCG CGGACTCTCCGCCGGTGAGAAGCGCATGCTCGCGAAGGCCCGCCAGATCCTGGTGAGCGAGCTCGCGCTCGCCGAGAGCAC 
S.rapamycinicus    725 CGTGACCTGTGGCGCCGAGAGCGTGAGCG CGGACTCTCCGCCGGTGAGAAGCGCATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTCGCCCTCGCCGAGAGCAC 
S.bingchenggensis  725 CGCGACCTGTGGCGCCGAGAGCGGGAGCG CGGACTCTCCGCCGGTGAGAAGCGCATGCTTGCCAAGGCACGCCAGATCCTGGTGAGTGAGCTCGCCCTCGCTGAGAACAC 
S.griseus          725 CGTGACCTGTGGCGTCGGGAGCGCGAGCG CGGTCTCTCCGCCGGAGAGAAGCGCATGCTCGCCAAGGCCCGCCAGATCCTGGTGAGCGAGCTCGCTCTCGCGGAAAACAC 
S.venezuelae       725 CGCGACCTGTGGCGGCGCGAGCGCGAGCG CGGTCTCTCCGCCGGTGAGAAGCGCATGCTCGCCAAGGCTCGGCAGATCCTGGTCAGCGAGCTGGCCCTCGCGGAGAACAC 
S.albus            725 CGCGACCTGTGGCGCCGGGAGCGCGAGCG CGGTCTGTCCGCCGGTGAGAAGCGCATGCTGGCGAAGGCTCGCCAGATCCTGGTCAGCGAGCTGGCGCTGGCCGAGAACAC 
 
 
S.coelicolor       835 CAACGAGGACAAGGCGGAGGCCCTGCTCG ACGAGGTGCTCGCCTCCTGA 
S.lividans         835 CAACGAGGACAAGGCGGAGGCCCTGCTCG ACGAGGTGCTCGCCTCCTGA 
S.avermitilis      835 GAACGAGGACAAGGCCGAGGCCCTGCTCG ACGAGGTTCTCGCGTCCTGA 
S.hygroscopicus    835 GAACGAGGACAAGGCCGAGGCCCTGCTCG ACGAGGTGCTCGCCTCCTGA 
S.scabiei          835 GAACGAGGACAAGGCCGAGGCCCTGCTCG ACGAGGTTCTCGCGTCCTGA 
S.violaceusniger   835 CAATGAGGACAAGGCCGAGGCTCTGCTCG ACGAGGTTCTCGCGTCCTGA 
S.rapamycinicus    835 CAACGAGGACAAGGCCGAGGCCCTGCTCG ACGAGGTTCTCGCGTCCTGA 
S.bingchenggensis  835 CAACGAGGACAAGGCCGAGGCCCTGCTCG ACGAGGTCCTCGCGTCCTGA 
S.griseus          835 GAATGAGGACAAGGCCGAGGCTCTGCTCG ACGAGGTCCTCGCGTCCTGA 
S.venezuelae       835 GAACGAGGACAAGGCCGAGGCTCTCCTCG ACGAGGTCCTCGCGTCCTGA 




4.2.2   Conservation	  of	  CarD	  in	  the	  Actinobacteria	  
To	  look	  more	  broadly	  at	  the	  conservation	  and	  distribution	  of	  CarD,	  a	  BLASTP	  search	  was	  
performed	  against	  diverse	  representatives	  of	  the	  Actinobacteria	  order	  (Gao	  and	  Gupta,	  
2012).	   	   CarD	   was	   present	   and	   well	   conserved	   in	   each	   of	   these	   representatives	   with	  
percentage	  identities	  compared	  to	  S.	  coelicolor	  CarD	  ranging	  from	  87%	  in	  Frankia	  alni	  to	  
58%	  in	  Bifidobacterium	  longum	  (Figure	  4.2).	  	  Homologues	  were	  all	  similar	  in	  length	  with	  
the	  exception	  of	  CarD	  from	  B.	  longum	  which	  had	  a	  35	  amino	  acid	  C-­‐terminal	  extension	  
and	  contributed	  to	  its	  poor	  identity	  score.	  
	  
Figure	  4.2	   -­‐	  CarD	  distribution	   in	   the	  Actinobacteria.	   	  A	  multiple	   sequence	  alignment	  of	  CarD	  homologues	   found	   in	  
diverse	   representatives	  of	   the	  Actinobacteria	  order,	  performed	  using	  CLUSTALW	  multiple	   sequence	  alignment	   tool	  
(version	  2.1).	   	  Box	  shading	  analysis	  was	  performed	  using	  BOXSHADE	  3.21.	   Identical	  amino	  acid	  residues	  are	  shaded	  
black,	  similar	  residues	  are	  shaded	  grey.	  	  
	  
	   	  
S.coelicolor       1 MTFKVGDTVVYPHHGAALIEAIETRQIKGVDKTYLVLKVA-QGDLTVRVPADNAEFVGVRDVVGQDGLDR 
F.alni             1 MAFQVGETVVYPHHGAALIDAIETRVIKGEERLYLVLKVA-QGDLTVRVPADNVGMVGVRDVVGQDGLER 
P.dioxanivorans    1 MVFKVGETVVYPHHGAALIEAIETRTIKGEERKYLVLKVA-QGDLTVRVPAENAEVVGVRDVVGQEGLDR 
K.radiotolerans    1 MAFTVGETVVYPHHGAALIEEIKTRTIKGEDKLYLVLKVA-QGDLTIEVPADNVDLVGVRDVVGREGLDR 
S.roseum           1 MTFQVGDTVVYPHHGAARIEAITTRTIKGEERTYLVLKVD-KGDLTVQVPADNAELVGVRDVVGQEGLER 
M.tuberculosis     1 MIFKVGDTVVYPHHGAALVEAIETRTIKGEQKEYLVLKVA-QGDLTVRVPAENAEYVGVRDVVGQEGLDK 
C.acidiphila       1 MTFKVGETVVYPHHGAALIEDIEIRVIKGEPKEYLVLKVA-QGDLTVRVPSEKAEYVGVRDVVDQGGLER 
M.aurantiaca       1 MVFSVGETVVYPHHGAALIEAIETRVIKGEPREYLVLRVA-QGDLTVRVPAENAEIVGVREVVGEEGLGK 
S.nassauensis      1 MSFSVGETVVYPHHGAALIEAVETRTIKGVEQEYLVLRVE-QGDLTVRVPAGNVELVGVREVVGAEGLTE 
P.acnes            1 MTFNVGETVVYPNHGAAVIEDIETRTIKGEEKLYLVLRILGQNDLVVRVPASNLDLVGVRDVVDDEGLEN 
M.luteus           1 MVFEVGETVVYPHHGAARIEEIKMRTIKGEEKMYLKLKVA-QGDLTIEVPAENVDLVGVRDVVDAEGLEH 
B.longum           1 MSYKVGDMVVYPRHGAAKVEAITERTVKGVTREYLQLSVLSSDGLVINVPVDNAKKVGVRDIVSASEVAK 
 
 
S.coelicolor      70 VFEVLRAPYAEEPTNWSRRYKANLEKLASGDVIKVAEVVRDLWRRER-ERGLSAGEKRMLAKARQILVSE 
F.alni            70 VFEVLRAPHTEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRRDR-ERGLSAGEKRMLSKARQILVSE 
P.dioxanivorans   70 VFEVLRAPHTEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRREK-DRGLSAGEKRMLAKARQILVSE 
K.radiotolerans   70 VFSVLRTPYAEEPTNWSRRYKANLEKLASGDVVKVAEVVRDLWRRDQ-DRGLSAGEKRMLAKARQILVSE 
S.roseum          70 VFDVLRMPHTEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRRDK-ERGLSAGEKRMLAKARQILVSE 
M.tuberculosis    70 VFQVLRAPHTEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRRDQ-ERGLSAGEKRMLAKARQILVGE 
C.acidiphila      70 VFDVLRAPHTEEPTNWSRRYKANIEKIQSGDVIKVAEVVRDLWRRDR-DRGLSAGEKRMLAKARQILVSE 
M.aurantiaca      70 VFDVLRAPHTEEPTNWSRRYKANLEKLASGNPLKVAEVVRDLWRRER-ERGLSAGEKRMLAKARDILVGE 
S.nassauensis     70 VFDVLRAPHTEEPTNWSRRYKANLEKLASGNPLKVAEVVRDLWRRDR-ERGLSAGEKRMLTKARDILVGE 
P.acnes           71 VFEVLRKTNVEEPSNWSRRYKANLEKLHSGNVLKVAEVVRDLWRRER-DRGLSAGEKRMLSKARQILVSE 
M.luteus          70 VMEVLRAEHVEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRRDQ-DRGLSAGEKRMLSKARQVLVSE 
B.longum          71 VFGILRTPIIEKEMNWSRRYKLNVEKIATGDVNKIAEVVRDLAQRDVDEHGLSAGEKRMLTKARAILTSE 
 
 
S.coelicolor     139 LALAENTNEDKAEALLDEVLAS----------------------------------- 
F.alni           139 LALAEGTNEDKAEAMLDEVLAG----------------------------------- 
P.dioxanivorans  139 LALAEGTDEERAEVLLDEVLATAATA------------------------------- 
K.radiotolerans  139 LALAENTNEDKAESLLDEVLAS----------------------------------- 
S.roseum         139 LALAEKTNEDKAEALLDEVLNS----------------------------------- 
M.tuberculosis   139 LALAESTDDAKAETILDEVLAAAS--------------------------------- 
C.acidiphila     139 LALAEATNEDKADAILDEVLAS----------------------------------- 
M.aurantiaca     139 VALAEKSTKDEAETLLDKVLTEA---------------------------------- 
S.nassauensis    139 VALAEASTKDDAEVLLDKVLAEA---------------------------------- 
P.acnes          140 LALAKKVADDRAEEMLDEVLAS----------------------------------- 
M.luteus         139 LALAKKVTEEEAEGRLDKVLEG----------------------------------- 






Strain	   Gene	  name	   Accession	   Length	   Identity	  (%)	  
Streptomyces	  coelicolor	   SCO4232	   Q9L0Q9	   160	   100	  
Frankia	  alni	   FRAAL6525	   Q0RBN6	   160	   86.88	  
Pseudonocardia	  dioxanivorans	   Psed_6102	   F4CLS3	   164	   86.88	  
Kineococcus	  radiotolerans	   Krad_0898	   A6W6E7	   160	   86.25	  
Streptosporangium	  roseum	   Sros_0963	   D2B9G1	   160	   86.25	  
Mycobacterium	  tuberculosis	   Rv3583c	   P9WJG3	   162	   85	  
Catenulispora	  acidiphila	   Caci_8145	   C7QIR8	   160	   84.38	  
Micromonospora	  aurantiaca	   Micau_5835	   D9T0G9	   161	   78.75	  
Stackebrandtia	  nassauensis	   Snas_0142	   D3Q1L4	   161	   76.88	  
Propionibacterium	  acnes	   PPA0357	   Q6AAV4	   161	   74.38	  
Micrococcus	  luteus	   Mlut_03770	   C5C8X3	   160	   72.5	  
Bifidobacterium	  longum	   BLD_0751	   B3DSS8	   197	   58.12	  
Table	  4.1	  -­‐	  CarD	  distribution	  in	  the	  Actinobacteria.	  	  A	  table	  showing	  the	  gene	  name,	  accession,	  length	  and	  percentage	  
sequence	   identity	   of	   CarD	   homologues	   in	   diverse	   representatives	   of	   the	   Actinobacteria	   order,	   performed	   using	  
CLUSTALW	  multiple	  sequence	  alignment	  tool	  (version	  2.1)	  
4.2.3   RNA-­‐seq	  analysis	  of	  carD	  in	  exponentially	  growing	  S.	  coelicolor	  
With	  the	  decreasing	  cost	  of	  high-­‐throughput	  next	  generation	  sequencing	  experiments,	  
an	   increasing	   number	   of	   datasets	   are	   becoming	   publicly	   available,	   allowing	   further	  
analysis	   beyond	   initial	   publication.	   	   Romero	   et	   al.	   (2014)	   performed	   RNA-­‐seq	   on	  
S.	  coelicolor	  M145	   liquid	   cultures	   in	   late	   exponential	   phase,	   enriching	   for	   mRNA	   by	  
depleting	   16S	   and	   23S	   rRNA.	   	   The	   study	   identified	   a	   number	   of	   RNA	   processing	   and	  
degradation	   sites	   as	   well	   as	   providing	   a	   single-­‐nucleotide	   resolution	   map	   of	   the	  
transcriptional	   landscape.	   The	   RNA-­‐seq	   data	   for	   this	   study	  was	   deposited	   in	   the	  GEO	  
archive	  under	  the	  accession	  number	  GSM1126846	  in	  the	  form	  of	  aligned	  BEDGRAPH	  files	  
representing	  the	  forward	  and	  reverse	  strands.	  	  Using	  Integrated	  Genome	  Browser	  (IGB)	  
(Version	  8.3.4)	   	  aligned	  BEDGRAPH	  files	  were	  visualised	  against	   the	  S.	  coelicolor	   (A3)2	  
genome	  sequence	  and	  annotation	  downloaded	  from	  the	  NCBI	  genome	  database	  (Figure	  
4.3).	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Enrichment	  at	  the	  carD	  locus	  shows	  gene	  expression	  in	  late	  exponential	  phase.	  	  The	  lack	  
of	  enrichment	  on	   the	  positive	  strand	  downstream	  from	  the	  ORF	  suggests	   that	  carD	   is	  
monocistronic.	  	  Interestingly,	  the	  putative	  “cutoRNA”	  named	  scr4233	  is	  located	  directly	  
downstream	   of	   carD	   on	   the	   opposite	   strand,	   defined	   as	   a	   convergent	   untranslated	  
overlapping	  RNA	  (Moody	  et	  al.,	  2013).	  Presence	  or	   function	  of	   this	  RNA	  has	  yet	  to	  be	  
determined	  experimentally.	  	  	  
The	  carD	  transcription	  start	  site	  could	  be	  identified	  at	  position	  4636723,	  21	  nucleotides	  
upstream	  from	  the	  ORF	  start	  codon.	  	  Further	  upstream,	  σHrdB	  promoter-­‐like	  sequences	  
can	  be	  identified	  at	  positions	  -­‐10	  and	  -­‐35	  (TACCCT	  and	  TTCAGA,	  respectively,	  separated	  
by	  17	  bp)	  (Figure	  4.3B).	  	  	  
In	   contrast	   to	   rbpA	  which	   is	   regulated	  by	  a	  σR-­‐dependent	  promoter	  and	   is	   induced	   in	  
response	   to	   diamide,	   microarray	   experiments	   performed	   by	   Kallifidas	   et	   al.	   (2010)	  
identified	  carD	  as	  a	  gene	  downregulated	  in	  response	  to	  diamide	  in	  both	  wild-­‐type	  and	  
∆sigR	  backgrounds.	  	  A	  similar	  downregulation	  response	  is	  also	  seen	  in	  a	  large	  number	  of	  
genes	   involved	   in	   protein	   and	   RNA	   synthesis	   such	   as	   ribosomal	   proteins	   and	   RNA	  




Figure	  4.3	   -­‐	  Analysis	  of	  carD	  mRNA	   transcript	   through	  RNA-­‐seq	   	   (A)	  RNA-­‐seq	  analysis	  of	   the	  carD	   gene	   region	  and	  
downstream	  sRNA	  scr4233	  (B)	  RNA-­‐seq	  analysis	  of	  the	  carD	  TSS	  and	  promoter	  region.	  RNA-­‐seq	  data	  was	  downloaded	  
from	  the	  GEO	  archive	  under	  the	  accession	  number	  GSM1126846	  in	  the	  form	  of	  aligned	  BEDGRAPH	  files	  representing	  
the	  forward	  and	  reverse	  strands.	  	  Data	  was	  visualised	  with	  Integrated	  Genome	  Browser	  (IGB)	  (Version	  8.3.4)	  






4.3   carD	  is	  an	  essential	  gene	  in	  S.	  coelicolor	  
CarD	   has	   been	   identified	   as	   essential	   for	   viability	   in	   both	   M.	   smegmatis	   and	  
M.	  tuberculosis	  (Stallings	  et	  al.,	  2009).	  	  Attempts	  to	  delete	  the	  gene	  were	  unsuccessful,	  
although	  it	  was	  possible	  to	  create	  a	  conditional	  mutant	  strain	  by	  expressing	  carD	  under	  
the	  control	  of	  a	  tetracycline-­‐inducible	  promoter	  and	  knocking	  out	  the	  wild-­‐type	  copy	  of	  
the	  gene.	  This	  experiment	  was	  performed	  in	  M.	  smegmatis	  and	  M.	  tuberculosis	  and	  both	  
strains	  only	  grew	  in	  the	  presence	  of	  anhydrotetracycline.	  	  This	  demonstrated	  that	  CarD	  
was	  essential	   for	  viability.	   	  To	   investigate	   if	   this	  was	  also	  the	  case	  for	  S.	  coelicolor,	  we	  
aimed	  to	  make	  a	  carD	  deletion	  mutant	  and	  investigate	  the	  phenotype.	  	  	  
4.3.1   Construction	  of	  a	  carD	  deletion	  mutant	  
The	   strategy	   for	   creation	   of	   a	   ∆carD	   mutant	   is	   outlined	   in	   Figure	   4.4.	   	   To	   create	   a	  
∆carD::hyg	  mutant	  allele,	  1.5	  kb	  upstream	  and	  downstream	  flanking	  regions	  were	  PCR	  
amplified	  from	  S.	  coelicolor	  gDNA	  using	  the	  primer	  pairs	  carD_eco_F/carD_bam_R	  and	  
carD_bam_F/carD_xba_R,	  respectively.	   	  The	  PCR	  products	  were	  cloned	  into	  EcoRV-­‐cut	  
pBlueScript	  SKII+	  and	  sequenced	  to	  confirm	  successful	  amplification	  with	  no	  mutations.	  	  
They	   were	   combined	   in	   pBlueScript	   SKII+	   by	   subcloning	   the	   downstream	   flank	   as	   a	  
BamHI/XbaI-­‐cut	  fragment,	  creating	  an	  in-­‐frame	  markerless	  mutant	  allele	  in	  which	  130	  of	  
161	   codons	   had	   been	   deleted.	   	   To	   allow	   positive	   selection	   of	   this	   mutant	   allele,	   a	  
hygromycin	   (hyg)	   resistance	  cassette	  was	   subcloned	   from	  pIJ963	   to	  between	   the	   two	  
flanking	  regions	   in	  the	  carD	  ORF	  as	  a	  BglII-­‐cut	  fragment,	  creating	  a	  ∆carD::hyg	  mutant	  
allele.	   	   The	  ∆carD::hyg	  mutant	   allele	  was	  digested	  with	   XbaI/HindIII,	   blunt-­‐ended	   and	  
sub-­‐cloned	  into	  EcoRV-­‐cut	  pIJ6650,	  a	  conjugative,	  non-­‐replicating	  plasmid.	  	  The	  mutant	  
allele	   construct	  was	   confirmed	  by	   restriction	   analysis	   before	   transformation	   of	  E.	   coli	  
ET12567/pUZ8002	   and	   conjugation	   into	   S.	  coelicolor	   J1915,	   an	   M145∆glkA	   (glucose	  
kinase)	  deletion	  mutant.	  	  Regardless	  of	  additional	  carbon	  sources,	  strains	  possessing	  GlkA	  
are	  sensitive	  to	  the	  glucose	  analogue	  2-­‐deoxyglucose	  (2-­‐DOG).	  	  This	  allows	  selection	  of	  
strains	  lacking	  glkA	  by	  growth	  in	  the	  presence	  of	  2-­‐DOG;	  by	  using	  a	  mutant	  strain	  lacking	  
wild-­‐type	  glkA	  (such	  as	  J1915),	  it	  can	  therefore	  be	  used	  as	  a	  counter-­‐selectable	  marker	  
allowing	  for	  selection	  of	  loss	  of	  glkA	  present	  on	  a	  plasmid	  backbone	  (Van	  Wezel	  and	  Bibb,	  
1996).	  Single	  crossover	  transconjugants	  were	  selected	  by	  plating	  onto	  MS	  agar	  containing	  
apramycin.	   	  To	  select	   for	  the	   loss	  of	  the	  glkA	  present	  on	  the	  pIJ6650	  backbone,	  single	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crossover	  transconjugants	  were	  plated	  onto	  minimal	  media	  agar	  (with	  0.5%	  mannitol	  as	  
a	   carbon	   source)	   containing	   2-­‐DOG	   and	   hygromycin.	   	   Despite	   screening	   numerous	  
transconjugants,	  no	  2-­‐DOGR	  HygR	  colonies	  could	  be	  isolated	  suggesting	  that	  carD	   is	  an	  
essential	  gene	  in	  S.	  coelicolor.	  	  	  
	  
Figure	   4.4	   	   -­‐	   Construction	   of	   a	   ∆carD	   deletion	   mutant.	   	   The	   diagram	   shows	   the	   plasmid	   pIJ6650∆carD::hyg,	   the	  
homologous	   regions	   and	   the	   two	   possible	   stable	   double	   crossover	   strains,	   J1915∆carD::hyg	   and	   J1915	   wild	   type	  
revertant	  (J1915	  WT	  rev).	  
As	  it	  was	  not	  possible	  to	  obtain	  a	  double	  crossover	  deletion	  mutant,	  we	  instead	  aimed	  to	  





















Figure	  4.5	  -­‐	  Construction	  of	  a	  conditional	  carD	  deletion	  mutant	  	  The	  diagram	  shows	  the	  plasmid	  pIJ6650∆carD::hyg,	  
the	  homologous	  regions	  and	  the	  two	  initial	  single	  crossover	  mutants,	  “A”	  and	  “B”.	  	  Following	  expression	  of	  carD	  from	  
the	  tipAp	  promoter,	  it	  was	  possible	  to	  obtain	  two	  stable	  double	  crossover	  strains,	  J1915∆carD::hyg/tipAp-­‐carD	  (S200)	  












































carD	   was	   placed	   under	   the	   control	   of	   the	   thiostrepton-­‐inducible	   tipAp	   promoter	   in	  
pIJ6902.	   	   The	   carD	   ORF	   was	   PCR	   amplified	   from	   gDNA	   using	   the	   primer	   set	  
carD_D_F/carD_O_R,	  designed	  to	  include	  an	  NdeI	  site	  overlapping	  the	  ORF	  start	  codon	  
and	  a	  BamHI	  site	  downstream	  from	  the	  stop	  codon,	  respectively.	  	  The	  PCR	  product	  was	  
cloned	   into	   EcoRV-­‐cut	   pBlueScript	   SKII+,	   sequenced	   to	   confirm	   amplification	   with	   no	  
mutations	  and	  sub-­‐cloned	  into	  pIJ6902	  as	  an	  NdeI/BamHI	  fragment,	  creating	  the	  plasmid	  
pIJ6902::carD.	   	  The	   recombinant	  plasmid	  was	  confirmed	  by	   restriction	  digest	  analysis,	  
used	   to	   transform	   E.	   coli	   ET12567/pUZ8002	   and	   transferred	   via	   conjugation	   into	   a	  
J1915/pIJ6650∆carD::hyg	   single	   crossover	   mutant,	   selecting	   for	   transconjugants	   with	  
thiostrepton.	  	  	  
Transconjugants	  were	  plated	  out	  onto	  MM	  containing	  2-­‐DOG	  and	  thiostrepton	  to	  force	  
the	  loss	  of	  glkA	  and	  “healthy”	  colonies	  were	  picked	  onto	  MS	  containing	  thiostrepton.	  	  It	  
was	  assumed	  that	  2-­‐DOGR	  ThioR	  colonies	  isolated	  at	  this	  stage	  were	  either	  ∆carD	  mutants	  
or	  wild-­‐type	  revertants.	  	  To	  screen	  for	  ∆carD	  mutants,	  colonies	  were	  replica	  plated	  onto	  
DN	   agar,	   DN	   agar	   containing	   thiostrepton	   and	   DN	   agar	   containing	   thiostrepton	   and	  
hygromycin;	   colonies	   that	   required	   thiostrepton	   for	   growth	   and	   were	   resistant	   to	  
hygromycin	  would	  represent	  ∆carD::hyg	  mutants	  expressing	  the	  essential	  carD	  from	  the	  
tipAp	  promoter.	  Three	  independent	  clones	  were	  isolated	  with	  the	  expected	  phenotype	  
representing	   the	   strain	   J1915∆carD::hyg/tipAp-­‐carD.	   	   To	   confirm	   these	   phenotypes,	  
these	  independent	  clones	  were	  streaked	  onto	  a	  number	  of	  selective	  plates	  and	  compared	  
to	   a	   wild-­‐type	   revertant	   (J1915/tipAp-­‐carD)	   and	   the	   parent	   strain	   J1915	   (Figure	   4.6).	  	  
J1915∆carD::hyg/tipAp-­‐carD	  #1,	  #2	  and	  #3	  grew	  very	  slowly	  on	  MM	  (Figure	  4.6A),	  but	  
were	  all	  partially	  complemented	  on	  MM	  +	  thio	  (Figure	  4.6B).	  	  All	  three	  strains	  were	  viable	  
in	  the	  presence	  of	  hyg	  and	  2-­‐DOG	  (Figure	  4.6C–F)	  but	  still	  grew	  poorly	  in	  the	  absence	  of	  
thiostrepton.	   	   J1915	  was	  only	  viable	  on	  MM	  and	  in	  the	  presence	  of	  2-­‐DOG,	  whilst	  the	  
wild-­‐type	  revertant	  J1915/tipAp-­‐carD	  was	  only	  viable	  in	  the	  presence	  of	  2-­‐DOG	  and	  thio	  
(Figure	  4.6).	  	  Notably,	  the	  three	  J1915∆carD::hyg/tipAp-­‐carD	  mutants	  were	  resistant	  to	  
hygromycin	   and	   2-­‐DOG	   but	   dependent	   on	   thiostrepton.	   	   J1915∆carD::hyg/tipAp-­‐carD	  





Figure	  4.6	  -­‐	  Phenotypic	  analysis	  of	  three	  conditional	  carD	  deletion	  mutants.	  	  Strains	  streaked	  out	  onto	  (A)	  MM	  only;	  (B)	  
MM	  +	  thio;	  (C)	  MM	  +	  hyg;	  (D)	  MM	  +	  2-­‐DOG	  +	  hyg;	  (E)	  MM	  +	  2-­‐DOG;	  (F)	  MM	  +	  2-­‐DOG	  +	  thio	  and	  incubated	  for	  5	  days	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4.3.2   Phenotypic	  analysis	  of	  ∆carD	  mutant	  
S200	   (J1915∆carD::hyg/tipAp-­‐carD)	  and	   J1915/tipAp-­‐carD	  were	   streaked	  out	   onto	  MS	  
only	  and	  MS	  containing	  a	  range	  of	  thiostrepton	  concentrations	  (5	  µg/mL,	  15	  µg/mL	  and	  
25	  µg/mL)	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  	  In	  the	  absence	  of	  thiostrepton,	  S200	  was	  
barely	  viable	  (Figure	  4.7A).	  	  Some	  growth	  was	  visible	  where	  concentrated	  spores	  were	  
plated	  and	  very	  small	  colonies	  could	  be	  observed	  throughout	  the	  streak.	  	  At	  a	  range	  of	  
thiostrepton	   concentrations,	   S200	   growth	  was	   restored.	   	   Colonies	   were	   smaller	   than	  
wild-­‐type	   at	   5	  µg/mL	   thiostrepton	  but	   restored	   to	  wild-­‐type	   size	   at	   12	   and	  25	  µg/mL	  
thiostrepton	  (Figure	  4.7B–D).	  	  Despite	  the	  ability	  of	  thiostrepton	  to	  complement	  growth,	  
at	  all	  concentrations	  colonies	  were	  lighter	  in	  colour,	  reminiscent	  of	  a	  whi	  phenotype	  for	  
mutants	  blocked	  in	  late	  stages	  of	  sporulation	  (Flärdh	  and	  Buttner,	  2009).	  	  Growth	  of	  wild-­‐
type	  revertant	  J1915/tipAp-­‐carD	  was	  consistent	  with	  a	  wild-­‐type	  phenotype	  in	  absence	  
and	  presence	  of	  thiostrepton	  at	  all	  concentrations.	  
	  
Figure	  4.7	  -­‐	  CarD	  is	  required	  for	  growth	  in	  S.	  coelicolor.	  	  J1915/tipAp-­‐carD	  revertant	  and	  S200	  (J1915∆carD::hyg/tipAp-­‐
carD)	  streaked	  out	  onto	   (A)	  MS	  only	   (B)	  MS	  +	   thiostrepton	   (5	  µg/mL)	   (C)	  MS	  +	   thiostrepton	   (12	  µg/mL)	   	   (D)	  MS	  +	  
thiostrepton	  (25	  µg/mL)	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  
A B
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MS  +  5  μg/mL  thioMS  only
J1915/tipAp-­carD   S200
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4.3.3   Full	  complementation	  of	  S200	  with	  an	  additional	  copy	  of	  carD	  
To	  confirm	  that	  the	  mutant	  phenotype	  observed	  when	  S200	  was	  grown	  in	  the	  absence	  
(or	  indeed	  presence)	  of	  thiostrepton	  were	  both	  due	  to	  a	  lack	  of	  CarD	  and	  not	  unwanted	  
polar	   effects	   caused	   during	   creation	   of	   the	   strain,	   it	   was	   deemed	   necessary	   to	  
complement	   the	   strain	  with	   an	   additional	   copy	   of	   CarD	   under	   the	   control	   of	   its	   own	  
promoter.	   The	   carD	   gene	   with	   400	   bp	   of	   upstream	   and	   downstream	   DNA	   was	   PCR	  
amplified	  from	  M145	  genomic	  DNA	  using	  the	  primer	  set	  ext_carD_F/ext_carD_R.	   	  The	  
PCR	   product	   was	   cloned	   into	   EcoRV-­‐cut	   pBlueScript	   SKII+,	   sequenced	   to	   confirm	  
amplification	  with	   no	  mutations	   and	   subcloned	   into	   pRT802	   as	   a	   BglII/BglII	   fragment,	  
producing	  the	  plasmid	  pRT802::carD.	  	  The	  recombinant	  plasmid	  was	  used	  to	  transform	  
E.	  coli	  ET12567/pR9406	  and	  transferred	  via	  conjugation	  into	  S200.	  	  	  
As	   an	   additional	   control,	   a	   frameshift	  mutation	  was	   introduced	   into	   the	   carD	   ORF	   to	  
confirm	  that	  the	  complementation	  of	  S200	  with	  pRT802::carD	  was	  exclusively	  due	  to	  the	  
carD	  ORF	  and	  not	  any	  other	  elements	  in	  the	  fragment.	  	  The	  plasmid	  pBlueScript-­‐carD	  was	  
digested	   with	   BstBI,	   “filled-­‐in”	   using	   Klenow	   fragment	   and	   religated	   together.	   	   This	  
procedure	  introduced	  a	  2	  bp	  insertion	  212	  bp	  into	  the	  ORF	  causing	  a	  frameshift	  mutation,	  
mistranslation	  of	  the	  C-­‐terminus	  of	  the	  protein	  and	  a	  premature	  stop	  codon.	  	  The	  insert	  
was	  re-­‐sequenced	  to	  confirm	  the	  presence	  of	  the	  frameshift	  mutation,	  subcloned	  into	  
pRT802	  as	  a	  BglII/BglII	  fragment,	  producing	  the	  plasmid	  pRT802::carDFS.	  This	  plasmid	  was	  
transferred	  via	  conjugation	  into	  S200.	  
S200/pRT802,	  S200/pRT802::carD	  and	  S200/pRT802::carDFS	  were	  streaked	  out	  onto	  MS	  
only	  and	  MS	  containing	  15	  µg/mL	  thiostrepton	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  	  In	  both	  
the	  presence	  and	  absence	  of	  thiostrepton,	  S200/pRT802::carD	  was	  fully	  complemented,	  
including	   the	   ability	   to	   produce	   dark	   grey	   spores	   (Figure	   4.8A–B).	   	   S200/pRT802	   and	  
S200/pRT802::carDFS	  appeared	  to	  be	  unaffected	  by	  the	  presence	  of	  the	  empty	  pRT802	  





Figure	   4.8	   -­‐	   carD	   fully	   complements	   a	   conditional	   carD	   deletion	   mutant.	   	   S200/pRT802,	   S200/pRT802::carD	   and	  
S200/pRT802::carDFS	  on	  (A)	  MS	  agar	  and	  (B)	  MS	  agar	  +	  15	  µg/mL	  thiostrepton	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  
4.3.4   Depletion	  of	  rbpA	  and	  carD	  in	  an	  sspB-­‐dependent	  manner	  
As	  an	  alternative	  method	   for	   investigating	   the	  essential	  nature	  of	  CarD,	  a	  method	   for	  
targeted	  proteolysis	  previously	  used	  in	  a	  variety	  of	  species	  including	  E.	  coli	  (McGinness	  
et	  al.,	  2006),	   	  B.	  subtilis	   (Griffith	  and	  Grossman,	  2008)	  and	  M.	  tuberculosis	   (Kim	  et	  al.,	  
2011)	  was	  adapted	  for	  use	  in	  S.	  coelicolor.	  	  Specific	  protein	  degradation	  can	  be	  achieved	  
through	   a	   number	   of	   different	   mechanisms	   including	   C-­‐	   or	   N-­‐terminal	   tags	   that	   are	  
specifically	  recognised	  by	  proteolytic	  enzymes.	  	  Trans-­‐translation	  is	  a	  natural	  system	  that	  
exists	   for	   degradation	   of	   incomplete	   polypeptides	   that	   result	   from	   the	   stalling	   of	  
ribosomes	  during	  translation	  (Keiler,	  2008).	   	  tmRNA	  (or	  SsrA)	   is	  a	  small	  RNA	  with	  both	  
mRNA	  and	  tRNA	  properties.	  	  It	   initiates	  the	  trans-­‐translation	  process	  by	  binding	  to	  the	  
unoccupied	  A-­‐site	  of	  a	  stalled	  ribosome,	  causing	  the	  ribosome	  to	  translocate	  to	  the	  mRNA	  
portion	  of	  the	  tmRNA	  leading	  to	  the	  addition	  of	  a	  short	  peptide	  tag.	  	  This	  both	  rescues	  
the	   stalled	   ribosome	   complex	   and	   targets	   the	   nascent	   polypeptide	   for	   degradation	  
(Gottesman	  et	  al.,	  1998;	  Choy	  et	  al.,	  2007;	  Keiler,	  2008).	   	  The	  degradation	  tag	   is	   then	  
recognised	  directly	  by	  a	  protease	  or	  protease	  adapter	  for	  proteolysis.	  	  The	  adaptability	  of	  
this	  system	  for	  use	  as	  a	  tool	  comes	  from	  the	  variability	  of	  each	  tmRNA	  system	  between	  
bacterial	  species.	  	  SsrA-­‐tagged	  proteins	  are	  degraded	  by	  a	  number	  of	  proteases	  including	  
ClpX,	  which	  is	  specifically	  enhanced	  by	  the	  adapter	  protein	  SspB	  (Dougan	  et	  al.,	  2003).	  	  
By	  modifying	  the	  last	  3	  residues	  of	  the	  SsrA-­‐tag,	  non-­‐SspB-­‐specific	  degradation	  can	  be	  
abolished	  making	   ClpX-­‐mediated	   degradation	   fully	   dependent	   on	   the	   adapter	   protein	  






SspB	   (McGinness	   et	   al.,	   2006;	   Griffith	   and	   Grossman,	   2008).	   	   In	  M.	   tuberculosis	   and	  
M.	  smegmatis,	   this	  was	  achieved	  by	  changing	   the	  E.	  coli	  SsrA	   tag	  with	   the	  amino	  acid	  
sequence	  “AANDENYALAA“	  to	  “AANDENYSENYADAS”	  (named	  DAS+4)	  (Kim	  et	  al.,	  2011).	  	  
The	  SspB	  protein	  was	  placed	  under	  control	  of	  a	  TetR-­‐regulated	  promoter	  allowing	  the	  
degradation	   of	   the	   DAS+4	   tagged	   protein	   to	   be	   induced	   by	   addition	   of	  
anhydrotetracycline.	  	  	  
To	  initially	  develop	  the	  system	  for	  S.	  coelicolor,	  it	  was	  decided	  to	  target	  RbpA,	  which	  is	  
required	   for	   rapid	   growth.	   	   An	   rbpA-­‐DAS+4	   fragment	   was	   synthesised	   (Eurofins	  
Genomics,	  see	  appendix)	  and	  cloned	  into	  the	  plasmid	  pRT802	  as	  a	  SpeI/BamHI	  fragment,	  
creating	  the	  plasmid	  pRT802::rbpA-­‐DAS+4.	  	  The	  synthesised	  fragment	  was	  designed	  with	  
HindIII	  restriction	  sites	  upstream	  of	  the	  rbpA	  promoter	  and	  at	  the	  intersection	  between	  
the	  rbpA	  ORF	  and	  the	  in-­‐frame	  C-­‐terminal	  DAS+4	  tag.	  	  To	  ensure	  that	  the	  DAS+4	  tag	  had	  
no	  effect	  on	  the	  physiological	  role	  of	  the	  protein	  in	  the	  absence	  of	  SspB,	  pRT802::rbpA-­‐
DAS+4	  was	  transferred	  via	  conjugation	  into	  the	  ∆rbpA	  mutant	  S101	  and	  the	  ability	  of	  the	  
tagged	  protein	  to	  complement	  the	  mutant	  was	  compared	  to	  the	  positive	  and	  negative	  
controls	  pRT802::rbpA	  and	  pRT802,	  respectively.	  
	  
Figure	   4.9	   -­‐	   rbpA-­‐DAS+4	   complements	   an	   ∆rbpA	   deletion	   mutant.	   	   S101/pRT802,	   S101/pRT802::rbpA	   and	  
S101/pRT802::rbpA-­‐DAS+4	  streaked	  onto	  MS	  agar	  and	  incubated	  for	  5	  days	  at	  30	  °C.	  






The	   plasmid	   pRT802::rbpA-­‐DAS+4	   fully	   complemented	   the	   small	   colony	   mutant	  
phenotype	  (observed	  in	  negative	  control	  S101/pRT802)	  and	  was	  indistinguishable	  from	  
the	  strain	  complemented	  with	  wild-­‐type	  rbpA	  (S101/pRT802::rbpA).	  	  This	  confirms	  that	  
RbpA-­‐DAS+4	  was	  fully	  functional	  and	  suitable	  for	  use	  in	  depletion	  experiments.	  
To	  ensure	  efficient	  expression	  and	  to	  remove	  some	  common	  restriction	  sites,	  sspB	  was	  
synthesised	  using	  the	  S.	  coelicolor	  codon	  usage	  table	  (Eurofins	  Genomics,	  see	  appendix).	  	  
The	  gene	  was	  subcloned	  into	  the	  plasmid	  pIJ6902	  as	  an	  NdeI/BamHI	  fragment,	  placing	  
the	  gene	  under	  the	  control	  of	  the	  thiostrepton-­‐inducible	  tipAp	  promoter	  and	  creating	  the	  
plasmid	   pIJ6902::sspB.	   	   Once	   confirmed	   by	   restriction	   analysis,	   pIJ6902::sspB	   and	   the	  
empty	   vector	   pIJ6902	   were	   transformed	   into	   ET12567/pUZ8002	   and	   transferred	   via	  
conjugation	   into	   S101/pRT802::rbpA-­‐DAS+4	   and	   the	   negative	   control	   strain	  
S101/pRT802::rbpA.	  
The	  four	  strains	  were	  streaked	  to	  single	  colonies	  on	  MS	  agar	  and	  MS	  agar	  containing	  a	  
range	  of	   thiostrepton	   concentrations.	   	   In	   the	   absence	  of	   thiostrepton,	   all	   four	   strains	  
showed	  no	  comparable	  difference	  and	  resembled	  a	  wild	   type	  phenotype.	   	  This	  shows	  
that	   in	   the	   absence	   of	   thiostrepton	   neither	   the	   DAS+4	   tag	   nor	   plasmids	   pIJ6902	   and	  
pIJ6902::sspB	  had	  any	  effect	  on	  growth.	  	  At	  thiostrepton	  concentrations	  of	  5	  µg/mL	  to	  
25	  µg/mL	  all	   three	  control	   strains	  were	  unaffected.	   	   S101/pRT802::rbpA/pIJ6902::sspB	  
shows	  that	  expression	  of	  sspB	  from	  the	  strong	  tipAp	  promoter	  has	  no	  effect	  on	  growth	  
in	  an	  otherwise	  wildtype	  background.	   	  S101/pRT802::rbpA-­‐DAS+4/pIJ6902,	  shows	  that	  
the	   DAS+4	   tag	   fully	   complements	   the	   ∆rbpA	   null	   strain,	   however	   isn’t	   effected	   by	  
thiostrepton	   in	   the	   absence	   of	   SspB	   protein.	   	   The	   third	   control	   strain	  
S101/pRT802::rbpA/pIJ6902	  shows	  that	  increasing	  concentrations	  of	  thiostrepton	  have	  
no	   effect	   on	   growth	   in	   the	   presence	   of	   the	   plasmid	   pIJ6902	  which	   possesses	   the	   tsr	  
thiostrepton	  resistance	  gene.	  	  	  
For	   the	   depletion	   strain	   S101/pRT802::rbpA-­‐DAS+4/pIJ6902,	   an	   ∆rbpA	  mutant	   small	  
colony	  phenotype	  can	  be	  seen	  at	  concentrations	  as	  low	  as	  5	  µg/mL.	  	  As	  the	  concentration	  
is	  increased	  to	  12	  µg/mL	  and	  25	  µg/mL	  the	  effect	  is	  further	  pronounced.	  	  The	  ability	  to	  
replicate	  a	  clear	  mutant	  phenotype	  in	  an	  inducible	  manner	  suggests	  that	  proteins	  can	  be	  




Figure	   4.10	   -­‐	   SspB-­‐mediated	   depletion	   of	   RbpA-­‐DAS+4.	   	   S101/pRT802::rbpA/pIJ6902::sspB	   (WT	   sspB),	  
S101/pRT802::rbpA-­‐DAS+4/pIJ6902::sspB	   (DAS+4	   sspB),	   S101/pRT802::rbpA/pIJ6902	   (WT	   6902)	   and	  
S101/pRT802::rbpA-­‐DAS+4/pIJ6902	  (DAS+4	  6902)	  streaked	  out	  onto	  (A)	  MS	  agar,	  (B)	  MS	  agar	  +	  5	  µg/mL	  thiostrepton,	  
(C)	  MS	  agar	  +	  12	  µg/mL	  thiostrepton	  and	  (D)	  MS	  agar	  +	  25	  µg/mL	  thiostrepton	  and	  incubated	  for	  5	  days	  at	  30	  °C.	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Following	  the	  successful	  depletion	  of	  RbpA,	  the	  system	  was	  used	  to	  deplete	  CarD.	   	  To	  
achieve	  this,	  carD	  (with	  its	  own	  promoter	  and	  no	  stop	  codon)	  was	  PCR	  amplified	  from	  
genomic	   DNA	   using	   the	   primers	   carD_3XFLAG_F/carD_3XFLAG_R,	   which	   introduced	  
flanking	  HindIII	  sites,	  then	  subcloned	  into	  HindIII-­‐cut	  pRT802::rbpA-­‐DAS+4,	  replacing	  the	  
rbpA	  gene	  with	  carD	  to	  create	  pRT802::carD-­‐DAS+4.	  	  	  
To	  ensure	  that	  in	  the	  absence	  of	  SspB	  the	  DAS+4	  tag	  had	  no	  effect	  on	  the	  physiological	  
role	  of	  CarD,	  the	  plasmid	  pRT802::carD-­‐DAS+4	  was	  transferred	  via	  conjugation	  into	  the	  
conditional	  ∆carD	  mutant	  S200	  and	  the	  ability	  of	  the	  tagged	  protein	  to	  complement	  the	  
mutant	  was	  compared	  to	  the	  positive	  and	  negative	  controls	  pRT802::carD	  and	  pRT802,	  
respectively.	  
	  
Figure	   4.11	   -­‐	   carD-­‐DAS+4	   complements	   S200,	   a	   ∆carD	   deletion	   mutant.	   	   S200/pRT802,	   S200/pRT802::carD	   and	  
S200/pRT802::carD-­‐DAS+4	  streaked	  onto	  (A)	  MS	  agar	  and	  (B)	  MS	  agar	  +	  15	  µg/mL	  thiostrepton	  and	  incubated	  for	  5	  
days	  at	  30	  °C.	  
The	  plasmid	  pRT802::carD-­‐DAS+4	  fully	  complemented	  the	  mutant	  phenotype	  both	  in	  the	  
absence	   (Figure	   4.11A)	   and	   presence	   of	   thiostrepton	   (Figure	   4.11B)	   and	   was	  
indistinguishable	  from	  the	  strain	  complemented	  with	  wild-­‐type	  carD.	  	  This	  confirms	  that	  
CarD-­‐DAS+4	  was	  fully	  functional	  and	  suitable	  for	  use	  in	  depletion	  experiments.	  
To	   deplete	   CarD	   in	   an	   SspB-­‐dependent	   manner,	   a	   strain	   possessing	   only	   one	  
chromosomal	  copy	  of	  carD	  with	  a	  DAS+4	  tag	  was	  required.	  	  Due	  to	  the	  essential	  nature	  
of	  CarD	   it	  was	  not	  possible	   to	   first	   create	  a	  ∆carD	  mutant	   and	   complement	   this	  with	  






carD-­‐DAS+4.	  	  Instead,	  the	  plasmid	  pRT802::carD-­‐DAS+4	  was	  transferred	  via	  conjugation	  
into	  a	  single	  crossover	  strain	  J1915/pIJ6650∆carD::hyg.	  	  As	  the	  strain	  now	  possessed	  an	  
additional	  functional	  copy	  of	  carD	  (carD-­‐DAS+4	  on	  pRT802	  integrated	  at	  the	  phage	  φBT1	  
site),	  following	  a	  round	  of	  non-­‐selective	  growth	  it	  was	  now	  possible	  to	  obtain	  AprS	  HygR	  
double	   crossover	   deletion	   mutants	   representing	   the	   strain	  
J1915∆carD::hyg/pRT802::carD-­‐DAS+4.	  	  This	  strain	  was	  named	  S201.	  	  pIJ6902::sspB	  was	  
transferred	   via	   conjugation	   into	   this	   strain	   and	   J1915	   (as	   a	   negative	   control	   with	  
untagged,	  native	  CarD)	  using	  apramycin	  resistance	  as	  selection.	  
	  
	  
Figure	  4.12	  -­‐	  SspB-­‐mediated	  depletion	  of	  CarD.	  	  S201/pIJ6902::sspB	  and	  J1915/pIJ6902::sspB	  streaked	  out	  onto	  (A)	  MS	  
agar,	  (B)	  MS	  agar	  +	  5	  µg/mL	  thiostrepton,	  (C)	  MS	  agar	  +	  12	  µg/mL	  thiostrepton	  and	  (D)	  MS	  agar	  +	  25	  µg/mL	  thiostrepton	  
and	  incubated	  for	  5	  days	  at	  30	  °C.	  
In	   the	  absence	  of	   thiostrepton	  on	  MS	  agar,	  S201/pIJ6902::sspB	   and	   the	  control	   strain	  
J1915/pIJ6902::sspB	  showed	  no	  comparable	  difference	  (Figure	  4.12A).	  	  At	  thiostrepton	  
concentrations	   of	   5	   µg/mL	   to	   25	   µg/mL,	   the	   control	   strain	   J1915/pIJ6902::sspB	   was	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on	  growth.	  	  At	  concentrations	  of	  5	  µg/mL,	  below	  the	  typical	  working	  concentration	  for	  
thiostrepton	  in	  S.	  coelicolor	  (Huang	  et	  al.,	  2005),	  a	  partial	  CarD	  null	  phenotype	  can	  be	  
observed	  (Figure	  4.12B).	  	  The	  colonies	  are	  smaller	  and	  lighter	  in	  colour,	  reminiscent	  of	  a	  
Whi	  phenotype	   for	  mutants	  blocked	   in	   late	  stages	  of	  sporulation	   (Flärdh	  and	  Buttner,	  
2009).	   	   This	   phenotype	   is	   further	   pronounced	   at	   a	   thiostrepton	   concentrations	   of	  
12	  µg/mL	  to	  25	  µg/mL	  (Figure	  4.12C	  and	  Figure	  4.12D).	  	  	  
The	   depletion	   phenotype	   observed	   in	   this	   experiment	   and	   strain	   S200	   grown	   in	   the	  
absence	   of	   thiostrepton	   are	   similar,	   further	   proving	   that	   CarD	   is	   a	   protein	   critical	   for	  
growth	  in	  S.	  coelicolor.	  	  These	  data	  also	  demonstrate	  that	  SspB-­‐mediated	  depletion	  can	  
be	  effectively	  used	  for	  observing	  mutant	  phenotypes	  in	  S.	  coelicolor.	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4.4   Purification	  of	  CarD	  
To	  further	  understand	  the	  biochemical	  role	  of	  CarD,	  it	  was	  necessary	  to	  perform	  in	  vitro	  
experiments	  with	   purified	   CarD	   protein.	   	   This	   section	   details	   the	   purification	   of	   CarD	  
heterologously	   expressed	   in	   E.	   coli,	   chosen	   as	   the	   most	   suitable	   host	   for	   obtaining	  
sufficient	  protein	  yields	  and	  purity.	  
4.4.1   Overexpression	  of	  His-­‐CarD	  protein	  in	  E.	  coli	  
To	  overexpress	  and	  purify	  CarD	  protein	  from	  E.	  coli,	  the	  ORF	  was	  amplified	  from	  M145	  
genomic	  DNA	  by	  PCR	  using	  primers	  CarD_D_F/CarD_O_R,	  designed	  to	  introduce	  an	  NdeI	  
site	   overlapping	   the	   start	   codon	   and	   a	  BamHI	   site	   downstream	   from	   the	   stop	   codon,	  
respectively.	  	  The	  PCR	  product	  was	  cloned	  into	  EcoRV-­‐cut	  pBlueScript	  SKII+,	  sequenced	  
to	  confirm	  amplification	  with	  no	  mutations,	  and	  subcloned	  into	  pET15b	  as	  an	  NdeI/BamHI	  
fragment,	  producing	  the	  plasmid	  pET15b-­‐carD.	   	  The	  recombinant	  plasmid	  was	  used	  to	  
transform	  E.	  coli	  BL21	  (pLysS)	  and	  a	  single	  colony	  was	  used	  to	  inoculate	  250	  mL	  LB.	  	  The	  
culture	  was	   grown	   in	   an	   orbital	   shaker	   at	   37	   °C	   to	  OD600	   0.5–0.6,	   then	   the	   flask	  was	  
submerged	   in	   ice-­‐water	   for	   10	   min	   before	   addition	   of	   1	   mM	   IPTG	   and	   continued	  
incubation	  in	  the	  orbital	  shaker	  for	  3	  h	  at	  30	  °C.	  	  Cells	  were	  harvested	  by	  centrifugation,	  
resuspended	   in	   15	   mL	   Ni-­‐NTA	   binding	   buffer	   (containing	   1.5	   mL	   protease	   inhibitor	  
cocktail	  and	  25	  µg/mL	  PMSF)	  and	  disrupted	  by	  sonication	  (6	  x	  10s	  @	  35%	  ampl.)	  (whole	  
cell	  lysate,	  WCL).	  	  	  
4.4.2   Purification	  of	  His-­‐CarD	  
The	  cleared	  cell	   lysate	   (CCL)	  was	  separated	  from	  the	  cell	  debris	  by	  centrifugation.	   	  To	  
purify	  His-­‐CarD,	  the	  CCL	  was	  first	   loaded	  onto	  a	  Ni-­‐NTA	  sepharose	  column	  and	  bound	  
His-­‐CarD	  was	  eluted	  with	  Ni-­‐NTA	  elution	  buffer.	   	  Eluted	  protein	  was	  filtered	  through	  a	  
0.22	   µM	   filter	   and	   further	   FPLC	   purified	   by	   passing	   through	   a	   size	   exclusion	   column	  
(HiLoadTM	  16/60	  SuperdexTM	  200	  column)	  with	  gel	  filtration	  (GF)	  buffer	  (Figure	  4.13B).	  	  
Elutions	  were	  collected	  as	  1	  mL	  fractions	  and	  those	  containing	  His-­‐CarD	  (fractions	  G8–
H5)	  were	  combined,	  concentrated	  to	  15	  µM	  by	  centrifugal	   filtration	  (VivaSpin	  6,	  3000	  
MWCO,	  Sartorius),	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  °C.	  	  SDS-­‐PAGE	  analysis	  
of	  the	  purification	  and	  elution	  fractions	  are	  shown	  in	  Figure	  4.13A.	  	  Purification	  via	  this	  




Figure	  4.13	  -­‐	  Purification	  of	  His-­‐CarD	  from	  E.	  coli	  	  (A)	  SDS-­‐PAGE	  analysis	  of	  His-­‐CarD	  purification.	  Lane	  1	  (M):	  SeeBlue	  
Plus2	  marker;	  lane	  2	  (WCL):	  whole	  cell	  lysate;	  lane	  3	  (FT):	  flow	  through;	  lane	  4	  (CCL):	  cleared	  cell	  lysate,	  lane	  5	  (W):	  
wash,	   lane	  6	  (G8–H5):	  size	  exclusion	  elution	  combined	  fractions	  G8–H5.	   	  (B)	  Size	  exclusion	  purification	  of	  His-­‐CarD.	  	  
HiLoadTM	  16/60	  SuperdexTM	  200	  column	  elution	  trace	  for	  purification	  of	  His-­‐CarD	  








4.5   CarD	  activates	  transcription	  from	  σHrdB-­‐dependent	  promoters	  in	  vitro	  
Initial	   published	   data	   suggested	  M.	   tuberculosis	  CarD	   as	   an	   important	   transcriptional	  
regulator.	   	   It	   was	   shown	   to	   be	   an	   essential	   protein,	   its	   depletion	   effected	   rRNA	  
transcription	   and	   revealingly,	   possessed	   an	   N-­‐terminal	   RNAP	   binding	   domain	  
homologous	  to	  the	  transcription	  repair	  coupling	  factor	  (TRCF)	  that	  binds	  to	  β	  (Stallings	  et	  
al.,	   2009).	   	   The	   role	   of	   M.	   tuberculosis	   CarD	   in	   transcription	   activation	   was	   later	  
demonstrated	  through	  in	  vitro	  transcription	  experiments.	  	  The	  following	  section	  details	  
the	  purification	  of	  S.	  coelicolor	  RNAP	  and	  subsequent	  in	  vitro	  transcription	  experiments	  
to	  investigate	  the	  role	  of	  S.	  coelicolor	  CarD	  in	  transcription.	  
4.5.1   Purification	  of	  S129	  RNA	  polymerase	  holoenzyme	  and	  core	  
To	  purify	  RNA	  polymerase	  holoenzyme	  in	  the	  absence	  of	  RbpA,	  the	  strain	  S129	  (M145	  
∆rpoC::rpoCHIS	  ΔrbpA::aac(3)IV)	  (Newell	  et	  al.,	  2006)	  was	  used.	  	  Four	  fresh	  spore	  plates	  
were	  combined	  and	  used	  to	   inoculate	  6	  x	  500	  mL	  YEME	  cultures	   in	  2	  L	  baffled	   flasks.	  	  
Cultures	   were	   grown	   at	   30	   °C	   to	   an	   OD450	   1.5–2	   before	   collecting	   the	   mycelium	   by	  
centrifugation	  at	  6,000	  rpm	  for	  2	  min	  at	  4	  °C.	  	  Pellets	  were	  washed	  twice	  with	  cell	  wash	  
buffer	  and	  centrifuged	  again	  at	  6,000	  rpm	  for	  2	  min	  at	  4	  °C	  before	  snap-­‐freezing	  in	  liquid	  
nitrogen	   and	   storage	   at	   -­‐80	   °C	   until	   further	   purification.	   The	   following	   method	   was	  
developed	  to	  improve	  the	  yield	  and	  purity	  of	  S.	  coelicolor	  RNA	  polymerase	  and	  combines	  
previous	   published	  methodology	  with	  minor	  modifications.	   The	   initial	   precipitation	  of	  
DNA	  along	  with	  associated	  RNA	  polymerase	  by	  PEG	  is	  based	  on	  the	  method	  described	  by	  
Gross	  et	  al.	  (1976)	  with	  minor	  adjustments	  (Fong	  et	  al.,	  2010).	  The	  subsequent	  Ni-­‐affinity	  
purification	   precedes	   purification	   of	   core	   RNAP	   by	   MonoQ	   ion	   exchange	  
chromatography,	  essentially	  as	  described	  by	  Hahn	  et	  al.	  (2003).	  
Pellets	  were	  cryogenically	  ground	  for	  2	  x	  90	  s,	   resuspended	   in	  20	  mL	  cell	  wash	  buffer	  
(containing	  1.5	  mL	  protease	   inhibitor	  cocktail	  and	  25	  µg/mL	  PMSF)	  and	  the	  cells	  were	  
disrupted	  by	  sonication	  for	  6	  x	  10	  s	  (35%	  ampl.)	  on	  ice.	  	  The	  cell	  lysate	  was	  centrifuged	  at	  
16,000	  x	  g	  for	  30	  min	  at	  4	  °C	  and	  the	  cleared	  cell	  lysate	  (or	  supernatant)	  was	  transferred	  
to	  a	  new	  tube.	  	  12	  mL	  of	  PEG-­‐PPT	  buffer	  was	  added	  and	  mixed	  by	  rotation	  for	  10	  min	  at	  
4	   °C,	   allowing	   precipitation	   of	   DNA	   (and	   bound	   RNAP)	   to	   occur.	   	   The	   mixture	   was	  
centrifuged	  at	  7,000	  x	  g	  for	  10	  min	  at	  4	  °C	  and	  the	  supernatant	  discarded	  (S1).	  	  The	  pellet	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was	   resuspended	   in	   2	   mL	   PEG-­‐HS	   buffer	   to	   dissociate	   RNAP,	   transferred	   to	   a	   2	   mL	  
microcentrifuge	  tube	  and	  centrifuged	  at	  10,000	  x	  g	  for	  10	  min	  at	  4	  °C.	  	  The	  supernatant	  
(S2)	  was	  collected	  and	  6	  mL	  of	  PEG-­‐Ni	  binding	  buffer	  was	  added	  –	  for	  six	  separate	  pellets	  
this	  totals	  48	  mL	  that	  was	  combined	  for	  Ni-­‐NTA	  purification.	  	  A	  column	  was	  constructed	  
with	  a	  4	  mL	  IDA-­‐sepharose	  bed	  volume	  and	  following	  washes	  with	  4	  column	  volumes	  of	  
PEG-­‐Ni	  binding	  buffer	  and	  3	  column	  volumes	  of	  wash	  buffer	  the	  protein	  was	  eluted	  in	  
6	  mL	  0.5	  M	  NaCl	  elution	  buffer	  (Figure	  4.14A).	  	  The	  protein	  was	  diluted	  with	  6	  mL	  dilution	  
buffer	  (to	  lower	  the	  NaCl	  concentration	  to	  0.2	  M),	  centrifuged	  at	  7,000	  x	  g	  for	  10	  min	  
before	  loading	  onto	  a	  Mono	  Q	  5/50	  GL	  column.	  	  This	  final	  anion-­‐exchange	  purification	  
step	  was	  designed	  to	  separate	  RNAP	  holoenzyme	  from	  RNAP	  core.	  	  The	  elution	  gradient	  
was	  set	  0%	  to	  40%	  for	  40	  mL	  followed	  by	  40%	  to	  100%	  for	  5	  mL	  and	  UV	  trace	  peaks	  were	  
analysed	  by	  western	  blot	  (Figure	  4.14B	  and	  Figure	  4.14C).	  	  By	  western	  blotting	  for	  σHrdB	  
were	  we	  able	  to	  identify	  the	  fractions	  without	  the	  sigma	  factor	  present.	  	  Similar	  fractions	  
were	  combined	  and,	  following	  final	  confirmation	  by	  western	  blot	  (Figure	  4.14D),	  were	  
designated	   holoenzyme	   (fractions	   D6–D9),	   “depleted”	   (fractions	   D11–D12)	   and	   core	  
(fractions	  E1–E2).	  	  
To	  confirm	  that	  functional	  core	  RNAP	  was	  purified,	  in	  vitro	  transcription	  reactions	  were	  
performed	  in	  the	  presence	  and	  absence	  of	  additional	  sigma	  factors.	  	  σHrdB	  and	  σR	  purified	  
from	   E.	   coli	   (gifts	   from	   P.	   Doughty)	   were	   added	   to	   in	   vitro	   transcription	   reactions	  
performed	  on	  atpIp	  and	  trxCp,	  respectively.	  	  Transcripts	  from	  both	  promoters	  were	  only	  
observed	  in	  the	  presence	  of	  the	  appropriate	  sigma	  factor	  indicating	  that	  functional	  core	  
RNAP	   had	   been	   purified	   and	   could	   be	   combined	   with	   different	   sigma	   factors	   for	   a	  




Figure	   4.14	   -­‐	   Purification	   of	   S129	   RNA	   polymerase	   holoenzyme	   and	   core.	   	   (A)	   SDS-­‐PAGE	   analysis	   of	   S129	   RNAP	  
purification.	  Lane	  1	  (M):	  SeeBlue	  Plus2	  marker;	   lane	  2	  (CCL):	  cleared	  cell	   lysate;	   lane	  3	  (S1):	   	  PEG-­‐PPT	  supernatant;	  
lane	  4	  (S2):	  PEG-­‐HS	  supernatant	  ;	  lane	  5	  (L):	  Ni-­‐NTA	  load;	  lane	  6	  (FT):	  Ni-­‐NTA	  loading	  flowthrough;	  lane	  7	  (W1):	  Ni-­‐NTA	  
wash	  1;	  lane	  8	  (W2):	  Ni-­‐NTA	  wash;	  lane	  9	  (E):	  Ni-­‐NTA	  elution	  (500	  mM	  imidazole).	  (B)	  Anion-­‐exchange	  purification	  of	  
RNAP.	   	  Mono	  Q	  5/50	  GL	  column	  elution	  trace	  for	  purification	  of	  RNAP	  (C)	  Western	  blot	  analysis	  of	  anion-­‐exchange	  
purification	  of	  S129	  RNAP.	  	  Lane	  1	  (E):	  Ni-­‐NTA	  elution;	  lanes	  2–10:	  Mono	  Q	  5/50	  GL	  elution	  fractions	  (D)	  Western	  blot	  
analysis	  of	  final	  RNAP	  stocks.	  	  Lane	  1	  (H):	  RNAP	  holoenzyme	  (fractions	  D6–D9);	  lane	  2	  (D):	  “depleted”	  RNAP	  (fractions	  
D11–D12);	  lane	  3	  (C):	  RNAP	  core	  (fractions	  E1–E2).	  (E)	  In	  vitro	  transcription	  testing	  of	  core	  RNAP.	  	  Reactions	  performed	  
on	  atpIp	  and	  trxCp	  promoters	  with	  core	  RNAP	  and	  additional	  σHrdB	  and	  σR,	  respectively.	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4.5.2   CarD	  activates	  transcription	  from	  σHrdB-­‐dependent	  promoters	  in	  vitro	  
M.	   tuberculosis	   CarD	   has	   been	   shown	   to	   activate	   transcription	   from	   σA-­‐dependent	  
promoters	   in	   vitro	   (Srivastava	   et	   al.,	   2013).	   	   To	   investigate	   if	  S.	   coelicolor	  CarD	  had	   a	  
similar	  effect,	  multi-­‐round	  in	  vitro	  transcription	  reactions	  were	  performed	  with	  purified	  
RNAP	   core	   and	   σHrdB	   on	   the	   σHrdB-­‐dependent	  atpIp	   promoter.	   An	  atpIp	   fragment	  was	  
amplified	   from	  M145	  gDNA	  using	   the	  primers	   atpIp_F/atpIp_R	   and	  purified	  using	   the	  
Promega	  Wizard®	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System.	  
The	   effect	   of	   CarD	   was	   observed	   by	   titrating	   increasing	   concentrations	   into	   in	   vitro	  
transcription	  reactions.	  	  Addition	  of	  CarD	  activated	  transcription	  from	  the	  atpIp	  promoter	  
at	  CarD:RNAP	  ratios	  of	  2:1	  (100	  nM)	  to	  10:1	  (500	  nM)	  (Figure	  4.15A).	  	  At	  a	  CarD:RNAP	  
ratio	  of	  20:1	  (1	  µM),	  a	  slight	  decrease	  in	  transcription	  was	  observed,	  possibly	  due	  to	  non-­‐
specific	  effects.	  	  Consequently	  for	  all	  further	  experiments	  a	  CarD:RNAP	  ratio	  of	  10:1	  was	  
used	  (500	  nM).	  
Additional	   in	   vitro	   transcription	   reactions	   were	   performed	   on	   a	   selection	   of	   linear	  
templates	   containing	   σHrdB-­‐dependent	   promoters.	   	   	   The	   actII-­‐ORF4p	   promoter	   was	  
amplified	  with	  the	  primers	  actIIORF4p_F/actIIORF4p_R,	  the	  rplJp	  promoter	  was	  amplified	  
with	  the	  primers	  rplJp_F/rplJp_R	  and	  the	  rrnDp3	  and	  rrnDp4	  promoters	  were	  amplified	  
with	  the	  primers	  rrnDp1-­‐4_F/rrnDp1-­‐4_R.	  	  In	  each	  case,	  addition	  of	  excess	  CarD	  (500	  nM)	  
stimulated	  transcription	  (Figure	  4.15B).	  
	  
Figure	   4.15	   -­‐	   CarD	   activates	   transcription	   from	   σHrdB-­‐dependent	   promoters.	   	   (A)	  Multi-­‐round	   in	   vitro	   transcription	  
reactions	  performed	  on	  the	  atpIp	  promoter	   template	   (5	  nM)	  with	  core	  RNAP	  (50	  nM),	  σHrdB	   (250	  nM)	  and	  CarD	  at	  
CarD:RNAP	  ratios	  of	  0,	  0.5	   (25	  nM),	  2	   (100	  nM),	  10	   (500	  nM)	  and	  20	   (1	  µM).	   (B)	  Multi-­‐round	   in	  vitro	   transcription	  
reactions	  performed	  on	  the	  actII-­‐ORF4p,	  rplJp,	  rrnDp3	  and	  rrnDp4	  promoter	  templates	  (5	  nM)	  with	  core	  RNAP	  (50	  nM)	  
and	  σHrdB	  (250	  nM)	  in	  the	  presence	  and	  absence	  of	  excess	  CarD	  (500	  nM).	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4.6   Activation	   of	   transcription	   by	   CarD	   and	   RbpA	   is	   dependent	   on	   the	  
absence	  of	  a	  conserved	  σHrdB	  -­‐35	  promoter	  region	  
4.6.1   CarD	  and	  RbpA	  selectively	  activate	  σHrdB-­‐dependent	  rrnD	  promoters	  
The	   results	   showing	  CarD	   is	   a	   general	   activator	  of	   transcription	   from	  σHrdB-­‐dependent	  
promoters	  in	  vitro	  are	  analogous	  to	  the	  findings	  for	  RbpA	  in	  S.	  coelicolor	  (Newell	  et	  al.,	  
2006;	  Tabib-­‐Salazar	  et	  al.,	  2013).	  	  It	  was	  therefore	  considered	  that	  RbpA	  and	  CarD	  might	  
have	  overlapping	  roles	  in	  transcription	  initiation.	  
To	  investigate	  the	  role	  of	  CarD	  and	  RbpA	  in	  transcription	  of	  rRNA,	  in	  vitro	  transcription	  
experiments	  were	  performed	  with	  the	  full	  rrnDp1–4	  promoter	  region,	  PCR	  amplified	  from	  
M145	   gDNA	   using	   the	   primers	   rrnDp1-­‐4_F/rrnDp1-­‐4_R.	   	   Four	   promoters	   and	   their	  
transcription	  start	  sites	  were	  previously	   identified	  through	  high	  resolution	  S1	  nuclease	  
protection	  mapping	  the	  region	  upstream	  of	  the	  rrnD	  gene	  set	  (Baylis	  and	  Bibb,	  1988).	  	  
Using	   this	   data	  we	  were	   able	   to	   predict	   four	   transcription	   products	   from	  our	   in	   vitro	  
transcription	  template	  115	  nt,	  195	  nt,	  341	  nt	  and	  392	  nt	  in	  size	  for	  the	  p4,	  p3,	  p2	  and	  p1	  
promoters,	  respectively.	  	  	  
Under	  all	   tested	  conditions	  no	  transcription	  was	  observed	  from	  the	  rrnDp1	  promoter.	  	  
The	  rrnDp2	  promoter	  was	  active	  in	  the	  absence	  of	  both	  RbpA	  and	  CarD	  and	  interestingly,	  
unlike	   the	  σHrdB	   promoters	   tested	  previously,	   addition	  of	   either	  CarD	  or	  RbpA	  had	  no	  
effect	  on	   transcriptional	  output	   (Figure	  4.16A).	   	   rrnDp3	   and	   rrnDp4	   showed	  very	   little	  
activity	  in	  the	  absence	  of	  CarD	  and	  RbpA	  but	  both	  were	  activated	  by	  addition	  of	  either	  
protein.	  
To	   confirm	   these	  data	   and	   to	  ensure	   that	   the	   rrnD	   promoters	  did	  not	   influence	  each	  
other,	   the	  p2	   and	  p3	   promoters	  were	   further	   investigated	   in	   isolation.	   	   To	   construct	  
synthetic	  promoters,	  complementary	  oligonucleotides	  up	  to	  60	  bp	  in	  size	  representing	  
the	  template	  and	  non-­‐template	  strands	  and	  designed	  to	  incorporate	  BamHI	  and	  HindIII	  
sites	  at	  the	  5’	  and	  3’	  ends	  respectively,	  were	  annealed	  and	  cloned	  into	  BamHI/HindIII-­‐cut	  
pBlueScript	   SKII+.	   	   Using	   these	   plasmids	   as	   a	   template,	   a	   linear	   in	   vitro	   transcription	  
template	  could	  be	  produced	  by	  PCR	  amplification	  using	  M13	  universal	  primers.	  	  Following	  
this	   method,	   rrnDp2	   and	   p3	   promoter	   fragments	   were	   constructed	   using	   the	  
oligonucleotide	  pairs	  rrnDp2_nt/rrnDp2_t	  and	  rrnDp3_nt/rrnDp3_t,	  respectively.	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The	   in	  vitro	  transcription	  results	  were	  as	  observed	  from	  the	  single	  rrnDp1–4	  fragment;	  
the	  rrnDp2	  promoter	  was	  active	  in	  the	  absence	  of	  both	  RbpA	  and	  CarD	  and	  addition	  of	  
either	  or	  both	  proteins	  had	   little	  effect	  on	   transcriptional	  output	   (Figure	  4.16B).	   	   The	  
rrnDp3	  promoter	  had	   little	  activity	   in	   the	  absence	  of	  RbpA	  and	  CarD	  but	   transcription	  
occurred	  upon	  addition	  of	  either	  protein.	  	  Addition	  of	  both	  CarD	  and	  RbpA	  at	  saturating	  
concentrations	   (RbpA/CarD:RNAP	   molar	   ratio	   of	   10:1)	   had	   an	   additive	   effect	   on	  
transcriptional	  output.	  
	  
Figure	  4.16	  -­‐	  In	  vitro	  transcription	  analysis	  of	  rrnDp1–4	  promoter	  region	  	  (A)	  Multi-­‐round	  in	  vitro	  transcription	  reactions	  
performed	  on	  the	  whole	  rrnDp1–4	  promoter	  region	  (5	  nM)	  with	  core	  RNAP	  (50	  nM),	  σHrdB	  (250	  nM)	  in	  the	  presence	  
and	  absence	  of	  excess	  CarD	  (500	  nM)	  and	  RbpA	  (100	  nM).	  	  (B)	  Multi-­‐round	  in	  vitro	  transcription	  reactions	  performed	  
on	  the	  rrnDp2	  and	  rrnDp3	  promoter	  templates	  (5	  nM)	  with	  core	  RNAP	  (50	  nM),	  σHrdB	  (250	  nM)	  in	  the	  presence	  and	  
absence	  of	  excess	  CarD	   (500	  nM)	  and	  RbpA	   (500	  nM).	   	  Data	  are	  presented	  as	   fold-­‐difference	   relative	   to	   reactions	  
lacking	  both	  CarD	  and	  RbpA.	  Transcript	  levels	  were	  quantified	  by	  phosphorimaging	  from	  triplicate	  data,	  and	  standard	  
deviation	  is	  indicated.	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4.6.2   Changes	   to	   the	   σHrdB	   -­‐35	  DNA	   element	   influence	   promoter	   sensitivity	   to	  
CarD	  and	  RbpA	  
Hahn	  and	  Roe	  (2007)	  previously	  aligned	  the	  rrnDp1–4	  promoter	  set,	  and	  identified	  -­‐35	  
DNA	  elements	   that	   closely	  matched	   the	   consensus	   for	   the	  p1	  and	  p2	  promoters,	   but	  
failed	  to	  identify	  -­‐35	  elements	  for	  the	  p3	  and	  p4	  promoters	  (Figure	  4.17).	  	  The	  spacing	  
and	  -­‐10	  region	  was	  largely	  similar	  in	  all	  four	  promoters.	  	  	  
	  
Figure	  4.17	  -­‐	  Comparison	  of	  the	  rrnDp1–4	  promoter	  sequences.	  	  Putative	  -­‐35,	  -­‐10	  sequences	  and	  transcription	  start	  
sites	  are	  shown	  in	  bold.	  	  Identical	  sequences	  between	  the	  rrnDp3	  and	  rrnDp4	  promoters	  are	  underlined.	  (Adapted	  from	  
Hahn	  and	  Roe,	  2007).	  	  	  
To	  investigate	  if	  the	  -­‐35	  region	  was	  related	  to	  the	  differential	  promoter	  sensitivity	  to	  CarD	  
and	  RbpA,	  synthetic	  promoters	  were	  designed	  initially	  swapping	  the	  conserved	  -­‐35	  region	  
from	   the	   rrnDp2	   promoter	   with	   the	   poorly	   conserved	   -­‐35	   region	   from	   the	   rrnDp3	  
promoter	  (Figure	  4.18).	   	  Using	  the	  same	  method	  as	  used	  previously	  for	  producing	  the	  
isolated	  rrnDp2	  and	  p3	  promoters,	  complementary	  oligonucleotides	  were	  used	  and	  the	  
in	  vitro	   transcription	  templates	  were	  PCR	  amplified	  using	  M13	  universal	  primers.	   	  The	  
newly	  created	  promoters	  named	  rrnDp3s	  (“rrnDp3strong”)	  and	  rrnDp2w	  (“rrnDp2weak”)	  










Figure	  4.18	  -­‐	  Comparison	  of	  rrnDp2,	  rrnDp3,	  rrnDp2w	  and	  rrnDp3s	  promoter	  sequences.	  	  Putative	  -­‐35,	  -­‐10	  sequences	  
and	  transcription	  start	  sites	  are	  shown	  in	  bold.	  	  Nucleotides	  conserved	  between	  the	  rrnDp3	  and	  rrnDp4	  promoters	  are	  
underlined.	  
rrnDp2w,	  the	  p2	  promoter	  without	  the	  conserved	  -­‐35	  region,	  was	  no	  longer	  active	  in	  the	  
absence	  of	  CarD	  and	  RbpA	   (Figure	  4.19).	   	  Addition	  of	  CarD	  and	  RbpA	   separately	  now	  
activated	  transcription	  and	  addition	  of	  both	  proteins	  at	  saturating	  concentrations	  had	  an	  
additive	   effect	   on	   transcriptional	   output.	   	   rrnDp3s,	   the	   p3	   promoter	   with	   the	  
conserved	  -­‐35	  region	  from	  the	  p2	  promoter,	  was	  now	  active	  in	  the	  absence	  of	  CarD	  and	  
RbpA.	   	  Addition	  of	  CarD	  or	  RbpA,	   two	  proteins	  previously	   identified	  as	   transcriptional	  
activators,	   inhibited	   transcription	   and	   the	   addition	   of	   both	   proteins	   at	   saturating	  
concentrations	  had	  a	  further	  inhibitory	  effect	  on	  transcription.	  
	  
Figure	  4.19	  -­‐	  	  CarD	  and	  RbpA	  activate	  transcription	  from	  rrnDp2w	  but	  inhibit	  transcription	  from	  rrnDp3s	  	  Multi-­‐round	  
in	  vitro	  transcription	  reactions	  performed	  on	  the	  rrnDp2w	  and	  rrnDp3s	  promoter	  template	  (5	  nM)	  with	  core	  RNAP	  (50	  
nM),	  σHrdB	  (250	  nM)	  in	  the	  presence	  and	  absence	  of	  excess	  CarD	  (500	  nM)	  and	  RbpA	  (500	  nM).	  	  Data	  are	  presented	  as	  
fold-­‐difference	  relative	  to	  reactions	  lacking	  both	  CarD	  and	  RbpA.	  Transcript	  levels	  were	  quantified	  by	  phosphorimaging	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4.7   Depletion	  of	  CarD	  or	  RbpA	  has	  no	  effect	  on	  rrnDp1–4	  transcript	  levels	  	  
In	  this	  study,	  two	  approaches	  have	  been	  used	  to	  study	  the	  growth	  of	  S.	  coelicolor	  in	  the	  
absence	  of	  CarD	  and	  RbpA.	  	  Initially	  the	  strain	  S200	  was	  created,	  a	  strain	  which	  possesses	  
a	  single	  copy	  of	  carD	  under	  the	  control	  of	  a	  thiostrepton-­‐inducible	  promoter.	  	  Growth	  of	  
this	   strain	   in	   the	   absence	   of	   thiostrepton	   represents	   a	   ∆carD	   null	   mutant.	   	   We	   also	  
implemented	  a	  ClpX-­‐SspB	  system	  for	  targeted	  degradation	  of	  carD	  and	  rbpA	  tagged	  with	  
a	  DAS+4	  tag.	  	  
Having	  identified	  that	  CarD	  and	  RbpA	  are	  required	  for	  transcription	  of	  promoters	  such	  as	  
rrnDp3	   in	  vitro,	  we	  wanted	  to	  investigate	  whether	  this	  was	  the	  case	   in	  vivo.	  	  The	  ClpX-­‐
SspB	  system	  was	  decided	  most	  suitable	  for	  depletion	  studies	  on	  CarD	  and	  RbpA.	  	  As	  the	  
system	   works	   through	   active	   targeted	   degradation,	   it	   was	   assumed	   that	   changes	   in	  
protein	  concentration	  would	  occur	  more	  rapidly	  than	  exploiting	  an	  inducible	  promoter	  
system	  which	  relies	  on	  preventing	  further	  gene	  transcription	  and	  protein	  turnover	   for	  
any	   observed	   change	   in	   protein	   concentration.	   	   Additionally,	   the	   process	   is	  
experimentally	  simpler;	  with	  the	  ClpX-­‐SspB	  system,	  depletion	  is	  induced	  by	  addition	  of	  
thiostrepton,	  rather	  than	  removal	  of	  the	  compound	  from	  culture	  medium.	  	  	  
To	   perform	   the	   depletions,	   cultures	   of	   S201/pIJ6902::sspB,	   S101/pRT802::rbpA-­‐
DAS+4/pIJ6902::sspB	   and	   negative	   controls	   S201/pIJ6902	   and	   S101/pRT802::rbpA-­‐
DAS+4/pIJ6902	  were	  grown	  in	  YEME-­‐10	  to	  an	  OD450	  of	  1.	  	  A	  10	  mL	  sample	  was	  taken	  from	  
each	   (marked	   as	   timepoint	   0)	   and	   thiostrepton	   was	   added	   to	   all	   cultures	   to	   a	   final	  
concentration	  of	  20	  µg/mL.	  	  10	  mL	  samples	  were	  taken	  subsequently	  at	  30,	  60	  and	  120	  
minute	   intervals	   and	   total	   RNA	   was	   extracted	   from	   each	   sample.	   	   To	   analyse	   the	  
transcriptional	  output	   from	  the	   rrnDp1–4	  promoters	   in	   response	  to	  depletion	  of	  CarD	  
and	  RbpA,	  S1	  nuclease	  protection	  mapping	  was	  performed	  on	  the	  RNA	  samples.	  	  	  	  The	  
primers	   rrnD_S1_F/rrnD_S1_R	  were	  used	   to	   create	   a	   probe	   suitable	   for	  mapping	   this	  
operon,	  with	  the	  reverse	  primer	  rrnD_S1_R	  labelled	  with	  32P	  radiolabel	  on	  the	  5’	  end.	  	  
Prior	   to	   S1	   nuclease	   protection	  mapping,	   30	  µg	   RNA	  was	   hybridised	   to	   the	   rrnDp1–4	  
probe	  following	  digestion,	  samples	  were	  run	  on	  an	  8%	  denaturing	  urea	  polyacrylamide	  
gel	  and	  visualised	  by	  phosphorimaging.	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Following	  depletion	  of	  either	  CarD	  or	  RbpA	  no	  significant	  change	  in	  transcript	  level	  was	  
observed	  by	  S1	  nuclease	  protection	  mapping	  (Figure	  4.20).	  The	  same	  was	  observed	  in	  
both	  control	  strains	  lacking	  the	  SspB	  adapter	  protein	  required	  for	  depletion.	  	  The	  most	  
distinct	  band	  was	   the	   rrnDp3	   transcript	  product.	   	  Despite	   the	   finding	   that	   the	   rrnDp3	  
promoter	   is	  dependent	  on	  CarD	  and	  RbpA	   in	  vitro,	   the	  transcript	   level	  was	  unaffected	  
following	  depletion	  of	  either	  protein.	  
	  	  
Figure	  4.20	  -­‐	  S1	  nuclease	  mapping	  of	  rrnDp1–4	  following	  the	  depletion	  of	  CarD	  and	  RbpA.	  	  (A)	  	  S1	  nuclease	  protection	  
analysis	  of	  S201/pIJ6902	  (-­‐	  sspB)	  and	  S201/pIJ6902::sspB	  (+	  sspB)	  strains.	  	  Cultures	  were	  grown	  in	  YEME-­‐10	  to	  OD450	  of	  
1	  and	  RNA	  was	  isolated	  30,	  60	  and	  120	  min	  following	  addition	  of	  thiostrepton	  (20	  µg/mL	  final	  concentration).	  	  30	  µg	  
RNA	  was	  hybridised	  to	  the	  rrnDp1–4	  probe	  and	  following	  S1	  nuclease	  digestion,	  samples	  were	  run	  on	  an	  8%	  denaturing	  
urea	  polyacrylamide	  gel	  and	  visualised	  by	  phosphorimaging.	  (B)	  S1	  nuclease	  protection	  analysis	  of	  S101/pRT802::rbpA-­‐
DAS+4/pIJ6902(-­‐	   sspB)	   and	   S101/pRT802::rbpA-­‐DAS+4/pIJ6902::sspB	   (+	   sspB)	   strains.	   	   Experiment	   as	   described	   in	  
Figure	  4.20A.	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4.8   Discussion	  	  
4.8.1   CarD	  is	  required	  for	  growth	  in	  S.	  coelicolor	  
Prior	  to	  this	  study,	  CarD	  had	  been	  identified	  as	  an	  essential	  gene	  in	  M.	  tuberculosis	  and	  
M.	  smegmatis	  (Stallings	  et	  al.,	  2009).	  	  Attempts	  to	  delete	  the	  chromosomal	  carD	  allele	  
were	  unsuccessful	  however	  it	  was	  possible	  to	  confirm	  the	  essentiality	  of	  CarD	  by	  creation	  
of	  a	  strain	  possessing	  a	  single	  carD	  gene	  under	  the	  control	  of	  an	  inducible	  promoter.	  	  Both	  
M.	  tuberculosis	  and	  M.	  smegmatis	  strains	  were	  not	  viable	  in	  the	  absence	  of	  the	  inducer.	  
In	  this	  study,	  initial	  attempts	  to	  make	  a	  CarD	  deletion	  mutant	  in	  S.	  coelicolor	  were	  also	  
unsuccessful.	  	  By	  placing	  an	  additional	  copy	  of	  carD	  under	  the	  control	  of	  the	  thiostrepton-­‐
inducible	  promoter	  it	  was	  possible	  to	  create	  a	  strain	  with	  a	  single	  inducible	  copy	  of	  carD.	  	  
In	  the	  absence	  of	  thiostrepton	  the	  strain	  grew	  very	  poorly,	  demonstrating	  that	  CarD	  is	  
required	  for	  normal	  growth	  in	  S.	  coelicolor.	  	  Whilst	  it	  is	  difficult	  to	  strictly	  define	  a	  gene	  
as	   “essential”	   it	   was	   assumed	   that	   small	   amounts	   of	   growth	   on	   solid	   media	   were	  
attributable	   to	   a	   low	   level	   of	   carD	   expression	   from	   the	   tipAp	   promoter,	   previously	  
characterised	  as	  “leaky”	  in	  the	  absence	  of	  inducer	  (M.	  Paget,	  personal	  communication).	  	  	  
In	  the	  presence	  of	  a	  range	  of	  thiostrepton	  concentrations,	  growth	  was	  restored	  however	  
the	   phenotype	   was	   only	   partially	   complemented.	   	   At	   the	   highest	   concentrations	   of	  
thiostrepton,	  colonies	  still	  exhibited	  a	  whi	  phenotype,	  typical	  of	  mutants	  blocked	  in	  the	  
later	  stages	  of	  sporulation	  (Flärdh	  and	  Buttner,	  2009).	  	  It	  is	  likely	  that	  this	  was	  due	  to	  low	  
expression	  from	  the	  tipAp	  inducible	  promoter	  in	  aerial	  mycelium,	  potentially	  caused	  by	  
the	   inability	   of	   the	   characterisitically	   insoluble	   thiostrepton	   to	   diffuse	   into	   the	   aerial	  
mycelium.	  	  	  
carD	  under	  the	  control	  of	  its	  own	  promoter	  and	  integrated	  at	  an	  alternative	  locus	  was	  
able	   to	   fully	   complement	   the	   inducible	   mutant	   in	   the	   presence	   and	   absence	   of	  
thiostrepton.	  	  This	  likely	  confirms	  that	  the	  partially	  complemented	  S200	  phenotype	  was	  
due	   to	   lack	   of	   CarD	   and	   not	   unwanted	   polar	   effects	   or	   mutations	   introduced	   when	  
creating	  the	  strain.	  
In	  addition	  to	  creation	  of	  a	  strain	  dependent	  on	  a	  thiostrepton-­‐inducible	  copy	  of	  carD,	  a	  
method	   of	   inducible,	   directed	   proteolysis	   was	   implemented	   for	   the	   first	   time	   in	  
Streptomyces	  and	  used	  to	  investigate	  the	  role	  of	  CarD.	  	  Active	  depletion	  of	  CarD	  yielded	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similar	  results,	  with	  colonies	  appearing	  small	  and	  white.	  	  One	  limitation	  of	  this	  method	  is	  
that	   it	   is	  not	  possible	  to	  ascertain	  the	  extent	  to	  which	  CarD	   is	  depleted.	   	   If	  CarD	   is	  an	  
essential	   gene	   then	   it	   is	   possible	   that	   small	   colonies	   are	   still	   able	   to	   form	  due	   to	   low	  
concentrations	  of	  CarD	  present	  in	  the	  cell.	  	  	  
4.8.2   Purification	  of	  CarD	  and	  RNAP	  core	  
Experiments	  in	  this	  chapter	  outline	  the	  successful	  purification	  of	  CarD	  protein.	  	  This	  was	  
achieved	  through	  heterologous	  expression	  of	  CarD	  with	  an	  N-­‐terminal	  His-­‐tag	  with	  the	  
pET	  system	  in	  E.	  coli.	  	  Following	  cell	  lysis,	  His-­‐CarD	  was	  purified	  from	  the	  cleared	  cell	  lysate	  
by	  Ni-­‐affinity	  chromatography	  followed	  by	  size-­‐exclusion	  chromatography.	  	  Purification	  
via	   this	   method	   achieved	   a	   yield	   of	   approximately	   1.04	   mg	   of	   protein	   from	   250	   mL	  
culture,	  identified	  as	  functional	  by	  in	  vitro	  transcription	  assays.	  
This	   chapter	   also	   outlined	   the	   purification	   of	   RNAP	   from	   S.	   coelicolor.	   	   The	   method	  
combined	  published	  methods	  for	  purification	  of	  RNAP	  utilisating	  initial	  PEG	  precipitation	  
of	  nucleic	  acids	  and	  associated	  proteins	  (Gross	  et	  al.,	  1976;	  Fong	  et	  al.,	  2010),	  Ni-­‐affinity	  
against	  the	  His-­‐tagged	  β’	  subunit	  (Babcock	  et	  al.,	  1997)	  and	  finally,	  separation	  of	  RNAP	  
holoenzyme	  from	  RNAP	  core	  by	  ion	  exchange	  chromatography	  (Hahn	  et	  al.,	  2003).	  	  This	  
method	  successfully	  produced	  functional	  RNAP	  core	  with	  no	  activity	   in	  the	  absence	  of	  
additional	  purified	  σ.	  	  This	  procedure	  is	  not	  without	  limitations;	  in	  addition	  to	  the	  length	  
of	   time	   the	  purification	   takes	  and	   relatively	   low	  yield,	   it	   is	  also	  not	  always	  possible	   to	  
purify	   RNAP	   ensuring	   absence	   of	   additional	   products.	   	   Whilst	   this	   study	   outlined	  
purification	  of	  RNAP	  from	  a	  ∆rbpA	  strain,	  it	  was	  not	  possible	  to	  purify	  RNAP	  in	  a	  ∆carD	  
background.	   	   Additionally	   Hahn	   et	   al.	   (2003)	   reported	   that	   the	   final	   ion	   exchange	  
chromatography	  necessary	   for	   removal	   of	   σ	   subunits	  may	   result	   in	   loss	  of	  ω	   subunit.	  	  
Recently	   Czyz	   et	   al.	   (2014)	   reported	   a	  method	   for	   purification	  of	   recombinant,	   active	  
M.	  bovis	   RNAP	   core	   from	  E.	   coli,	   with	   four	   subunit	   genes	   co-­‐expressed	   from	   a	   single	  
plasmid	   (used	   in	   chapter	   6).	   	   This	  method,	   also	   used	   for	   purification	   of	   T.	   aquaticus	  
(Minakhin	  et	  al.,	  2001)	  and	  E.	  coli	  RNAP	  core	   (Artsimovitch	  et	  al.,	  2003),	  would	  be	  an	  
attractive	  solution	  for	  purification	  of	  S.	  coelicolor	  RNAP	  in	  future	  studies.	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4.8.3   CarD	  activates	  transcription	  from	  σHrdB-­‐dependent	  promoters	  in	  vitro	  
Following	   purification	   of	   CarD	   and	   RNAP,	   experiments	   performed	   in	   this	   study	   have	  
shown	  that	  S.	  coelicolor	  CarD	  activates	  transcription	  from	  a	  selection	  of	  σHrdB-­‐dependent	  
promoters	  in	  vitro,	  including	  rRNA	  promoters	  rrnDp3	  and	  rrnDp4.	  	  These	  data	  replicated	  
findings	   showing	   that	  M.	   tuberculosis	   CarD	  activates	   transcription	   from	  σA-­‐dependent	  
rRNA	  promoters	   in	  vitro	   (Srivastava	  et	  al.,	  2013).	   	  Experiments	  also	  showed	  that	  CarD	  
activates	   transcription	   from	   a	   diverse	   selection	   of	   σHrdB-­‐dependent	   including	   genes	  
involved	   in	   central	   metabolism,	   atpI	   and	   rplJ,	   and	   the	   actinorhodin	   CSR,	   actII-­‐ORF4.	  	  
Results	  obtained	  in	  this	  experiment	  are	  reminiscent	  of	  studies	  performed	  on	  RbpA	  which	  
identify	   the	   protein	   as	   an	   activator	   of	   transcription	   from	   σHrdB-­‐dependent	   promoters,	  
including	  rrnDp3,	  atpIp	  and	  rplJp	  (Newell	  et	  al.,	  2006;	  Tabib-­‐Salazar	  et	  al.,	  2013).	  
4.8.4   CarD	  and	  RbpA	   selectively	   activate	   transcription	   from	   rrnD	   promoters	   in	  
vitro	  
Further	  in	  vitro	  transcription	  experiments	  performed	  on	  the	  entire	  rrnD	  promoter	  region,	  
containing	   four	   promoters	   rrnDp1–4,	   identified	   differences	   in	   regulation	   by	   CarD	   and	  
RbpA.	   	   The	   rrnDp2	   promoter	   was	   active	   in	   the	   absence	   of	   both	   CarD	   and	   RbpA	   and	  
addition	  of	  either	  or	  both	  proteins	  had	  no	  effect	  on	  transcription	  from	  this	  promoter	  in	  
vitro.	  	  The	  rrnDp3	  and	  rrnDp4	  promoters	  were	  very	  poorly	  expressed	  in	  the	  absence	  of	  
CarD	  and	  RbpA	  however	  both	  promoters	  were	  activated	  by	  addition	  of	  the	  two	  proteins.	  	  
When	   in	   vitro	   transcription	   experiments	   were	   performed	   on	   the	   rrnDp2	   and	   rrnDp3	  
promoters	  in	  isolation,	  similar	  results	  were	  found.	  	  	  
These	  results	  draw	  remarkable	  comparisons	  with	  studies	  performed	  by	  Hahn	  and	  Roe,	  
(2007)	  into	  regulation	  of	  rRNA	  in	  S.	  coelicolor.	  	  The	  study	  showed	  that	  partially	  purified	  
RNAP	   preparations	   were	   able	   to	   support	   transcription	   from	   rrnDp3	   and	   rrnDp4	  
howevever	  reconstituted	  RNAP	  core	  and	  σHrdB	  did	  were	  not.	  	  Fractionation	  of	  the	  partially	  
purified	   RNAP	   preparation	   by	   size	   and	   reconstitution	   into	   an	   in	   vitro	   transcription	  
reaction	   identified	  a	  protein	  roughly	  30–35	  kDa	  able	  to	  restore	  transcription	  from	  the	  
rrnDp3	  and	  rrnDp4	  promoters.	  	  Whilst	  the	  molecular	  of	  weights	  of	  CarD	  and	  RbpA	  are	  18	  
and	  14	  kDa,	  respectively,	   the	  results	  of	  this	  experiment	  would	  otherwise	  replicate	  the	  
findings	  from	  this	  study.	  	  Further	  proteomic	  analysis	  of	  this	  fraction	  would	  either	  identify	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the	  protein	  in	  question	  as	  CarD	  or	  RbpA,	  or	  alternatively	  identify	  a	  novel	  protein	  with	  a	  
potentially	  similar	  function.	  
4.8.5   CarD	   and	   RbpA	   stimulate	   promoter	   activity	   in	   the	   absence	   of	   -­‐35	   σ4	  
interactions	  
Following	  the	  discovery	  by	  Hahn	  and	  Roe	  (2007)	  that	  expression	  of	  rrnDp3	  and	  rrnDp4	  
required	  the	  presence	  of	  an	  additional	  factor,	  this	  raised	  the	  questions	  about	  why	  the	  
promoter	  was	  unable	  to	  support	  transcription	  without	  this	  factor	  in	  a	  minimal	  system.	  	  
Alignments	  of	  the	  four	  rrnD	  promoters	  revealed	  that	  absence	  of	  a	  recognisable	  σHrdB	  -­‐35	  
promoter	  elements	  in	  the	  p3	  and	  p4	  promoters.	  	  To	  investigate	  if	  this	  was	  responsible	  for	  
the	   requirement	   of	   CarD	   and	   RbpA	   for	   transcription	   in	   vitro,	   synthetic	   promoter	  
fragments	  were	  constructed	  exchanging	  the	  -­‐35	  hexamer	  from	  the	  p2	  and	  p3	  promoters.	  	  
Indeed,	  altering	  the	  -­‐35	  element	  changed	  the	  requirement	  for	  CarD	  and	  RbpA.	  	  	  
The	   p2	   promoter	   which	   was	   previously	   unaffected	   by	   presence	   or	   absence	   of	   both	  
proteins	  now	  required	  CarD	  or	  RbpA	  and	  presence	  of	  both	  proteins	  had	  an	  additive	  effect.	  	  	  
Modifications	   to	   include	  a	   conserved	   -­‐35	   region	  abolished	   the	   requirement	  of	   the	  p3	  
promoter	  for	  CarD	  or	  RbpA.	  	  Remarkably,	  addition	  of	  either	  CarD,	  RbpA	  or	  both	  proteins	  
inhibited	  transcription.	  	  Despite	  a	  number	  of	  studies	  into	  the	  properties	  of	  CarD	  and	  RbpA	  
as	  transcriptional	  activators,	  this	  is	  the	  first	  reported	  incidence	  of	  either	  protein	  inhibiting	  
transcription	  in	  vitro.	  	  
The	  phage	  Φ29	  protein	  p4	  has	  similar	  properties,	  able	  to	  activate	  or	  repress	  transcription	  
from	  B.	  subtilis	  σA-­‐dependent	  promoters.	  	  The	  late	  A3	  promoter	  is	  activated	  by	  p4,	  whilst	  
the	   early	   A2c	   promoter	   is	   repressed	   by	   p4	   (Monsalve	   et	   al.,	   1996a,	   1996b).	   	   Closer	  
inspection	  of	   these	  promoters	   revealed	   that	   the	  difference	   in	  p4	  activity,	  which	  binds	  
DNA	  upstream	  and	  makes	  contact	  with	  the	  α-­‐CTD,	  is	  dependent	  on	  promoter	  sequence	  
(Monsalve	  et	  al.,	  1997).	  	  The	  activated	  A3	  promoter	  lacks	  a	  -­‐35	  element,	  whilst	  the	  A2c	  
has	  a	   conserved	   -­‐35	  element.	   	   Further	   in	   vitro	   transcription	  assays	   identified	   that	   the	  
mechanism	  of	  inhibition	  was	  through	  preventing	  promoter	  escape	  into	  elongation.	  	  	  
It	  is	  possible	  that	  CarD	  and	  RbpA	  have	  the	  ability	  to	  repress	  transcription	  through	  a	  similar	  
mechanism	   to	   Φ29	   protein	   p4,	   by	   providing	   an	   extra	   point	   of	   contact	   on	   DNA	   and	  
overstabilising	  RNAP	  at	  the	  promoter.	  	  Both	  proteins	  are	  thought	  to	  interact	  with	  DNA	  
117	  
	  
upstream	   of	   the	   -­‐10	   element	   (Srivastava	   et	   al.,	   2013;	   Hubin	   et	   al.,	   2015).	   	   Indeed,	  
increased	  contact	  with	  DNA	  upstream	  of	  the	  -­‐10	  element	  has	  been	  shown	  to	  stabilise	  
RNAP	  through	  interaction	  between	  an	  extended	  -­‐10	  region	  and	  σ3	  (Barne	  et	  al.,	  1997).	  	  
Additionally	  in	  vitro	  transcription	  data	  suggests	  that	  presence	  of	  an	  extended	  -­‐10	  element	  
can	  absolve	  requirement	  the	  -­‐35	  element	  or	  σ4	  altogether	  (Yuzenkova	  et	  al.,	  2011).	  	  Most	  
interestingly	  this	  result	  brings	  into	  question	  whether	  CarD	  and	  RbpA	  are	  able	  to	  inhibit	  
transcription	  in	  vivo,	  particularly	  at	  naturally	  occurring	  promoters	  with	  similar	  properties	  
to	  the	  synthetic	  promoter	  created	  in	  this	  study.	  
4.8.6   Depletion	  of	  CarD	  or	  RbpA	  has	  no	  effect	  on	  rrnDp1–4	  transcript	  levels	  
Having	   shown	   that	   the	   rrnDp3	   and	   rrnDp4	   promoters	   required	   CarD	   or	   RbpA	   for	  
transcription	  in	  vitro,	  depletion	  studies	  were	  performed	  to	  investigate	  the	  requirement	  
for	   transcription	   in	   vivo.	   	   Using	   the	   the	   SspB-­‐dependent	   ClpX	   system	   demonstrated	  
elsewhere	   in	   this	   study,	   CarD	   and	   RbpA	   were	   depleted	   and	   S1	   nuclease	   protection	  
analysis	  was	  performed.	  	  Follow	  depletion	  no	  changes	  to	  the	  rrnDp1–4	  transcript	  level	  
was	  observed.	  	  Unfortunately	  it	  was	  not	  possible	  to	  determine	  the	  extent	  to	  which	  either	  
protein	  was	  depleted.	  	  In	  future	  studies	  it	  would	  be	  possible	  to	  determine	  the	  presence	  
or	  absence	  of	  either	  protein	  through	  generation	  of	  an	  antibody	  and	  western	  blot	  analysis.	  	  	  
Additionally,	   in	  vitro	  transcription	  data	  identified	  that	  presence	  of	  either	  CarD	  or	  RbpA	  
was	  required	  for	  transcription	  of	  rrnDp3	  and	  rrnDp4.	  	  It	  therefore	  remains	  a	  possibility	  
that	  CarD	  and	  RbpA	  were	  depleted	  in	  this	  experiment	  however	  no	  effect	  was	  observed	  
due	   to	   the	   presence	   of	   RbpA	   and	   CarD,	   respectively.	   	   If	   so	   this	   would	   raise	   further	  
questions	  about	  an	  overlapping	  role	  of	  CarD	  and	  RbpA	  in	  S.	  coelicolor.	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5   ChIP-­‐seq	  analysis	  of	  transcription	  initiation	  factors	  in	  S.	  coelicolor	  
5.1   Overview	  
This	  chapter	  first	  outlines	  the	  creation	  of	  a	  S.	  coelicolor	  strain	  possessing	  a	  single	  copy	  of	  
carD	  with	  a	  C-­‐terminal	  3xFLAG	  tag,	  designated	  S202.	  	  ChIP-­‐seq	  was	  performed	  on	  mid–
late	  exponential	  phase	  cultures	  of	  this	  strain	  using	  antibodies	  specific	  to	  RNAP,	  σHrdB,	  and	  
CarD-­‐3xFLAG.	   	   Additional	   sequencing	   data	   was	   analysed	   from	   a	   similar	   experiment	  
performed	  on	  RbpA	  in	  the	  presence	  and	  absence	  of	  rifampicin.	  	  ChIP-­‐seq	  data	  revealed	  
that	   CarD	   and	   RbpA	   co-­‐localise	   with	   σHrdB	   at	   all	   σHrdB-­‐dependent	   promoters	   in	  
S.	  coelicolor.	  
5.2   ChIP-­‐seq	  analysis	  of	  CarD	  
5.2.1   Construction	  of	  a	  3xFLAG	  tagged	  carD	  allele	  
As	  an	  alternative	   to	  ordering	  a	   custom	  antibody,	   it	   is	   a	   common	  approach	   to	   fuse	  an	  
epitope	  tag	  to	  the	  protein	  of	   interest	  allowing	  recognition	  of	  the	  recombinant	  protein	  
with	  a	  readily	  available	  monoclonal	  antibody.	  	  One	  such	  example	  of	  this	  is	  the	  FLAG®	  tag	  
system	  which	  encodes	  a	  small,	  hydrophilic	  8-­‐amino	  acid	  peptide	  (DYKDDDDK)	  (Hopp	  et	  
al.,	  1988).	  	  Due	  to	  the	  hydrophilic	  nature	  of	  the	  FLAG	  tag,	  it	  is	  typically	  surface	  exposed	  
allowing	  the	  anti-­‐FLAG	  antibody	  to	  readily	  recognise	  and	  bind.	  	  As	  an	  improvement	  upon	  
this	   system,	   a	   3xFLAG	   tag	   comprises	   3	   consecutive	   FLAG	   epitopes	  
(DYKDHDGDYKDHDIDYKDDDDK)	  and	  detection	  is	  up	  to	  200	  times	  more	  sensitive	  than	  any	  
other	  epitope	  tag	  system	  (“FLAG®	  and	  3xFLAG®	  Overview”,	  Sigma	  Aldrich).	  
It	  was	  decided	   to	  express	   the	  carD-­‐3xFLAG	  allele	   in	  a	  S.	   coelicolor	   strain	   in	  which	   the	  
native	  carD	  gene	  had	  been	  deleted,	  ensuring	  that	  the	  epitope-­‐tagged	  protein	  was	  the	  
dominant	   cellular	   species.	   	   To	   allow	   this,	   pRT802,	   which	   integrates	   into	   the	   ϕBT1	  
attachment	   site,	   was	   adopted	   as	   cloning	   vector.	   	   Prior	   to	   the	   construction	   of	   a	  
3xFLAG-­‐tagged	  carD	  allele	  in	  the	  appropriate	  vector,	  an	  initial	  plasmid	  was	  constructed	  
in	  which	  rbpA	  was	  fused	  to	  a	  3xFLAG	  tag	  with	  HindIII	  restriction	  sites	  upstream	  of	  the	  
rbpA	   promoter	   and	   at	   the	   intersection	   between	   the	   rbpA	   ORF	   and	   the	   in-­‐frame	  
C-­‐terminal	  FLAG	  tag.	  	  To	  achieve	  this,	  rbpA-­‐3xFLAG	  was	  first	  amplified	  by	  PCR	  using	  the	  
primers	  RbpA_3xFLAG_F/RbpA_3xFLAG_R	  and	  the	  plasmid	  pMT3000::rbpA-­‐3xFLAG	  as	  a	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template.	  	  The	  PCR	  product	  was	  cloned	  into	  EcoRV-­‐cut	  pBlueScript	  SKII+	  and	  sub-­‐cloned	  
into	  pRT802	   as	   a	   SpeI/BamHI	   fragment,	   producing	   the	  plasmid	  pRT802::rbpA-­‐3xFLAG.	  	  
This	  created	  a	  construct	  that	  allowed	  the	  rbpA	  portion	  of	  rbpA-­‐3xFLAG	  to	  be	  swapped	  as	  
a	  HindIII/HindIII	  fragment	  with	  carD.	  	  Thus,	  carD	  was	  PCR	  amplified	  from	  M145	  genomic	  
DNA	  using	  the	  primers	  carD_3xFLAG_F/carD_3xFLAG_R,	  which	  incorporated	  SpeI-­‐HindIII	  
restriction	   sites	  upstream	  of	   the	  carD	   promoter	   region	  and	  a	  HindIII	   site	   immediately	  
upstream	   of	   the	   carD	   stop	   codon.	   	   The	   PCR	   product	   was	   cloned	   into	   EcoRV-­‐cut	  
pBlueScript	  SKII+	  and	  sub-­‐cloned	  into	  pRT802::rbpA-­‐3xFLAG	  as	  a	  HindIII/HindIII	  fragment,	  
replacing	  the	  rbpA	  insert	  and	  producing	  the	  plasmid	  pRT802::carD-­‐3xFLAG.	  
5.2.2   CarD-­‐3xFLAG	  fully	  complements	  a	  ∆carD	  mutant	  
Before	  conducting	  any	  further	  experiments	  on	  the	  biological	  role	  of	  CarD	  using	  the	  CarD-­‐
3xFLAG	   expressing	   construct,	   it	   was	   necessary	   to	   confirm	   that	   the	   epitope-­‐tagged	  
recombinant	  protein	  was	  fully	  functional	  in	  vivo	  and	  that	  the	  addition	  of	  an	  N-­‐terminal	  
3xFLAG	  tag	  does	  not	  affect	  protein	  function.	  	  The	  plasmid	  pRT802::carD-­‐3xFLAG	  was	  used	  
to	  transform	  ET12567/pR9406	  and	  transferred	  via	  conjugation	  into	  the	  conditional	  carD	  
mutant	  S200.	  	  The	  3xFLAG-­‐tagged	  construct	  fully	  complemented	  the	  mutant	  phenotype	  
and	  removed	  any	  dependence	  of	  the	  strain	  for	  thiostrepton,	  compared	  with	  the	  positive	  
and	   negative	   controls	   pRT802::carD	   and	   pRT802,	   respectively	   (Figure	   5.1).	   	   This	  
confirmed	  that	  a	  3xFLAG	  tagged	  copy	  of	  CarD	  was	  fully	  functional	  in	  S.	  coelicolor.	  	  
	  
Figure	   5.1	   -­‐	   carD-­‐3xFLAG	   complements	   a	   ∆carD	   deletion	   mutant.	   	   S200/pRT802,	   S200/pRT802::carD	   and	  
S200/pRT802::carD-­‐3xFLAG	  streaked	  onto	  (A)	  MS	  agar	  (B)	  MS	  agar	  +	  15	  µg/mL	  thiostrepton	  and	  incubated	  for	  5	  days	  
at	  30	  °C.	  






5.2.3   Creation	  of	  a	  ∆carD-­‐3xFLAG	  mutant	  
It	  was	  necessary	  to	  create	  a	  strain	  possessing	  only	  one	  chromosomal	  copy	  of	  carD	  with	  a	  
3xFLAG	  tag.	  	  Due	  to	  the	  essential	  nature	  of	  CarD,	  it	  was	  not	  possible	  to	  first	  create	  a	  ∆carD	  
mutant	   and	   complement	   this	   with	   carD-­‐3xFLAG.	   	   Instead,	   the	   plasmid	  
pRT802::carD-­‐3xFLAG	   was	   transferred	   via	   conjugation	   into	   a	   single	   crossover	  
recombinant	  strain	  J1915/pIJ6650∆carD::hyg	  (obtained	  in	  chapter	  4).	  	  As	  the	  strain	  now	  
possessed	  an	  additional	  functional	  copy	  of	  carD	   (carD-­‐3xFLAG	  integrated	  at	  the	  phage	  
φBT1	  site),	  following	  a	  round	  of	  non-­‐selective	  growth	  it	  was	  now	  possible	  to	  obtain	  AprS	  
HygR	   KanR	   double	   crossover	   deletion	   mutants	   representing	   the	   strain	  
J1915∆carD::hyg/pRT802::carD-­‐3xFLAG.	  	  This	  strain	  was	  named	  S202.	  
5.2.4   Chromatin	   immunoprecipitation	   (ChIP)	   on	   S.	   coelicolor	   grown	   in	   liquid	  
cultures	  
Chromatin	   immunoprecipitation	   (ChIP)	   is	   a	   technique	   used	   to	   study	   protein-­‐DNA	  
interactions.	  	  It	  involves	  crosslinking	  all	  protein-­‐DNA	  complexes,	  precipitating	  the	  protein	  
of	   interest	   with	   an	   appropriate	   antibody	   and	   analysing	   the	   DNA	   fragments	   purified,	  
typically	  through	  qPCR	  or	  high-­‐throughput	  DNA	  sequencing.	  	  
To	  perform	  the	  crosslinking,	  cultures	  of	  S202	  were	  grown	  in	  YEME-­‐10	  (with	  glycerol	  as	  a	  
carbon	   source)	   to	   mid-­‐late	   exponential	   phase	   (OD450	   =	   1.5–2).	   	   37%	   formaldehyde	  
solution	  was	  added	  to	  a	  final	  concentration	  of	  1%	  before	  incubation	  for	  a	  further	  20	  min	  
at	   30	   °C.	   	   To	   quench	   the	   remaining	   formaldehyde,	   glycine	   was	   added	   to	   a	   final	  
concentration	   of	   0.5	  M	   before	   incubation	   for	   5	  min	   at	   room	   temperature.	   	   For	   each	  
immunoprecipitation,	   70	  mL	   aliquots	   of	   cells	   were	   harvested	   by	   centrifugation	   at	  
6,000	  x	  g	  for	  2	  min	  at	  4	  °C,	  washed	  twice	  with	  25	  mL	  ice-­‐cold	  PBS	  and	  cell	  pellets	  were	  
stored	  at	  -­‐80	  °C	  until	  required.	  
Keeping	  frozen	  in	  liquid	  nitrogen,	  pellets	  were	  cryogenically	  ground	  for	  3	  x	  90	  s	  before	  
resuspension	  in	  2.2	  mL	  IP	  buffer	  (with	  0.1	  mg/mL	  RNase	  A	  +	  protease	  inhibitor).	   	  Cells	  
were	  further	  disrupted	  and	  DNA	  fragmented	  by	  sonication	  using	  a	  Diagenode	  Bioruptor.	  	  
To	  do	  this,	  each	  pellet	  suspension	  was	  divided	  into	  6	  x	  400	  µL	  aliquots	  and	  sonicated	  for	  
35	  cycles	  of	  sonication	  (30	  s	  on,	  30	  s	  off)	  at	  4	  °C.	  	  Samples	  were	  centrifuged	  at	  16,000	  x	  g	  
for	  30	  min	  to	  remove	  cell	  debris	  and	  the	  supernatant	  transferred	  to	  a	  new	  tube.	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To	  visualise	  the	  degree	  of	  DNA	  fragmentation,	  a	  20	  µL	  sample	  of	  the	  supernatant	  was	  
treated	  with	  2	  µL	  Riboshredder	  RNase	  Blend	  at	  room	  temperature	  for	  30	  min	  followed	  
by	  2	  µL	  proteinase	  K	  at	  55	  °C	  for	  2	  hours	  and	  de-­‐crosslinked	  at	  65	  °C	  for	  6	  hours.	  	  This	  
sample	  was	  run	  on	  a	  1.2%	  agarose	  gel	  to	  check	  DNA	  fragment	  size;	  a	  smear	  ranging	  from	  
~150	  bp	  to	  600	  bp	  was	  seen	  and	  judged	  suitable	  for	  sequencing.	  
To	  perform	  the	  immunoprecipitation,	  the	  chromatin	  samples	  were	  first	  pre-­‐cleared	  with	  
the	  appropriate	  Protein	  A/G	  magnetic	  beads;	  this	  is	  a	  process	  that	  reduces	  non-­‐specific	  
binding	  by	  removing	  proteins	  that	  may	  bind	  immunoglobulins.	  	  Protein	  G	  magnetic	  beads	  
(New	   England	   Biolabs)	   were	   used	   for	   RNAP	   and	   3xFLAG	   immunoprecipitations	   and	  
Protein	   A	   magnetic	   beads	   (New	   England	   Biolabs)	   were	   used	   for	   σHrdB	  
immunoprecipitation.	  	  Pre-­‐clearing	  was	  performed	  with	  50	  µL	  magnetic	  beads	  incubated	  
at	  4	  °C	  for	  1.5	  hours	  rotating	  at	  20	  rpm.	  	  Following	  incubation,	  the	  magnetic	  beads	  were	  
immobilised	  with	  a	  magnetic	  rack	  and	  the	  cleared	  supernatant	  was	  transferred	  to	  a	  new	  
tube.	   	   100	  µL	   of	   this	   pre-­‐cleared	   chromatin	  was	   removed	   and	   stored	   at	   -­‐20	   °C	   as	   an	  
"input"	  control.	  	  1–5	  µg	  of	  the	  following	  antibodies	  was	  added	  to	  the	  remaining	  cleared	  
chromatin	  and	  incubated	  at	  4	  °C	  for	  2.5	  hours	  rotating	  at	  20	  rpm:	  
•   7	  µL	  anti-­‐FLAG	  M2	  monoclonal	  antibody	  (Sigma	  F18041MG)	  	  
•   7	  µL	  anti-­‐σHrdB	  polyclonal	  antibody	  (a	  gift	  from	  P.	  Doughty)	  
•   2	  µL	  anti-­‐RNAP	  β	  monoclonal	  antibody	  (Abcam	  ab12087)	  
30	  µL	  of	  appropriate	  magnetic	  beads	  were	  added	  and	  incubated	  for	  a	  further	  1.5	  hours.	  	  
The	   beads	   were	   immobilised	   with	   a	   magnetic	   rack	   and	   the	   spent	   supernatant	   was	  
discarded.	  	  The	  beads	  were	  gently	  resuspended	  in	  750	  µL	  ice-­‐cold	  IP	  buffer,	  transferred	  
to	   a	   new	   tube	   and	   incubated	   at	   4°C	   for	   10	  min	   rotating	   at	   20	   rpm.	   	   The	   same	  wash	  
procedure	  was	  performed	  with	  1	  mL	  ice-­‐cold	  IP	  +	  salt	  buffer,	  IP	  wash	  buffer	  and	  finally	  
pH	  8	  TE	  buffer.	  	  After	  washing,	  the	  magnetic	  beads	  were	  resuspended	  in	  100	  µL	  1	  x	  IP	  
elution	  buffer	  +	  5	  µL	  RiboShredder	  RNase	  blend	  and	  incubated	  at	  room	  temperature	  for	  
30	  min.	  	  At	  this	  point,	  the	  “input”	  control	  sample	  was	  thawed	  and	  incubated	  with	  5	  µL	  
RiboShredder	  RNase	  blend	  at	  room	  temperature	  for	  30	  min	  before	  de-­‐crosslinking	  both	  
the	  IP	  and	  input	  samples	  in	  a	  65°C	  water	  bath	  overnight.	  	  The	  following	  day	  the	  beads	  
were	  immobilised	  and	  washed	  with	  an	  additional	  50	  µL	  pH	  7.5	  TE	  buffer.	  	  50	  µL	  pH	  7.5	  TE	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buffer	  was	  added	  to	  the	  input	  sample.	  	  150	  µL	  IP	  and	  input	  samples	  were	  finally	  purified	  
through	  a	  Qiagen	  MinElute	  PCR	  purification	  kit	  and	  eluted	  with	  22	  µL	  MQ	  water.	  
5.2.5   Aligning	  and	  visualising	  ChIP-­‐seq	  data	  
The	  samples	  were	  sequenced	  using	  an	  Illumina	  HiSeq	  2500	  platform	  (Rapid-­‐Run	  mode)	  
with	  50	  bp	  single-­‐end	  reads.	  	  16	  samples	  were	  simultaneously	  sequenced	  via	  multiplex	  
sequencing.	   	   This	   process	   was	   performed	   externally	   (The	   Genome	   Analysis	   Centre	  
(TGAC),	  Norwich,	  UK)	  and	  de-­‐multiplexed	  sequencing	  results	  were	  received	  as	  individual	  
FASTQ	  files	  for	  each	  ChIP	  sample.	  
For	   downstream	  processing,	   files	  were	  uploaded	   to	  Galaxy	   (https://usegalaxy.org),	   an	  
“open,	   web-­‐based	   platform	   for	   data	   intensive	   biomedical	   research”.	   	   To	   allow	  
downstream	  processing,	  FASTQ	  files	  were	  first	  converted	  from	  Illumina	  to	  Sanger	  format	  
with	  FASTQ	  Groomer	  (Galaxy	  Tool	  version	  1.0.4).	  	  	  
Before	  alignment	  and	  analysis,	  it	  was	  necessary	  to	  perform	  quality	  control	  on	  the	  FASTQ	  
sequence	  files	  as	  evidence	  of	  successful	  sequencing	  of	  uncontaminated	  samples	  using	  
FASTQC	  (Galaxy	  Tool	  Version	  0.63).	  	  For	  all	  samples	  the	  mean	  GC	  content	  passed	  QC	  with	  
the	   around	   72%	   (Figure	   5.2A).	   	   Results	   indicated	   a	   decrease	   in	   average	   quality	   and	  
deviation	  from	  the	  expected	  GC	  content	  at	  positions	  1–10	  of	  the	  50	  bp	  reads	  for	  every	  
result	   (Figure	   5.2B).	   	   It	   has	   been	   reported	   that	   this	   phenomena	   caused	   by	   random	  
hexamer	   mis-­‐priming	   is	   often	   seen	   with	   Illumina	   NGS	   data	   and	   may	   not	   affect	  
downstream	  applications.	  	  However,	  to	  ensure	  this	  did	  not	  affect	  the	  ability	  of	  Bowtie	  to	  
map	   the	   reads	   onto	   the	   S.	   coelicolor	   genome,	   the	   first	   10	   bases	   of	   every	   read	  were	  
removed	   with	   Trim	   sequences	   as	   a	   precaution	   (Galaxy	   Tool	   version	   1.0.0).	   	   For	   all	  
immunoprecipitation	   results,	   FASTQC	   failed	   on	   the	   sequence	  duplication	   level	   (Figure	  
5.2C).	  	  Errors	  at	  this	  step	  in	  ChIP-­‐seq	  are	  typically	  introduced	  via	  the	  PCR	  amplification	  
step.	  	  As	  library	  preparation	  did	  not	  include	  any	  PCR	  steps	  and	  the	  sequence	  duplication	  
level	  was	  normal	  for	  the	  input	  samples	  (Figure	  5.2D)	   it	  was	  considered	  that	  this	  result	  




Figure	  5.2	  -­‐	  FASTQC	  analysis	  of	  ChIP-­‐seq	  results.	  	  	  (A)	  Mean	  GC	  content	  result	  for	  RNAP	  sample	  (B)	  Per	  base	  sequence	  
content	   across	   all	   bases	   for	   RNAP	   sample	   (C)	   Sequence	   duplication	   level	   result	   for	   RNAP	   sample	   (D)	   Sequence	  
duplication	  level	  result	  for	  input	  sample.	  
Once	  the	  FASTQ	  files	  were	  suitably	  prepared,	  the	  processed	  reads	  were	  aligned	  to	  the	  
S.	  coelicolor	   A3(2)	   genome	   sequence	   (NCBI	   reference	   sequence:	   NC_003888.3)	   with	  
Bowtie	   for	   Illumina	   (Galaxy	  Tool	   version	  1.1.2,	  using	   the	   settings	   “-­‐n	  2	   -­‐e	  70	   -­‐S	   -­‐-­‐un”)	  
(Langmead	  et	  al.,	  2009).	   	  By	  using	  the	   -­‐-­‐un	  mode,	  unmapped	  reads	  were	  written	  to	  a	  
separate	   file	   and	   compared	   to	   the	   number	   of	   mapped	   reads	   as	   a	   measure	   of	   read	  
mapping	   efficiency.	   	   Percentage	  mapped	   reads	   of	   97.6%	   to	   98.9%	   revealed	   that	   the	  
alignment	  was	  successful	  (Table	  5.1).	  






Sample	   Mapped	  Reads	   Unmapped	  Reads	   Total	  Reads	   %	  Mapped	  
Input	   22,998,668	   242,041	   23,240,709	   99.0%	  
RNAP	   16,256,217	   253,948	   16,510,165	   98.5%	  
σHrdB	   24,146,596	   370,590	   24,517,186	   98.5%	  
CarD	   28,004,757	   675,407	   28,680,164	   97.6%	  
Table	  5.1	  -­‐	  Percentage	  of	  reads	  mapped	  with	  Bowtie.	  	  Mapped	  and	  unmapped	  read	  counts	  were	  obtained	  with	  IdxStats	  
(Galaxy	  Tool	  Version	  2.0).	  
The	  Bowtie	  output	  SAM	  file	  was	  compressed	   to	  a	  binary	  BAM	  file	  using	  SAM	  to	  BAM	  
(Galaxy	  Tool	  version	  2.0)	  before	  sorting	  by	  chromosomal	  co-­‐ordinates	  with	  the	  Sort	  BAM	  
dataset	  tool	  (Galaxy	  Tool	  version	  2.0).	  
To	  create	  histogram	  plots	  of	  the	  mapped	  reads,	  the	  sorted	  BAM	  files	  were	  uploaded	  to	  
the	  Galaxy	  deepTools	  server	  (http://deeptools.ie-­‐freiburg.mpg.de)	  and	  the	  bamCoverage	  
tool	  (Galaxy	  Tool	  Version	  1.5.9.1.0)	  was	  used	  for	  creation	  of	  a	  bigWig	  file	  (Ramírez	  et	  al.,	  
2014).	  	  The	  average	  fragment	  size	  captured	  from	  the	  ChIP	  samples	  in	  the	  final	  stages	  of	  
library	   preparation	   by	   TGAC	   was	   200	   bp;	   this	   fragment	   size	   was	   entered	   into	   the	  
bamCoverage	   parameters	   and	   used	   to	   extend	   the	   length	   of	   every	  mapped	   read.	   	   As	  
ChIP-­‐seq	  involves	  high	  throughput	  sequencing	  of	  very	  short	  reads,	  in	  this	  case	  just	  50	  bp,	  
likely	  to	  map	  to	  the	  5’	  ends	  of	  each	  strand,	  the	  reads	  are	  likely	  to	  map	  to	  the	  left	  and	  right	  
of	  the	  true	  protein	  location	  (Myers	  et	  al.,	  2015).	  	  The	  process	  of	  extending	  the	  read	  length	  
compensates	   for	   this	   and	  gives	   a	   truer	   representation	  of	   the	  protein-­‐DNA	   interaction	  
in	  vivo.	   	  To	  normalise	   for	  sequencing	  depth,	  all	  samples	  were	  normalised	  to	  reads	  per	  
kilobase	  per	  million	  mapped	  reads	  (RPKM)	  (Mortazavi	  et	  al.,	  2008;	  Bailey	  et	  al.,	  2013).	  	  
The	  process	  of	  aligning	  and	  visualising	  ChIP-­‐seq	  reads	  is	  outlined	  in	  Figure	  5.3.	  	  Integrated	  
Genome	  Browser	  (IGB)	  (Version	  8.3.4)	  was	  used	  to	  visualise	  the	  bigWig	  histogram	  against	  






Figure	  5.3	  -­‐	  Flowchart	  outlining	  the	  procedures	  for	  ChIP-­‐seq	  alignment	  and	  analysis.	  
	  
	  
Figure	  5.4	  -­‐	  Visualisation	  of	  bigWig	  histogram	  files	  with	  Integrated	  Genome	  Browser	  	  ChIP-­‐seq	  analysis	  performed	  on	  
S202.	  	  bigWig	  histograms	  represent	  total	  number	  of	  aligned	  reads,	  RPKM	  normalised	  for	  sequencing	  depth.	  	  The	  entire	  
S.	  coelicolor	  genome	  is	  represented.	  	  Input	  tracks	  are	  grey,	  RNAP	  are	  blue,	  σHrdB	  are	  orange	  and	  CarD	  are	  pink.	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5.3   CarD	  and	  σHrdB	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo	  
Initial	  analysis	  of	  the	  distribution	  of	  RNAP,	  CarD	  and	  σHrdB	  was	  performed	  by	  calculating	  
the	  correlation	  of	  the	  entire	  datasets	  using	  deepTools	  bamCorrelate	  (Galaxy	  Tool	  version	  
1.5.9.1).	  	  Pearson	  correlation	  analysis	  revealed	  that	  the	  distribution	  of	  CarD	  and	  σHrdB	  was	  
highly	  correlated	  with	  a	  value	  of	  0.89	  (Figure	  5.5).	  	  Data	  also	  revealed	  that	  distribution	  of	  
RNAP	  correlated	  with	  CarD	  (0.55)	  and	  σHrdB	  (0.60).	  Positive	  correlation,	  albeit	  with	  low	  
scores,	  between	  the	  input	  and	  RNAP	  (0.22),	  σHrdB	  (0.29),	  and	  CarD	  (0.37)	  is	  likely	  to	  be	  
due,	   at	   least	   in	   part,	   to	   the	   relationship	   between	   gene	   position	   and	   expression.	   	   In	  
S.	  coelicolor,	  the	  highly	  expressed	  core	  genes	  responsible	  for	  essential	  functions	  including	  
replication,	  transcription	  and	  translation	  are	  positioned	  in	  the	  central	  core	  region	  of	  the	  
linear	   chromosome	   (Bentley	   et	   al.,	   2002).	   Accessory	   genes,	   including	   cryptic/silent	  
secondary	  metabolic	  gene	  clusters,	  tend	  to	  be	  located	  in	  the	  chromosome	  arms.	  In	  this	  
ChIP-­‐seq	  experiment,	  alignment	  of	  the	  sequenced	  input	  DNA	  revealed	  a	  higher	  number	  
of	  reads	  for	  DNA	  derived	  from	  the	  central	  region	  of	  the	  genome,	  as	  expected	  given	  the	  
centrally	  located	  	  origin	  of	  replication	  (Figure	  5.4).	  Therefore,	  a	  positive	  correlation	  would	  
be	   expected	   due	   to	   the	   presence	   of	   highly	   expressed	   genes	   being	   in	   the	   core	   of	   the	  
genome	  where	  the	  gene	  copy	  number	  is	  higher	  due	  active	  growth	  and	  replication.	  
	  
Figure	  5.5	  -­‐	  Distribution	  of	  CarD	  and	  σHrdB	  is	  highly	  correlated	  throughout	  S.	  coelicolor	  genome	  	  Pearson	  correlation	  of	  








The	  regions	  surrounding	  σHrdB-­‐dependent	  genes	  SCO4808	  (succinyl-­‐CoA	  synthetase	  beta	  
chain,	   sucC),	   SCO1947	   (glyceraldehyde-­‐3-­‐phosphate	   dehydrogenase,	   gap1),	   SCO2136	  
(putative	   secreted	   protein)	   and	   SCOr07–9	   (rrnD)	   are	   four	   examples	   that	   represent	  
observations	  made	  throughout	  the	  genome	  (Figure	  5.6A–D).	  
σHrdB	  enrichment	  was	  distributed	  throughout	  the	  genome	  primarily	  in	  intergenic	  regions,	  
upstream	  of	  genes,	  typical	  of	  promoter	  location	  (Figure	  5.6A–D).	  	  These	  enriched	  regions	  
are	  consistent	  with	  predicted	  and	  known	  transcription	  start	  sites,	  thus	  confirming	  that	  
this	  ChIP-­‐seq	  method	  is	  reliable	  for	  identification	  of	  σHrdB-­‐dependent	  promoters.	  	  Little	  or	  
no	  σHrdB	  enrichment	  was	  detected	  within	  the	  main	  body	  of	  genes,	  consistent	  with	  the	  
efficient	   dissociation	   of	   σ	   from	   RNAP	   core	   during	   elongation	   (Raffaelle	   et	   al.,	   2005).	  	  
However,	  it	  should	  be	  noted	  that	  cross-­‐linking	  efficiency	  between	  σ	  and	  DNA	  is	  likely	  to	  
decrease	  during	  the	  transition	  from	  initial	  transcribing	  complex	  to	  elongation	  and	  so	  the	  
absence	   of	   enrichment	   does	   not	   necessarily	   correlate	   with	   an	   absence	   of	   σ	   in	   the	  
elongating	  complex.	  	  
RNAP	   enrichment	   was	   distributed	  more	   widely	   throughout	   the	   genome,	   at	   expected	  
promoter	   regions	   as	   well	   as	   downstream	   into	   ORFs.	   	   However,	   enrichment	   was	  
significantly	  greater	  at	  promoter	  regions	  than	  downstream	  into	  the	  gene	  (Figure	  5.6A–D)	  
suggesting	   that	   the	   transition	   from	   initiation	   to	   elongation	   is	   limiting	   factor	   for	  most	  
promoters,	  as	  has	  been	  suggested	  for	  E.	  coli	  (Reppas	  et	  al.,	  2006).	  Furthermore,	  as	  also	  
seen	  in	  E.	  coli	  (Reppas	  et	  al.,	  2006),	  the	  enrichment	  of	  RNAP	  at	  promoters	  compared	  to	  
the	  main	  gene	  body	  was	  highly	  variable;	   for	  example	   the	  travelling	  ratio	   for	  exemplar	  
genes	   in	   Figure	   5.6,	   defined	   by	   the	   enrichment	   800	   bp	   into	   the	   gene	   divided	   by	  
enrichment	  at	  the	  promoter,	  was	  0.03	  for	  sucC,	  0.09	  for	  SCO1947	  and	  0.15	  for	  SCO2136.	  
The	   reason	   for	   this	   is	   not	   currently	   understood	   although	   one	   possibility	   is	   that	   the	  
transition	   from	   initiation	   to	  elongation	   is	  highly	  variable,	  possibly	   reflecting	  regulatory	  
differences	   between	   promoters.	   	   Analysis	   of	   the	   region	   surrounding	   rRNA	   operons	  
revealed	  that	  while	  RNAP	  accumulates	  at	  the	  promoter,	   it	   is	  proportionally	  distributed	  
more	   evenly	   throughout	   the	   operon	   (Figure	   5.6D).	   	   To	   maintain	   high	   levels	   of	   rRNA	  
expression	   it	   is	   likely	   that	   RNAP	   proceeds	   more	   rapidly	   from	   these	   promoters	   into	  
elongation.	  	  Under	  the	  growth	  conditions	  used	  in	  this	  experiment,	  the	  vast	  majority	  of	  
RNAP	  peaks	  upstream	  from	  ORFs	  correlated	  with	   the	  presence	  of	  σHrdB.	   	  Two	  notable	  
129	  
	  
exceptions	   were	   hrdB	   (SCO5820)	   and	   cwgA	   (SCO6179)	   which	   are	   controlled	   by	   the	  
alternative	  sigma	  factors	  σShbA	  and	  σE,	  respectively	  (Otani	  et	  al.,	  2013;	  Hong	  et	  al.,	  2002)	  
(see	  chapter	  6).	  	  
CarD	   enrichment	   revealed	   that	   the	   protein	   co-­‐localises	   with	   σHrdB	   and	   RNAP	   at	  
σHrdB-­‐dependent	   promoters	   throughout	   the	   genome	   (Figure	   5.6A–D).	   	   It	   was	   found	  
exclusively	  at	  promoter	  regions,	  suggesting	  that	  CarD	  is	  not	  a	  component	  of	  elongating	  
RNAP.	   Interestingly,	   despite	   the	   absence	   of	   σHrdB,	   CarD	   was	   enriched	   in	   the	   hrdB	  
(SCO5820)	  and	  cwgA	  (SCO6179)	  promoter	  regions,	  which	  suggested	  that	  CarD	  might	  be	  
present	  in	  RNAP	  initiation	  complexes	  that	  contain	  alternative	  sigma	  factors;	  this	  discovery	  




Figure	  5.6	  -­‐	  CarD	  and	  σHrdB	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	   in	  vivo.	   	  ChIP-­‐seq	  analysis	  performed	  on	  S202.	  	  
bigWig	   histograms	   represent	   total	   number	   of	   aligned	   reads,	   RPKM	   normalised	   for	   sequencing	   depth.	   	   (A)	   sucC	  
(SCO4808)	  (B)	  gap1	   (SCO1947)	  (C)	  SCO2136	  (putative	  secreted	  protein)	  (D)	  rrnD	   (SCOr07-­‐9).	   	   Input	  tracks	  are	  grey,	  
RNAP	  are	  blue,	  σHrdB	  are	  orange	  and	  CarD	  are	  pink.	  	  Predicted	  transcription	  start	  site	  (if	  available)	  is	  indicated	  with	  a	  















5.4   RbpA	  and	  σHrdB	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo	  
ChIP	   experiments	   were	   also	   performed	   as	   described	   above	   on	   the	   strain	  
S115/pRT802::rbpA-­‐3xFLAG	   (M145∆rbpA::apr/pRT802::rbpA-­‐3xFLAG)	   by	   A.	   Tabib-­‐
Salazar.	  	  Sequencing	  results	  were	  received	  and	  analysed	  as	  part	  of	  this	  study.	  	  Due	  to	  the	  
presence	  of	  glkA	  in	  the	  parent	  strain,	  cultures	  were	  grown	  in	  YEME-­‐10	  with	  glucose	  as	  a	  
carbon	   source.	   	   As	   before,	   immunoprecipitations	   were	   performed	   using	   antibodies	  
specific	   to	   RNAP	   β,	   σHrdB	   and	   3xFLAG	   tagged	   RbpA.	   	   Otherwise,	   ChIP	   and	   sequencing	  
procedures	  were	  performed	  as	  with	  S202.	  	  Samples	  from	  this	  experiment	  were	  run	  across	  
two	  HiSeq	  lanes	  so	  produced	  two	  FASTQ	  files	  per	  sample.	  	  Following	  conversion	  to	  Sanger	  
format	  with	  FASTQ	  groomer,	  the	  two	  FASTQ	  files	  from	  each	  sample	  were	  combined	  with	  
the	  Concatenate	  Datasets”	  function	  (Galaxy	  Tool	  version	  1.0.0).	   	  Once	  combined,	  data	  
were	  prepared	  and	  aligned	  as	  described	  above	  (Figure	  5.3).	  	  As	  before,	  comparison	  of	  the	  
number	  of	  mapped	  to	  unmapped	  reads	  was	  performed	  and	  percentage	  mapped	  reads	  of	  
97.7%	  to	  99%	  revealed	  that	  DNA	  fragment	  alignment	  was	  successful	  (Table	  5.2).	  
Sample	   Mapped	  Reads	   Unmapped	  Reads	   Total	  Reads	   %	  Mapped	  
Input	   18,431,999	   194,693	   18,626,692	   99.0%	  
RNAP	   39,283,744	   582,635	   39,866,379	   98.5%	  
σHrdB	   34,865,132	   571,610	   35,436,742	   98.4%	  
RbpA	   34,508,616	   823,139	   35,331,755	   97.7%	  
Table	  5.2	  -­‐	  Percentage	  of	  reads	  mapped	  with	  Bowtie.	  	  Mapped	  and	  unmapped	  read	  counts	  were	  obtained	  with	  IdxStats	  
(Galaxy	  Tool	  Version	  2.0).	  
The	  correlation	  of	  RNAP,	  σHrdB	  and	  RbpA	  distribution	  was	  analysed	  as	  described	  in	  Section	  
5.3.	   	   RbpA	   and	   σHrdB	   displayed	   a	   very	   high	   positive	   correlation	   (0.98;	   Figure	   5.7),	  
suggesting	  that	  they	  co-­‐localise	  throughout	  the	  S.	  coelicolor	  genome.	  	  RNAP	  distribution	  
showed	   a	   slightly	   lower	   positive	   correlation	   score	   with	   σHrdB	   (0.72)	   and	   RbpA	   (0.69),	  
consistent	  with	  data	  presented	   for	  σHrdB	  and	  CarD.	   	   Furthermore,	   input	   samples	  were	  




Figure	  5.7	  -­‐	  Distribution	  of	  RbpA	  and	  σHrdB	  is	  highly	  correlated	  throughout	  S.	  coelicolor	  genome	  	  Pearson	  correlation	  of	  
aligned	  ChIP-­‐seq	  files	  performed	  with	  deepTools	  bamCorrelate,	  using	  a	  bin	  size	  of	  500	  bp.	  
The	   four	   representative	   σHrdB-­‐dependent	   genes	   described	   in	   Section	   5.3	   were	   again	  
chosen	   to	   illustrate	   key	   points:	   SCO4808	   (succinyl-­‐CoA	   synthetase	   beta	   chain,	   sucC),	  
SCO1947	   (glyceraldehyde-­‐3-­‐phosphate	   dehydrogenase,	   gap1),	   SCO2136	   (putative	  
secreted	  protein)	  and	  SCOr07–9	  (rrnD)	  (Figure	  5.8A–D).	  	  	  
The	  distribution	  of	  σHrdB	  and	  RNAP	  was	  highly	  similar	  to	  that	  observed	  in	  previous	  S202	  
ChIP-­‐seq	  experiments	  (Figure	  5.8)	  demonstrating	  the	  reproducibility	  of	  this	  technique	  for	  
observing	  DNA	  binding	  in	  vivo.	  	  Consistent	  with	  the	  remarkably	  high	  correlation	  scores,	  
RbpA	   and	   σHrdB	   co-­‐localised	   throughout	   the	   genome	   at	   σHrdB-­‐dependent	   promoters	  
(Figure	  5.8).	  	  There	  were	  no	  incidences	  observed	  throughout	  the	  entire	  genome	  where	  









Figure	   5.8	   -­‐	   RbpA	   and	   σHrdB	   co-­‐localise	   at	   σHrdB-­‐dependent	   promoters	   in	   vivo	   	   ChIP-­‐seq	   analysis	   performed	   on	  
S115/pRT802::rbpA-­‐3xFLAG.	   	   bigWig	   histograms	   represent	   total	   number	   of	   aligned	   reads,	   RPKM	   normalised	   for	  
sequencing	  depth.	  	  (A)	  sucC	  (SCO4808)	  (B)	  gap1	  (SCO1947)	  (C)	  SCO2136	  (putative	  secreted	  protein)	  (D)	  rrnD	  (SCOr07–
9).	   Input	  tracks	  are	  grey,	  RNAP	  are	  blue,	  σHrdB	  are	  orange	  and	  RbpA	  are	  green.	   	  Predicted	  transcription	  start	  site	  (if	  

















5.5   ChIP-­‐seq	  analysis	  of	  effects	  of	  rifampicin	  
In	  previous	  ChIP-­‐chip	  studies	  performed	  on	  RNAP,	  rifampicin	  has	  been	  used	  to	  treat	  cells	  
prior	  to	  harvesting	  to	  aid	  identification	  of	  promoter	  regions	  (Herring	  et	  al.,	  2005;	  Grainger	  
et	  al.,	  2005).	  	  Rifampicin	  is	  an	  antibiotic	  that	  inhibits	  bacterial	  transcription	  by	  binding	  to	  
the	   β	   subunit	   in	   the	   DNA/RNA	   channel,	   preventing	   the	   enzyme	   from	   entering	   the	  
elongation	   phase	   of	   transcription	   (Campbell	   et	   al.,	   2001).	   	   Consequently,	   rifampicin-­‐
bound	   RNA	   polymerase	   molecules	   are	   prevented	   from	   escaping	   initiation	   and	   are	  
confined	  to	  promoter	  regions	  (Herring	  et	  al.,	  2005).	  
In	  addition	  to	  samples	  prepared	  from	  exponentially	  growing	  cultures,	  ChIP	  experiments	  
were	   performed	   on	   S115/pRT802::rbpA-­‐3xFLAG	   following	   addition	   of	   rifampicin	   by	  
A.	  Tabib-­‐Salazar.	   	   Mycelia	   was	   harvested	   from	   cultures	   exposed	   to	   the	   140	   µg/mL	  
rifampicin	  for	  20	  min	  (conditions	  shown	  previously	  to	  be	  suitably	  for	  studying	  effects	  of	  
rifampicin	  on	  transcription	  in	  vivo)	  (Herring	  et	  al.,	  2005).	  	  	  	  Immunoprecipitations	  were	  
performed	  as	  above	  with	  antibodies	  specific	  to	  RNAP	  β,	  σHrdB	  and	  3xFLAG	  tag.	  	  Samples	  
were	  sequenced	  externally	  and	  sequencing	  was	  analysed	  as	  described	  above.	  
Comparison	   of	   the	   number	   of	   mapped	   to	   unmapped	   reads	   was	   performed	   and	  
percentage	  mapped	  reads	  of	  98.2%	  to	  98.9%	  revealed	  that	  the	  alignment	  was	  successful	  
(Table	  5.3).	  
Sample	   Mapped	  Reads	   Unmapped	  Reads	   Total	  Reads	   %	  Mapped	  
Input	  +	  RIF	   30,000,367	   320,836	   	  30,321,203	  	   98.9%	  
RNAP	  +	  RIF	   	  38,969,681	  	   	  701,081	  	   	  39,670,762	  	   98.2%	  
σHrdB	  +	  RIF	   	  34,013,740	  	   	  440,525	  	   	  34,454,265	  	   98.7%	  
RbpA	  +	  RIF	   	  38,020,694	  	   	  626,876	  	   	  38,647,570	  	   98.4%	  
Table	  5.3	  -­‐	  Percentage	  of	  reads	  mapped	  with	  Bowtie.	  	  Mapped	  and	  unmapped	  read	  counts	  were	  obtained	  with	  IdxStats	  
(Galaxy	  Tool	  Version	  2.0).	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The	  correlation	  of	  RNAP,	  σHrdB	  and	  RbpA	  distribution	  was	  analysed	  as	  described	  above.	  	  
Following	  addition	  of	  rifampicin,	  RNAP,	  RbpA	  and	  σHrdB	  were	  all	  distributed	  throughout	  
the	  S.	  coelicolor	  with	  a	  very	  high	  correlation	  (Figure	  5.7).	  	  With	  comparison	  to	  untreated	  
samples,	  the	  correlation	  of	  RbpA	  and	  σHrdB	  was	  unchanged.	  	  However,	  RNAP	  correlation	  
with	  σHrdB	   (and	  RbpA)	   increased	   considerably	   following	  addition	  of	   rifampicin	   (0.72	   to	  
0.97),	  suggesting	  that	  RNAP	  was	  globally	  trapped	   in	   initiating	  transcription	  complexes,	  
unable	  to	  escape	  promoters	  into	  elongation.	  
	  
Figure	  5.9	  -­‐	  Addition	  of	  rifampicin	  increases	  the	  correlation	  of	  RNAP,	  RbpA	  and	  σHrdB	  across	  the	  S.	  coelicolor	  genome	  	  
Pearson	  correlation	  of	  aligned	  ChIP-­‐seq	  files	  performed	  with	  deepTools	  bamCorrelate	  using	  a	  bin	  size	  of	  500	  bp.	  
This	  was	  confirmed	  by	  visualisation	  of	  bigWig	  files	  using	  IGB,	  which	  indicated	  a	  general	  
increase	   in	   the	  enrichment	  of	  RNAP	  and	  σHrdB	  at	   the	  promoter	   regions,	  and	  a	  general	  
decrease	   in	   coding	   sequences.	   	   As	   illustration,	   there	   is	   a	   large	   difference	   in	   RNAP	  
enrichment	  enriched	  throughout	  the	  ATP	  synthase	  operon	  (atpIBEFHAGDC)	  prior	  to	  and	  
after	  the	  addition	  of	  rifampicin	  (Figure	  5.10A).	  	  The	  20	  min	  period	  following	  the	  addition	  
of	  rifampicin,	  prior	  to	  cross-­‐linking	  would	  be	  expected	  to	  be	  long	  enough	  to	  allow	  RNAP	  
to	  complete	  the	  current	  round	  of	  transcription	  at	  most	  genes.	  	  However,	  Streptomyces	  
spp.	  are	  characterised	  by	  some	  extremely	   large	  antibiotic	  biosynthetic	  operons	  where	  
this	  might	  not	  be	  the	  case.	  	  The	  CDA	  peptide	  synthetase	  operon	  at	  40	  kb	  is	  the	  largest	  















enriched	   in	   the	   promoter-­‐proximal	   region	   of	   the	   cda	   operon,	   suggesting	   either	   that	  
expression	  of	  the	  cda	  operon	  had	  only	  recently	  started	  at	  the	  time	  of	  sampling,	  or	  that	  
the	  initial	  stages	  of	  transcription	  elongation	  are	  limiting.	  	  Following	  rifampicin	  treatment,	  
there	  was	  a	  striking	  redistribution	  of	  RNAP	  to	  the	  promoter-­‐distal	  region	  of	  the	  operon	  
(Figure	  5.10B).	  	  Notwithstanding	  the	  unknown	  time	  taken	  for	  rifampicin	  to	  inhibit	  further	  
rounds	  of	  transcription	  initiation,	  the	  location	  of	  the	  trailing	  edge	  of	  RNAP	  enrichment	  
should	   indicate	   distance	   travelled	   by	   RNAP	   in	   20	   min,	   and	   allow	   an	   estimation	   of	  
transcription	  speed.	  	  Thus,	  the	  position	  of	  the	  trailing	  edge	  of	  RNAP	  at	  ~23	  kb	  into	  the	  
operon	  suggests	  a	  transcription	  speed	  of	  19	  nt	  per	  second.	  	  This	  can	  be	  compared	  to	  that	  
in	  E.	  coli,	  where	  the	  speed	  of	  RNAP	  elongation	  has	  been	  estimated	  to	  be	  approximately	  
30–100	  nt	  per	  second	  (Vogel	  and	  Jensen,	  1994).	  	  
In	  addition	  to	  a	  global	  decrease	  in	  elongating	  RNAP,	  treatment	  with	  rifampicin	  caused	  the	  
appearance	  of	  a	  number	  of	  new	  RNAP	  and	  σHrdB	  peaks	  throughout	  the	  genome	  where	  
transcription	  would	   not	   be	   expected	   to	   initiate	   (Figure	   5.10).	   	   This	   is	   consistent	  with	  
previous	   observations	   from	   ChIP	   experiments	   performed	   on	   rifampicin-­‐treated	   cells	  
(Herring	  et	  al.,	  2005;	  Grainger	  et	  al.,	  2005).	  	  One	  possibility	  is	  that	  these	  sites	  represent	  
unannotated	  ORFs	  or	  small	  regulatory	  RNAs.	  	  It	  is	  also	  possible	  that	  an	  increase	  in	  free	  
RNAP	  following	  rifampicin	  treatment	  allows	  RNAP	  and	  σHrdB	  to	  bind	  at	  genomic	  loci	  not	  





Figure	  5.10	  -­‐	  Rifampicin	  inhibits	  transcription	  initiation.	  	  ChIP-­‐seq	  analysis	  performed	  on	  S115/pRT802::rbpA-­‐3xFLAG	  
before	  and	  20	  mins	  after	  addition	  of	  	  140	  µg/mL	  (A)	  ATP	  synthase	  operon	  (B)	  CDA	  synthetase	  operon.	  	  Input	  tracks	  are	  
grey,	  RNAP	  are	  blue	  and	  σHrdB	  are	  orange.	  	  Predicted	  transcription	  start	  site	  (if	  available)	  is	  indicated	  with	  a	  grey	  line	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Although	   rifampicin	   inhibited	   transcription	   from	   the	   majority	   of	   promoters,	   it	   was	  
possible	   to	   identify	   a	   number	   of	   promoters	   where	   transcription	   was	   activated.	   	   For	  
example	   hflX,	   which	   encodes	   a	   universally	   conserved	   GTP-­‐binding	   protein,	   displayed	  
increased	  RNAP	  enrichment	  throughout	  the	  ORF	  following	  rifampicin	  treatment,	  which	  
correlated	  with	   increased	  RNAP	  enrichment	  at	   the	  promoter.	   	   Interestingly,	  however,	  
σHrdB	  enrichment	  was	  unaffected	  suggesting	  that	  the	  increased	  transcription	  activity	  did	  
not	   involve	  σHrdB	   (Figure	  5.11A).	   	  A	   similar	   effect	  was	   also	  observed	  at	   the	   rpmE/prfA	  
operon	  (Figure	  5.11B),	  although	  in	  this	  case	   level	  of	  σHrdB	  enrichment	  at	  the	  promoter	  
actually	   decreased.	   	   Whilst	   both	   promoters	   bind	   σHrdB,	   these	   genes	   have	   also	   been	  
identified	   as	   σR	   targets	   (Paget	   et	   al.,	   2001a).	   This	   suggests	   that	   rifampicin	   treatment	  




Figure	  5.11	  -­‐	  Rifampicin	  increases	  transcription	  of	  selected	  genes.	  	  ChIP-­‐seq	  analysis	  performed	  on	  S115/pRT802::rbpA-­‐
3xFLAG	  before	  and	  20	  mins	  after	  addition	  of	  	  140	  µg/mL	  	  (A)	  hflX	  (B)	  rpmE/prfA	  operon.	  	  Input	  tracks	  are	  grey,	  RNAP	  






















5.6   Discussion	  
5.6.1   CarD	  and	  σHrdB	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo	  
ChIP-­‐seq	  has	  emerged	  as	  a	  key	  technique	  for	  studying	  the	   localisation	  of	  transcription	  
factors	  in	  all	  organisms	  and	  has	  recently	  been	  applied	  to	  Streptomyces	  for	  the	  location	  of	  
a	  range	  of	  DNA	  binding	  proteins	  including	  the	  developmental	  regulator	  WhiA	  (Bush	  et	  al.,	  
2013)	   and	   the	   oxidative	   stress	   regulator	   NdgR	   (Kim	   et	   al.,	   2015).	   	   The	   current	   work	  
demonstrates	   that	   the	   technique	   is	   also	   suitable	   for	   studying	   the	   distribution	   of	   the	  
transcription	   machinery	   in	   S.	   coelicolor	   despite	   the	   much	   wider	   distribution	   of	   RNA	  
polymerase.	   	   Sequencing	   depth	   is	   an	   important	   consideration	   when	   studying	   such	  
broadly	  distributed	   transcription	   factors,	   since	  an	   insufficient	  numbers	  of	   reads	  might	  
lead	  to	  saturation	  at	  highly	  expressed	  genes	  or	  the	  inability	  to	  detect	  occupancy	  at	  poorly	  
expressed	   genes	   (Sims	   et	   al.,	   2014).	   	   While	   this	   point	   had	   not	   been	   extensively	  
investigated	   here,	  with	   as	   low	   as	   ~16	  million	   reads	   per	   sample,	   there	  was	   clearly	   no	  
saturation	   within	   gene	   bodies,	   and	   RNAP	   was	   readily	   detected	   in	   coding	   sequences	  
throughout	  the	  genome.	  The	  application	  of	  RNAP	  ChIP-­‐seq	  to	  quantify	  gene	  expression	  
has	  been	  termed	  “RNA	  polymerase-­‐omics”	  and	  it	  can	  be	  argued	  that	  it	  provides	  a	  better	  
snapshot	  of	  active	  transcription	  compared	  to	  the	  analysis	  of	  the	  transcriptome	  (Grainger	  
and	  Busby,	  2008).	  
The	  data	  presented	  here	  demonstrate	   that	   in	  mid-­‐late	  exponential	   cultures,	  CarD	   co-­‐
localises	  with	  σHrdB	  at	   transcription	   intiation	  complexes.	  Similarly,	  during	  the	  course	  of	  
these	  experiments,	  a	  related	  study	  revealed	  that	  CarD	  co-­‐localises	  with	  the	  principal	  σ	  
factor	  σA	  at	  promoters	   in	  M.	  smegmatis	   (Srivastava	  et	  al.,	  2013;	  Landick	  et	  al.,	  2014).	  
Together,	  these	  data	  suggest	  that	  CarD	  is	  a	  genome-­‐wide	  transcription	  initiation	  factor	  in	  
all	  actinobacteria,	  and	  possibly	  in	  other	  phyla.	  	  Data	  presented	  in	  chapter	  4	  demonstrate	  
that	  CarD	  is	  essential	  for	  growth	  and	  can	  activate	  a	  wide	  range	  of	  promoters,	  and	  the	  
global	  distribution	  of	  this	  transcription	  activator	  is	  consistent	  with	  this.	  	  
Sigma	  factors	  dissociate	  from	  elongating	  RNA	  polymerase	  soon	  after	  the	  enzyme	  enters	  
the	  elongation	  phase	  (Raffaelle	  et	  al.,	  2005).	  Since	  CarD	  was	  not	  detected	  in	  main	  gene	  
bodies,	  it	  too	  appears	  to	  dissociate	  as	  soon	  as	  RNAP	  escapes	  the	  promoter.	  However,	  the	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mechanism	   for	   this	   dissociation	   remains	  unknown.	   	   In	   the	   case	  of	   σ,	   dissociation	   is	   a	  
multi-­‐step	  process	  that	  begins	  when	  the	  nascent	  RNA	  displaces	  the	  region	  3.2	  linker	  from	  
the	   RNA	   exit	   channel.	   It	   is	   thought	   that	   this	   leads	   to	   disruption	   of	   the	   σ4/β	   flap	  
interactions,	   followed	  by	  stochastic	  dissociation	   	  of	  σ2	   from	  the	  β’	  coiled	  coil	  as	  RNAP	  
enters	  elongation.	  	  Furthermore,	  it	  has	  been	  proposed	  that	  NusG	  competes	  with	  σ	  for	  
binding	  to	  the	  β’	  coiled	  coil,	  which	  drives	  the	  process	  forward,	  swapping	  initiation	  factor	  
for	  elongation	  factor	  and	  trapping	  RNAP	  in	  elongation	  mode	  (Sevostyanova	  et	  al.,	  2008).	  	  
It	  is	  possible	  that	  the	  structure	  of	  elongating	  RNAP	  is	  somehow	  incompatible	  with	  CarD	  
binding,	  leading	  to	  its	  dissociation.	  	  Furthermore,	  similar	  to	  the	  case	  of	  σ	  and	  NusG,	  the	  
CarD	  binding	  site	  is	  shared	  with	  other	  cellular	  factors.	  	  CarD	  binds	  to	  the	  β1	  domain	  via	  
its	  RNAP	  interacting	  domain	  (RID).	  	  The	  same	  region	  of	  β	  is	  also	  contacted	  by	  other	  RID-­‐
containing	   proteins	   including	   TRCF,	   which	   is	   involved	   in	   transcription	   coupled	   repair	  
(Westblade	  et	  al.,	  2010).	  However,	  TRCF	  is	  unlikely	  to	  be	  involved	  in	  the	  displacement	  of	  
CarD	  since	  it	  is	  thought	  to	  specifically	  associate	  with	  stalled	  RNAP	  elongation	  complexes.	  
5.6.2   RbpA	  and	  σHrdB	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo	  
Experiments	  performed	  in	  this	  chapter	  detail	  the	  first	  time	  RbpA	  has	  been	  localised	  at	  a	  
genome	  level.	   	   	  Similar	  to	  experiments	  performed	  with	  CarD,	  the	  data	  presented	  here	  
demonstrate	   that	   in	   mid-­‐late	   exponential	   cultures,	   RbpA	   co-­‐localises	   with	   σHrdB	   at	  
transcription	  intiation	  complexes.	  	  These	  findings	  are	  consistent	  with	  recently	  published	  
interaction	   and	   structural	   data	   showing	   that	   RbpA	   specifically	   binds	   σHrdB	   and	   σA	   in	  
S.	  coelicolor	   and	  M.	  tuberculosis,	   respectively.	   (Tabib-­‐Salazar	  et	  al.,	  2013;	  Hubin	  et	  al.,	  
2015).	   	   It	   has	   also	   been	   proposed	   that	   RbpA	   binds	   elsewhere	   on	   RNAP	   through	   the	  
uncharacterised	   RCD	   or	   N-­‐terminal	   domains,	   with	   one	   possible	   location	   being	   the	   β’	  
clamp	  domain	  	  (Hubin	  et	  al.,	  2015).	  	  It	  is	  therefore	  conceivable	  that	  RbpA	  is	  present	  in	  the	  
absence	  of	  σHrdB	  on	  elongation	  complexes.	  	  However,	  ChIP-­‐seq	  data	  suggests	  this	  is	  not	  
the	   case,	   with	   enrichment	   data	   showing	   no	   RbpA	   present	   in	   the	   absence	   of	   σHrdB	  
throughout	   the	   genome.	   	   Additionally,	   observations	   show	   that	   enrichment	   peaks	   for	  
RbpA	  and	  σHrdB	  are	  identical	  in	  shape	  and	  relative	  size.	  	  It	  is	  therefore	  proposed	  that	  RbpA	  
dissociates	  with	  σHrdB	  following	  transcription	  initiation.	  
RbpA	  was	  previously	  not	  thought	  to	  be	  a	  DNA	  binding	  protein;	  however,	  recent	  structural	  
studies	  show	  that	  RbpA	  contacts	  DNA	  near	  the	  upstream	  edge	  of	  the	  -­‐10	  element	  through	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conserved	   arginine	   and	   lysine	   residues.	   	   Indeed,	   formaldehyde	   has	   been	   shown	   to	  
crosslink	  RbpA	  with	  DNA	  (Hubin	  et	  al.,	  2015).	  	  This	  therefore	  suggests	  that	  the	  crosslinking	  
step	  used	  for	  ChIP-­‐seq	  analysis	  is	  likely	  to	  capture	  interactions	  between	  RbpA	  and	  DNA,	  
as	  well	  as	  DNA	  crosslinks	  via	  RNAP.	  
The	  presence	  of	  RbpA	  at	  transcription	  initiation	  complexes	  does	  not	  appear	  to	  indicate	  
whether	   RbpA	   plays	   a	   role	   in	   initiation	   events.	   	   As	   described	   in	   chapter	   4,	   not	   all	  
promoters	  are	  likely	  to	  require	  RbpA	  for	  activity.	  	  With	  this	  in	  mind,	  the	  key	  question	  for	  
the	   future	   is	   understanding	   what	   factors	   determine	   whether	   RbpA	   plays	   a	   role	   in	  
transcription	  initiation.	  Considering	  RbpA	  appears	  to	  be	  present	  at	  all	  σHrdB-­‐dependent	  
promoters,	  this	  suggests	  that	  such	  determinants	  may	  lie	  in	  the	  intrinsic	  properties	  of	  the	  
promoter	  or	  potential	  regulation	  of	  RbpA	  transcription,	  translation	  or	  post-­‐translational	  
modifications.	  	  
5.6.3   CarD	  and	  RbpA	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo	  
Data	  from	  independent	  ChIP-­‐seq	  experiments	  shows	  that	  CarD	  and	  RbpA	  both	  co-­‐localise	  
with	  σHrdB	  at	  initiation	  complexes	  (Figure	  5.12).	  	  This	  suggests	  that	  both	  proteins	  may	  be	  
present	  on	  the	  same	  initiation	  complex.	  	  ChIP-­‐seq	  experiments	  performed	  in	  this	  study	  
were	   unable	   to	   identify	   whether	   this	   is	   the	   case	   although	   structural	   modelling	   has	  
suggested	   that	   binding	   of	   both	   proteins	   to	   one	   holoenzyme	   is	   possible	   (E.	   Hubin,	   E.	  
Campbell	   and	   S.	   Darst,	   personal	   communication)	   (Figure	   5.13).	   	   Interestingly,	   both	  
proteins	  are	  suggested	  to	  interact	  with	  the	  minor	  groove	  upstream	  of	  the	  -­‐10	  element,	  
on	  the	  opposite	  side	  of	  DNA	  to	  σ3,	  which	  interacts	  with	  an	  extended	  -­‐10	  element	  (Barne	  
et	  al.,	  1997).	  	  Therefore,	  in	  principle,	  if	  CarD	  and	  RbpA	  binding	  is	  compatible	  in	  vivo,	  all	  
three	  interactions	  could	  occur	  to	  stabilise	  transcription	  complexes.	  	  This	  raises	  interesting	  
questions	  regarding	  how	  the	  stoichiometry	  of	  CarD	  and	  RbpA	  may	  affect	  transcription.	  	  
For	  example,	   following	  oxidative	  stress,	  RbpA	   transcription	   is	  upregulated	  and	  CarD	   is	  
downregulated	   	   (Kallifidas	   et	   al.,	   2010).	   	   It	   is	   possible	   that	   such	   changes	   in	   the	  




Figure	  5.12	  -­‐	  RbpA	  and	  CarD	  co-­‐localise	  at	  σHrdB-­‐dependent	  promoters	  in	  vivo.	  	  ChIP-­‐seq	  analysis	  performed	  on	  S202	  
(RNAP,	  σHrdB,	   CarD)	   and	   S115/pRT802::rbpA-­‐3xFLAG	   (RbpA).	   	   bigWig	  histograms	   represent	   total	   number	  of	   aligned	  
reads,	  RPKM	  normalised	  for	  sequencing	  depth.	  RNAP	  track	  is	  blue,	  σHrdB	  is	  orange,	  CarD	  is	  pink	  and	  RbpA	  is	  green.	  
	  
Figure	  5.13	  -­‐	  Structural	  model	  of	  CarD	  and	  RbpA.	  	  Structural	  model	  of	  T.	  aquaticus	  RNAP	  holoenzyme,	  T.	  thermophilus	  
CarD	  and	  M.	  tuberculosis	  RbpA	  in	  complex	  with	  promoter	  DNA.	  	  RNAP	  core	  is	  light	  blue,	  σ	  is	  pink,	  CarD	  is	  green	  and	  
RbpA	  is	  purple,	  DNA	  is	  shown	  as	  a	  phosphate	  backbone	  worm.	  	  Reproduced	  with	  permission	  from	  E.	  Hubin,	  E.	  Campbell	  










5.6.4   Rifampicin	  has	  diverse	  effects	  on	  transcription	  
Rifampicin	  is	  an	  antibiotic	  that	  inhibits	  bacterial	  transcription	  by	  binding	  to	  the	  β	  subunit	  
in	  the	  DNA/RNA	  channel,	  preventing	  the	  enzyme	  from	  entering	  the	  elongation	  phase	  of	  
transcription	  (Campbell	  et	  al.,	  2001).	  	  Consequently,	  rifampicin-­‐bound	  RNA	  polymerase	  
molecules	  are	  prevented	  from	  escaping	  initiation	  and	  are	  confined	  to	  promoter	  regions	  
(Herring	   et	   al.,	   2005).	   	   ChIP-­‐seq	   experiments	   performed	   in	   this	   chapter	   identify	   the	  
localisation	  of	  RNAP,	  σHrdB	  and	  RbpA	  before	  and	  after	  treatment	  of	  cells	  with	  rifampicin.	  	  
Consistent	  with	  published	  data	   (Herring	  et	  al.,	  2005;	  Grainger	  et	  al.,	  2005),	   treatment	  
with	  rifampicin	  reduced	  distribution	  of	  RNAP	  throughout	  coding	  regions	  but	   increased	  
enrichment	  at	  promoter	  regions.	  	  Additionally,	  RNAP,	  σHrdB	  and	  RbpA	  peaks	  appeared	  at	  
new,	  unexpected	   locations	  where	   transcription	  would	  not	  be	  expected	   to	   initiate.	   	   In	  
actively	  growing	  cells,	  where	  the	  majority	  of	  RNAP	  is	  performing	  transcription	  and	  free	  
RNAP	  is	  limited,	  inhibition	  of	  transcription	  initiation	  is	  likely	  to	  lead	  to	  a	  large	  increase	  in	  
the	  level	  of	  free	  core	  RNAP.	  	  The	  increase	  of	  free	  core	  RNAP	  might	  therefore	  allow	  RNAP	  
to	  bind	  at	  weaker	  sites	  and	  could	  explain	  the	  appearance	  of	  new	  peaks.	  	  	  Although	  this	  is	  
unlikely	   to	   be	   a	   physiologically	   relevant	   response,	   comparisons	   can	   be	   made	   to	   the	  
stringent	  response	  in	  which	  inhibition	  of	  transcription	  by	  ppGpp	  leads	  to	  redistribution	  
of	  RNAP.	  	  In	  the	  passive	  model	  for	  positive	  control	  of	  promoters	  unregulated	  as	  part	  of	  
the	  stringent	  response,	  it	  is	  proposed	  that	  an	  increase	  in	  the	  concentration	  of	  free	  RNAP	  
leads	  to	  stimulation	  of	  amino	  acid	  biosynthetic	  promoters	  (Barker	  et	  al.,	  2001a).	  	  	  
The	  concentration	  of	   rifampicin	  used	   in	   this	  experiment	   is	   lethal	  and	  was	  expected	  to	  
inhibit	  all	  transcription.	  	  However,	  preliminary	  evidence	  suggests	  that	  some	  genes	  were	  
still	  expressed	  even	  after	  20	  minutes	  of	  treatment.	  	  Two	  of	  the	  promoters	  that	  have	  been	  
identified	  as	  still	  active,	  hflX	  and	  rpmE/prfA,	  are	  members	  of	  the	  σR-­‐regulon	  (Kallifidas	  et	  
al.,	   2010).	   	   It	   has	   previously	   been	   observed	   that	   σR	   activity	   is	   induced	   by	   sub-­‐lethal	  
concentrations	  of	  rifampicin	  and	  it	  has	  been	  proposed	  that	  this	  is	  due	  to	  increased	  core	  
concentration	   able	   to	   compete	   with	   anti-­‐sigma	   RsrA	   (Newell	   et	   al.,	   2006).	   	   Indeed,	  
modelling	  experiments	  have	  also	  suggested	  that	  an	  increase	  in	  core	  RNAP	  would	  lead	  to	  
a	  passive	  rise	  of	  alternative	  holoenzyme	  forms	  (Mauri	  and	  Klumpp,	  2014).	  	  Despite	  this,	  
discovery	  of	   active	   transcription	  at	  high	   concentrations	  of	   rifampicin	   is	   surprising	   and	  
suggests	   that	   holoenzymes	   may	   differ	   in	   their	   sensitivity	   to	   rifampicin	   although	   the	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reason	   for	   this	   is	   unknown.	   	   This	   finding	   may	   also	   have	   medical	   implications,	   with	  
rifampicin	  used	  as	  a	  first-­‐line	  drug	  in	  the	  treatment	  of	  tuberculosis.	  	  M.	  tuberculosis	  has	  
a	   σR	   orthologue,	   σH	   that	   is	   also	   thought	   to	   play	   a	   key	   role	   in	   protein	   quality	   control	  
(Manganelli	   et	   al.,	   2002).	   	   Consequently,	   results	   from	   this	   study	   suggest	   that	   the	   σH	  
regulon	  could	  potentially	  be	  induced	  following	  rifampicin	  treatment.	  




Chapter	  6:	  	  
Results	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6   The	  sigma	  specificity	  of	  CarD	  and	  RbpA	  
6.1   Overview	  
ChIP-­‐seq	   studies	   revealed	   that	   CarD	   and	   RbpA	   are	   present	   at	   all	   σHrdB-­‐dependent	  
promoters	  in	  S.	  coelicolor	  and	  in	  vitro	  transcription	  experiments	  demonstrated	  that	  each	  
activate	  transcription	  from	  σHrdB-­‐dependent	  promoters.	  	  To	  investigate	  the	  association	  of	  
CarD	  with	  alternative	  holoenzymes,	  ChIP-­‐seq	  and	  ChIP-­‐qPCR	  were	  performed	  following	  
induction	  of	  the	  σR	  regulon	  with	  diamide.	  	  The	  enrichment	  of	  CarD,	  σR	  and	  RNAP	  at	  σR-­‐
dependent	   promoters,	   together	   with	   the	   absence	   of	   σHrdB,	   revealed	   that	   CarD	   is	   a	  
component	  of	  alternative	  forms	  of	  holoenzyme	  during	  transcription	  initiation.	  	  Despite	  
this,	  in	  vitro	  transcription	  experiments	  performed	  on	  σR-­‐dependent	  promoters	  showed	  
that	  addition	  of	  CarD	  had	  no	  effect	  on	  transcription.	  
RbpA	   has	   been	   shown	   to	   bind	   specifically	   to	   primary	   and	   primary-­‐related	   but	   not	  
alternative	  sigma	  factors	  (Tabib-­‐Salazar	  et	  al.,	  2013).	  	  To	  investigate	  this	  specificity,	  the	  
structure	  of	  RbpA-­‐SID	  in	  complex	  with	  domain	  2	  of	  σA	  was	  solved	  and,	  following	  sequence	  
alignments,	  site-­‐directed	  mutagenesis	  and	  in	  vitro	  transcription	  experiments,	  a	  number	  
of	  key	  residues	  essential	  for	  RbpA-­‐σA	  interaction	  were	  identified.	  
6.2   CarD	   is	   present	   at	   alternative	   sigma	   factor	   promoters	   in	   association	  
with	  alternative	  holoenzymes	  
6.2.1   CarD	  is	  present	  at	  σShbA	  and	  σE-­‐dependent	  promoters	  under	  normal	  growth	  
conditions	  
ChIP-­‐seq	  experiments	  revealed	  that	  CarD	  is	  present	  at	  all	  σHrdB-­‐dependent	  promoters	  in	  
S.	  coelicolor	  in	  vivo.	  	  This	  finding	  is	  concurrent	  with	  results	  showing	  that	  CarD	  is	  present	  
at	  σA-­‐dependent	  promoters	  throughout	  the	  M.	  smegmatis	  chromosome	  (Srivastava	  et	  
al.,	  2013).	  	  Whilst	  ChIP-­‐seq	  studies	  show	  that	  CarD	  and	  σA	  are	  highly	  co-­‐localised	  and	  both	  
appear	   to	  dissociate	   from	  RNAP	   following	   initiation,	   structural	   studies	  have	   shown	  no	  
interaction	  between	  the	  two	  proteins	  when	  modelled	  on	  a	  T.	  thermophilus	  open	  complex	  
(Srivastava	  et	  al.,	  2013).	  	  This	  raises	  the	  question	  of	  whether	  CarD	  is	  able	  to	  bind	  to	  RNAP	  
holoenzymes	  containing	  alternative	  sigma	  factors.	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Under	  normal	  growth	  conditions	  used	  for	  ChIP-­‐seq	  experiments	   in	  chapter	  5,	  the	  vast	  
majority	  of	  transcription	  is	  directed	  from	  σHrdB-­‐dependent	  promoters.	  	  Despite	  this,	  it	  was	  
possible	   to	   identify	   two	  active	  promoters	   regulated	  by	  alternative	   sigma	   factors.	   	   The	  
hrdB	  (SCO5820)	  promoter	  is	  regulated	  by	  the	  alternative	  sigma	  factor	  σShbA	  (Otani	  et	  al.,	  
2013).	  	  Analysis	  of	  the	  ChIP-­‐seq	  data	  for	  this	  promoter	  region	  revealed	  RNAP	  and	  CarD	  
present	   at	   the	   promoter	   (Figure	   6.1A).	   	   Small	   amounts	   of	   σHrdB	   enrichment	   was	   also	  
observed	  meaning	  it	  was	  not	  possible	  to	  attribute	  presence	  of	  CarD	  at	  the	  hrdB	  promoter	  
as	   bound	   to	   a	   σShbA	   holoenzyme.	   	   The	   cwgA	   (SCO6179)	   promoter	   is	   regulated	  by	   the	  
alternative	  sigma	  factor	  σE	  (Hong	  et	  al.,	  2002).	  	  Analysis	  of	  this	  promoter	  region	  revealed	  
presence	  of	  RNAP	  and	  CarD	  but	  no	  σHrdB	  (Figure	  6.1B).	  	  This	  suggests	  that	  CarD	  is	  present	  
at	  the	  cwgA	  promoter	  bound	  to	  a	  σE	  holoenzyme.	  
	  
Figure	  6.1	   -­‐	   CarD	   is	   present	   at	   σShbA	   and	  σE-­‐dependent	  promoters.	   	   ChIP-­‐seq	   analysis	   performed	  on	   S202.	   	   bigWig	  
histograms	  represent	  total	  number	  of	  aligned	  reads,	  RPKM	  normalised	  for	  sequencing	  depth.	  	  (A)	  hrdB	  (SCO5820)	  (B)	  










6.2.2   Chromatin	  Immunoprecipitation	  following	  diamide	  treatment	  
To	  further	  investigate	  whether	  CarD	  is	  able	  to	  associate	  with	  non-­‐σHrdB	  holoenzymes,	  it	  
was	   necessary	   to	   induce	   an	   alternative	   sigma	   factor	   regulon.	   	   Cultures	   of	   S202	  were	  
grown	  in	  YEME-­‐10	  (with	  glycerol	  as	  a	  carbon	  source)	  to	  mid-­‐late	  exponential	  phase	  (OD450	  
=	  1.5-­‐2).	  	  To	  induce	  the	  σR	  regulon,	  0.5	  mM	  diamide	  was	  added	  to	  cultures	  followed	  by	  
incubation	  for	  15	  minutes	  prior	  to	  crosslinking	  with	  formaldehyde.	  	  This	  concentration	  
and	  time-­‐point	  was	  chosen	  for	  maximum	  expression	  of	  the	  σR	  regulon	  (Paget	  et	  al.,	  1998,	  
2001).	  	  Following	  crosslinking,	  ChIP	  protocols	  were	  followed	  as	  described	  in	  chapter	  5.	  	  
Immunoprecipitations	  were	  performed	  as	  before	  with	  the	  following	  antibodies:	  	  
•   7	  µL	  anti-­‐FLAG	  M2	  monoclonal	  antibody	  (Sigma	  F18041MG)	  	  
•   7	  µL	  anti-­‐σHrdB	  polyclonal	  antibody	  (a	  gift	  from	  P.	  Doughty)	  
•   2	  µL	  anti-­‐RNAP	  β	  monoclonal	  antibody	  (Abcam	  ab12087)	  
•   7	  µl	  anti-­‐σR	  polyclonal	  antibody	  (a	  gift	  from	  M.	  Feeney	  and	  M.	  Buttner)	  	  
6.2.3   ChIP-­‐seq:	  CarD	  is	  present	  at	  all	  σR-­‐dependent	  promoters	  
Library	  preparation	  and	  sequencing	  was	  performed	  by	  TGAC	  as	  described	  in	  chapter	  5.	  	  
De-­‐multiplexed	  sequencing	  results	  were	  received	  as	  individual	  FASTQ	  files	  for	  each	  ChIP	  
sample.	  	  FASTQ	  files	  were	  analysed,	  processed	  and	  aligned	  as	  described	  in	  chapter	  5.	  	  All	  
samples	  were	  efficiently	  aligned	  with	  proportion	  of	  mapped	  reads	  ranging	  from	  96-­‐99%	  
(Table	   6.1).	   	   Samples	   obtained	   from	   control	   cultures	   that	   had	   not	   been	   treated	  with	  
diamide	  were	  described	  in	  chapter	  5.	  	  In	  the	  absence	  of	  diamide,	  the	  σR	  antibody	  failed	  
to	   immunoprecipitate	  sufficient	  DNA	  for	  ChIP-­‐seq	  analysis	  and	  so	  this	  sample	  was	  not	  
sequenced.	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Sample	   Mapped	  Reads	   Unmapped	  Reads	   Total	  Reads	   %	  mapped	  
Input*	   22,998,668	   242,041	   23,240,709	   99.0%	  
RNAP*	   16,256,217	   253,948	   16,510,165	   98.5%	  
σHrdB*	   24,146,596	   370,590	   24,517,186	   98.5%	  
CarD*	   28,004,757	   675,407	   28,680,164	   97.6%	  
Input	  +	  DIA	   	  17,169,352	  	   	  624,660	  	   	  17,794,012	  	   96.5%	  
RNAP	  +	  DIA	   	  16,731,644	  	   	  284,060	  	   	  17,015,704	  	   98.3%	  
σHrdB	  +	  DIA	   	  14,073,796	  	   	  221,455	  	   	  14,295,251	  	   98.5%	  
σR	  +	  DIA	   	  28,041,346	  	   	  1,078,579	  	   	  29,119,925	  	   96.3%	  
CarD	  +	  DIA	   	  23,264,961	  	   	  489,931	  	   	  23,754,892	  	   97.9%	  
Table	  6.1	  -­‐	  Percentage	  of	  reads	  mapped	  with	  Bowtie.	  	  Mapped	  and	  unmapped	  read	  counts	  were	  obtained	  with	  IdxStats	  
(Galaxy	  Tool	  Version	  2.0).	  Samples	  marked	  with	  an	  asterix	  are	  from	  experiments	  performed	  in	  chapter	  5.	  
bigWig	  histogram	  plots	  of	  mapped	  reads	  were	  created	  for	  each	  sample	  as	  described	  in	  
chapter	  5	  and	  visualised	  with	  IGB.	  	  The	  region	  surrounding	  σR-­‐dependent	  genes	  SCO1936	  
(probable	   transaldolase	   tal2),	   SCO2763	   (ABC	   transporter	   protein),	   SCO4109	   (possible	  
oxidoreductase)	   and	   SCO6551	   (probable	   oxidoreductase)	   are	   four	   examples	   that	  
represent	  observations	  throughout	  the	  genome	  (Figure	  6.2).	  	  Each	  gene	  was	  previously	  
reported	  as	  a	  σR	  target	  (Kim	  et	  al.,	  2012).,	  consistent	  with	  presence	  of	  enrichment	  peaks	  
upstream	  from	  each	  ORF	  in	  the	  “σR	  +	  DIA”	  sample.	  	  This	  confirmed	  that	  these	  genes	  are	  
σR	  targets	  and	  that	  σR	  was	  present	  at	  the	  promoter	  under	  these	  experimental	  conditions.	  	  
When	  comparing	  untreated	  and	  treated	  samples,	  addition	  of	  diamide	  increased	  CarD	  and	  
RNAP	  enrichment	  at	   the	  promoter	   region.	   	  The	  co-­‐enrichment	  of	  RNAP,	  σR,	   and	  CarD	  
suggests	   that	  upon	  addition	  of	  diamide,	  σR	   recruits	  RNAP	  to	   the	  promoters	  with	  CarD	  
present	   on	   the	   holoenzyme.	   	   The	   lack	   of	   σHrdB	   enrichment	   in	   both	   the	   presence	   and	  
absence	   of	   diamide	   demonstrates	   that	   CarD	   does	   not	   require	   σHrdB	   to	   associate	  with	  




Figure	  6.2	  -­‐	  CarD	  is	  present	  at	  σR-­‐dependent	  promoters.	   	  ChIP-­‐seq	  analysis	  performed	  on	  S202	  in	  the	  presence	  and	  
absence	  of	  0.5	  mM	  diamide	  (“+DIA”).	  	  bigWig	  histograms	  represent	  total	  number	  of	  aligned	  reads,	  RPKM	  normalised	  
for	  sequencing	  depth.	  	  Regions	  with	  σR	  targets	  (A)	  SCO1936	  (probable	  transaldolase	  tal2)	  (B)	  SCO2763	  (ABC	  transporter	  
protein)	  (C)	  SCO4109	  (possible	  oxidoreductase)	  (D)	  SCO6551	  (probable	  oxidoreductase).	  	  Input	  tracks	  are	  grey,	  RNAP	  























6.2.4   ChIP-­‐qPCR:	  CarD	  is	  present	  at	  σR-­‐dependent	  promoters	  
qPCR	   was	   performed	   with	   the	   primer	   sets	   PSCO6551_F/PSCO6551_R	   and	  
PSCO2763_F/PSCO2763_R,	   which	   amplify	   the	   promoter	   region	   of	   SCO6551,	   and	  
SCO2763,	  respectively.	  	  SCO6551	  is	  a	  probably	  oxidoreductase,	  previously	  identified	  as	  a	  
σR	  target	  by	  S1	  nuclease,	  microarray	  and	  ChIP-­‐on-­‐chip	  experiments	  (Paget	  et	  al.,	  2001a;	  
Kallifidas	  et	  al.,	  2010;	  Kim	  et	  al.,	  2012).	  	  SCO2763	  is	  a	  putative	  ATP-­‐binding	  cassette	  (ABC)	  
transporter	   and	   has	   also	   been	   identified	   as	   a	   σR	   target	   by	   S1	   nuclease	  mapping	   and	  
ChIP-­‐on-­‐chip	  (Kim	  et	  al.,	  2012).	  	  In	  addition	  to	  being	  σR-­‐regulated	  promoters,	  these	  two	  
promoters	  were	  identified	  as	  suitable	  for	  qPCR	  analysis	  due	  to	  their	  non-­‐divergent	  nature	  
and	  lack	  of	  additional	  known	  promoters	  within	  1	  kb	  upstream	  or	  downstream.	  	  A	  standard	  
curve	  was	  prepared	  with	  serial	  dilutions	  of	  S.	  coelicolor	  gDNA	  containing	  3,000,000	  to	  
300	  copies	  of	   the	  genome.	   	  ChIP	   input	  and	  elutions	  samples	  were	  diluted	  1:1000	  and	  
1:100,	  respectively.	  
	  
Figure	  6.3	  -­‐	  CarD	  is	  present	  at	  σR-­‐dependent	  promoters.	  	  Occupancy	  of	  RNAP,	  HrdB,	  CarD	  and	  SigR	  at	  (A)	  SCO6551p	  (B)	  
SCO2763p	  following	  induction	  of	  oxidative	  stress	  with	  diamide.	  	  ChIP-­‐qPCR	  data	  is	  quantified	  against	  a	  standard	  curve	  
prepared	   with	   S.	   coelicolor	   gDNA,	   normalised	   to	   input	   and	   shown	   relative	   to	   untreated	   sample	   data.	   	   Standard	  
deviations	  from	  two	  technical	  replicates	  are	  indicated	  as	  error	  bars.	  
ChIP-­‐qPCR	  results	  show	  that	  following	  induction	  of	  oxidative	  stress	  with	  diamide,	  RNAP,	  
CarD	  and	  SigR	  accumulate	  at	  the	  promoter	  region	  of	  SCO6551	  (Figure	  6.3A)	  and	  SCO2763	  
(Figure	  6.3B).	  	  Enrichment	  of	  σHrdB	  was	  unaffected	  by	  treatment	  with	  diamide.	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6.2.5   Identification	  of	  novel	  σR	  targets	  
Transcriptome	  (Kallifidas	  et	  al.,	  2010)	  and	  ChIP-­‐on-­‐chip	  studies	   (Kim	  et	  al.,	  2012)	  have	  
provided	  a	  detailed	  picture	  of	  the	  σR	  regulon	  with	  108	  promoters	  identified,	  expressing	  a	  
total	  of	  163	  genes.	  However,	  it	  was	  possible	  that	  these	  microarray-­‐based	  studies	  might	  
not	  have	   identified	   all	   σR	  binding	   sites,	   for	   example,	   if	   a	   region	  was	  missing	   from	   the	  
microarray	  tiles.	  	  Therefore,	  to	  identify	  possible	  additional	  members	  of	  the	  σR	  regulon,	  
peak	   calling	   was	   performed	   on	   “σR	  +	  DIA”	   ChIP	   alignments.	   	   MACS2	   (version	  
2.1.0.20140616.0,	   using	   the	   settings	   “q=1e-­‐7	   -­‐nolambda	   -­‐nomodel	   -­‐keepdup=0	   -­‐
slocal=100	  -­‐llocal=500”)	  (Zhang	  et	  al.,	  2008)	  was	  used	  to	  call	  peaks	  on	  the	  sorted	  BAM	  
file	  with	  the	  “input	  +	  DIA”	  sample	  as	  a	  negative	  control.	  	  The	  list	  was	  further	  filtered	  with	  
stringent	  conditions	  (-­‐log10	  p-­‐value	  >	  500,	  -­‐log10	  q-­‐value	  >	  2000	  and	  fold	  enrichment	  >	  
10).	  	  Loci	  previously	  reported	  by	  Kallifidas	  et	  al.	  (2010)	  and	  Kim	  et	  al.	  (2012)	  and	  were	  
excluded	  from	  the	  dataset.	   	  Finally,	  as	  the	  immunoprecipitation	  was	  performed	  with	  a	  
polyclonal	   antibody	   and	   to	   ensure	   hits	   were	   true	   σR	   targets,	   only	   genes	   that	   had	   an	  
increase	  in	  RNAP	  enrichment	  but	  no	  change	  in	  σHrdB	  enrichment	  following	  exposure	  to	  
diamide	  (Figure	  6.4)	  were	  reported.	  	  The	  process	  identified	  14	  previously	  unreported	  σR	  
targets	  (Table	  6.2).	  
The	  majority	  of	  the	  targets	  represented	  previously	  uncharacterised	  genes.	  	  Interestingly,	  
the	  RNA	  polymerase	  β-­‐subunit	  gene	  rpoB	  was	  identified	  as	  a	  σR	  target.	  	  Sequence	  analysis	  
revealed	   it	   possesses	   a	   σR-­‐dependent	   promoter	   upstream	   of	   the	   σHrdB-­‐dependent	  
promoter	   (data	   not	   shown)	   and	   RNAP	   enrichment	   suggests	   it	   is	   upregulated	   upon	  
addition	   of	   diamide	   (Figure	   6.4C).	   	   Two	   cold-­‐shock	   proteins,	   scoF1	   and	   F40,	   were	  





Figure	  6.4	  -­‐	  Validation	  of	  novel	  σR	  targets.	  	  ChIP-­‐seq	  analysis	  performed	  on	  S202	  in	  the	  presence	  and	  absence	  of	  0.5	  
mM	  diamide	  (“+DIA”).	  	  bigWig	  histograms	  represent	  total	  number	  of	  aligned	  reads,	  RPKM	  normalised	  for	  sequencing	  
depth.	  	  Regions	  with	  σR	  targets	  (A)	  SCO1023	  (B)	  SCO2951	  (C)	  rpoB	  (D)	  SCO5821a.	  	  Input	  tracks	  are	  grey,	  RNAP	  are	  blue,	  

























Gene	   Peak	  summit	  position	   Annotation	  
SCO0792	   838732	  	   Sugar	  epimerase	  SCF43.03	  
SCO1023	   1078499	   Possible	  membrane	  protein	  SCG20A.03	  
SCO1556	   1668919	   Putative	  acetyltransferase	  SCL11.12c	  
SCO2191	   2357697	   Probable	  oxidoreductase	  SC5F7.10	  
SCO2570	   2775451	   Putative	  secreted	  protein	  SCC123.08c	  
SCO2951	   3208719	   Putative	  malate	  oxidoreductase	  SCE59.10c	  
SCO3568	   3948807	   Conserved	  hypothetical	  protein	  SCH17.02c	  
SCO3731	   4105176	   Cold	  shock	  protein	  scoF1	  
SCO3748	   4119290	   Cold	  shock	  protein	  F40	  
SCO4654	   5077793	   DNA-­‐directed	  RNA	  polymerase	  beta	  subunit,	  rpoB	  
SCO4934	   5368616	   Putative	  lipoprotein	  SCK13.26	  
SCO5393	   5862698	   Putative	  ABC	  transporter	  ATP-­‐binding	  subunit	  2SC6G5.37c	  
SCO5439	   5912247	   Conserved	  hypothetical	  protein	  SC6A11.15	  
SCO5821a	   6370622	   Hypothetical	  protein	  (see	  below)	  
Table	  6.2	  -­‐	  Novel	  σR	  targets	  identified	  by	  ChIP-­‐seq.	  	  A	  list	  of	  genes	  identified	  as	  novel	  σR	  targets	  with	  the	  summit	  position	  
identified	  by	  MACS2	  and	  gene	  annotation	  as	  listed	  on	  StrepDB	  (http://strepdb.streptomyces.org.uk).	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6.2.6   Discovery	  of	  SCO5821a,	  a	  previously	  unidentified	  small	  ORF	  
Further	  analysis	  of	  novel	  σR	  targets	  revealed	  a	  peak	  with	  summit	  position	  6370622	  bp,	  
located	  between	  SCO5821	  (serine	  protease)	  and	  SCO5822	  (DNA	  gyrase	  B)	  that	  did	  not	  
correspond	  to	  an	  annotated	  open	  reading	  frame	  (Figure	  6.4D).	  	  Sequence	  analysis	  of	  the	  
region	  revealed	  a	  small	  previously	  unidentified	  228	  bp	  ORF	  that	  encodes	  a	  76	  amino	  acid	  
protein,	  which	  was	  designated	  SCO5821a.	  
Analysis	  of	  ChIP-­‐seq	  data	   for	   the	  region	  surrounding	  SCO5821a	  show	  that	   the	  gene	   is	  
upregulated	   in	   response	   to	   oxidative	   stress	   (Figure	   6.4D).	   	   RNA-­‐seq	   data	   from	  
experiments	  performed	  by	  Romero	  et	  al.	  (2014)	  further	  confirm	  presence	  of	  the	  ORF	  and	  
indicate	  that	  it	  is	  expressed	  under	  normal	  growth	  conditions	  (Figure	  6.5A)	  and	  a	  promoter	  
matching	   the	  σR	  consensus	  sequence	   (GGAT/C-­‐N16-­‐GTT)	  was	   located	  41	  bp	  upstream	  
from	  the	  start	  codon	  (Figure	  6.5B).	   	  Despite	  σHrdB	  enrichment	  upstream	  of	  the	  gene,	  it	  
could	   not	   be	   established	   whether	   this	   represented	   σHrdB-­‐dependent	   expression	   of	  
SCO5821a	  or	  the	  divergent	  DNA	  gyrase	  B	  (SCO5822)	  gene.	  	  	  
Analysis	  of	  the	  protein	  sequence	  revealed	  presence	  of	  a	  CXXC	  motif	  that	  could	  potentially	  
co-­‐ordinate	  a	  metal	  ion	  such	  as	  zinc	  (Figure	  6.5D).	  	  A	  structural	  prediction	  performed	  with	  
Phyre2	  revealed	  a	  predicted	  structure	  based	  upon	  a	  number	  of	  different	  proteins	  (Figure	  
6.5C).	  	  The	  region	  containing	  the	  CXXC	  motif	  was	  predicted	  as	  homologous	  to	  a	  known	  
metal-­‐binding	   rubredoxin	   protein	   (PDB:	   1DXG)	   while	   the	   region	   containing	   the	   large	  
alpha	  helix	  was	  predicted	  with	  high	  homology	  to	  an	  RNA	  binding	  protein	  (PDB:	  3VRH).	  	  
Sequence	  homology	  searches	  revealed	  that	  the	  protein	  was	  conserved	  in	  M.	  tuberculosis	  
as	  well	  as	  actinophages	   including	  Streptomyces	  and	  Mycobacterium	  phages	  Peebs	  and	  




Figure	  6.5	  -­‐	  SCO5821a	  is	  a	  previously	  unreported	  ORF.	  	  	  (A)	  RNA-­‐seq	  analysis	  of	  the	  region	  around	  SCO5821a.	  RNA-­‐seq	  
data	   was	   downloaded	   from	   the	   GEO	   archive	   under	   the	   accession	   number	   GSM1126846	   in	   the	   form	   of	   aligned	  
BEDGRAPH	  files	  representing	  the	  forward	  and	  reverse	  strands.	  	  Data	  was	  visualised	  with	  Integrated	  Genome	  Browser	  
(IGB)	  (Version	  8.3.4)	  (B)	  Sequence	  of	  SCO5821a	  σR-­‐dependent	  promoter	  highlighted	  in	  grey,	  SCO5821a	  ORF	  underlined	  
with	   start	   and	   stop	  codons	   in	  bold.	   (C)	   	   Structural	  prediction	  of	   SCO5821a,	  prediction	  performed	  with	  Phyre2	  and	  
visualised	  with	  PyMOL	  (version	  1.3).	  (D)	  	  Multiple	  sequence	  alignment	  of	  S.	  coelicolor	  SCO5821a	  (Sco),	  and	  hypothetical	  
proteins	   from	   M.	   tuberculosis	   (Mtb),	   Streptomyces	   phage	   Peebs	   (Peebs)	   and	   Mycobacteria	   phage	   Gaia	   (Gaia)	  
performed	  using	  CLUSTALW	  multiple	  sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  was	  performed	  using	  
BOXSHADE	  3.21.	  Identical	  amino	  acid	  residues	  are	  shaded	  black,	  similar	  residues	  are	  shaded	  grey	  and	  conserved	  CXXC	  


























6.3   CarD	   does	   not	   activate	   transcription	   from	   the	   σR-­‐dependent	   trxCp	  
promoter	  
ChIP-­‐qPCR	   and	  ChIP-­‐seq	   results	   suggested	   that,	   unlike	  RbpA,	   CarD	   is	   a	   component	   of	  
alternative	  sigma	  factor	  holoenzymes	  and	  is	  present	  at	  transcription	  initiation	  complexes	  
(section	   6.2).	   	   CarD	   was	   shown	   to	   be	   a	   transcriptional	   activator	   of	   σHrdB-­‐dependent	  
promoters.	   	  To	  investigate	  if	  CarD	  activates	  transcription	  from	  alternative	  sigma	  factor	  
promoters,	   in	  vitro	   transcription	  experiments	  were	  performed	  using	  the	  σR-­‐dependent	  
trxC	   promoter	   region,	   PCR	   amplified	   from	   M145	   gDNA	   using	   the	   primers	  
PTRXC_EXT/PTRXC_INT.	  	  The	  trxCp	  promoter	  had	  previously	  been	  identified	  as	  a	  σR-­‐target	  
by	  S1	  nuclease	  mapping	  and	  microarray	  analysis	  of	  a	  ∆sigR	  mutant	  (Paget	  et	  al.,	  2001a;	  
Kallifidas	  et	  al.,	  2010).	  	  Using	  these	  data	  and	  a	  well	  conserved	  σR	  promoter	  consensus	  we	  
expected	  a	  single	  transcription	  product	  from	  the	  in	  vitro	  transcription	  template	  129	  bp	  in	  
size.	  	  To	  confirm	  this,	  in	  vitro	  transcription	  reactions	  were	  performed	  with	  core	  RNAP	  in	  
the	  presence	  and	  absence	  of	  purified	  σR	  (a	  gift	  from	  P.	  Doughty).	  	  A	  transcript	  from	  the	  
trxCp	  was	  only	  observed	  in	  the	  presence	  of	  additional	  purified	  σR.	  
To	  test	  the	  effect	  of	  CarD,	  reactions	  were	  performed	  with	  increasing	  concentrations	  of	  
CarD,	  from	  CarD:RNAP	  molar	  ratios	  of	  0.5:1	  to	  10:1.	  	  As	  a	  positive	  control	  for	  function	  of	  
CarD	  as	  a	  transcriptional	  activator,	  reactions	  were	  performed	  simultaneously	  under	  the	  
same	   conditions	   with	   core	   RNAP,	   purified	   σHrdB	   and	   the	   atpIp	   in	   vitro	   transcription	  
template	  (see	  chapter	  4).	  	  The	  inclusion	  of	  CarD	  had	  no	  effect	  on	  transcription	  from	  the	  
trxCp	  promoter	  at	  all	  concentrations	  (Figure	  6.6),	  whereas	  CarD	  increased	  transcriptional	  
output	  from	  the	  atpIp	  promoter	  by	  up	  to	  3-­‐fold.	  	  This	  result	  suggests	  that	  while	  CarD	  can	  





Figure	  6.6	   -­‐	  CarD	  does	  not	  affect	   transcription	   from	  the	   trxCp	  promoter	   in	  vitro.	   	  Multi-­‐round	   in	  vitro	   transcription	  
reactions	  performed	  on	  the	  atpIp	  and	  trxCp	  promoter	  templates	  (5	  nM)	  with	  core	  RNAP	  (50	  nM),	  σHrdB	  (250	  nM)	  and	  
CarD	  at	  CarD:RNAP	  ratios	  of	  0,	  0.5	  (25	  nM),	  2	  (100	  nM),	  and	  10	  (500	  nM).	  
6.4   RbpA	  is	  not	  present	  at	  alternative	  sigma	  factor	  promoters	  
It	  has	  been	  shown	  that	  RbpA	  makes	  key	  contacts	  with	  σHrdB	  which	  are	  necessary	  for	  its	  
function	  as	  a	  transcriptional	  activator	  (Hubin	  et	  al.,	  2015).	  	  Additionally,	  RbpA	  distribution	  
is	   highly	   correlated	   with	   σHrdB	   and	   found	   both	   proteins	   are	   found	   co-­‐localised	   at	  
σHrdB-­‐dependent	  promoters	  (see	  chapter	  5).	  	  Despite	  this,	  it	  is	  possible	  that	  RbpA	  makes	  
additional	  contacts	  with	  RNAP.	  	  It	  has	  previously	  been	  proposed	  that	  RbpA	  could	  bind	  to	  
the	  β/β’	  active-­‐site	  channel	  near	  the	  rifampicin	  binding	  site	  (Dey	  et	  al.,	  2011)	  or	  the	  β	  
subunit	  (Hu	  et	  al.,	  2012).	  	  However,	  these	  binding	  sites	  are	  incompatible	  with	  the	  most	  
recently	  model	  of	  RbpA	  in	  complex	  with	  with	  σ2	  of	  σA	  (see	  below).	  	  A	  more	  likely	  binding	  
site	  is	  the	  β’	  clamp	  (M.	  Paget,	  personal	  communication).	  	  Therefore,	  it	  is	  conceivable	  that	  
RbpA	  could	  associate	  with	  RNAP	  in	  the	  absence	  of	  σHrdB.	  	  To	  test	  this,	  ChIP-­‐seq	  data	  was	  
used	   to	   study	   the	   occupancy	   of	   RbpA	   at	   alternative	   sigma	   promoters.	   	   For	   ChIP-­‐seq	  
experiments	   performed	   under	   normal	   growth	   conditions,	   neither	   σHrdB	   nor	   RbpA	  was	  
observed	  at	  the	  hrdB	  (SCO5820)	  or	  cwgA	  (SCO6179)	  promoters,	  known	  to	  be	  controlled	  




















increase	  RNAP,	  σHrdB	  and	  RbpA	  enrichment,	   increased	  enrichment	  of	  RNAP	  but	  had	  no	  
effect	  on	  σHrdB	  or	  RbpA	  at	  these	  promoters.	  	  This	  suggests	  that	  RbpA	  does	  not	  associate	  
with	  alternative	  holoenzymes.	  
	  
Figure	   6.7	   -­‐	   RbpA	   is	   not	   present	   at	   σShbA	   and	   σE-­‐dependent	   promoters.	   	   ChIP-­‐seq	   analysis	   performed	   on	  
S115/pRT802::rbpA-­‐3xFLAG.	   	   bigWig	   histograms	   represent	   total	   number	   of	   aligned	   reads,	   RPKM	   normalised	   for	  
sequencing	  depth.	  	  (A)	  hrdB	  (SCO5820)	  (B)	  cwgA	  (SCO6179).	  Input	  tracks	  are	  grey,	  RNAP	  are	  blue,	  σHrdB	  are	  orange	  and	  
RbpA	  are	  green.	  	  Predicted	  transcription	  start	  site	  is	  indicated	  with	  a	  grey	  line	  (B.K.	  Cho,	  personal	  communication).	  
6.5   Identification	  of	  residues	  involved	  in	  sigma	  selectivity	  of	  RbpA.	  
It	   was	   previously	   demonstrated	   that	   S.	   coelicolor	   and	   M.	   tuberculosis	   RbpA	   binds	  
specifically	   to	   principal	   and	   related	   sigma	   factors	   (Tabib-­‐Salazar	   et	   al.,	   2013).	   	   BACTH	  
analysis	  showed	  that	  RbpA	  binds	  to	  S.	  coelicolor	  σHrdB	  (group	  I)	  and	  σHrdA	  (group	  II)	  but	  
does	  not	   interact	  with	  sigma	  factors	  σHrdC,	  σHrdD	  (group	  II)	  σB,	  σWhiG	  (group	  III),	  σE	  or	  σR	  
(group	  IV).	   	  Similarly	   it	  was	  shown	  that	  M.	  tuberculosis	  RbpA	  binds	  σA	  (group	  I)	  and	  σB	  
(group	  II)	  but	  does	  not	  affect	  σF	  (group	  III)	  holoenzymes	  in	  vitro	  (Hu	  et	  al.,	  2012).	  	  Further	  
in	  vitro	  pull	  down	  assays	  and	  BACTH	  analysis	  on	  truncated	  fragments	  of	  S.	  coelicolor	  RbpA	  












domain	  of	  σHrdB.	  	  The	  same	  was	  also	  found	  with	  M.	  tuberculosis	  RbpA	  and	  σA,	  suggesting	  
that	  the	  σ2-­‐RbpA	  interaction	  was	  conserved	  across	  the	  actinobacteria.	  	  These	  data	  raise	  
the	  question	  of	  how	  RbpA	  distinguishes	  between	  different	  sigma	  factors,	  including	  the	  
closely-­‐related	  group	  II	  sigma	  factors	  in	  S.	  coelicolor.	  
6.5.1   Alignment	  of	  conserved	  regions	  1.2-­‐2.3	  in	  σ2-­‐domains	  of	  M.	  tuberculosis	  σA,	  
σB,	  and	  σF	  and	  S.	  coelicolor	  σHrdB,	  σHrdA	  and	  σHrdC	  
Through	  work	  completed	   in	  collaboration	  with	  Elizabeth	  Campbell	  and	  Seth	  Darst	  and	  
colleagues	  at	  The	  Rockefeller	  University,	  we	  have	  recently	  obtained	  a	  crystal	  structure	  of	  
the	  RbpA	  sigma	  interacting	  domain	  (RbpA-­‐SID)	  in	  complex	  with	  σ2	  of	  σA	  (Figure	  6.8A	  and	  
B).	  	  	  From	  this	  crystal	  structure,	  the	  σA	  residues	  that	  potentially	  contact	  RbpA	  could	  be	  
identified	  (Figure	  6.8B).	  	  To	  probe	  the	  sigma	  specificity	  of	  RbpA,	  the	  amino	  acid	  regions	  
of	  σ2	  included	  in	  the	  structure	  were	  aligned	  for	  the	  RbpA-­‐interacting	  M.	  tuberculosis	  σA	  
and	  σB,	  S.	  coelicolor	  σHrdB,	  σHrdA	  and	  non-­‐interacting	  M.	  tuberculosis	  σF	  and	  S.	  coelicolor	  
σHrdC.	   	   Although	   there	   is	   extensive	   conservation	   between	   M.	  tuberculosis	   σA	   and	  
S.	  coelicolor	   σHrdC	   among	  most	  of	   these	  RbpA	   interacting	   residues,	   there	  were	   several	  
positions	  in	  σHrdC	  that	  were	  substituted	  with	  physicochemically	  dissimilar	  amino	  acids	  that	  




Figure	  6.8	  -­‐	  The	  X-­‐ray	  crystal	  structure	  of	  the	  M.	  tuberculosis	  σA-­‐RbpA	  complex	  and	  prediction	  of	  interacting	  residues.	  	  	  
(A)	  	  Crystal	  structure	  of	  the	  M.	  tuberculosis	  σA2-­‐RbpA-­‐SID	  complex.	  	  Accessed	  from	  Protein	  Data	  Bank	  (PDB	  ID	  4X8K)	  
and	  visualised	  with	  PyMOL	   (version	  1.3).	   	  RbpA-­‐SID	   (residues	  77-­‐108)	   is	   shown	   in	  purple,	  σA2	   (residues	  242-­‐363)	   is	  
shown	  in	  teal.	  	  (B)	  Close	  up	  of	  M.	  tuberculosis	  σA2-­‐RbpA-­‐SID	  complex	  showing	  σ
A
2	  residues	  selected	  for	  mutagenesis	  
and	  their	  interacting	  residues	  on	  RbpA.	  	  (C)	  	  Amino	  acid	  multiple	  sequence	  alignment	  of	  conserved	  σ	  regions	  1.2-­‐2.3	  of	  
M.	  tuberculosis	  σA,	  σB	  and	  σF	  and	  S.	  coelicolor	  σHrdB,	  σHrdA	  and	  σHrdC.	  	  Alignment	  performed	  using	  CLUSTALW	  multiple	  
sequence	  alignment	  tool	  (version	  2.1).	  	  Box	  shading	  analysis	  was	  performed	  using	  BOXSHADE	  3.21.	  Identical	  residues	  
are	  shaded	  black,	  similar	  residues	  are	  shaded	  grey.	  	  σA	  residues	  that	  contact	  RbpA	  indicated	  with	  red	  dots	  and	  those	  
selected	  for	  mutagenesis	  outlined	  in	  black.	  
	   	  
A
SigA Mtb 226 DSVRAYLKQIGKVALLNAEEEVELAKRIEAGLYATQLMTELSERGEKLPAAQRRDMMWIC
SigB Mtb 25 DLVRVYLNGIGKTALLNAAGEVELAKRIEAGLYAEHLLETR----KRLGENRKRDLAAVV
SigF Mtb 1 --MTARAAG-GSASRANEYADVPEMFRELVGLPAG-------------SPEFQR------
HrdB Sco 212 DPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEDKLANS----DKLAPKLKRELEIIA
HrdA Sco 98 DLFRQYLREIGRIPLLSAAEEVDLARRVEAGLFAEEKLRCS----PGLDDRLALDLDRLV
HrdC Sco 37 DLLGQYLTQIGATPLLTAEDEVRLATRIEAGVRAREELETADTGEPAPTPRRRRTLEETV
SigA Mtb 287 RDGDRAKNHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFDYTKGYKFST
SigB Mtb 82 RDGEAARRHLLEANLRLVVSLAKRYTGRGMPLLDLIQEGNLGLIRAMEKFDYTKGFKFST
SigF Mtb 39 -----HRDKIVQRCLPLADHIARRFEGRGEPRDDLIQVARVGLVNAAVRFDVKTGSDFVS
HrdB Sco 269 EDGRRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFDYTKGYKFST
HrdA Sco 154 VLGRLAKRRLIEANLRLVVSVAKRYVGRGLTMLDLVQEGNLGLIRAVEKFDYARGYKFST



























Four	  of	  these	  residues	  not	  conserved	  between	  M.	  tuberculosis	  σA	  and	  S.	  coelicolor	  σHrdC	  
identified	  as	  possibly	  essential	  for	  σ-­‐selectivity	  of	  RbpA	  were:	  
•   σA	  E248/σHrdC	  R59	  
•   σA	  K251/σHrdC	  T62	  
•   σA	  L257/σHrdC	  V68	  
•   σA	  Y258/σHrdC	  R69	  
To	   test	   this,	   site-­‐specific	  mutagenesis	  was	  performed	  to	   introduce	   these	  substitutions	  
into	  σA	  and	  the	  ability	  of	  RbpA	  to	  bind	  and	  activate	  transcription	  was	  assessed.	  	  	  
6.5.2   Purification	  of	  σA	  and	  σA	  mutants	  
To	  overexpress	   and	  purify	  M.	   tuberculosis	   σA	   from	  E.	   coli,	   the	   sigA	  ORF	   (Rv2703)	  was	  
amplified	  from	  M.	  tuberculosis	  H37Rv	  genomic	  DNA	  by	  PCR	  using	  primers	  SigA_F/SigA_R,	  
designed	   to	   introduce	   an	   NdeI	   site	   overlapping	   the	   start	   codon	   and	   a	   BglII	   site	  
downstream	  from	  the	  stop	  codon	  respectively.	  	  The	  PCR	  product	  was	  cloned	  into	  EcoRV-­‐
cut	   pBlueScript	   SKII+,	   sequenced	   to	   confirm	   amplification	   with	   no	   mutations	   and	  
subcloned	  into	  pET15b	  as	  an	  NdeI/BglII	  fragment,	  producing	  the	  plasmid	  pET15b-­‐sigA.	  
To	   introduce	   the	  mutations	   into	   sigA,	   inverse	   PCR	   for	   site	   directed	  mutagenesis	   was	  
performed.	  	  Two	  mutant	  σA	  proteins	  were	  designed	  with	  L257V	  and	  Y258R	  mutations,	  
and	  E248R,	  K251T,	  L257V	  and	  Y258R	  mutations	  named	  σA(VR)	  and	  σA(RTVR),	  respectively.	  	  
Using	  pBlueScript-­‐sigA	  as	  a	  template,	  the	  primer	  sets	  SigA-­‐VRA_F/SigA-­‐VRA_R	  and	  SigA-­‐
double_F/SigA-­‐double_R	  created	  σA(VR)	  and	  σA(RTVR)	  mutants,	  respectively,	  and	  following	  
sequencing	  to	  confirm	  presence	  of	  the	  expected	  mutations,	  the	  σA	  mutant	  alleles	  were	  
subcloned	  into	  pET15b	  as	  NdeI/BglII	  fragments.	  	  	  
The	  recombinant	  plasmids	  pET15b-­‐sigA,	  pET15b-­‐sigA(VR)	  and	  pET15b-­‐sigA(RTVR)	  were	  used	  
to	  transform	  E.	  coli	  BL21	  (pLysS)	  and	  a	  single	  colony	  used	  to	  inoculate	  500	  mL	  LB.	  	  The	  
culture	  was	  grown	  in	  an	  orbital	  shaker	  at	  37	  °C	  to	  OD600	  0.5	  -­‐	  0.6,	  the	  flask	  was	  submerged	  
in	  ice-­‐water	  for	  10	  minutes	  before	  addition	  of	  1	  mM	  IPTG	  and	  returning	  the	  culture	  to	  
the	   orbital	   shaker	   for	   3	   hours	   at	   30	   °C.	   	   Cells	   were	   harvested	   by	   centrifugation,	  
resuspended	   in	  15	  mL	  binding	  buffer	  +	  1.5	  mL	  protease	   inhibitor	   cocktail	  +	  25	  ug/mL	  
PMSF	  and	  disrupted	  by	  sonication	  (6	  x	  10s	  @	  35%	  ampl.).	  	  The	  cleared	  cell	  lysate	  (CCL)	  
164	  
	  
was	  separated	  from	  the	  cell	  debris	  by	  centrifugation	  at	  12,000	  x	  g	  for	  15	  minutes	  at	  4	  °C.	  	  
To	   purify	   6His-­‐tagged	   σA,	   the	   CCL	   was	   loaded	   onto	   a	   Ni-­‐NTA	   sepharose	   column	   and	  
washed	  with	   10	   C.V.	   of	   10	  mM	   imidazole	  wash	   buffer	   followed	   by	   20	   C.V	   of	   25	  mM	  
imidazole	  wash	  buffer.	  	  	  
To	  cleave	  the	  6His-­‐tag	  and	  elute	  the	  untagged	  protein,	  the	  column	  was	  incubated	  with	  
10	  NIH	  units	  thrombin	  in	  4	  mL	  thrombin	  cleavage	  buffer	  for	  5	  hours	  at	  4	  °C.	   	  Samples	  
were	   analysed	   at	   this	   point	   by	   SDS-­‐PAGE	   (Figure	   6.9A).	   	   Following	   digestion,	  
approximately	   4	  mL	   of	   eluate	   was	   further	   purified	   by	   size-­‐exclusion	   chromatography	  
(HiLoad	  16/60Superdex	  200;	  GE	  Healthcare)	   (Figure	  6.9B).	   	   Elutions	  were	  collected	  as	  
0.5	  mL	   fractions,	   analysed	   by	   SDS-­‐PAGE	   (Figure	   6.9C)	   and	   those	   containing	   σA	   were	  
combined,	   concentrated	   to	   ~5	   µM	   by	   centrifugal	   filtration	   (VivaSpin	   6,	   3000	  MWCO,	  
Sartorius),	  analysed	  by	  SDS-­‐PAGE	   (Figure	  6.9D)	  and	   flash	   frozen	   in	   liquid	  nitrogen	  and	  





Figure	  6.9	  -­‐	  Purification	  of	  σA	  and	  σA	  mutants.	  	  (A)	  SDS-­‐PAGE	  analysis	  of	  σA	  Ni-­‐NTA	  purification.	  Lane	  1	  (M):	  SeeBlue	  
Plus2	  marker;	  lane	  2	  (U):	  uninduced	  culture;	  lane	  3	  (I):	  	  IPTG	  induced	  culture;	  lane	  4	  (FT):	  Ni-­‐NTA	  flowthrough;	  lane	  5	  
(W1):	  Ni-­‐NTA	  wash	  1;	  lane	  6	  (W2):	  Ni-­‐NTA	  wash	  2;	  lane	  7	  (E):	  thrombin-­‐cleavage	  elution.	  (B)	  Size	  exclusion	  purification	  
of	  σA.	   	  HiLoadTM	  16/60	  SuperdexTM	  200	  column	  elution	   trace	   for	  purification	  of	  σA	   (C)	  SDS-­‐PAGE	  analysis	  of	  σA	  size	  
exclusion	  purification.	   	   Lane	  1	   (M):	  SeeBlue	  Plus2	  marker;	   lane	  2	   (E):	   thrombin-­‐cleaved	  elution;	   lanes	  3-­‐6	   (D5)	   size	  
exclusion	  elution	  fractions	  D5-­‐D11.	  (D)	  SDS-­‐PAGE	  analysis	  of	  σA,	  σA(VR)	  and	  σA(RTVR)	  final	  purification	  products.	  Lane	  1	  
(M):	   SeeBlue	   Plus2	   marker;	   lane	   2	   (σA	   E):	   thrombin-­‐cleavage	   σA	   elution;	   lane	   3	   (σA	   final):	   σA	   final	   concentrated	  
purification	  product;	   lane	  5	   (σA(VR)	  E):	   thrombin-­‐cleavage	  σA(VR)	  elution;	   lane	  6	   (σA(VR)	   final):	  σA(VR)	   final	   concentrated	  
purification	   product;	   lane	   8	   (σA(RTVR)	   E):	   thrombin-­‐cleavage	   σA(RTVR)	   elution;	   lane	   9	   (σA(RTVR)	   final):	   σA(RTVR)	   final	  
concentrated	  purification	  product.	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6.5.3   σA(VR)	  and	  σA(RTVR)	  mutants	  are	  functional	  but	  unresponsive	  to	  RbpA	  
Multi-­‐round	   in	   vitro	   transcription	   reactions	   performed	   on	   the	   vapB10L	   promoter	  
template	   with	  M.	   bovis	   RNAP	   (50	   nM)	   (a	   gift	   from	   E.	   Campbell);	   σA	   (250	   nM),	   σA(VR)	  
(250	  nM)	  or	  σA(RTVR)	  (250	  nM)	  in	  the	  presence	  and	  absence	  of	  excess	  M.	  tuberculosis	  RbpA	  
(500	   nM)	   (a	   gift	   from	   A.	   Tabib-­‐Salazar).	   	   In	   the	   absence	   of	   RbpA,	   σA(VR)	   and	   σA(RTVR)	  
performed	  similarly	  to	  σA	  in	  directing	  transcription	  from	  the	  vapB10L	  promoter	  (Figure	  
6.10).	  	  However,	  unlike	  wild-­‐type	  σA	  which	  was	  activated	  up	  to	  3-­‐fold,	  neither	  σA(VR)	  nor	  
σA(RTVR)	  were	  affected	  by	  the	  addition	  of	  RbpA	  to	  the	  reaction	  mixture.	  	  This	  confirms	  that	  
the	  interaction	  between	  σ	  and	  RbpA	  is	  essential	  for	  the	  role	  of	  RbpA	  as	  a	  transcriptional	  
activator.	  
	  
Figure	  6.10	  -­‐	  σA(VR)	  and	  σA(RTVR)	  mutants	  are	  functional	  but	  unresponsive	  to	  RbpA.	   	  Multi-­‐round	  in	  vitro	  transcription	  
reactions	  performed	  on	  the	  vapB10L	  promoter	  template	  (5	  nM)	  with	  M.	  bovis	  RNAP	  (50	  nM);	  σA	  (250	  nM),	  σA(VR)	  (250	  
nM)	  or	  σA(RTVR)	  (250	  nM)	  in	  the	  presence	  and	  absence	  of	  excess	  RbpA	  (500	  nM).	  	  Data	  are	  presented	  as	  fold-­‐difference	  
relative	  to	  data	  obtained	  with	  σA	  in	  the	  absence	  of	  RbpA.	  	  Transcript	  levels	  were	  quantified	  by	  phosphorimaging	  from	  
triplicate	  data,	  and	  standard	  deviation	  is	  indicated.	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6.6   Discussion	  
6.6.1   CarD	  is	  present	  on	  alternative	  holoenzymes	  
Structural	  studies	  have	  shown	  that	  CarD	  binds	  to	  the	  β1	  lobe	  of	  the	  β	  subunit	  of	  RNAP	  
(Srivastava	  et	  al.,	  2013).	  	  Consistent	  with	  predictions	  based	  on	  the	  amino	  acid	  sequence,	  
the	  CarD	  RNAP	  interaction	  domain	  (RID)	  strongly	  resembles	  the	  TRCF-­‐RID	  in	  structure	  as	  
well	   as	   sequence.	   	   Therefore	   using	   a	   crystal	   structure	   of	   TRCF	   in	   complex	   with	   the	  
β1-­‐lobe,	  Srivastava	  et	  al.	  (2013)	  were	  able	  to	  model	  CarD	  onto	  the	  RNAP	  open	  complex	  
structure.	  	  Bound	  to	  the	  β1	  lobe,	  the	  model	  positioned	  CarD	  on	  the	  opposite	  face	  of	  RNAP	  
to	  the	  σ	  subunit.	  	  Based	  on	  this	  it	  seemed	  unlikely	  for	  CarD	  to	  interact	  with	  σ.	  	  	  
ChIP-­‐seq	   experiments	   performed	   under	   normal	   growth	   conditions	   in	  M.	   tuberculosis	  
showed	  that	  CarD	  distribution	  highly	  correlates	  with	  σA	  (Srivastava	  et	  al.,	  2013).	  	  Similar	  
experiments	  performed	  in	  S.	  coelicolor	  showed	  that	  CarD	  localised	  with	  σHrdB	  throughout	  
the	   genome	   under	   normal	   growth	   conditions.	   	   Under	   these	   conditions,	   it	   was	   only	  
possible	   to	   conclusively	   identify	   the	   presence	   of	   CarD	   and	   absence	   of	   σHrdB	   at	   one	  
alternative	   sigma	   promoter,	   σE-­‐dependent	   cwgA.	   	   During	   oxidative	   stress	   caused	   by	  
addition	  of	  diamide	  to	  cultures	  of	  S.	  coelicolor,	  expression	  of	  the	  σR	  regulon	  is	  induced.	  	  
As	  part	  of	  this	  response,	  ChIP-­‐seq	  experiments	  revealed	  that	  CarD	  co-­‐localises	  with	  RNAP	  
and	  σR	  at	  σR-­‐dependent	  promoters	  (Figure	  6.2).	  	  The	  absence	  of	  σHrdB	  at	  these	  loci	  reveals	  
that	  CarD	  must	  be	  bound	  to	  σR	  holoenzymes.	  	  This	  is	  the	  first	  time	  it	  has	  been	  reported	  
that	  CarD	  binding	  is	  not	  σ	  factor	  specific.	  	  
6.6.2   CarD	  does	  not	  activate	  transcription	  from	  σR-­‐dependent	  trxCp	  promoter	  
CarD	  activates	  transcription	  from	  σHrdB-­‐dependent	  promoters	  in	  vitro.	  	  The	  discovery	  that	  
CarD	   binding	   is	   not	   σ	   specific	   and	   is	   present	   on	   alternative	   holoenzymes	   raised	   the	  
possibility	   that	   CarD	   could	   also	   activate	   transcription	   from	   alternative	   promoters.	  	  
However,	  the	  addition	  of	  CarD	  at	  CarD:RNAP	  ratios	  of	  up	  to	  10:1	  has	  no	  effect	  on	  the	  σR-­‐
dependent	  trxC	  promoter	  in	  vitro.	  	  While	  the	  activity	  of	  CarD	  at	  other	  alternative	  sigma	  
factor	  dependent	  promoters	  has	  not	  been	  tested,	  it	  seems	  possible	  that	  CarD	  specifically	  
activates	  promoters	  dependent	  on	  the	  principal	  sigma	  factor.	  	  The	  reason	  for	  this	  is	  not	  




Following	  the	  structural	  elucidation	  of	  CarD	  and	  modelling	  onto	  the	  T.	  thermophilus	  RNAP	  
open	  complex	  structure,	   it	  was	  revealed	  that	  the	  CarD-­‐CTD	  was	  positioned	  to	   interact	  
directly	  with	  the	  promoter	  DNA	  just	  upstream	  of	  the	  -­‐10	  element	  (Srivastava	  et	  al.,	  2013).	  	  	  	  
Structural	   studies	  performed	  on	   the	  E.	   coli	   ECF	   sigma	   factor	  σE	   revealed	  a	  number	  of	  
differences	  in	  the	  mechanism	  of	  -­‐10	  element	  recognition	  and	  open	  complex	  formation	  
compared	  to	  housekeeping	  sigma	  factors	  (Campagne	  et	  al.,	  2014).	  	  Biochemical	  studies	  
showed	  that	  similar	  differences	  were	  observed	  in	  a	  number	  of	  other	  ECF	  sigma	  factors	  
included	  S.	  coelicolor	  σR.	  	  Notably,	  whilst	  two	  nucleotides	  are	  flipped	  from	  the	  base	  pair	  
stack	   at	   positions	   -­‐11	   and	   -­‐7	   in	   recognition	   of	   housekeeping	   sigma	   factors,	   a	   single	  
nucleotide	  at	  position	  -­‐10	  is	  flipped	  into	  a	  binding	  pocket	  on	  σ2	  of	  σE	  and	  other	  ECF	  sigma	  
factors	   (Feklistov	   and	   Darst,	   2011;	   Campagne	   et	   al.,	   2014).	   	   It	   is	   possible	   that	   such	  
differences	   in	   structural	   recognition	   and	   bubble	   formation	   in	   ECF	   sigma	   factors	   are	  
incompatible	   with	   the	   mechanism	   through	   which	   CarD	   activates	   transcription	   by	  
interacting	  with	  DNA	  upstream	  edge	  of	  the	  -­‐10	  element.	  
ECF	  sigma	  factors	  also	  differ	  in	  the	  absence	  of	  σ1.1	  and	  σ3.	  	  During	  initiation,	  σ1.1	  sits	  in	  the	  
the	   active-­‐site	   cleft	   downstream	  of	   the	   transcription	   start	   site	   and	  must	  be	  displaced	  
during	   open	   complex	   formation	   (Vuthoori	   et	   al.,	   2001).	   	   It	   is	   possible	   that	   CarD	   is	  
important	   in	  suitably	  stabilising	  promoters	  to	  allow	  displacement	  of	  σ1.1	  and	  therefore	  
has	  no	  effect	  on	  transcription	  from	  ECF	  sigma	  promoters.	  
6.6.3   Heterologous	  expression	  and	  purification	  of	  σA	  and	  σA	  mutants	  
This	   chapter	   demonstrated	   a	  method	   for	   heterologous	   expression	   and	   purification	   of	  
M.	  tuberculosis	  σA	  from	  E.	  coli	  without	  the	  presence	  of	  additional	  affinity	  tags.	  	  Following	  
Ni	   affinity,	   His-­‐tag	   cleavage,	   and	   size-­‐exclusion	   chromatography,	   wild-­‐type	   σA	   and	   σA	  
mutants	  were	  successfully	  purified.	   	  Purification	  profiles	  for	  σA,	  σA(VR)	  and	  σA(RTVR)	  were	  
similar	   indicating	   that	   presence	   of	   point	   mutants	   didn’t	   affect	   protein	   expression	   or	  
solubility.	  	  SDS-­‐PAGE	  analysis	  of	  all	  three	  proteins	  revealed	  the	  presence	  of	  a	  number	  of	  
smaller	  bands,	  potentially	  σA	  degradation	  products	  (Figure	  6.9).	  	  Whilst	  the	  presence	  of	  
these	  products	  could	  not	  be	  prevented	  or	  explained,	  they	  did	  not	  appear	  to	  affect	  σA,	  
σA(VR),	  or	  σA(RTVR)	  performance	  in	  vitro.	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6.6.4   Identification	  of	  residues	  involved	  in	  sigma	  selectivity	  of	  RbpA	  	  
It	   had	   previously	   been	   identified	   in	   BACTH	   experiments	   that	   RbpA	   interacts	   with	  
S.	  coelicolor	  σHrdB	  and	  σHrdA,	  and	  M.	  tuberculosis	  σA	  and	  σB	  (Tabib-­‐Salazar	  et	  al.,	  2013;	  Hu	  
et	   al.,	   2012).	   	   Additionally,	   these	   experiments	   identified	   a	   number	   σ	   factors	   in	   both	  
organisms	   that	   would	   not	   bind	   to	   RbpA.	   	   Multiple	   sequence	   alignment	   of	   these	  
interacting	   and	   non-­‐interacting	   proteins,	   in	   combination	   with	   predicted	   interacting	  
residues	  based	  on	  a	  structure	  of	  RbpA	   in	  complex	  with	  σA,	  revealed	  substitutions	  that	  
might	   determine	   RbpA	   sigma	   specificity.	   	   An	   ELAK/LYA	   motif,	   conserved	   throughout	  
RbpA-­‐binding	   σ	   factors	   but	   absent	   in	   σHrdC	   and	   σF	   was	   identified	   as	   a	   region	   for	  
site-­‐directed	  mutagenesis.	  	  In	  σHrdC,	  an	  RLAT/VRA	  motif	  is	  present	  at	  the	  corresponding	  
position.	  	  Substitution	  of	  VRA	  or	  RLAT/VRA	  motif	  into	  σA	  created	  the	  point	  mutants	  σA(VR)	  
and	  σA(RTVR).	  	  In	  vitro	  transcription	  experiments	  showed	  that	  while	  the	  σA	  point	  mutants	  
were	  still	  functional	   in	  directing	  transcription,	  addition	  of	  RbpA	  to	  the	  reaction	  had	  no	  
effect.	   	   Published	   BACTH	   experiments	   on	   σA,	   σA(RT),	   σA(VR)	   and	   σA(RTVR)	   showed	   similar	  
results,	   with	   only	   wild-­‐type	   σA	   showing	   interaction	   with	   RbpA	   (Hubin	   et	   al.,	   2015).	  	  
Together	  these	  results	  served	  as	  biochemical	  evidence	  to	  complement	  the	  structure	  of	  
RbpA	  in	  complex	  with	  σA.	  






Chapter	  7:	  	  
General	  discussion	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7   General	  discussion	  
7.1   Summary	  of	  findings	  
The	  aims	  of	  this	  study	  were	  to	  investigate	  global	  regulators	  of	  transcription	  initiation	  in	  
S.	  coelicolor.	   	  This	  study	  added	  to	  the	  body	  of	  knowledge	  about	   the	   function	  of	   three	  
RNAP-­‐binding	  proteins	  in	  S.	  coelicolor:	  DksA,	  CarD	  and	  RbpA.	  	  	  
DksA	  is	  a	  protein	  implicated	  in	  the	  function	  of	  ppGpp	  and	  the	  stringent	  response	  in	  E.	  coli.	  	  
Recently	  it	  has	  been	  proposed	  that	  the	  mechanism	  of	  action	  of	  ppGpp	  in	  a	  number	  of	  
organisms	  including	  B.	  subtilis	  differs	  from	  that	  in	  E.	  coli.	  	  In	  these	  organisms,	  instead	  of	  
directly	  binding	  RNAP,	  ppGpp	  regulates	  intracellular	  GTP	  concentration,	  the	  initiating	  NTP	  
at	  stringently	  regulated	  promoters	  (Kriel	  et	  al.,	  2012;	  Liu	  et	  al.,	  2015).	  	  Furthermore	  it	  was	  
proposed	   that	   this	   was	   consistent	   with	   the	   absence	   of	   a	   DksA	   homologue	   in	   such	  
organisms	  (Liu	  et	  al.,	  2015).	  	  The	  situation	  in	  S.	  coelicolor	  was	  unclear	  because	  although	  
S.	   coelicolor	   appears	   to	   lack	   a	   ppGpp	   binding	   site	   on	   RNAP,	   a	   DksA	   homologue	   was	  
identified.	  	  However,	  it	  was	  demonstrated	  here	  that	  deletion	  of	  dksA	  had	  no	  visible	  effect	  
on	   growth	   and	   antibiotic	   production,	   in	   contrast	   to	   the	   known	   effect	   of	   deleting	   the	  
ppGpp	  synthase	  relA.	  	  Nonetheless,	  overexpression	  of	  dksA	  induced	  the	  overproduction	  
of	   the	   blue-­‐pigmented	   antibiotic	   actinorhodin	   in	   a	   manner	   that	   appears	   to	   require	  
binding	  to	  the	  RNA	  polymerase	  secondary	  channel.	  	  These	  studies	  suggest	  a	  role	  for	  DksA	  
that	  does	  not	  involve	  ppGpp,	  although	  the	  mechanism	  for	  actinorhodin	  overproduction	  
and	  biological	  function	  of	  DksA	  in	  S.	  coelicolor	  remains	  unknown.	  
This	  study	  also	  initiated	  investigations	  into	  the	  function	  of	  CarD	  in	  S.	  coelicolor.	  	  CarD	  is	  
essential	  in	  M.	  smegmatis	  and	  M.	  tuberculosis	  (Stallings	  et	  al.,	  2009)	  and	  was	  shown	  here	  
to	  be	  essential	  for	  growth	  in	  S.	  coelicolor.	   	   In	  vitro	  transcription	  experiments	   indicated	  
that	   CarD	   activates	   housekeeping	   promoters	   dependent	   on	   σHrdB.	   	   CarD	   ChIP-­‐seq	  
experiments	  demonstrated	  that	  it	  is	  found	  exclusively	  at	  promoter	  regions.	  	  Interestingly,	  
despite	   CarD	   only	   activating	   transcription	   from	  σHrdB-­‐dependent	   promoters	   in	   vitro,	   it	  
associates	  with	   RNAP	   containing	   alternative	   sigma	   factors,	   indicating	   that	   it	   does	   not	  
display	  holoenzyme	  specificity.	  
This	   study	   also	   detailed	   ChIP-­‐seq	   experiments	   performed	   on	   RbpA,	   an	   RNAP	   binding	  
transcriptional	  activator	  exclusive	  to	  the	  Actinobacteria.	  	  RbpA	  binds	  specifically	  to	  σHrdB	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and	  co-­‐localised	  with	  σHrdB	  throughout	  the	  genome.	   	  Thus,	  σHrdB	  co-­‐localises	  with	  both	  
CarD	  and	  RbpA	   suggesting	   that	  all	   three	   factors	  are	  present	  at	   transcription	   initiation	  
complexes.	   	  Furthermore,	  structural	  modelling	  suggests	  that	  both	  proteins	  are	  able	  to	  
bind	  RNAP	  simultaneously,	  each	  interacting	  with	  DNA	  upstream	  of	  the	  -­‐10	  element.	  	  In	  
vitro	  transcription	  analysis	  of	  natural	  and	  synthetic	  promoters	  suggested	  that	  RbpA	  and	  
CarD	  can	  overcome	  the	  absence	  of	  a	  consensus	  -­‐35	  element,	  a	  common	  occurrence	  in	  
actinobacteria.	  	  Together,	  these	  data	  present	  a	  convincing	  model	  for	  an	  overlapping	  role	  
of	  CarD	  and	  RbpA	  in	  S.	  coelicolor.	  
7.2   General	  discussion	  
Historically,	   E.	   coli	   has	   served	   as	   the	   model	   organism	   for	   studying	   prokaryotic	  
transcription,	  owing	  to	  its	  amenability	  to	  genetic	  analysis,	  protein	  purification,	  and	  this	  
has	  recently	  been	  bolstered	  by	  recent	  crystal	  structures	  of	  RNAP	  transcription	  initiation	  
complexes.	  	  However,	  while	  transcription	  initiation	  is	  fundamentally	  conserved	  across	  all	  
bacteria,	   recent	   studies	   in	   a	   range	   of	   organisms	   are	   revealing	   key	   mechanistic	   and	  
regulatory	  differences.	  	  
Understanding	  transcription	  initiation	  in	  diverse	  bacterial	  species	  comes	  with	  far	  reaching	  
implications.	   	   For	   instance,	  mycobacterial	   RNAP	   is	   a	   key	   target	   for	   the	   first	   line	   drug	  
rifampicin.	  	  However,	  the	  emergence	  and	  spread	  of	  rifampicin	  resistance	  worldwide	  has	  
potentially	  dire	  consequences	  for	  human	  health.	  	  Further	  research	  into	  transcription	  in	  
actinobacteria	   will	   be	   necessary	   to	   fully	   exploit	   this	   proven	   anti-­‐mycobacterial	   target	  
through	  the	  discovery	  of	  novel	  compounds.	  	  Understanding	  of	  transcriptional	  regulation	  
in	  diverse	  bacterial	   species	   also	  has	   implications	  within	   the	   growing	   field	  of	   synthetic	  
biology.	  	  For	  example,	  to	  use	  an	  organism	  like	  S.	  coelicolor	  as	  a	  production	  chassis,	  or	  to	  
express	  S.	  coelicolor	  genes	  or	  systems	  heterologously	  will	  require	  full	  understanding	  of	  
gene	  transcription	  to	  ensure	  that	  a	  controlled,	  engineered	  approach	  can	  be	  taken.	  
A	  key	  finding	  in	  this	  study	  is	  that	  RbpA	  and	  CarD	  are	  present	  at	  all	  vegetative	  promoters	  
dependent	   on	   σHrdB.	   	   RbpA	   is	   confined	   to	   the	   actinobacteria,	   while	   CarD	   is	   more	  
widespread,	  present	  in	  diverse	  phyla	  such	  as	  Firmicutes	  and	  α-­‐proteobacteria	  but	  notably	  
absent	  from	  all	  γ-­‐proteobacterial	  species	  including	  E.	  coli.	  	  CarD	  has	  been	  shown	  as	  an	  
essential	  protein	  in	  both	  mycobacteria	  and	  S.	  coelicolor.	  	  It	  was	  previously	  thought	  that	  
173	  
	  
RbpA	  is	  not	  an	  essential	  protein	  although	  recent	  findings	  have	  shown	  that	  S.	  coelicolor	  
possesses	  a	  paralogue,	  RbpB,	  which	  shares	  a	  functional	  redundancy	  with	  RbpA	  (M.	  Paget,	  
personal	  communication).	  The	  basis	  for	  the	  essentiality	  of	  both	  CarD	  and	  RbpA	  remains	  
unknown.	  	  Whilst	  there	  appears	  to	  be	  striking	  similarities	  between	  the	  two	  proteins	  and	  
potentially	  an	  overlap	  in	  function,	  there	  is	  no	  genetic	  redundancy	  suggesting	  they	  have	  
specific	  essential	  roles.	  
Whilst	  it	  has	  been	  shown	  that	  both	  proteins	  activate	  transcription	  from	  σHrdB-­‐dependent	  
promoters	   in	   vitro,	   much	   is	   still	   unknown	   about	   both	   proteins	   in	   vivo.	   	   The	   cellular	  
stoichiometry	  of	  CarD,	  RbpA	  and	  σHrdB	  could	  be	  important	  to	  the	  role	  of	  both	  proteins.	  	  
Evidence	  suggests	  that	  RbpA	  is	  a	  major	  component	  of	  RNAP,	  following	  its	  discovery	  as	  a	  
major	  band	  in	  RNAP	  preparations	  (Paget	  et	  al.,	  2001a).	  	  One	  way	  the	  stoichiometry	  could	  
affect	  activity	  is	  whether	  both	  proteins	  are	  present	  on	  the	  same	  transcription	  complexes.	  	  
Modelling	  suggests	  that	  both	  proteins	  may	  be	  able	  to	  simultaneously	  bind	  RNAP	  although	  
this	  is	  something	  that	  would	  need	  to	  be	  confirmed	  by	  crosslinking/pulldown	  studies.	  	  It	  is	  
possible	  that	  different	  outputs	  on	  transcription	  could	  occur	  if	  one	  or	  both	  proteins	  are	  
present.	   	   In	   this	   study,	  an	  additive	  effect	  of	  both	  proteins	  was	  observed	  at	   saturating	  
concentrations.	  
Present	  on	  all	  at	  all	  housekeeping	  promoters	  and	  able	  to	  activate	  or	  potentially	  inhibit	  
transcription,	  CarD	  and	  RbpA	  are	  well	  placed	  to	  orchestrate	  major	  global	  transcriptional	  
changes.	   	   For	   example,	   for	   streptomycetes	   to	   enter	   stationary	   phase	   requires	   major	  
reprogramming	  of	  the	  transcriptome	  (Nieselt	  et	  al.,	  2010).	  	  The	  basis	  of	  this	  change	  is	  not	  
yet	  understood	  but	  it	  is	  possible	  that	  global	  transcription	  factors	  such	  as	  CarD	  and	  RbpA	  
could	  be	  involved	  in	  such	  widespread	  changes.	  	  This	  could	  either	  be	  for	  example	  through	  
regulation	   of	   CarD/RbpA	   levels	   or	   post-­‐translational	   modifications.	   	   Interestingly	  
differences	   have	   already	   been	   observed	   in	   how	   transcription	   of	   the	   two	   genes	   is	  
regulated.	  	  Diamide	  has	  been	  shown	  to	  have	  opposing	  effects	  on	  transcription	  of	  these	  
two	   proteins,	   repressing	   transcription	   of	   carD	   but	   activating	   transcription	   of	   RbpA	  
(Kallifidas	  et	  al.,	  2010).	  	  Post-­‐translational	  modification	  might	  involve	  acetylation	  which	  is	  
an	  emerging	  phenomenon	  in	  bacteria	  and	  occurs	  extensively	  in	  M.	  tuberculosis	  (Liu	  et	  al.,	  
2014).	  	  A	  potential	  target	  for	  acetylation	  of	  RbpA	  is	  the	  basic	  linker	  that	  contains	  three	  
lysine	   residues.	   	   Reversible	   acetylation	  of	   these	   lysine	   residues	  would	  be	  expected	   to	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influence	  the	  interaction	  between	  RbpA	  and	  the	  -­‐10	  upstream	  region,	  which	  might	  in	  turn	  
affect	  promoter	  activity	  at	  RbpA-­‐controlled	  promoters.	  	  Another	  unexplored	  mechanism	  
is	  the	  possibility	  that	  CarD	  and	  RbpA	  have	  unidentified	  binding	  partners	  that	  are	  able	  to	  
control	  their	  activity.	  
7.3   Future	  directions	  
One	  of	   the	  most	   striking	   results	   obtained	   in	   this	   study	  was	   in	   vitro	   transcription	  data	  
showing	   that	   CarD	   and	   RbpA	   are	   both	   able	   to	   inhibit	   transcription	   from	   specifically	  
designed	  promoters	  possessing	  a	  conserved	  -­‐35	  region.	  	  Through	  screening	  of	  additional	  
promoters	   by	   in	   vitro	   transcription,	   it	  may	   be	   possible	   to	   identify	   naturally	   occurring	  
promoters	   that	   are	   similarly	   affected	   by	   CarD	   or	   RbpA.	   	   Characterisation	   of	   these	  
promoters	  in	  vivo	  would	  give	  novel	  insights	  into	  the	  function	  of	  both	  proteins.	  	  	  
As	   an	   essential	   gene,	   performing	   in	   vivo	   studies	   on	   the	   function	   of	   CarD	   presents	   a	  
number	  of	  difficulties,	  primarily	  the	  inability	  to	  obtain	  and	  characterise	  a	  stable	  deletion	  
mutant.	   	  As	  an	  alternative	  approach,	   this	   study	  has	   succeeded	   in	  creating	   two	  strains	  
suitable	   for	   depletion	   of	   CarD.	   	   To	   further	   understand	   the	   importance	   of	   CarD	   in	  
regulation	  of	  transcription,	  it	  would	  be	  of	  interest	  to	  perform	  transcriptomic	  analysis	  on	  
strains	  depleted	  of	  CarD.	  	  Whilst	  ChIP-­‐seq	  experiments	  have	  identified	  CarD	  is	  present	  at	  
all	  promoters	  in	  vivo,	  comparisons	  in	  gene	  expression	  between	  a	  wild-­‐type	  strain	  and	  one	  
depleted	   of	   CarD	   may	   identify	   differences	   in	   role	   of	   CarD	   at	   individual	   promoters.	  	  
Additionally,	  this	  study	  has	  demonstrated	  the	  power	  of	  studying	  distribution	  of	  RNAP	  by	  
ChIP-­‐seq.	  	  It	  might	  therefore	  be	  advantageous	  to	  perform	  such	  “RNA	  polymerase-­‐omics”	  
experiments	  over	  transcriptomic	  techniques	  such	  as	  RNA-­‐seq.	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